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Introduction Pulmonary embolism (PE) is a relatively common 
cardiovascular condition, occasionally and tragically manifesting as 
sudden cardiac arrest (SCA). The natural history of SCA complicating 
PE has been poorly evaluated. Guidelines suggest the consideration of 
thrombolytic therapy when PE-related SCA is suspected, despite the 
absence of evidence. In this study, we described the characteristics 
and management of PE-related SCA in a large regional registry.
Patients and methods In this prospective population-based study, 
we included all patients admitted at hospital alive after out-of-hospital 
SCA, in Paris and suburbs, France (6.6 million inhabits), from May 2011 
to September 2015. Regarding PE, we collected risk factors, clinical 
decision rules (Wells rule and Geneva score) and diagnostic strategy.
Results Of 2926 patients hospitalized after SCA, 82 cases were diag-
nosed as PE-related SCA (2.8%, 95% CI 2.2–3.4). Independent factors 
associated with SCA due to PE were non-shockable initial rhythm (OR 
12.4, 95% CI 4.9–31.0, P < 0.001), past history of thromboembolism (OR 
10.4, 95% CI 5.6–19.4, P < 0.001), absence of known heart disease (OR 
3.8, 95% CI 2.0–7.3, P < 0.001) and female sex (OR 1.9, 95% CI 1.2–3.0, 
P  =  0.008). Considering non-shockable initial rhythm and previous 
thromboembolism as major predictors of PE, combination of those 
factors had a specificity for detection of PE-related SCA of 98% and a 
sensitivity of 23%, with a positive predictive value of 31% and a nega-
tive predictive value of 98% (Fig. 1).
Systemic thrombolysis was performed in 47 patients (57%). After 
adjustment, PE was associated with survival at discharge (OR 2.4, 95% 
CI 1.2–4.7, P  =  0.001), compared with non-PE SCA. Finally, among 
patients hospitalized for PE-related SCA, only thrombolysis (OR 12.5, 
95% CI 1.8–89.1, P = 0.01) and delay from CPR to ROSC < 20 min (OR 
6.8, 95% CI 1.3–35.2, P  =  0.02) were independently associated with 
survival to hospital discharge.
Conclusion In this population-based study, PE was not an unusual 
cause of SCA, and was associated with better survival, challenging 
the traditional view. Thrombolysis was associated with an increased 
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Introduction Donation after circulatory death corresponds to the cat-
egory III of the Maastricht classification (DCDM III) and may provide 
mostly kidney and liver transplants with good long-term function. 
Patients suffering from irreversible brain damages after cardiac arrest 
are commonly considered candidates for DCDMIII, but little is known 
regarding the proportion of these patients who could be eligible for 
this procedure. Using a cohort of post-cardiac arrest patients, our aim 
was to assess the rate of contra-indications for DCDMIII and to meas-
ure the delay between withdrawal of life sustaining treatments (LSTW) 
and the appearance of low values for common physiological param-
eters during the agonal phase, which may compromise the process by 
altering graft function.
Patients and methods Using the Cochin registry (Paris, France), we 
conducted a retrospective single-centre study from January 2007 
to December 2014. We included all patients who died in ICU after 
LSTW decision because of post-anoxic brain damages. For each 
patient, we collected exclusion criteria for DCDMIII and the length 
of time between LSTW implementation and death. We also col-
lected hemodynamic and respiratory parameters during the agonal 
phase.
Results We included 404 patients in the study, of whom 275 (68%) had 
at least one exclusion criteria for a DCDMIII process, mostly because 
of age >65 (190 patients). Other exclusion criteria were: multiple 
organ failure (n = 88), neoplastic diseases (n = 55, including 46 solid 
tumours), brain-dead state that occurred after LSTW decision (n = 18), 
unknown cause of the initial cardiac arrest (n = 13), chronic viral dis-
eases (n = 13), uncontrolled sepsis (n = 4), occurrence of a new refrac-
tory cardiac arrest (n = 2), and judicial problems (n = 3).
The 130 potentially eligible patients for DCDMIII included 94 men 
(72%) with a mean age of 51 years (±7.7). At time of death after LSTW, 
the mean length of stay in ICU was 11.6 days (±6). The most common 
aetiology of cardiac arrest was acute myocardial ischemia (n  =  59, 
45%). LSTW consisted in terminal weaning of mechanical ventilation 
in 71 patients (55%), extubation in 12 patients (9%) and infusion of 
vasopressors was stopped in 3 patients (2%).
The average duration of the agonal phase (time between LSTW 
implementation and death) was 746 min (min) (±162) and this delay 
was >180  min in 92 patients (71%). After LSTW implementation, an 
oxygen transcutaneous saturation (SpO2) <70% occurred in 637  min 
(±545), a mean arterial pressure (MAP) <60 mmHg in 723 min (±586) 
and a systolic arterial pressure (SAP) <50  mmHg in 733  min (±596). 
The delay between SpO2 < 70% and death was 154 min (±262), and 
this delay was 59 min (±160) after MAP < 60 mmHg and 23 min (±134) 
after SAP < 50 mmHg.
Conclusion In this large cohort of brain damaged patients with 
LSTW decision, we observed that a high proportion of patients would 
not have been eligible for a DCDMIIII process. Even in those without 
contra-indication, the delay between LSTW implementation and 
the final circulatory arrest was not compatible with French national 
guidelines. Low values for arterial pressure and oxygenation persisted 
during a substantial part of time before final circulatory arrest. This 
information may help in refining the management of the DCDMIII 
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Introduction Predicting the neurological outcome of patients admit-
ted to the ICU after a cardiac arrest successfully resuscitated remains 
difficult [1]. The bispectral index (BIS) allows for the rapid and stand-
ardised assessment of the cortical function based upon eletroenceph-
alogram analysis whereas the ratio of suppression (RS) is indicative of 
the absence of electrical activity of the brain. We aimed to evaluate the 
prognostic value of the BIS and the RS for predicting neurologic out-
come after cardiac arrest.
Patients and methods This was a prospective, single center, 
observational study performed in a large regional University 
hospital. Adult patients admitted to the ICU for cardiac arrest 
between March 2012 and October 2014 were included in the study. 
The exclusion criteria was pregnancy. The BIS and the RS were 
collected as soon as possible after ICU admission. The patients 
were not included in the analysis if they died within 24  h, if they 
had a low signal quality [defined as high EMG artefacts (≥30 dB)], 
or if the monitoring of BIS started 24  h after ICU admission. The 
neurological outcome of the patients was based upon the cerebral 
performans category (CPC) calculated at 3 months. CPC score of 1 
or 2 indicated good outcome, whereas CPC score of 3–5 indicated 
poor outcome.
Results During the study period 148 patients were admitted to 
our ICU for a cardiac arrest. The BIS and RS were monitored in 
103 patients.17 patients were excluded (early death ≤24  h; low 
quality of signal; BIS and RS performed ≥24  h after ICU admission). 
Thus, 86 patients were enrolled in this study. The means age was 
57.6 ±  16.8  years, 61 patients (70.9%) were male, the cardiac arrest 
was out-of-hospital in 63 patients (73.3%), hypoxia was the main 
cause of cardiac arrest (43%), 60 patients (70.6%) were treated with 
therapeutic hypothermia. At 3  month of follow-up, a total of 50 
patients (58.1%) had died and 55 patients (63.9%) were classified 
as having a poor outcome. The mean duration from the return of 
spontaneous circulation (ROSC) to the BIS and RS measurements 
was 5.7  ±  3.0  h. The BIS values were significantly lower in patient 
with poor outcome compared with patients with a good outcome 
(5.9 ± 11.1 vs 37.1 ± 18.0, p < 0.0001). The RS values were significantly 
higher in patient with poor outcome group compared to those with 
good neurological outcome (85.9 ± 26.3 vs 18.4 ± 31.3, p < 0.0001). 
The BIS predicted poor outcome with a likelihood ratio of 23.8 and 
an area under the curve (AUC) of 0.918 [95% CI (0.839–0.966)]. The 
optimal sensitivity [78.4%, 95% CI (67.3–89.5)] and specificity [96.5%, 
95% CI (89.8–100)] for neurological outcome prediction was obtained 
using a cut-off value of BIS < 5. The RS predicted poor outcome with a 
likehood ratio of 23.8 and an AUC of 0.936 [95% CI (0.862–0.977)]. The 
optimal sensitivity [78.0%, 95% CI (66.9–89.0)] and specificity [96.8%, 
95% CI (90.8–100)] for neurological outcome prediction was obtained 
using a cut-off value of RS  >  84. In multivariable logistic regression 
model, BIS or RS predicted poor outcome with an odds ratio of 65.0 
[95% CI (6.1–689.2), p = 0.0005].
Discussion The results of this study using the EEG derived parameters 
BIS and RS confirm previous findings showing that they are linked 
to the neurological outcome of patients admitted to the ICU after a 
cardiac arrest [2]. In particular, a BIS < 5 and/or a RS > 84, measured at 
ICU admission, were both strongly associated with a poor neurological 
outcome at 3-months.
Conclusion BIS values may be used to predict long term neurological 
outcome of patients following cardiopulmonary resuscitation. The 
ability to accurately predict early non-recovery after cardiac arrest 
could facilitate discussions with families and limit use of ICU resources 
in futile cases. BIS and RS values measured at ICU admission might be 
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Introduction Cardiac arrest represents one of the greatest medical 
challenges because of its terrible mortality, morbidity and cost. 
International guidelines for cardiopulmonary resuscitation led to 
survival and prognosis improvement, based on the Chain of Survival 
and the Advanced Life Support, including Targeted Temperature 
management (TTM) [1]. Although routinely used, guidelines do 
not provide detailed management of patients with TTM, especially 
how to adapt associated therapies such as sedation or nutrition. 
Guidelines encourage early nutrition for intensive care patients, within 
24–48  h after admission [2]. Nevertheless, after cardiac arrest, early 
nutrition (EN) is disputed. Common post-cardiac arrest syndrome with 
circulatory failure, frequent diarrheic collapse; and supposed lower 
digestive tolerance in hypothermia do not encourage this practice.
This study first aims to determine if EN is associated with better 
neurological outcome for patient under TTM. Secondly, we evaluate 
nutritional tolerance in hypothermia.
Patients and methods We retrospectively included patients under 
TTM after cardiac arrest in a single mixed intensive care unit from 
January 2008 to December 2014. Patients fed within 48  h after 
admission (EN; enteral or parenteral) were compared to those fed after 
48 h or not fed [delayed nutrition (DN); after rewarming] concerning 
neurological and infectious outcomes. Enteral nutrition was initiated 
at maximal caloric objective define at 20 kCal/kg/day until day 7, with 
isocaloric product. Incidence of vomiting and use of prokinetic drugs 
were recorded for enteral nutrition tolerance comparison between 
<36 and ≥36 °C feeding.
Results Among 203 patients under TTM at 33  °C after cardiac arrest, 
142 were early fed. EN was associated with better neurological out-
come assessed by Cerebral Performance Category (CPC) at 3  month 
(42.3 vs 18%; p = 0.001). After propensity adjustment, EN was still pro-
tective for good neurological outcome at 3 month (OR 3.1 [1.36–7.05]; 
p = 0.01). Comparison between EN and DN showed no difference for 
early-onset pneumonia (p  =  0.4); ventilator-associated pneumonia 
(VAP) (p  =  0.07), nosocomial urinary tract infection (p  =  0.35), and 
nosocomial bacteraemia (p  =  0.3). Considering death as compet-
ing-risk, VAP were not more frequent with EN (HR 1.07 [0.68–1.69], 
p = 0.76, Fig. 2). Prokinetic use and vomiting were not increased when 
nutrition was instituted at temperature <36 °C as compared as ≥36 °C 
(respectively, 27.2% at 36 °C vs 27.3%, p = 0.99; 34 vs 33%, p = 0.87).
Conclusion EN is associated with better neurological outcome 
during targeted temperature management. EN is not associated with 
more adverse event (infectious and poor nutrition tolerance) when 
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Introduction Cardiac arrest in children has a very poor prognosis. 
Knowledge of its epidemiological characteristics is necessary to 
improve the patient care and survival. The French National Cardiac 
Arrest registry (RéAC), created in 2009, combines all epidemiological 
data on out-of-hospital cardiac arrests (OHCA). The objective of 
this study was to describe the epidemiological characteristics and 
outcomes of OHCA in children under 18 years old.
Materials and methods All patients under 18  years old victims of 
out-of-hospital cardiac arrest and registered in the French National 
Cardiac Arrest registry between July 2011 and September 2015 were 
included. Patients were divided into four groups: infants (under 
1  year old), toddlers (1–4  years old), children (5–12  years old) and 
adolescents (13–17  years old). Variables related to anamnesis, basic 
cardiopulmonary resuscitation, specialized CPR and outcome of 
patients were collected.
Results Out of 42,960 registered cardiac arrest, 900 (2%) involved 
children under 18 years of age. Out of the 900 patients enrolled, 393 
(44%) were less than 1 year old. The OHCA occurred mainly at home 
(67%). The percentage of traumatic cardiac arrest increased with age, 
reaching up to 49% in adolescents. Respiratory failure was the leading 
cause of cardiac arrest in toddlers and children (respectively 40 and 
31%). Adolescents were more likely to have an initial shockable rhythm 
(8%) than other groups (p < 10−3). The intraosseous access was used 
in 33% of the children. Overall survival at 1 month was 8.3% (75/900) 
and 66.7% (50/75) of these patients had a favorable neurological 
prognosis. Outcomes description per age is described in Table 1.
Conclusion There were significant differences between the patient’s 
groups regarding the location, type of cardiac arrest, initial rate, and 
survival. An age group approach could be considered to improve care 
strategy and survival of cardiac arrest victims.
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Introduction Avoiding the use of iodinated contrast media (CM) is 
frequent, fearing it may contribute to AKI. The aim of this systematic 
review and meta-analysis was to quantify the risk of AKI attributable to 
CM in ICU patients.
Materials and methods A systematic review until December 
31st 2015, through 5 databases, searched for studies evaluating 
intravascular administration of iodinated CM. Only controlled studies 
evaluating AKI following CM exposure in ICU patients matched to 
unexposed patients were included in the meta-analysis. Meta-analysis 
was performed on patient-level data using a hierarchical Bayesian 
nested mixed effects multiple logistic regression model. Bayesian 
methodology allows evaluating how evidence-based physicians 
would assess the AKI risk attributable to CM according to both their a 
priori belief and the presentation of the controlled studies identified 
in the systematic review. Two meta-analyses were performed with 
different a priori hypotheses. An objective meta-analysis modeled 
a neutral state of a priori belief (Odds Ratio [OR] of 1 with impartial 
distribution) yielding a posteriori OR distribution representative 
of data collected in controlled studies. A subjective meta-analysis 
modeled the common belief that CM increases the AKI risk, using 
an a priori OR of 1.37 based on uncontrolled studies holding clinical 
community consensus. We determined the minimum a priori relative 
effective sample size (RESS, representing the a priori strength of belief ) 
needed to observe a significant a posteriori OR distribution: how much 
physicians have to be convinced a priori that CM increases AKI risk to 
maintain this belief after being confronted with the studies data.
Results Among 5696 references, 10 compared ICU patients receiving 
CM with an unexposed group and 4 performed risk adjustments for 
baseline AKI risk. Three studies used patient matching: overall, 280 
CM patients were matched with 280 control patients. The resulting 
a posteriori OR did not reach statistical significance: with no prior 
assumption, there is no evidence that CM increases the risk of AKI in 
the ICU.
Using an a priori OR of 1.37 (subjective meta-analysis), the a posteriori 
distribution of the OR did not reach statistical significance except 
when modelling a very high a priori belief that CM causes AKI 
(minimum a priori RESS 4.8-folds higher than the RESS of the objective 
meta-analysis and 70-folds higher than a neutral objective a priori 
hypothesis).
Conclusion This systematic review and meta-analysis did not 
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Introduction Acute kidney injury (AKI) is associated with significant 
morbidity and mortality, particularly in intensive care unit (ICU) 
patients. In stable patients, glomerular filtration rate (GFR), the best 
overall index of kidney function, can be estimated measuring the 
plasma clearance of an exogenous tracer such as iohexol [1]. There 
is no reliable method to assess GFR in unstable patients, as classical 
methods such as MDRD (modifications of diet in renal disease) and 
urinary clearance calculations have shown their limits [2]. The aim 
of this study was to determine GFR using iohexol plasma clearance 
(Cliox) at the initial phase of acute circulatory failure and to evaluate its 
association with subsequent development of AKI.
Patients and methods Multicentric study in 3 French ICUs. Patients 
suffering from acute circulatory failure were included within 12  h of 
ICU admission and administered intravenously a non-toxic dose of 
iohexol (5 mL; 300 mg/mL) followed by collection of 9 blood samples 
for iohexol plasma concentration determination (5 and 30  min, 1, 
3, 6, 9, 12, 18 and 24  h). Iohexol concentrations were determined 
using high performance liquid phase chromatography and a three-
compartment population pharmacokinetic model was implemented 
to calculate individual iohexol clearances.
Results 100 patients were included. Median age was 65 years (Q1: 55; 
Q3: 77), baseline MDRD 93  mL/min (73; 116) and SAPS II 59 (45; 75). 
Most patients were admitted for septic shock. We could calculate 
Cliox in 85 patients (85%). Failures to calculate Cliox included 
iodinate contrast media injection outside of the study and early renal 
replacement therapy. Median Cliox was 38 mL/min (19–58).
76 patients (76%) developed AKI according to the kidney disease, 
improving global outcome classification (KDIGO): 15 KDIGO 1, 30 
KDIGO 2, 31 KDIGO 3. In 59 patients out of 92 for whom enough serum 
creatinine dosages were available (64%), serum creatinine decreased 
in the first 24  h of ICU stay, including 44 patients among the the 76 
developing AKI (58%). Cliox was inversely related to the severity of 
AKI: median Cliox for KDIGO 0 patients was 68 mL/min (44; 77), 40 mL/
min (30; 58) for KDIGO 1 patients, 36  mL/min (24; 52) for KDIGO 2 
patients and 16  mL/min (9; 22) for KDIGO 3 patients. In 40 out of 82 
patients (49%) the difference between MDRD (calculated from serum 
creatinine at the time of inclusion) and Cliox exceeded 20 mL/min, and 
in most cases (90%) MDRD overestimated estimated GFR (eGFR). For 
Table 1 Outcome description of patients














68 (17) 52 (36) 43 (30) 85 (39) <10−3
Survival at 
day 30
13 (3) 20 (14) 13 (9) 29 (13) <10−3
CPC 1 or 2 at 
day 30
12 (3) 13 (9) 3 (2) 22 (10) <10−3
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AKI patients, eGFR according to MDRD was >60 mL/min in 18 patients. 
According to MDRD, 8 patients had glomerular hyperfiltration 
defined by an eGFR > 130 mL/min. Only 4 patients had hyperfiltration 
according to Cliox. For the 2 patients with eGFR  >  130  mL/min with 
both methods, one suffered denutrition; his Cliox was 138  mL/min, 
while MDRD was 281  mL/min. For the 6 patients with hyperfiltration 
according to MDRD and not Cliox, 4 had denutrition, 1 had a very 
low baseline serum creatinine (18  μmol/L), and one suffered morbid 
obesity. Four patients with eGFR  >  130  mL/min according to MDRD 
had a maximum KDIGO score of 2.
Discussion Our study confirms that variations of serum creatinine 
are not a good marker of GFR. We hypothesize this to be related to 
the large amount of fluid infusion at the acute phase following ICU 
admission and the influence of nutritional factors. The MDRD formula 
tended to overestimate eGFR. Cliox may enable to overcome the limits 
of the MDRD formula at the acute phase of critical illness, as it seems 
not to be influenced by nutritional factors or fluid infusion, unlike 
creatinine variations.
Conclusion The close link between Cliox and AKI is very encouraging 
for the development of this method of eGFR assessment in critically 
ill patients. Cliox could be used for early determination of AKI risk and 
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Introduction Acute kidney injury is particularly common in septic-
shock patients and is associated with high mortality. The putative 
effect of renal replacement therapy (RRT) on the prognosis of such 
patients is highly debated; some advocating that outcome might 
improve owing to modulation of inflammation. We aimed to compare 
outcomes of septic-shock patients with severe acute kidney injury 
(stage 3 of KDIGO classification) treated with an early RRT strategy (all 
patients immediately received RRT) with those treated with a delayed 
RRT strategy (patients received late RRT or no RRT at all).
Patients and methods We did a post hoc subgroup analysis in a 
subset of septic-shock patients with severe acute kidney injury (stage 
3 of KDIGO classification) from a multicenter randomized controlled 
trial. In the trial, patients from 31 intensive care were randomly 
assigned (1:1) to either an early or a delayed RRT initiation strategy. 
With the early strategy, RRT was initiated within 6  h after inclusion 
criteria were met. With the delayed strategy, RRT was started if at least 
one of the following criteria was met: severe hyperkalemia, metabolic 
acidosis, pulmonary edema, serum urea concentration greater than 
40  mmol/l, or oliguria for more than 72  h after randomization. The 
primary outcome was overall survival at day 60.
Results Of the 413 septic-shock patients (on a total of 620 patients), 
209 were managed with early strategy and 204 with delayed strat-
egy. The Kaplan–Meier estimates of mortality at day 60 did not differ 
significantly between the early and delayed strategies; 101 deaths 
occurred among 209 patients in the early-strategy group (48.5%; 95% 
confidence interval [CI] 41.3–54.9), and 99 deaths occurred among 
204 patients in the delayed-strategy group (48.5%, 95% CI 41.2–55.0; 
P = 0.97) (Fig. 3). A total of 97 patients (47.5%) in the delayed-strategy 
group did not receive renal-replacement therapy. The number of days 
RRT-free days was significantly higher in the delayed strategy group 
(21 [5–29] vs 17 [2–25], p  <  0.001). Median length of stay in hospital 
did not differ significantly between groups (20 [8–39] vs 19 [7–40] 
days, p = 0.9).
Conclusion The timing of RRT in septic-shock patients with severe 
acute kidney injury did not significantly influence mortality. However, 
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Introduction There is growing evidence that fluid accumulation 
beyond the correction of hypovolaemia is associated with increased 
morbidity, mortality and a longer hospital stay. We recently published 
a prospective cohort observational study “The Dose Response 
Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically 
ill patients” aimed to investigate the impact of fluid balance and fluid 
accumulation on mortality for both AKI and (Non) N-AKI patiens as for 
those who receive renal replacement therapy (AKI-RRT).
Aim of the present is to assess the fluid administration of the French 
subgroup of patients.
Patients and methods We analysed 209 (12.05%) of the 1734 enrolled 
patients, from the 2 French ICUs. Fluid overload (FO) was defined 
as the ratio between cumulative fluid balance and the initial body 
weight, in percentage. Maximum fluid overload (MFO) referred to the 
peak value of FO during the entire ICU stay. TMFO represented the 
number of days between. ICU admission and day of MFO. Velocity of 
fluid accumulation was defined by Fluid overload slope (FOSL) as the 
MFO/TMFO ratio. A boxplots for the three groups (N-AKI, AKI and AKI-
RRT) illustrated the MFO for both survivors and non-survivors during 
the ICU stay. A Kaplan–Meier analysis was performed to evaluate 
the time to death for the three groups (N-AKI, AKI and AKI-RRT). The 
time to death was evaluated by a Cox proportional hazard regression 
analysis.
Results 53% of patients had AKI (38% stage 1, 20% Stage 2, 42% 
Stage3). The Kaplan–Meier analysis including the first 28  days of 
ICU, highlighted a significant survival benefit for patients without 
AKI, in particular for longer ICU stay. The AKI and AKI-RRT group 
had, conversely form the entire study population, similar survival 
rates. In all cohorts as in N-AKI, AKI and AKI-RRT non-survivors had a 
higher MFO than survivors. Again, the AKI-RRT and AKI groups had 
similar levels of MFO, with a lower over-hydration for the RRT group. 
Cox regression analysis of the velocity of fluid accumulation showed 
that for every increase of one unit of the FOSL, the hazard of death 
increased significantly by a factor of 1.44. The hazard ratio decreased 
to 1.41 when adjusting for SAPS II score.
Discussion The fluid assessment in critically ill patients enrolled on the 
French ICUs confirm the findings of the Doremifa study. Fluid overload 
is strongly correlated with mortality at any degree. A lower degree of 
fluid overload for the AKI-RRT group, when compared with the AKI 
population, and a similar survival curve between the 2 groups, may 
suggest that CRRT has a protective effect. More analysis are needed to 
confirm this hypothesis, an early initiation of the treatment have to be 
also investigated.
Conclusion The velocity of fluid accumulation, as in the findings of the 
main study, contribute to worse patients outcome.
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Introduction Doppler-based renal resistive index (RI) measurement 
may hold promise in differentiating transient from persistent AKI in 
selected critically ill patients. Although several studies have suggested 
adequate performance in predicting short-term reversibility of AKI, 
most of these studies were performed in limited patient samples [1]. 
Additionally, a recent study has identified discrepant results regarding 
its diagnostic performance [2] suggesting confirmatory studies to be 
required.
The main objective of this study was to assess diagnostic performance 
of RI in predicting persistent AKI in critically ill patients. Secondary 
objectives were to assess diagnostic performance of semi-quantitative 
assessment of renal perfusion (SQP) using color-Doppler in predicting 
persistent AKI and performance of both tests in predicting needs for 
renal replacement therapy (RRT).
Patients and methods Prospective multicenter study performed in 
eight ICUs from December 2013 to April 2016. This study was declared 
to Clinicaltrial.gov.
Adult patients requiring mechanical ventilation were included in 
this study. Patients with mild to severe chronic kidney diseases, 
arrhythmia, or obstructive renal dysfunction were excluded from this 
study. Patients with hospital stay shorter than 72 h and in whom renal 
reversibility could not be assessed were secondarily excluded.
Acute kidney injury (AKI) was defined according to the KDIGO 
definition.
Transient AKI was defined as AKI with recovery within the first 3 days 
following inclusion.
Intra-renal RI was calculated as (peak systolic velocity − end-diastolic 
velocity)/peak systolic velocity.
SQP was assessed using a scale ranging from 0 (absence of renal 
perfusion) to 3 (renal vessels identifiable until the arcuate arteries in 
the entire field of view).
Results are reported as number (%), median (IQR) and area under 
curve (95% CI).
Results Overall, 371 patients were included. Median age was 76 years 
(66–89) and 236 patients were of male gender (63.6%). Most of the 
patients were admitted with medical conditions (n  =  253; 68.2%) 
and 162 patients (43.7%) had sepsis at ICU admission. Median LOD 
score was of 8 (5–11) at study inclusion and 198 patients required 
vasopressors (53.4%).
Of the included patients, 253 (68.2%) had an AKI at study inclusion, 
including 158 patients (42.6%), 35 (9.4%) and 60 (16.2%) with AKI 
stage 1, 2 and 3 respectively. Doppler-based RI was obtained in 365 
patients (98.4%), semi-quantitative assessment of renal perfusion in 
367 (98.9%). Patients with AKI had a higher RI at ICU admission [0.70 
(0.62–0.77) vs. 0.65 (0.59–0.70); P = 0.0001] and a lower SQP [2(1–3) vs. 
2 (2–3); P = 0.0003].
Twenty patients were discharged before day 3 leaving 351 patients in 
the final analysis, including 118 (33.6%), 97 (27.6%) and 136 patients 
(38.7%) no AKI, transient AKI or persistent AKI respectively.
Resistive index at inclusion was of respectively 0.65 (0.59–0.70), 0.69 
(0.62–0.77) and 0.71 (0.62–0.77) in patients without AKI, with transient 
AKI and with persistent AKI (P  =  0.0005). Resistive index failed to 
demonstrate any interest in predicting persistent AKI (Area under ROC 
curve: 0.58; 95% CI 0.52–0.64).
Semi-quantitative assessment of renal perfusion was of respectively 2 
(2–3), 2 (2–3), and 2 (1–3) in patients without AKI, with transient AKI 
and with persistent AKI (P  =  0.002)]. Semi-quantitative assessment 
of renal perfusion failed to demonstrate any interest in predicting 
persistent AKI (Area under ROC curve: 0.59; 95% CI 0.52–0.65).
Overall, 46 patients (12.4%) required RRT during ICU stay. In these 
patients, RI and SQP were of respectively 0.75 (0.65–0.77) [vs. 0.67 
(0.60–0.74) in non-RRT patients; P = 0.0003] and 2 (1–2) [vs. 2 (2–3) in 
non-RRT patients; P = 0.0003]. Both test displayed a poor performance 
in predicting subsequent renal replacement therapy at study inclusion 
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[AUC ROC curve of respectively 0.67 (0.59–0.74) and 0.65 (0.57–0.73) 
for RI and semi-quantitative perfusion].
Conclusion Our results suggest that renal perfusion monitoring using 
Doppler-based resistive index or color-Doppler, although feasible in 
ICU setting, failed to predict short term AKI reversibility and displayed 
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Introduction Tuberculous meningitis (TBM) is frequently associated 
with neurological complications requiring admission in intensive care 
unit (ICU). Adjunctive steroids reduce mortality, but may have no effect 
on disabling neurologic deficits in survivors. Moreover, the benefit 
of steroids is controversial in immunocompromised patients and in 
patients with severely altered mental status at hospital presentation. 
We aimed to identify indicators of poor functional outcome in 
adult patients with severe forms of TBM requiring ICU admission. 
In particular, we investigated the effect of adjunctive steroids on 
functional outcomes and 1-year mortality.
Patients and methods We conducted a retrospective cohort study 
(January 1st 2004 to June 15th 2016) in consecutive TBM cases 
admitted to the medical ICUs of 12 university-affiliated hospitals, 
located in the Paris area, France. We used multivariate logistic 
regression analysis to identify factors associated with a poor functional 
outcome. A poor functional outcome was defined as a score of 3–6 
on the modified Rankin scale (mRS) 90 days after ICU admission. In a 
secondary analysis, we used Cox proportional hazards modeling to 
evaluate the risks of death at 1  year. Data are presented in median 
(interquartile range) or numbers (percentage).
Results A total of 95 patients were studied, including 44 (46%) 
immunocompromised patients. At ICU admission, the Glasgow Coma 
Scale score was 11 (8–14), 64 (67%) patients had Medical Research 
Council (MRC) grade 3 illness, and 66 (69%) required invasive 
mechanical ventilation. Brain MRI was performed in 79/95 (83%) cases. 
Antituberculous therapy was administered to 90/95 (95%) patients 
(5 died before treatment could be started), and 76/90 (84%) patients 
received adjunctive steroids. The duration of ICU stay was 10 (4–24) 
days.
A poor functional outcome was reported for 55/90 (61%) patients at 
90 days (5 patients were lost to follow-up). The following factors were 
independently associated with a poor outcome at 90 days: older age 
(per 1-year increment, adjusted odds ratio (aOR): 1.04, 95% CI 1.0–1.08, 
p = 0.035), cerebrospinal fluid (CSF) protein level >1.9 g/L (aOR: 8.85, 
95% CI 2.49–39.64, p = 0.002), hydrocephalus on MRI (aOR: 8.6, 95% CI 
2.05–46.5, p = 0.006). By contrast, the use of adjunctive steroids had a 
protective effect (aOR: 0.15, 95% CI 0.02–0.87, p = 0.045).
The Kaplan–Meier estimated 1-year mortality was 51% (0.39–0.61). 
The following factors were independently associated with mortality: 
CSF protein levels >1.9  g/L [adjusted relative risk (aRR): 2.47, 95% CI 
1.17–5.25, p = 0.018], hydrocephalus on MRI (aRR: 3.45, 95% CI 1.50–
7.91, p = 0.003), brain infarction on MRI (aRR: 2.40, 95% CI 0.99–5.81, 
p =  0.051). The use of adjunctive steroids had a protective effect on 
1-year mortality (aRR = 0.16, 95% CI 0.05–0.45, p = 0.0006).
Conclusion Despite antituberculous therapy and supportive care, 
severe forms of TBM are characterized by a poor outcome in more 
than 50% of cases. Elevated CSF protein levels, hydrocephalus and 
brain infarction on MRI at ICU admission represent major indicators 
of poor outcome. Our data suggest that use of adjunctive steroids 
is associated with reduced disability and mortality, irrespective of 
immune status and severity of illness. We conclude that adjunctive 





Value of diaphragmatic echography for predicting respiratory 
insufficiency in 123 patients with neuromuscular disorders
Abdallah Fayssoil1, Tania Stojkovic2, Anthony Behin2, Adam Ogna3, Frédé‑
ric Lofaso4, Pascal Laforet2, Karim Wahbi2, Helene Prigent4, Denis Duboc5, 
David Orlikowski3, Bruno Eymard2, Djillali Annane6 
1Neurologie et reanimation polyvalente, Institute De Myologie et CHU 
Raymond Poincaré, Garches, France; 2Neurologie, Institute De Myologie, 
Paris, France; 3Réanimation polyvalente et pole ventilation à domi‑
cile, CHU Raymond Poincare, Garches, France; 4Service d’explorations 
fonctionnelles respiratoires, Hôpital Raymond‑Poincaré (AP‑HP), Garches, 
France; 5Cardiologie, Hôpital Cochin, Paris, France; 6Réanimation 
médico‑chirurgicale, Hôpital Raymond‑Poincaré, Garches, France
Correspondence: Abdallah Fayssoil ‑ fayssoil2000@yahoo.fr
Annals of Intensive Care 2017, 7(Suppl 1):O12
Introduction Diaphragm is the main muscle of ventilation. 
Diaphragmatic echography is a non invasive tool used in Intensive 
Care Unit. We sought to compare diaphramatic echography and 
spirometric function in neuromuscular disorders.
Patients and methods We included retrospectively patients with 
neuromuscular disorders followed in 2 neuromuscular centers (Pitié 
and Garches, France). Ultrasonographic (US) analysis of the right and 
the left hemidiaphragm, using M-mode, was performed during quiet 
breathing and deep breathing. For the right hemidiaphragmatic 
analysis, the transducer was placed on the anterior subcostal region at 
the right mid-clavicular line. For the left hemidiaphragmatic analysis, 
the transducer was placed on the anterior subcostal region between 
the anterior and midaxillary lines.
Results 123 patients with muscular dystrophies (DM1, PROMM, DMD, 
BMD, LGMD, FSH, mitochondriopathies and other myopathies) were 
included in our study. Mean age was 39  ±  14  years. Mean Walton 
score was 2.6  ±  2. Mean forced vital capacity (FVC) was 74  ±  28% 
of predicted value and mean PCO2 was 42  ±  6  mmHg. Mean right 
hemidiaphragmatic excursion (RHDE) during quite breathing was 
14.5  ±  6  mm and 44.7  ±  22  mm during deep breathing. Mean left 
hemidiaphragmatic excursion (LHDE) during quite breathing was 
14.3  ±  6  mm and 34  ±  22  mm during deep breathing. FCV was 
significantly correlated with RHDE during quite breathing (r  =  0.55, 
p < 0.001), with LHDE during quite breathing (r = 0.57, p < 0.001), with 
RHDE (r = 0.71, p < 0.001) and LHDE (r = 0.78, p < 0.001) during deep 
breathing. RHDE during deep breathing predicts a FVC  <  60% with 
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AUC at 0.86. RHDE during deep exhalation predicts a peak expiratoty 
flow <270 l/min with AUC at 0.78.
Conclusion Diaphragmatic echography may predict respiratory 
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Introduction Veno-arterial extracorporeal membrane oxygenation 
(VA-ECMO) is used to provide cardiac support in patient suffering 
refractory cardiogenic shock. Its use is increasing and associated with 
neurological complications, mainly cerebrovascular. The frequency of 
those events and their impact on patients are not well described. We 
therefore study the epidemiology, risk factors and impact of cerebral 
complications occurring in VA-ECMO patients.
Patients and methods Observational study conducted in a tertiary 
referral center (2006–2014) on patients developing a neurological 
complication (ischemic stroke or intracranial bleeding) while on 
VA-ECMO versus those who did not.
Results The main clinical characteristics of the patients are reported in 
Table 2. Among 873 consecutive patients who had received VA-ECMO, 
72 developed cerebral complications on ECMO: ischemic stroke in 47 
(5%) with and cerebral bleeding in 25 (3%), occurring after a median 
[IQR) of 11 [7–21.5] and 6 [5–11] days of ECMO support, respectively.
No specific risk factor of ischemic stroke was found in univariable 
analysis except body mass index >26 (OR 2.16, 95% CI 1.15–4.05). 
Hematological failure (defined as platelets <50 000/mL) at ECMO 
initiation (OR CI 3.64, 95% 1.30–10.21) and platelets <20,000/
mL during ICU stay (OR 3.01, 95% CI 1.22–7.40) were significantly 
associated with cerebral bleeding in univariable analysis. Age, 
comorbidities, renal replacement therapy, and intra-aortic balloon 
pump use were not associated with neurological complications. 
Twenty-three (49%) patients with ischemic stroke and 21 (84%) with 
intracranial bleeding died versus 385 (48%) of patients without brain 
injury.
Conclusion Neurological events occurred frequently in patients on 
VA-ECMO. Ischemic stroke is the most frequent, occurs late during 
ECMO support and does not seem to be associated with higher 
mortality than patients without brain injury. Cerebral bleeding occurs 
early and is associated with high mortality rate. Low platelets count 
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Introduction Patients with subarachnoid hemorrhage (SAH), 
admitted to the neurointensive care unit (NICU) are exposed to 
complications including rebleeding, vasospasm, hydrocephalus, pain 
and sepsis. The autonomic nervous system (ANS) is a warning system 
which can be assessed noninvasively by heart rate variability (HRV). 
Many reports have shown a relationship between HRV and outcome in 
myocardial infarction, stroke and renal insufficiency. To our knowledge 
very few papers have addressed this issue in the NICU. The aim of this 
study was to check whether HRV could predict outcome in patients 
with SAH admitted to the NICU.
Patients and methods Following Institutional Review Board approval, 
patients with SAH, admitted to the NICU were included in this 
prospective monocentric study. Those with persistent arrhythmia, 
cardiac pacing or younger than 18  years were excluded. All subjects 
were assessed everyday starting from their arrival at NICU, i.e. day 
2 after SAH, to day 7. HRV was measured between 2 and 4 p.m. 
during 10-min. HRV was achieved by connecting a computer to 
the electrocardiogram (ECG) monitor. Online power spectrum was 
calculated from the ECG R–R interval using the maximum entropy 
method (MemCalc™, Suwa Trust, Japan). Low (LF: 0.04–0.15  Hz) 
and high frequency (HF: 0.15–0.4  Hz) spectra were associated 
with sympathetic (Σ) and vagal activities respectively. Entropy and 
coefficient of variation of RR intervals (CVVR) were also measured.
Concomitantly, we noted demographic, hemodynamic, respiratory 
and comorbidity data. The severity of SAH was classified using the five 
points World Federation of Neurological Surgeons (WFNS) score (were 
1 =  less severe and 5 =  very severe) and the four point Fisher scale 
(where 1 = less severe and 4 = very severe). Outcome at discharge was 
assessed by the modified Rankin scale, a poor outcome was defined 
by either death or Rankin score of 4–5 which means severe disability 
and inability to walk without assistance Outcome was defined as good 
or poor based on the absence or presence of Rankin score of 4–5 
and/death. Univariate and multiple logistic regression models were 
applied on these data to determine the predictive (s) factor (s) of poor 
outcome.
Table 2 Admission characteristics, hemostasis disorders 
during VA‑ECMO and patient outcomes according to brain 
damage or not
Results are expressed as mean ± SD, number (%) or median [27th–75th 
percentile interquartile range]
Characteristic No brain damage Patients 
with brain 
damage




Age (years) 50 ± 15 50 ± 16 48 ± 18
Male sex [n (%)] 568 (71) 32 (68) 12 (48)
SAPS II 72 [54–85] 70 [61–86] 74 [57–90]
SOFA score 5 [3–14] 5 [3–8] 3 [3–7]
Biologic values (J1 ECMO)
 Lactates 
(mmol/L)
6 [2.7–11.1] 5 [2.9–10.1] 4 [4.0–10.0]
 PT (%) 45 [30–62] 54 [34–65.8] 47 [27.5–54]
 ACT 1.6 [1.2–2.3] 1.4 [1.1–1.8] 1.8 [1.4–3]
 Fibrinogen (g/L) 3.0 [2.0–5.0] 3.0 [2.4–5.0] 4.0 [1.7–4.0]
 Platelets 
(×109/L)
155 [96–215] 163 [100–246] 86 [56.5–164]
Type of ECMO
 Peripheral 698 (87) 35 (74) 20 (80)
 Switch to 
central ECMO
38 (5) 2 (4) 4 (16)
 Central 107 (13) 12 (26) 5 (25)
 Intra‑aortic 
balloon pump
265 (33) 16 (34) 5 (25)
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Results The inclusion criteria were fulfilled by 125 patients, but com-
plete data was only available in 53 of them. Among them, five died 
before discharge, 10 were discharged with a Rankin score of 4 or 5. The 
most significant modifications of our study parameters were observed 
on day 2 after SAH. These observations are summarized in Table  3. 
Consequently, on day 2 after hemorrhage, LF (p = 0.02), VLF (p = 0.03), 
entropy (p < 0.001) and CVVR (p < 0.01) were significantly decreased in 
patients with poor prognosis. This trend was sustained The multivari-
ate logistic regression model revealed an odds ratio [95% confidence 
interval] for LF = 0.997 [0.995–1.000]; Entropy = 0.919 [0.0.872–0968]; 
VLF = 0.997 [0.995–1.000] and CVVR 0.586 [0.388–0.885] considered as 
significant predictors of poor outcome.
Discussion These results corroborate previous reports showing that a 
decrease in HRV, particularly the sympathetic pathway, at admission, 
is associated with poor outcome (1).The mechanisms are not clearly 
known. Ischemic or hemorrhagic lesions had been observed in the 
hypothalamus of patients with poor outcome after SAH, which is the 
predominant modulator of autonomic system (2).
Conclusion This study suggests that early assessment of HRV in 
the NICU could predict outcome in patients with SAH. A decrease in 
HRV at admission of patients was significantly associated with poor 




1. Brain J Neurol. 1963; 86: 301–14.
2. Am J Emerg Med. 2012; 30: 651–56.
O15 
Electrical muscle stimulation and bicycling combined to early 
standard rehabilitation versus early standard rehabilitation 
alone: impact on global muscle strength at ICU discharge—an 
open‑label, single‑centre, assessor‑blinded randomised trial
Guillaume Fossat1, Florian Baudin1, Cécile Coulanges2, Sabrine Bobet1, 
Arnaud Dupont3, Léa Courtes1, Anne Bretagnol1, Dalila Benzekri1, Toufik 
Kamel1, Grégoire Muller1, Nicolas Bercault1, François Barbier1, Isabelle 
Runge1, Mai‑Anh Nay1, Marie Skarzynski1, Armelle Mathonnet1, Thierry 
Boulain1 
1Réanimation médicale polyvalente, Hôpital de La Source, CHR Orléans, 
Orléans, France; 2Service de pneumologie, Hôpital de La Source, CHR 
Orléans, Orléans, France; 3Service de réanimation chirurgicale, Hôpital de 
La Source, CHR Orléans, Orléans, France
Correspondence: Thierry Boulain ‑ thierry.boulain@chr‑orleans.fr
Annals of Intensive Care 2017, 7(Suppl 1):O15.
Introduction Early Standard Rehabilitation (ESR), first passive and 
then passive/active, is recommended for critically ill patients in whom 
it reduces the duration of mechanical ventilation (MV), improves 
functional status, muscle strength and quality of life after hospital 
discharge. The early addition of leg bicycling on a cyclo-ergometer and 
of electrical muscle stimulation (EMS) is now part of common practice 
in the ICU. Whether it can preserve or improve muscle strength and 
further increase the beneficial effects of ESR is little known.
Patients and methods Single-centre, randomised study comparing 
the effects of the combination of early and daily leg bicycling + EMS 
of the quadriceps + ESR (intervention group) versus ESR alone (usual 
care group) on the global muscle strength assessed by the MRC score 
at ICU discharge by a physiotherapist blinded to the randomization 
group (NCT02185989). All consecutive patients were potentially 
eligible if they were deemed to need more than 72  h of care in ICU. 
Main non-inclusion criteria were resuscitated cardiac arrest, presence 
of pacemaker or implantable defibrillator, acute cerebral disease 
requiring deep sedation for at least 72  h, known neuromuscular 
disease, and amputation of a lower limb. Randomization was stratified 
by sex, MV or not at study entry, and day of admission (Thursday/
Friday vs other days). The interventions were applied right from Day 
1 (within 72 h of admission), 5 days/week. Protocoled ESR consisted of 
daily multistep program (from 10 passive mobilisations of each joint 
in comatose patients to passive/active muscle work, transfer to chair, 
standing and walking, depending on patient’s level of wakefulness/
cooperation). In the intervention group, 30  min passive/active 
leg bicycling (even in bed-ridden patients) and 54  min EMS of the 
quadriceps were performed 5 days/week in addition to ESR, according 
to pre-established programs.
Results From July 2014 to June 2016, 314 patients were included 
(as planned per protocol) and 313 were analysable (1 consent 
withdrawal): 155 in usual care group and 158 in intervention group. 
Among the whole population, ICU mortality was 18%, SAPSII 46 ± 18, 
admission SOFA 8 (IQR 6; 12), patients treated with MV 85%. Clinical 
characteristics at study entry were similar between groups. Primary 
endpoint: 124 and 121 patients upon the 131 and 125 ICU survivors 
in usual care and intervention groups respectively, could be assessed 
for the primary endpoint. The discharge MRC score was 53 (IQR 44; 
60) and 51 (44; 58) in usual care and intervention groups, respectively 
(P  =  0.86), and was also not different between groups in patients 
under MV at time of study entry: 52 (IQR: 44; 58) (n = 95) and 49 (43; 
57) (n = 89) (P = 0.26). Secondary endpoints: There was no between-
group difference in discharge functional status as assessed by the ICU 
mobility scale in the whole population (P = 0.54) (P = 0.64 in patients 
under MV at study), or by the change in the Katz index from inclusion 
to discharge (P = 0.39) (P = 0.47 in patients under MV at study entry), 
or in the day-28 ventilator-free days [21  days (17; 22) vs 20  days (18; 
21); P = 0.34]. The thickness of the rectus femoris muscle, assessed by 
echography at inclusion and discharge in survivors, showed a lower 
decline in the intervention group: −1.8 mm (−4.4; −0.2) vs −0.7 mm 
(−1.5; −0.25); P  =  0.009. The impact on delirium occurrence in ICU 
is still under analysis. Data concerning physical and mental status at 
6 months are not fully available yet.
Safety: We observed no serious adverse event related to the studied 
interventions.
Conclusion Although safe and resulting in lower decline in muscle 
thickness as observed on echography (not blinded assessment), 
the addition of daily leg bicycling and EMS to ESR did not result 
in higher global muscle strength as assessed by the MRC score 
(blinded assessment) at ICU discharge in a mixed and heterogeneous 
population of critically ill patients. Exploratory subgroup analyses 
are underway and perhaps will help to identify subsets of patients in 





Post‑intensive care syndrome: a population‑based observational 
study of healthcare use
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Table 3 Univariate analysis of data in the study population
Good outcome Poor outcome p value
No of patients (%) 38 (72) 15 (28)
Mean age (years) 56.2 ± 11.7 59.6 ± 12.1 0.004
Female sex 23 (60) 9 (60) 0.86
WFNS IV–V 10 (26) 7 (47) <0.001
Fisher grade 4 18 (47) 9 (60) <0.001
HRV on day 2
 LF (ms) 519 ± 528 171 ± 385 0.02
 HF (ms) 513 ± 863 224 ± 505 0.24
 Entropy 50.3 ± 12.0 34.3 ± 16.4 <0.001
 LF/HF 1.97 ± 1.41 1.87 ± 2.27 0.85
 VLF (ms) 1471 ± 2152 184 ± 364 0.02
 CVVR (%) 4.18 ± 2.01 2.25 ± 2.31 0.006
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Introduction Intensive care unit (ICU) admission is known to 
lead, among survivors, to numerous and persistent disabilities 
and impairments after discharge, forming the “post intensive care 
syndrome” (PICS). However, PICS consequences in term of healthcare 
use is less studied. Recent data tend to demonstrate that ICU survivors 
have increased healthcare use after ICU. However, little is known about 
healthcare use for the most severely ill patients, which are supposed 
to be at higher risk of PICS, and, to our knowledge, no epidemiological 
data are available in France.
Patients and methods We conducted a retrospective multicenter 
study using comprehensive administrative hospital discharge 
databases of the Centre Val de Loire region, France (2.5 millions of 
inhabitants). Based on an ICD-10 algorithm, we included all adult 
patients admitted in an ICU for septic shock or acute respiratory 
distress syndrome (ARDS) during 2011 and invasively ventilated at 
least 5  days. Performance of the selection algorithm was validated 
through review of a subsample of medical charts. Comorbidities 
were also extracted from ICD-10 coding and reported using a scoring 
system derived from Charlson Comorbidity Index. Healthcare use and 
comorbidities were analyzed 2  years before (pre-ICU period) and 2 
years after ICU (post-ICU period).
Results 552 patients were selected, of which 249 (45%) died during 
the hospital stay. Among the 303 survivors, 293 (97%) had complete 
data required for analysis and none was lost for follow up. Mean ± SD 
age was 61 ± 14 years, SAPS2 49 ± 17 and median ventilation duration 
was 10  days (Q1  =  7; Q3  =  20). Regarding chronic comorbidities 
during the pre-ICU period, cardiac disease was reported for 26% of 
the patients, respiratory disease for 16%, kidney disease for 13%, and 
hepatic disease for 12%.
Healthcare resources utilization analysis during the pre-ICU period 
revealed that 58% of the patients required hospitalization, 54% 
ambulatory care, 57% emergency admissions and 10% rehabilitation 
facilities. Twenty-three percent of the patients had no healthcare use.
During the post-ICU period, the 2-year mortality rate was 15%. 
Healthcare resources utilization was significantly increased during the 
post-ICU period compared to the pre-ICU period for hospitalizations 
(72%, p < 0.001), ambulatory care (73%, p < 0.001) and rehabilitation 
facilities (54%, p < 0.001). No patient had no healthcare use. Regarding 
chronic comorbidities, cardiac, respiratory and renal diseases 
were significantly more frequent compared to the pre-ICU period 
(respectively 32, 27, and 21%, p < 0.001 for the three conditions). Time 
trend analysis of the healthcare use in the post-ICU period revealed 
that the first 9 months were at high healthcare use (essentially 
hospitalizations and rehabilitation facilities), and emergency 
admissions tended to increase at the end of the 2-years follow-up.
Discussion Patients admitted to ICU for acute respiratory distress 
syndrome and septic shock frequently have a significant healthcare 
resources utilization during the 2 years before. The 2 years following 
admission is characterized by a more important healthcare use, 
together with a significant increase in comorbidities.
Conclusion Our study highlights the epidemiological impact of PICS 
at the population level in a French region, underpinning observational 
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Introduction Consequences of hospitalization in critically ill patients 
have been recognized for several years with physical, cognitive and 
psychological consequences published under the denomination 
of the post intensive care syndrome which will become a new 
challenge for intensivists. The impact of social, personal and financial 
consequences has been less reported. The primary objective of this 
pilot study is to report the social, financial, psychological, physical and 
emotional consequences in a group of critically ill patients compared 
to a group of patients never hospitalized in ICU. The second objective 
is to investigate patient’s perceptions to better understand their 
memories of their hospitalization through a qualitative approach.
Patients and methods We designed a case control study in three ICUs 
belonging to the Outcomerea research group (July 2014–May 2015). 
Case patients were adult patients ventilated for more than 48  h. We 
excluded patients not speaking or understanding French and patients 
who denied participation. Clinical and demographics characteristics of 
the cases were extracted from the Outcomerea database. They were 
interviewed 6-months after ICU discharge. Control patients, matched 
on age and sex and never hospitalized in ICU, were interviewed face-
to-face during an hospital consultation. All patients completed the 
same questionnaires in a random order, exploring emotional and post 
traumatic-stress syndrome (Impact of Event Scale-revised, cut-off >22), 
self-sufficiency in daily activities (activity of daily Living, ADL), quality 
of life (first question of the SF-36), and questions about their place of 
living, of working and financial conditions, need of psychological help 
and marital status. We used a phenomenological approach to report 
patient’s perceptions.
Results Of the 96 eligible patients, 20 (20.8%) died at 6  months, 
39 (40.6%) were excluded and 37 were entered in the analysis and 
compared to 37 control patients. Characteristics of the case patients 
were: age (median: 65, range: 47–73), 64% male, SAPS II (51, 37–64), 
ICU stay (12  days, 8–19), hospital stay (29  days, 22–41). The median 
IES-R score was significantly higher in cases (14, 8–31) vs control 
(6, 3–10), p < 0.01. IES-R > 22 was found in 13 (35.1%) cases patients 
versus 1 (2.7%) of control patients (p < 0.01). Activities of daily living 
without help were significantly most often performed in control 
versus cases for bathing (n = 37, 100% vs n = 33, 89%, p = 0.04) and 
continence (n  =  37, 100% vs n  =  33, 89% p  =  0.04). Perception of 
the quality of life was not significantly different between cases and 
controls but increasing quality of life was much important in cases 
(n = 15, 40.6%) versus control (3, 8.1%), p < 0.01. See Table 4.
Table 4 Functional and  personal changes in  cases 
and controls
Variables Cases n = 37 Control n = 37 p value
Return home within 1 month 17 (45.9%) 37 (100%) <0.01
Need of help at home 22 (59.4%) 5 (13.5%) <0.05
Change in working 
conditions
12 (32.4%) 3 (8.1%) <0.05
Change in financial 
conditions
10 (27%) 7 (18.9%) 0.6
Psychologist help 17 (45.9%) 5 (13.5%) <0.05
Use of medications 9 (24.3%) 8 (21.6%) 1
Change in marital status 2 (5.4%) 3 (8.1%) 1
Eating disorders 8 (21.6%) 5 (13.5%) 0.54
Disorder of sexual life 12 (32.4%) 7 (18.9%) 0.3
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Three themes were found in the qualitative analysis: the ICU stay seen 
as a traumatized period, a period without memories and support from 
families and friends. Their representations in the verbatims were 13 
(35.1%), 13 (35.1%) and 3 (8.1%).
Conclusion This pilot study reported substantial neuropsychological 
and functional alterations related to the ICU stay and emphasized the 
need for better estimating these modifications in a multicenter study. 
Addressing these consequences adds to the role of intensivists for 
elaborating prevention programs and promoting post intensive care 
syndrome to non ICU practitioners to collaborate together for the best 
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Introduction In the ICU context, in the case of organ donation, 
patients’ relatives are at the centre of the decision process: within 
a limited time frame, they will be told that the patient is brain dead 
and will be asked to consider organ donation. Qualitative studies 
have put forward that understanding brain death facilitates decision-
making and impacts on the final decision (donation vs non donation). 
However the impact of understanding brain death on relatives’ 
grieving process has never been evaluated. In this study, we searched 
for correlation between semi-quantitative answers to questions 
related to understanding of brain death and experience of the process 
in a questionnaire completed by relatives 1 month after the patient’s 
death and post-traumatic related symptoms (PTSD) and complicated 
grief.
Patients and methods This is an ancillary study of a larger prospective, 
observational study in 28 ICUs in France that aimed to compare grief 
symptoms of relatives of donor patients versus relatives of non-donor 
patients. For each brain dead patient, the relative who served as the 
surrogate was included at time of organ donation discussion. Relatives 
were assessed at 3 time points during a telephone interview: at 1 
month, to complete a questionnaire regarding their experience in the 
ICU and description of the organ donation request and procedure, 
including understanding of brain death; at 3 months to complete the 
Hospital Anxiety and Depression Scale (HADS) and the Impact of Event 
Scale-Revised (IES-R) for PTSD symptoms; at 9  months, to complete 
the IES-R and the Inventory of Complicated Grief (ICG).
Results 202 relatives were included in the study. At 1 month after the 
patient’s death, 79.2% of relatives completed the questionnaire, at 
3 months 70.3% completed the HADS and the IES-R and at 9 months 
61.4% completed the IES-R and the ICG.
One month after the death, 35% of relatives declared having 
difficulties in understanding brain death and 32% experienced 
decision-making as difficult. Results show that experience of the 
decision making process impacts on relatives’ well-being. At 3 months, 
compared to relatives who did not find the decision difficult, those 
who did find it difficult more often presented significant PTSD 
symptoms (40.54 vs 65.88%, p  =  0.016). At 9  months, compared to 
relatives who understood brain death, those who did not understand 
brain death had higher global ICG score [23 (12.5–36.5) vs 36 (28–
43.75), p  =  0.010] and more often presented complicated grief 
symptoms (46.15 vs 75%, p =  0.026). There was a trend in increased 
prevalence of PTSD related symptoms with 60% in the group of 
relatives who did not understand brain death versus 47.2% in the 
group that did, but this was not significant (p = 0.33).
Discussion Results show that difficulty experienced during organ 
donation discussion and decision impacts on relatives’ well-being 
in the months that follow the patient’s death. Support to relatives 
should be proposed in this context. Interestingly, understanding of 
brain is a key component of relatives’ experience: on top of possibly 
impacting on the decision itself, it significantly impacts on relatives’ 
grieving process 9 months after the patient’s death. Promoting better 
understanding of brain death, proposing clearer explanations, by 
using various media, may improve both relatives’ understanding and 
well-being.
Conclusion Our study shows that understanding of brain death is 
a key component of relatives’ experience that significantly impacts 
on the grieving process. Efforts should be made to improve relatives’ 
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Introduction Relatives of patients who die in the ICU experience 
a considerable burden of harm such as symptoms of anxiety and 
depression, posttraumatic stress disorder (PTSD) symptoms and 
quality-of-life alterations. Improving the quality of dying and death 
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is recognized as a priority. Nevertheless, specific data are needed 
to understand what specific aspects of ICU care affect the relatives’ 
grieving process. This study aims at providing information on potential 
links between anxiety/depression, PTSD related symptoms, complicated 
grief and components of ICU end-of-life care in order to specify ICU 
practices that may affect the risk of developing these symptoms.
Patients and methods This is an ancillary study of the CAESAR 
study—a prospective, observational study in 41 ICUs in France. Eligible 
patients were adults who died after at least 48 h in the ICU. For each 
patient, the relative who served as the surrogate was included at time 
of death. Relatives were assessed 21  days then 3, 6, and 12  months 
after the death during a telephone interview. At 21  days they com-
pleted the CAESAR scale; at 3  months, they completed the Hospital 
Anxiety and Depression Scale (HADS) and the Impact of Event Scale-
Revised (IES-R) and at 6 and 12 months they completed the IES-R and 
the Inventory of Complicated Grief. In this study, we searched for cor-
relation between semi-quantitative answers to CAESAR questions (and 
not scores) and outcomes.
Results 475 patients and their relatives were included. Response rates 
were 90.5, 81.3, 59.4 and 45.2%, at day-21, 3, 6 months and at 1 year, 
respectively.
5 domains are associated with significant increased risk of developing 
ICU burden (p ≤ 0.05 for each variable).
1. Quality of care and symptom control. Perception that pain was not under 
control and that the patient had difficulties in breathing is associated 
with increased risk of developing anxiety and depression at 3 months, 
PTSD related symptoms at 6 and 12 months, complicated grief at 
6 months. Dissatisfaction with quality of care is associated with increased 
risk of developing anxiety and depression at 3 months, PTSD related 
symptoms at 3 months, complicated grief at 12 months.
2. Quality of communication. Dissatisfaction with communication with 
either doctors or nurses is associated with increased risk of developing 
anxiety and depression at 3 months, PTSD related symptoms at 3 and 
6 months, complicated grief at 6 months.
3. Kindness. Perception that the team was not kind enough is associated 
with increased risk of developing anxiety and depression at 3 months, 
PTSD related symptoms at 3, 6 and 12 months.
4. Preparation for death. Relatives who were not informed that the patient 
was dying, who were unable to express important things or to say 
goodbye were more at risk of developing anxiety and depression 
at 3 months, PTSD related symptoms at 3, 6 and 12 months and 
complicated grief at 6 and 12 months.
5. Presence at time of death is associated with increased risk of developing 
PTSD related symptoms and complicated grief at 6 and 12 months.
Discussion Relatives are sensitive to interaction between the ICU 
team and themselves as well as between the team and the patient. 
Quality of communication (both verbal and non verbal) and support, 
as well as preparation for the death, are key components of relatives’ 
experience that impact on grief symptoms in the months that follow 
the patient’s death.
Conclusion Quality of care and support during the dying process 
are at the heart of the relatives’ experience. This study puts forward 
practices that may be improved in order to promote both palliative 
care and family centered care in the ICU and, in fine, decrease grief 
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Introduction In 2015, 1824 organ donations were performed in 
France. We already know that complicated grief after the death of 
a relative in the intensive care unit is frequent but the population of 
organ donors’relatives hasn’t been studied. Currently, there doesn’t 
exist any sector to orientate donors’ families. The purpose of our study 
is to investigate the complicated grief donors’ relatives, its associated 
diseases and risk factors.
Patients and methods Prospective, single-center, observational 
study. During the first meeting with the transplantation coordination 
team of our hospital, it was proposed to the organ donors’ relatives to 
participate. The relatives who had accepted received the ICG, IDS-SR 
and PCLS questionnaires at 1, 3 and 6  months after the death. The 
primary endpoint was the presence of complicated grief, defined 
by an ICG  >  25, among the relatives of organ donors after 6  months 
from the death. The secondary end points were the presence of major 
depressive disorders (IDS-SR ≥ 15) and post-traumatic stress disorders 
(PTSD) (PCLS ≥ 44) at 6 months and the analysis of complicated grief‘s 
risk factors: about the deceased person (age, sex, cause of the death, 
place of the death, time between the hospital’s entrance and the 
death) and about the relative (sex, age, relationship with the donor, 
occupational category, PCLS ≥ 44 and IDS-SR ≥ 15 6 months after the 
death).
Results From December 2014 to January 2016, 81 donors’ relatives 
were included. An average of 3.24 relatives per donor was included. 
16 of the 29 relatives who responded at 6  months had an ICG  >  25. 
The prevalence of complicated grief is 55.2% [95 CI  =  37–73]. The 
prevalence of major depressive disorder and PTSD are respectively 
72% [95 CI  =  55.7–88.3] and 31% [95 CI  =  14.2–47.8] (Table  1). No 
variable were significantly associated with a complicated grief at 
6 months from the death.
Discussion Even if only 36% of the relatives completed the scales at 
6  months, this study shows a high risk of complicated grief among 
donor’s relatives. But we can see that the prevalence of complicated 
grief in this population is closed to the prevalence find after the death 
of a relative in the intensive care unit. Because of the lake of responses 
at 6 months, we can’t conclude on the risk factors.
Conclusion 55.2% of donor’s relatives developed a complicated grief 
6 months after the death. The establishment of dedicated channels to 
orientate these bereaved persons seems important. Further studies 
should be conducted to define better the complicated grief’s risk 
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Introduction The harmfulness of fluid-induced hyperchloremia 
(H-Cl) remains debated. Large randomized trial showed that chloride-
rich crystalloids did not worsen outcome [1]. The volume of fluids, 
however, was limited and the incidence of H-Cl was not recorded.
Patients and methods In a post hoc analysis of the database of the 
RCT “Hyper2S”, a study comparing normal to 3% hypertonic saline for 
72 h in 434 patients with septic shock, we assessed the incidence and 
the impact of H-Cl (≥110 mmol/L) on adverse events and mortality. Cl, 
pH, bicarbonate (Bic) and lactate (Lac) were recorded at H0-12-24-72. 
Episodes of hyperlactatemia (H-Lac  >  2  mmol/L), metabolic acidosis 
(pH < 7.35 + Bic < 22) either H-Cl (pH < 7.35 + Bic < 22 + Cl ≥ 110 + L
act ≤ 2) or H-Lac (pH < 7.35 + Bic < 22 + Lact > 2) were recorded. Acute 
kidney injury (AKI) was defined by doubling creatinine or dialysis.
Results 413 patients without missing data were analysed. H-Cl and 
HCl-acidosis were recorded in 257 (62%) and 77 (19%) patients, respec-
tively, H-Lact and H-Lact-acidosis in 294 (71%) and 209 (51%) patients, 
respectively. Baseline severity scores were similar in patients with and 
without H-Cl but vasopressor dose was higher in patients with H-Cl 
(Table  5). The chloride load was significantly higher in patients with 
H-Cl (Table 5). Both, H-CL acidosis and H-Lac acidosis were more fre-
quent in patients with than without H-Cl episode (Table 5). H-Cl was 
not associated with AKI or mortality (Table 5). The mortality of patients 
who experienced H-Cl acidosis (25%) was similar to patients who 
never experienced metabolic acidosis (28%), p = 0.65.
Conclusion H-Cl is frequent in septic shock patients resuscitated with 
chloride-rich fluids but does not increase AKI or mortality. H-Lact is 
more frequent in patients with H-Cl, which is an important bias for the 
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Introduction Long after the death of a loved one, end-of-life decisions 
can remain with the living and have been implicated in post ICU 
burden. In the case of organ donation, the relatives are at the centre of 
the decision process: within a limited time frame, they will be told that 
the patient is brain dead and will be asked to consider organ donation. 
Attention has been focused on how relatives make the decision to 
donate or not to donate the patient’s organs but only very few studies 
have focused on the impact of organ donation decision making on 
their psychological well-being during the months that follow the 
patient’s death. The goal of this study was to describe the grieving 
process of relatives who were approached about organ donation in 
the context of brain death and to compare grief symptoms of relatives 
of donor patients (DPs) versus relatives of non-donor patients (NDPs).
Patients and methods We conducted a prospective, observational 
study in 28 ICUs in France. For each brain dead patient, the relative 
who served as the surrogate was included at time of organ donation 
discussion. Relatives were assessed at 3 time points during a telephone 
interview: At 1 month, to complete a questionnaire regarding their 
experience in the ICU; at 3 months to complete the Hospital Anxiety 
and Depression Scale (HADS) and the Impact of Event Scale-Revised 
(IES-R) for PTSD symptoms; at 9 months, to complete the IES-R and the 
Inventory of Complicated Grief (ICG). The primary outcome measure 
was the IES-R (at 3 and 9 months).
Results 202 relatives were included in the study among which 158 
were relatives of DPs and 44 of NDPs. At 1 month after the patient’s 
death, 79.2% of relatives completed the questionnaire, at 3  months 
70.3% completed the HADS and the IES-R and at 9 months 61.4% com-
pleted the IES-R and the ICG.
Table 5 Characteristics and  outcome of  patients with  and 
without  H‑Cl (results are number and  % of  patients 
and medians IQR)
No H-Cl (n = 156) H-Cl (n = 257) P
Characteristics at inclusion
 SAPS II (points) 55 (46–63) 56 (48–65) 0.65
 SOFA (points) 10 (8–12) 10 (8–12) 0.31
 Vasopressor dose (µg/
kg/min)
0.32 (0.20–0.66) 0.44 (0.23–0.80) 0.04
 Serum creatinine 
(µmol/L)
137 (79–208) 132 (80–191) 0.31
Evolution from H0 to H72
 Volume of fluid 
resuscitation (L)
1.4 (0.6–2.3) 2.2 (1.1–3.9) <0.001
 Chloride load (all fluids) 
(mmol)
287 (129–491) 690 (293–1127) <0.001
 Mean pH 7.36 (7.29–7.40) 7.32 (7.26–7.37) <0.001
 ≥1 episode metab. 
acidosis [n (%)]
82 (53) 204 (79) <0.001
 ≥1 episode H‑Cl 
acidosis [n (%)]
NA 77 (30) –
 ≥1 episode H‑Lact 
acidosis [n (%)]
41 (26) 149 (58) <0.001
Outcomes
 AKI [n (%)] 96 (64) 146 (58) 0.42
 D28 mortality [n (%)] 60 (38) 95 (37) 0.76
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Relatives’ experience of ICU and decision-making varies between the 
2 groups. Relatives of NDPs are less satisfied with communication with 
ICU team than relatives of DPs (26.6 vs 8%, p  =  0.021). Relatives of 
NDPs were more often shocked by organ donation request than rela-
tives of DPs (64.52 vs 19%, p < 0.0001). During organ donation discus-
sions, relatives of NDPs more often declared an absence of support 
from the ICU team (19.35 vs 1.59%, p =  0.0008) and more often felt 
under pressure (41.94 vs 7.14%, p < 0.0001).
At 3  months, there was no difference in the IES-R score between 
relatives of DPs (31 [21–41]) and NDPs (31.5 [11.25–34]) (p  =  0.29). 
Similarly there were no differences in HADS score (13 [9–20] and 
13.5 [8.25–20] respectively, p  =  1.00) and anxiety and depression 
subscores. At 9  months, there was no difference in the IES-R score 
between relatives of DP (26 [12.75–38]) and NDP (33.5 [21.25–43.25]) 
(p  =  0.17). Similarly there were no differences in ICG score (25.5 
[14.37–25] and 32.5 [17.43–25] respectively, p = 0.11).
Discussion Relatives of DPs and NDPs have different experience of 
quality of communication and quality of support during the patient’s 
ICU stay. More than the decision itself, quality of the organ donation 
process impacts on relatives’ grief symptoms.
Conclusion The decision (donation vs no donation) has no impact on 
grief symptoms in the months following the patient’s death. However, 
experience of the request and of the decision itself, as well as quality 
of communication and support, are elements that effect relatives’ 




Implementation and impact of the surviving sepsis campaign 
protocol: results of a quasi‑experimental study in Democratic 
Republic of Congo (DRC)
Joseph Nsiala Makunza1, Mejeni Kamdem Nathalie1, Akilimali Pierre2, 
Kilembe Manzanza Adolphe3 
1Anesthésie‑Réanimation, Cliniques universitaires de Kinshasa, Kinshasa, 
Democratic Republic of the Congo; 2Statistics, School Of Public Health, 
Kinshasa, Democratic Republic of the Congo; 3Anesthéthésie‑réanima‑
tion, Cliniqes Universitaires de Kinshasa, Kinshasa, Democratic Republic 
of the Congo
Correspondence: Joseph Nsiala Makunza ‑ mnsiala78@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):O23
Introduction In developed countries, the application of the “Surviving 
Sepsis Campaign” (SSC) protocols in the management of sepsis and 
septic shock has been associated with increased survival [1].
In the context of a fragile health system, the application of these 
protocols may be expected to prove to be difficult to undertake and 
the impact may also be expected to vary [2].
Patients and methods We conducted a prospective, quasi-
experimental before and after study in the university hospital of 
Kinshasa (DRC) comparing 33 consecutive patients in septic shock 
treated according to usual care versus 39 patients treated according 
to a protocol type EGDT from 1st February 2014 to 31st July 2014 
(pre- protocol phase) and 1st September 2014 to 28th February 2015 
(post- protocol phase). Between the 2 phases, we have drawn and 
implemented a local protocol based on SSC recommendations. A kit 
consisting of central venous catheters, devices capable of measuring 
central venous pressure, flow regulator (Dosiflow R) and lactate reader 
was available.
In the absence of electrically driven syringe pumps, catecholamines 
were administered by continuous perfusion using a flow regulating 
device (Dosiflow). We drew up calculating tables based on a standard 
dilution and a variable administration rate controlled by the flow 
regulating device, thus permitting precise and constant dose 
administration in millilitres/hour (ml/h).
The main outcome measures were: the rate of compliance with 6-h 
sepsis care bundles and the hospital mortality until J30. The Stu-
dent’s and U Mann–Whitney tests were used to compare quantitative 
variables, and the chi-square test to compare qualitative variables. 
Kaplan–Meier survival curves were used and the differences between 
the two curves were analyzed using the log rank test.
This study received the approval of ethics committee and was regis-
tered 23th January 2014 under number ESP/CE/053/14.
Results Baseline characteristics of patients were similar in both 
two groups. Lung infection was the main source of septic shock and 
antibiotics administration delay was less than 3 h in the two groups. 
In contrast, blood cultures and blood lactate were performed only in 
patients of the EGDT group.
Patients of the EGDT group received more IV fluids (+1226  ml on 
average), more catecholamines (+24, 9%) and were more often 
transfused (+13, 7%) than the patients treated in the habitual fash-
ion. Protocol compliance was substantially improved, passing from 
0 to 50%. The absolute risk reduction of mortality was 17% (100 
vs 83%; p  =  0.0037) when all the therapeutic measures had been 
employed.
The Kaplan–Meier survival curves showed that the patients in the pre-
protocol group had a significantly greater risk of dying compared with 
those in the post-protocol group. The average length of stay was 2.2j 
vs 5.2j p = 0.0037.
Discussion Our results in terms of compliance with the sepsis bundle 
were satisfying given that even in highly developed countries the 
compliances rates are often below 50% [3]. Ignorance of the very 
existence of these recommendations and logistical factors are often 
quoted as the reasons why compliance is so poor
The positive impact that we observed on mortality was found in 
similar studies [4].
Other more recent randomized controlled studies have not found 
significant differences but this may be explained by the similarity of 
treatment protocols in the two groups [5].
Our study is coherent according to current literature but there exist 
certain limits which might be expected in this kind of study.
Our research was implemented in only one centre and these results 
cannot be extrapolated to all sub-Saharan Africa, nor even to our 
own country. As in all before/after studies, comparison with a historic 
control group is liable to introduce a bias based on confusion. We 
sought to minimize this bias however by choosing a short study 
period (12 months) with the same therapeutic team during the entire 
study.
Conclusion Despite a difficult socio-economic context, the 
implementation of a local protocol based on the recommendations 
of the SSC was associated with improved outcome in septic shock 
patients in our hospital compared to usual care.
We thus intend to continue and to widen the application of this 
protocol in an effort to evaluate if this positive effect will be observed 
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Introduction Despite being a fully preventable infectious disease, 
tetanus is still responsible for about 500,000 death worldwide. In 
developed countries, the incidence is strongly associated with a lack 
of vaccination coverage in the elderly. In the USA or in France, people 
over 65 year-old have a twice to tenfold increase in annual incidence 
of tetanus versus younger patients [1]. Considering the long lasting 
effects of tetanus toxin up to 6  weeks, elderly people admitted in 
intensive care units (ICU) are of particular risk of complications. 
Prognostics factors are well known in developing countries with a 
mortality rate above 20% but clinical data in developed countries are 
missing. We conducted a multi-center retrospective study in France on 
90-day and 1-year mortality in patients with tetanus admitted in ICU.
Patients and methods This study was conducted over 15 French 
ICUs. All adults patients admitted for tetanus from January 2000 to 
December 2014 were included. Data were retrospectively collected 
from medical files. Long-term vital outcome was obtained by 
interrogating town hall registries.
Results Seventy patients were recruited over the study period. Median 
age was 80 years [IQ range 73–84], 86% were women. Median Charlson 
comorbidity index score was 4 [3–5] and Knaus chronic health score 
status was distributed equally between category A or B (50% each). All 
patients had trismus and 56% had generalized form at presentation. 
The median incubation period was 10  days [IQR 8–14]. Mechanical 
ventilation (MV) was performed in 90% of patients for a median dura-
tion of 36 days [IQR 26–46]. Median SAPS II score at ICU admission was 
33 [IQR 26–40], corresponding to an predicted hospital mortality rate 
of 14%. Median length of stay in ICU was 41 days [IQR 24–53]. Ninety-
day and one-year mortality rates were 13% (n = 9) and 16% (n = 11) 
respectively. Kaplan–Meier survival curve is presented Fig. 4.
Death typically occurred within the first week (55%) due of severe 
arrhythmia at admission or during the fourth ICU week (withdrawal 
of life sustaining therapies in 3 patients or multiple organ dysfunction 
syndrome due to nosocomial infections in 2). Ventilator-associated 
pneumoniae incidence was 15 episodes per 1000 ventilation-days 
(total of 2234 ventilator-days observed) corresponding to 48% of ICU 
patients receiving MV.
Mortality was associated with older age (83 [81–85] versus 79 [73–84] 
years, p = 0.06) and baclofen use (intrathecal or intravenous, 4/9 non 
survivors vs. 8/61 in survivors, p  =  0.04). Shorter incubation period 
(under the median delay of 10  days), generalized tetanus, wound 
debridement (performed in 11 patients) and higher SAPSII (above 30) 
were significantly associated with longer duration of MV.
Discussion In-hospital mortality rate was low and consistent with 
SAPS II estimation [2], despite long-term mechanical ventilation in 
an elderly population. Surprisingly, baclofen use was associated with 
an increased risk of death and may be linked to drug-related adverse 
events. Association of wound debridement with MV duration may 
either be related to higher bacterial inoculum in larger wound or to 
per-procedure toxin release.
Conclusion Long-term follow-up for tetanus-related ICU admission 
highlights the favorable outcome of this elderly population despite 
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Introduction The available data on Purpura Fulminans in adult patients 
are scarce, old and mainly limited to patients with meningococcal 
infections. Our aims were:
1. to describe the clinical features.
2. to identify predictive factors of in‑ICU mortality.
3. to compare the presentation and outcomes between causative 
micro‑organisms.
4. to report the rate of limb amputation and identify predictive factors for 
limb amputation in adult patients admitted in intensive care unit for an 
infectious Purpura Fulminans.
Patients and methods We performed a 16-year national multicenter 
retrospective study in 56 ICUs in France from 2000 to 2016. Infectious 
PF was defined by the association of a sudden and extensive purpura, 
whatever its causative microorganism, together with the need for 
vasopressor support. Patients with a noninfectious purpura or with a 
purpura in a context of infectious endocarditis were excluded from the 
study.
Results (1) Clinical features upon ICU admission A total of 306 patients 
were included in the study for an incidence of 0.35 patients per year 
and per center. Patients were young (median age 34  years [21–53]) 
and had no previously known comorbidity in 69% of cases. Symptoms 
before ICU admission included fever (77%), digestive symptoms (61%), 
headache (45%), myalgia (25%) and lower limb pain (21%), for which 
16% of the patients consumed non-steroidal anti-inflammatory drugs 
before admission. Before ICU admission, 77% of patients had a purpura 
notified and 75% received a parenteral β-lactam antibiotic. A successful 
resuscitation of an out-of-hospital cardiac arrest was recorded for 
5% of patients. Mean coma Glasgow score at ICU admission was 
15 [13–15] and 20% of patients had a neck stiffness. A lumbar 
puncture was performed in 56% of patients and showed a meningitis 
(pleocytosis > 10/mm3) in 45% of them. A bacteremia was documented 
in 66% of cases (n = 202/306) and a positive cerebrospinal fluid culture 
was obtained for 51% of lumbar punctures performed (n = 85/171). In 
all, the two predominantly identified microorganisms were Neisseria 
meningitidis (n = 195/306, 63%), mainly serogroup B (39%) and C (34%), 
and Streptococcus pneumoniae (n = 67/306, 22%).
(2) Patients’ outcomes In-ICU mortality was 41% (n  =  126/306). 
Compared to ICU non-survivors, ICU survivors were younger (29 vs. 43 
years, p < 0.0001), had more frequently received a β-lactam antibiotic 
before ICU admission (83 vs. 64%, p < 0.0001), had more frequent neck 
stiffness (26 vs. 12%, p  =  0.004) and cytological meningitis (51 vs. 
31%, p = 0.029) and were more frequently documented with Neisseria 
meningitidis (69 vs. 56%, p =  0.04). Age (OR 1.02/year, 95% CI [1.01–
1.04]; p =  0.002) and SOFA score (OR 1.44/point, 95% CI [1.30–1.58]; 
p < 0.0001) upon ICU admission were the only variables independently 
associated with ICU mortality.
(3) Impact of the identified microorganism As compared with others, 
patients with pneumococcal PF were older (p  <  0.0001), had more 
frequent asplenia (48 vs. 2%, p  <  0.0001), higher SAPS 2 and SOFA 
scores together with a higher ICU mortality (52 vs. 36%, p = 0.04), and 
required more frequent limb amputation (31 vs. 9%, p < 0.0001).
(4) Surviving patients requiring amputations 22% of ICU survivors 
(n  =  39/180) eventually required amputation during their ICU stay 
with a median of 3 [2–4] limbs amputated. Among ICU survivors 
(n  =  180/306, 59%), those who were amputated (n  =  39/180, 22%) 
were older (42 vs. 26 years, p  =  0.016) and presented with higher 
SOFA and SAPS 2 scores, lower platelets counts (38 vs. 87.103 mm−3, 
p  <  0.0001), more severe kidney injury and higher arterial lactate 
(7 vs. 5  mmol/L, p  <  0.001) and creatine kinase (856 vs. 159  IU/L, 
p < 0.001) levels than those who were not amputated. By multivariable 
regression analysis, the following risk factors for limb amputation were 
identified among ICU survivors: SOFA score upon ICU admission (OR 
1.34/point, 95% CI [1.14–1.59]; p < 0.0001), Streptococcus pneumoniae 
PF (OR 5.05, 95% CI [1.73–14.74]; p = 0.003), and platelets transfusion 
(OR 6.06, 95% CI [2.20–16.73]; p < 0.0001).
Conclusion Purpura Fulminans is a rare disease mainly affecting young 
healthy patients. Most patients had an extensive purpura identified 
before ICU admission and those receiving antibiotics before ICU 
admission had a lower mortality than others. Neisseria meningitidis and 
Streptococcus pneumoniae were the main micro-organisms identified. 
The overall ICU mortality was high and limb amputations were needed 
in almost one quarter of ICU survivors. Patients with Streptococcus 
pneumonia PF had a poorer outcome with a higher ICU mortality and a 
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Introduction To date, there is no consensus on which anesthetic 
protocol should be used before neonatal intubation. As a result, 
awake intubation, although strongly discouraged by current 
recommendations, is still common in neonates, especially in France. 
Many experts consider Propofol, a short-acting anesthetic agent, 
an appropriate drug for premedication before neonatal intubation. 
Propofol is known to decrease systemic vascular resistance leading to 
low arterial blood pressure, which consequently raises concerns about 
its hemodynamic tolerance. However in neonates, low mean arterial 
blood pressure (MABP) is poorly correlated with low systemic or 
cerebral blood flow. NIRS (Near InfraRed Spectroscopy) allows cerebral 
tissue oxygenation monitoring, reflecting cerebral blood flow.
The aim of our study was to compare cerebral oxygenation profiles 
between a combination of a synthetic opioid plus a muscle-blocker 
and propofol, used as premedication prior to neonatal endotracheal 
intubation.
Patients and methods Observational prospective study, conducted in 
2 of the 8 centers participating in a randomized, controlled, double-
blind, multicenter trial (PRETTINEO study, ClinicalTrial.gov identifier 
NCT01490580). Patients were randomly assigned (1:1) between 
“atropine-propofol” and “atropine-atracurium-sufentanil” before 
elective or semi-urgent intubation in the neonatal intensive care unit. 
Randomization was stratified on weight and center. Exclusion criteria 
included low blood pressure defined as a MABP (in mmHG) below 
gestational age (in weeks). Physiological parameters, including pulse 
oxymetry (SpO2) and regional cerebral oxygen saturation (rScO2), 
were collected 1 min prior to induction of anesthesia, and then up to 
60 min after. To investigate the balance between oxygen delivery and 
consumption, cerebral fractional tissue oxygen extraction (FTOE) was 
calculated as FTOE =  (SpO2 −  rScO2)/SpO2. The analyzed parameters 
included changes in rScO2 and FTOE over time and their relative 
change from baseline value in both treatment groups.
Results From March to August, 2016, 65 neonates were assessed for 
eligibility. Among them, 28 were finally included in this ancillary study. 
Their mean (SD) gestational age at birth was 32 (5) weeks. Median 
[IQR] age and mean (SD) weight at the time of intubation were 0.5 
[0.2–5.4] days and 1886 (900) g respectively. At the time this abstract 
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was conceived, data validation had not been completed. Results will 
be available at the time of the meeting.
Discussion To our knowledge, only two studies to date have 
investigated the cerebral hemodynamic effects of propofol in 
neonates. Both reported persistent low MABP after a propofol bolus 
but a very short decrease in rScO2. Only one studied propofol before 
intubation and suggested that low rScO2 could be attributable to 
low SpO2 during the procedure, but not to low MABP (Smits et  al., J 
Pediatr, 2016). None of them compared propofol to another anesthetic 
protocol. Our study is thus the first to compare cerebral oxygenation 
between two currently acceptable regimens of anesthesia for 
premedication before neonatal intubation.
Conclusion This observational study is expected to provide useful 
information about cerebral oxygenation in neonates during intubation 
and to disentangle the effects of the drugs from the effects of the 
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Introduction Cellulitis (CEL) and Necrotizing Fasciitis (NF) are life-
threatening skin infections much more frequent in adults than in 
children. Therefore, despite major differences in epidemiology, 
microbiology, and outcome, clinical guidelines for management 
are directly adapted from adult ICU experience. We designed a 
prospective multicentric cohort study to describe the clinical course of 
CEL/NF requiring admission to PICU.
Patients and methods This study was approved by the IRB Paris Nord 
and the French Data Protection Authority (CCTIRS/CNIL). After parents’ 
consent was obtained, thirty centers (France, French Polynesia, Mayotte 
and La Réunion Islands, French Caraibs Islands, Switzerland, Belgium, 
Canada, Netherlands, Norway) included on a secure-dedicated-website 
all patients aged from 28 days to 18 years and admitted to PICU 
for a suspected or confirmed CEL/NF with association of the three 
following signs: (i) area of skin inflammation, (ii) rapid evolution or 
skin necrosis, (iii) variation in core temperature (>38.5 °C or <36 °C). 
Premature infants (<37 weeks of gestation) and patients with Stevens 
Johnson syndrome, Purpura Fulminans or Hereditary Angioedema were 
excluded. We collected all data concerning past medical history, first 
clinical signs, PICU stay, antibiotherapy, microbiology (Staphylococcus 
and Streptococcus species were send to French Reference Centers), 
radiological diagnosis, surgery and outcome 1 year after discharge. Data 
are presented as mean ± SD according to their Gaussian distribution.
Results 50 patients (age: 5.9 ± 5.2 months and weight: 24.2 ± 18.1 kg) 
were included from October 2011 to April 2016. The diagnosis was 
suspected 3.5  ±  2.7  days after a known risk factor (46%; surgery: 12; 
NSAIDs: 10; varicella: 9; cancer: 4). Only two patients had travelled 
abroad. Skin lesions observed on 10.6  ±  16% of body surface were 
erythema (28), necrosis (13) and bulla (10) and were located on 
face (17), legs/feet (16), abdomen/pelvis (14), arms/hands (13) and 
trunk (10). On admission, mortality and organ dysfunction scores 
were as follow: PRISM  =  9.3  ±  7.5; PIM2  =  12.6  ±  23.3; PELOD 
D1 = 12.6 ± 3.2 and POPC = 1.6 ± 1.0. Main biological tests showed: 
hemoglobin: 10.0 ± 2.2 g/dl; neutrophils: 10320 ± 8740/mm3; platelets: 
197700 ±  140764  mm3; CRP: 189 ±  122  mg/l; PCT: 69.3 ±  75.3  mg/l; 
fibrinogen: 5.2  ±  2.2  g/l; ASAT: 108  ±  166  UI/l and ALAT: 61  ±  82 
UI/l; protidemia: 53  ±  13  g/l. 28 patients (56%) showed low blood 
pressure for age including 14 with oliguria, needing fluid challenges 
(45  ±  26  ml/kg) and vasopressors for 3  ±  1  days. 29 patients (68%) 
were ventilated invasively for 8.2 ± 10.5 days, with PEEP = 7±3 cmH2O 
and FIO2 = 58 ± 27% during the first 3 days. 80% of patients received 
continuous intravenous analgesia (morphine and benzodiazepines). 
Half of patients were transfused with blood products and also a half 
received albumin. While MRI was performed in only 7 cases, CT scan and 
ultrasound were performed to confirm diagnosis in 23 cases (46%, 14 on 
day 1) and in 21 cases (42%, 15 on day 1), respectively. 28 patients (56%) 
were operated. One bacterial strain alone was identified in 36 cases 
(72%) and at least two in eight cases (16%), including Staphylococcus 
aureus (17), GAβH–S (13), Escherichia coli (5), Pseudomonas aeruginosa 
(4). Antibiotics used were penicillin G (26), clindamycin (21), 3rd 
generation cephalosporin (12) and rifampicin (9). A third of patients 
received immunoglobulins and five children (10%) received hyperbaric 
oxygen (22 sessions). Length of stay in PICU was 12.5 ± 14.7 days. Three 
patients (6%) died and only two (4%) were readmitted to PICU because 
of failure directly link to skin lesion. POPC score on discharge was 
1.9 ± 1.3. Long term follow-up at 1 year is ongoing.
Discussion This study reports the largest prospective multicentric 
international cohort of pediatric skin infections needing PICU 
admission to date. Surgery was the first risk factor reported in our 
cohort, before varicella. Severe circulatory and respiratory failures on 
admission in a context of deep biological inflammatory syndrome 
required aggressive treatments during the first 3  days. Lower part 
of the body was more frequently involved than reported before in 
childhood. The diagnosis was quickly suspected and confirmed mainly 
by ultrasound and CT scan, with the use of MRI still very rare. More 
than a half of patients have been operated after classical treatments 
associating immunoglobulins and antitoxin-antibiotics. Infection 
appeared mainly monobacterial as usually described in children 
but gram-negative strains are emerging. Mortality was still low and 
sequella were rare.
Conclusion Cellulitis (CEL) and Necrotizing Fasciitis (NF) are still rare in 
childhood, with low mortality and few sequella if aggressive treatment 
including surgery is emergently performed. However, it seems that 
epidemiology has changed during the last decade in high-income 
countries. Statistical analysis of this database is ongoing to identify 
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Introduction Immunosuppression induced by sepsis is well described 
in adults. Therapeutic trials with immunomodulatory treatments 
are already underway, using HLA-DR expression on monocytes 
(mHLA-DR) or lymphopenia as biomarkers of immunosuppression. 
Pediatric patients with Septic Shock (SS) have been much less studied. 
Thus, the main objective of this study was to explore post-sepsis 
immunoparalysis in a pediatric cohort study. Both sides of cellular 
immunity were assessed: innate immunity (mHLA-DR) and adaptive 
immunity (lymphocyte subsets). We also wanted to obtain normal 
values of mHLA-DR in healthy children, according to age.
Materials and methods We performed a single-center prospective 
study with children under 18 years-old, admitted in Pediatric Intensive 
Care Unit for SS (“Surviving Sepsis Campaign” criteria), between 
September 2014 and July 2016. We recruited controls from healthy 
children hospitalized for an elective surgery, without any criteria of 
infection. mHLA-DR, total lymphocyte count, and lymphocyte sub-
populations’ proportions (CD4+ and CD8+ T cells, regulatory T cells, 
NK cells, and B cells) were determined by flow cytometry. Samples 
were analyzed at Day 1, 3 and 7, after sepsis onset. Clinical data were 
collected prospectively, especially severity scores [PIM2, PELOD2 
and Cumulative Vasopressor Index (CVI)], and secondary nosocomial 
infection occurrence.
Results 30 controls and 26 patients were recruited. mHLA-DR in 
healthy children presented no variation according to age, and was 
similar to healthy adults. At each time points, mHLA-DR in SS group 
was decreased, comparing with controls. The medians of mHLA-DR 
were respectively 6.066 IQR [3.737–16.310], 6.308 IQR [3.185–8.965] 
and 9.323 IQR [6.384–12.738], versus 29.668 ab/c IQR [24.335–39.199] 
in the control group (p  <  0.0001 at D1, D3 and D7; Mann–Whitney). 
mHLA-DR at D3 was significantly correlated with the Cumulative 
Vasopressor Index (Spearman’s correlation coefficient r  =  −0.50; 
p = 0.031). Patients secondarily infected presented a lower mHLA-DR 
at D3 than patients without secondary infection: respectively 4398 
ab/c [2437–6212] versus 8474 ab/c [5904–10844] (p = 0.022, Student 
t test) (Fig. 5).
Total lymphocytes and CD4 T cells were decreased at D1 and D3. This 
lymphopenia corrected between D3 and D7. NK cells were decreased 
at each time points. B lymphocytes were decreased comparing to 
controls at D1 and D7 (not D3), but much less pronounced than T cells. 
Regulatory T cells percentage was initially comparable to controls. 
Then, a gradual increase was observed, which became statistically 
significant at D7, compared to controls (p = 0.0058; Mann–Whitney). 
No significant difference was observed between patients with or 
without secondary infections, according to any lymphocyte subsets.
Concerning clinical data, patients contracting a secondary 
infection stayed significantly longer at the hospital than others: 
respectively 33.5  days [19.5–58.0] versus 14.0 [7.5–21.0] (p =  0.0094; 
Mann–Whitney).
Conclusion For the first time, we reported that healthy children 
presented mHLA-DR values with no variation according to age, and 
similar to those seen in adults. Innate immunity was similarly altered in 
children with Septic Shock than in adult patients. Adaptive immunity 
seemed to be less impaired by the shock than in adults. Further 
analyses will be conducted to complete these findings as functional 
tests on T cells. As secondary infections considerably increase 
the length of stay at the hospital, this report paves the way for a 
multicenter therapeutic trial, in order to evaluate immunostimulatory 
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Introduction Ventilator associated pneumonia (VAP) is the second 
cause of nosocomial infection in pediatric intensive care. Recent 
modifications of the CDC criteria for VAP diagnosis included VAP 
diagnostic criteria for children [1] and criteria to identify ventilator 
associated events (VAE) in adults [2] that are not validated for children. 
The purposes of this study were to determine retrospectively the 
incidence, risk factors and management of VAP using the new CDC 
definition and to study the validity of adult VAE diagnostic criteria in 
critically ill children.
Patients and methods We conducted a single center retrospective 
study in the pediatric intensive care unit (PICU) of Sainte-Justine 
Hospital, a medical and surgical PICU including cardiac surgery 
patients. All patients invasively mechanically ventilated (IMV) >48  h 
between November 2013 and November 2015 were included. Patient 
records were analyzed for VAP diagnosis, risk factors, management 
and VAE. Statistical analysis included median and range calculation for 
descriptive data and children with and without VAP were compared 
using a Mann–Whitney test with a significant level: p < 0.05.
Results Of 688 invasively ventilated patients, 287 were included in our 
study (IMV > 48 h). Thirty patients met radiologic and clinical VAP CDC 
criteria. VAP rate was 10.4% and VAP incidence was 7/1000 invasive 
ventilation days. Mortality rate was higher in the VAP group but in the 
VAP group was not statistically significant [16.0 vs 9.7% respectively, 
(p  =  0.23)]. VAP occurred early in IMV course (4  days). The main 
technique to identify the pathogen was tracheal aspiration with semi 
quantitative culture, the most common VAP organisms identified were 
Gram Negative bacteria (60%) with predominance of Haemophilus 
influenza and Pseudomonas aeruginosa with sensitive profile and 
antibiotherapy used was in accordance with guidelines. Median 
duration of ventilation (15 vs 6 days, p < 0.001) and PICU stay (19 vs 
9  days, p  <  0.001) increased significantly in children with VAP versus 
no VAP. Univariate analysis showed that age, reintubation, ARDS and 
continuous enteral feeding were risk factors for VAP. Among the thirty 
patients with VAP, 17 had adult CDC VAE’s criteria (sensitivity = 56%).
Discussion The following points are in agreement with VAP literature. 
Using VAE criteria could constitute a faster, more objective method to 
Fig. 5 See text for description
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screen VAP. However, sensitivity should be improved by adapting VAE 
criteria to children.
Conclusion Using the CDC updated VAP definition for children, VAP 
incidence is similar to adults. Adult VAE cannot be used to screen 
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Introduction Ventilator associated pneumonia (VAP) is defined as a 
lung infection occurring after 48 h of mechanical ventilation. Ventilator 
associated pneumonia incidence, complications and mortality are well 
known in critically ill adults but probably under diagnosed in critically 
ill neonates. The main objective of our study was to evaluate the 
incidence of VAP in neonatal intensive care units, evaluate associated 
mortality and morbidity and find potential risk factors.
Patients and methods This is a prospective, observational, single-
center conducted in neonatal intensive care unit of Armand Trousseau 
hospital from 01/11/2014 to 31/10/15. All infants aged 28 days or less 
hospitalized in the service are included.
Results 381 patients were enrolled including 327 intubated patients. 
17 of 327 patients intubated presented VAP. The incidence of VAP was 
4.05 per 1000 days of hospitalization with an incidence rate of 8.78 per 
1 000 days of invasive ventilation. The average age at diagnosis of VAP 
was 21.47 ± 13.02 days for an average duration of invasive ventilation 
of 15.23 ± 11.48 days. After VAP, invasive ventilation time is prolonged 
to 25.71 ± 20.90 days (OR 1.19 [1.12–1.27]). The nosocomial infection 
rate was significantly higher in the VAP group (p < 0.001) with 9 on 17 
patients in VAP group (52.94%) versus 21 on 310 patients (6.77%). The 
occurrence of VAP was significantly associated with higher mortality 
(OR 4.46 [1.32–14.94]) and an increase in invasive ventilation times 
(p < 0.001) and non-invasive (p < 0.001) and hospital stay (p < 0.001). 
There is a significant difference in the duration of invasive ventilation 
before VAP [average 15.23  ±  11.48 (1–35)] compared to patients 
without VAP [mean 4.84  ±  4.92 (1–28), p  <  0.001]. Patients with a 
birth weight less than or equal to 1000 grams are associated with risk 
of VAP (OR 4.31 [1.38–13.39]) in multivariate analysis contrary to the 
term. Intubated patients with a balloon are associated with risk of VAP 
(adjusted OR 4.03 [1.14–14.26]) and a Snappe-II score above 16 also 
(OR 4.98 [1.40–17.67]).
Conclusion We managed one of the larger neonatal study for VAP 
in critically ill neonates. These pneumonias remained frequent in 
critically ill neonate and are associated with a higher mortality and 
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Introduction The proportion of immunocompromised patients with 
extracorporeal life support (ECLS)-treated severe ARDS varies from 
5 to 31% in recent cohorts. To date, very few data on ECMO use and 
its associated outcomes are available on this population. Our aims 
were to (1) describe the clinical features, (2) compare the outcomes 
between causative immunocompromised status, (3) identify predictive 
pre-ECLS factors of 6-month mortality, and (4) report the rate of ECLS-
related complications.
Patients and methods We performed an international multicenter 
retrospective study in 10 ICUs from 2008 to 2014. mmunocompro-
mised status was defined by hematologic malignancies, solid tumor, 
solid organ transplant, human immunodeficiency virus (HIV), or long 
term or high dose glucosteroids or immunosuppressant use. Inclusion 
criteria were immunocompromised patient with acute respiratory fail-
ure rescued by extracorporeal membrane oxygenation or (ECMO) or 
extracorporeal CO2 removal (ECCO2R).
Results 1. A total of 225 patients (age 48.6  ±  15.1  years; APACHE II 
26.4 ± 9.0) were included in the study (30% hematologic malignancies, 
28% long-term corticosteroids or immunosuppressant use, 18% solid 
tumor, 16% solid organ transplant, and 9% HIV). ECLS was initiated 
for severe ARDS, moderate ARDS, or chronic end-stage respiratory 
in 190(84%), 14(6%), and 19(8%) patients, respectively. Main ARDS 
etiologies were bacterial pneumonia (30%), viral pneumonia (18%), 
and specific lung involvement (12%). Refractory hypoxemia (73%) 
was the main indication for ECLS with lowest pre-ECLS PaO2/FiO2 at 63 
(51–87) mmHg. Venovenous ECMO and ECCO2R were initiated in 199 
(88%) and 15(7%) patients, respectively. Pre-ECLS tidal volume was 
5.7(4.7–6.4) mL/kg, with a positive end-expiratory pressure at 10(8–13) 
cmH2O and a plateau pressure at 32(30–35) cmH2O. Interval between 
mechanical ventilation onset and cannulation was 2(1–8) days.
2. Six-month mortality of patients with hematologic malignancies, 
long-term corticosteroids or immunosuppressant use, solid tumor, 
solid organ transplant, and HIV were 76, 60, 80, 51, and 71%, 
respectively (log-rank test, p = 0.02). Cumulative survival at 6 months 
were lower for patients with hematologic malignancies versus others 
(log-rank test, p =  0.003) whereas those with solid organ transplant 
exhibited higher cumulative survival at 6  months (log-rank test, 
p = 0.02).
3. One hundred and three patients (46%) were successfully weaned 
from ECLS. In-ICU and 6-month post ICU discharge survival were 
37% (n =  83/225) and 32% (n =  72/225), respectively. Compared to 
patients who died within 6  months after ICU admission, 6-month 
survivors were younger (46 vs. 49 years, p  =  0.05), had more fre-
quently a newly diagnosed immunocompromised status (39 vs. 17%, 
p = 0.0003), were more frequently patients with solid organ transplant 
(24 vs 12%, p = 0.02, had a higher pre-ECMO hemoglobin (9.4 vs 8.8 g/
dL) and platelet counts (160 vs 112 × 103/µL; p = 0.008), and exhib-
ited lower mechanical ventilation-ECMO onset interval (1[0–5] vs 3[1–
9] days, p = 0.002). Age (OR 1.02/year, 95% CI [1.002–1.04], p = 0.035), 
solid organ transplant (0.38 [0.17–0.85], p = 0.019), newly diagnosed 
immunocompromised status (0.32 [0.16–0.65], p  =  0.002), platelet 
count ≥200,000 × 103/µL (0.33[0.15–0.72], p = 0.005) and delay from 
mechanical ventilation initiation to ECMO cannulation >7  days (3.23 
Page 20 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
[1.42–7.34], p = 0.005) were independently associated with 6-month 
mortality.
4. Eighty-two (36%) patients had at least one ECMO-related major 
bleeding event (oro-nasal bleeding 10%; hemothorax 7%; cerebral 
bleeding 7%), which was less frequent with patients alive at 6-months. 
One hundred and four (46%) and 20 (9%) patients reported ventilator 
associated pneumonia and cannula infection, respectively, with no 
impact on 6-month survival.
Conclusion Six-month survival of ECLS-treated severe ARDS in 
immunocompromised patients appears low, especially for patients 
with hematologic malignancies and solid tumor. However, young 
age, solid organ transplant, newly diagnosed immunocompromised 
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Introduction Driving pressure (ΔP) across the respiratory system 
has been suggested as the strongest predictor of hospital mortal-
ity in ARDS patients. We wonder whether this result may be due to 
the wide range of tidal volume (VT) and PEEP used across the trials 
included and whether a strict control of them would minimize the 
role of ΔP as predictor. Therefore, we investigated ΔP in two trials in 
which lung protective mechanical ventilation was applied to ARDS 
patients. Our working hypothesis was that ΔP was a risk factor just 
like compliance (Crs) or Plateau pressure (Pplat) of the respiratory 
system.
Patients and methods ARDS patients included in the Acurasys and 
Proseva trials previously reported were used. Both had near inclusion 
criteria (notably PaO2/FIO2 < 150 mm Hg and PEEP ≥ 5 cm H2O) and 
similar lung protective mechanical ventilation (in particular VT 6  ml/
kg predicted body weight and PEEP/FIO2 table). Both found survival 
benefit in the experimental group. SOFA, continuous neuromuscu-
lar blocking agent (NMBA) infusion, prone position, combined use of 
NMBA and prone position, pH, PaCO2, PaO2/FIO2, lactate, breathing 
frequency, VT, PEEP, Pplat, Crs and ΔP were recorded at day 1 after 
inclusion together with gender, age and SAPSII at the time of admis-
sion and compared between survivors and nonsurvivors at day 90. Cox 
proportional hazard models were used with covariates significantly 
different between survivors and non survivors at the threshold of 
0.20 and mortality at day 90 as dependent variable. Due to the obvi-
ous colinearity between ΔP, Crs and Pplat we performed the following 
analyses. First we made a specific Cox model for each of them. Second, 
we developed three Cox models in which we used the above variables 
by couples (Pplat-ΔP; Crs-ΔP and Crs-Pplat). We made the following 
assumptions: if both variables in the couple lacked significance in the 
second model, the same information was carried by each component 
of the couple; if one or both variables kept significant correlation each 
brought significant and distinct information; if significant correlation 
was kept for one of the variables in the couple and lost for the other 
the former would be more informative than the latter.
Results Both trials enrolled 805 patients of who 787 had data avail-
able at day 1 of who 533 survived and 254 did not. In the univariate 
analysis, ΔP averaged 13.7 ± 3.7 and 12.8 ± 3.7 cmH2O (P = 0.002) in 
nonsurvivors and survivors, respectively. In each single Cox model, 
Hazard ratios (HR) were 1.05 (1.02–1.08) (P =  0.005), 1.04 (1.01–1.08) 
and 0.985 (0.972–0.999) (P  =  0.023) for ΔP, Pplat and Crs, respec-
tively. PEEP and VT were not significant risk factors in any model. In 
the model with ΔP and Pplat used together, each of them kept sig-
nificance [HR 1.31 (1.07–1.61) and 1.13 (1.02–1.26)]. In the model with 
ΔP and Crs both lost significance and the same was true in the model 
using Pplat and Crs.
Discussion ΔP was a significant predictor with a 5% increase in 
mortality per each cmH2O increment of ΔP, a result similar to that 
found by Amato et al. However, Pplat conveys the same information. 
This is likely due to the fact that VT and PEEP were similar in each 
group of both trials and not different between survivors and non 
survivors.
Conclusion When strict lung protective mechanical ventilation 
is applied to ARDS patients ΔP, Crs and Pplat were risk factors of 
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Introduction Prone positioning (PP) for long sessions in association 
with use of low tidal volume and cisatracurium infusion have been 
shown survival benefit in ARDS patients. Little is known about 
evaluation of PEEP setting based on end-expiratory transpulmonary 
pressure at zero flow (PEEPtotL) in PP. We hypothesized that 
esophageal pressure (Pes) was lower in PP than in supine position 
due the relief of the weight of the mediastinum. Hence, the PEEP level 
to achieve positive PEEPtotL should be lower in PP. Furthermore, the 
inclination of the body should also influence the measurements of Pes. 
The main objective of the study was to evaluate the variation of end-
expiratory esophageal pressure at zero flow (PEEPtotes) in PP and in 
supine position, each at two body inclinations, and the subsequent 
effects on PEEPtotL and transpulmonary driving pressure (ΔPL).
Materials and methods A prospective interventional physiologic 
study was performed in patients with severe ARDS (PaO2/FIO2 < 150) 
and requiring PP. Pes was measured with an esophageal balloon. 
Transpulmonary pressure (Ptp) was computed as the difference 
between airway pressure and Pes. DPL was computed as the 
difference in Ptp at the end of inspiration and at the end of expiration 
at zero flow. Chest wall elastance (Est,cw) was calculated as the ratio 
of end-inspiratory Pes minus PEEPtotes divided by tidal volume. End-
expiratory lung volume (EELV) was measured by nitrogen wash-out 
method. Thorax angulation was 30° and 0° in supine position (SP) and 
0° and 15° in PP. From PEEP set according to the low PEEP/FIO2 table of 
the ARMA trial (1), PEEP level was further adjusted to achieve PEEPtotL 
close to 3 cmH2O. Measurements were done in supine position and 
after 1 h in PP.
Results Twenty patients were included. PEEPtotes did not vary 
significantly between SP(30°) and PP(0° or 15°). However, opposite 
variations were found according to thorax angulation in PP: a rise of 
1.9 (SD 1.7) cmH2O in PP(0°), p =  0.005 and a drop in PP(15°) of 2.2 
(SD 3.2) cmH2O, p  =  0.06. In a complementary analysis, PEEPtotes 
was studied in four positions [SP(30°), SP(0°), PP(0°) and PP(15°)] and 
followed an inversed U-shape pattern with mean values of 8.6 (SD 
3.2), 12.8 (SD 2.7), 10.2 (SD 3.3) and 2.6 (SD 2.1) cmH2O, respectively. 
These differences were statistically significant (Holm adjusted p value 
for multiple comparisons <0.05) except between SP(30°) and PP(15°). 
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As a consequence, PEEPtotL rose of 2.6 cmH2O between SP(0°) and 
PP(0°). With postural variations, EELV was significantly altered. Hence, 
PEEPtotL at PP(0°) was computed at the EELV in SP(0°), allowing to 
eliminate the impact of the change of EELV between postures: 77% 
of PEEPtotL changes were due to change of posture per se [+3.7 (SD 
2.6) cmH2O, p  <  0.05]. Between SP(30°) and PP(0°), posture effect on 
PEEPtotL variation was +2.7 (SD 4.5) cmH2O, p = 0.055. A linear mixed 
model disclosed that rise of PEEPtotL was explained by PP for an 
amount of 2.7 (SD 0.44) cmH2O and by thorax angulation for 0.13 (SD 
0.02) cmH2O per degree (p < 10
−6).
PP was associated with lower ΔPL [−1.0 cmH20 (SD 1.3), P =  0.004]. 
Chest wall elastance did not change between 30° supine and 0°PP 
[10.4 (SD 3) vs. 8.5 (SD 3.2) L/cmH2O, P = 0.85].
Discussion Variation of thorax angulation significantly alters Pes and 
Ptp values. Splitting the variation of Pes into those due to change in 
either EELV or posture allows a better understanding of the impact of 
PP on Pes.
Conclusion PP(0°) was associated with Pes rise as compared with 
SP(30°) and Pes drop when compared with SP(0°). However, when 
analyzing PEEPtotL variation due only to posture change (and not 
EELV change), a rise of almost 3 cmH2O of PEEPtotL was seen in PP(0°) 
compared to SP(0°) or SP(30°). Clinicians might therefore consider 
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Introduction According to the Berlin definition for ARDS, the degree 
of hypoxemia must be assessed under either invasive or noninvasive 
ventilation (NIV). In a recent large international survey, about 15% of 
ARDS were diagnosed while treated with NIV. However, NIV is debated 
in hypoxemic patients with acute respiratory failure. We aimed to 
assess whether the use of NIV is really needed to diagnose ARDS in 
patients with spontaneous breathing under oxygen.
Patients and methods We included all ICU patients treated first 
with standard oxygen and then with NIV for non-hypercapnic acute 
respiratory failure from 2 prospective studies [1, 2]. PaO2/FiO2 was 
assessed at ICU admission under oxygen with an easily bedside 
calculated FiO2, and under NIV after 1 h of initiation and within the first 
24  h. Severity of hypoxemia was considered as mild when PaO2/FiO2 
ranged from 201 to 300, moderate from 101 to 200 and severe when 
≤100 mmHg.
Results Among the 219 patients with acute respiratory failure treated 
with NIV, 172 (79%) fulfilled ARDS criteria within the first 24 h following 
ICU admission. ARDS was classified as mild in 14%, moderate in 53%, 
and severe in 33% of cases. The overall rates of intubation and ICU 
mortality were 58 and 30% respectively.
When considering the 155 patients with bilateral infiltrates on chest 
X-ray and PaO2/FiO2 ≤ 300 mmHg under oxygen, 87% (n = 135) had 
ARDS criteria after 1 h of NIV and 95% (n = 148) within the first 24 h. 
ICU-mortality according to the severity of hypoxemia did not differ 
under standard oxygen or NIV: 29 versus 20% in mild (p =  0.55), 22 
versus 30% in moderate (p = 0.29), and 45 versus 43% in those with 
severe hypoxemia (p > 0.99).
Conclusion Almost all patients with bilateral infiltrates and PaO2/
FiO2  ≤  300  mmHg under oxygen standard meet ARDS criteria after 
NIV initiation. Mechanical ventilation does not seem necessary to 
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Introduction Influenza infection has a major impact on ICU 
hospitalizations during epidemic season, mainly affecting the elderly 
with exacerbation of their comorbidities.
To identify bad prognosis factors in severe influenza and the impact of 
delayed antiviral therapy among ICU patients infected with influenza.
Patients and methods We conducted a retrospective, observational 
study in Angers CHU medical ICU, from November 2009 to April 
2015. Influenza infection was confirmed by Immunofluorescence. 
Demographic datas, comorbid conditions, antiviral treatment and 
time elapsed between ICU admission and treatment, clinical outcome, 
bacterial infection associated, type of virus, antibiotic, ventilation, 
renal injury, use of vasopressive drugs were recorded. Risk factors for 
death were analyzed by backward stepwise logistic regression.
Results The study population consisted of 85 patients whom mean 
age was 63  years old. 80% had at least one comorbidity. Influenza 
A infected 71% of our patients and type B 28%. [iz1] Most of them 
was admitted for respiratory distress and 59% were under invasive 
ventilation. The rate of death was 25% at day 28. 40% were under 
vasopressive drug. 84% received NAI among whom 76% received 
it in the first 2  days after ICU admission. Risk factors for death were, 
shock at the admission, immunosuppressive conditions and late 
administration of NAI. patients receiving NAI more than 48 h after ICU 
admission had a higher risk of death.
A multivariate analysis was performed. Shock at the admission was 
associated with mortality (OR −2.38: 95% CI 0.03–0.045) and time 
elapsed from ICU to [RM1] NAI less than 3  days was associated with 
survival at 28 day (OR 1.68: 95% CI 1.30–22.11).
See Table 6.
Conclusion Cases of severely ill suspected influenza infections in epi-
demic period may benefit as soon as they are admitted in ICU from 
antiviral therapy. Our results add to the existing observational datas 
on the effectiveness of starting antiviral treatment with Neuramini-
dase Inhibitors as soon as Influenza is clinically suspected, even if sus-
picion appears at ICU admission and with delay from symptoms onset.
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Introduction Non invasive ventilation (NIV) is a widely used technique 
to treat hypercapnic acute respiratory failure (ARF) in Chronic 
Obstructive Pulmonary Disease (COPD) patients. Nebulization of beta 
2 agonists is recommended to treat COPD exacerbations. Nebulizing 
beta 2 agonist on NIV circuits could be potentially helpful but had 
been studied only in stable COPD patients. Our aim was to compare 
effectiveness of salbutamol and placebo nebulized in NIV circuit in 
patients admitted to the intensive care unit (ICU) for exacerbation of 
COPD. Aerosols were generated by a vibrating mesh nebulizer, whose 
optimal place in the circuit (just after the Y-piece) was determined by a 
preliminary bench study.
Patients and methods We conducted a double-blinded trial compar-
ing salbutamol and placebo delivered in a random order as two aero-
sols separated by 60  min, during NIV, in 43 patients admitted to the 
ICU for ARF. A spirometry was obtained at several points before and 
after nebulizations, as were clinical and biological safety parameters.
Results Forced expiratory volume in one second (FEV1) increased 
significantly from baseline to 40  min after the end of salbutamol 
nebulization, when compared to placebo (+5.6 vs. −8.9%, p = 0.04). 
At the same time, potassium level decreased slightly in the placebo 
arm (p  <  0.01), when glucose and lactate levels increased (NS). 
Symmetric changes were observed in the salbutamol arm after the 
second nebulization (+13.7 vs. −8.9%, p < 0.01). Nebulization was well 
tolerated in all patients.
Conclusion Placing the nebulizer immediately after the Y-piece is 
appropriate to deliver aerosols in NIV circuit and compatible with 
crimped circuit. Salbutamol nebulization is well tolerated during 
NIV and increase significantly FEV1 when compared to placebo. If 
this physiological effect is associated with clinical benefit remains to 
demonstrate.
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Introduction One of major determinants of non-invasive ventilation 
(NIV) success is its tolerance. Numerous strategies have been 
assessed to improve this tolerance, such as pharmacological sedation 
or sophrology. Music therapy has been showed to be effective in 
healthcare settings, in particular in ICU invasively ventilated subjects 
[1]. We therefore investigated the effect of a musical session provided 
by a trained caregiver on NIV tolerance and efficacy in ICU patients 
with acute respiratory failure.
Patients and methods MUS-IRA is a randomized 3-centers, 3-arm 
open-label trial (PHRIP 2013). Subjects included were adult acute 
respiratory failure patients for whom the physician in charge considers 
NIV as indicated with a level of consciousness allowing a benefit from 
the musical intervention (Glasgow Coma Scale >11). Non inclusion 
criteria were contra-indication to NIV; severe hearing impairment; 
withdrawal of life sustaining therapies with expected survival of 
less than 48  h; subjects included in another trial dealing with acute 
respiratory failure. NIV was conducted in the same fashion in the three 
arms of randomization. The “musical intervention” subjects received a 
30-min L-type music session with the MUSIC CARE© software (2), with 
Table 6 See text for description
Death d28 Alive d28 p
Baseline characteristics
 Age 66.1 ± 12.8 61.9 ± 17.2 0.3
 Sex (M) 12 (54.5) 28 (45.2) 0.45
 BMI 25.5 ± 5.3 28.1 ± 8.6 0.2
 Corticosteroids in 10th days before 
ICU admission
5 (23.8) 5 (7.9) 0.052
 Charlson score 3.2 ± 3.4 2.1 ± 2.5 0.16
 IGS II 49.1 ± 20.8 36.5 ± 15.5 0.0039
Clinical presentation
 Fever (>38 °C) 18 (85.7) 40 (63.5) 0.056
 Body aches 1 (4.8) 16 (25.4) 0.085
Initial influenza diagnostic test 0.77
 Rapid diagnosis 8 (38.1) 26 (41.3)
 Immunofluorescence 11 (52.4) 28 (44.4)
 PCR 2 (9.5) 9 (14.3)
Clinical complications
 Shock 18 (85.7) 16 (25.4) <0.0001
 ARDS 11 (52.4) 18 (28.6) 0.047
 Acute renal failure 12 (57.1) 13 (20.6) 0.0015
 Secondary bacterial infection 13 (61.9) 22 (34.9) 0.03
Details of antiviral treatment
 ICU to Neuraminh delay <3 days 9 (42.9) 45 (71.4) 0.018
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a sleeping mask concealing the eyes. The “sensory deprivation” group 
had the sleeping mask and the insulating around-ear headphone, 
during a 30-min period. The “NIV alone” group had their NIV conducted 
as it is usually in our ICUs.
The main objective was to determine if a musical intervention 
improved NIV tolerance, measured by respiratory comfort, and 
ventilation parameters at 30 min of NIV in comparison to conventional 
care. The respiratory comfort was assessed by a nurse or nurse 
assistant blinded to the treatment arm with a numeric visual scale 
(from 0 to 10) at the initiation (T0), after 30 min (T30), and at different 
time points of each NIV session. The primary endpoint was the change 
in respiratory comfort at initiation and after 30  min of the first NIV 
session. The secondary endpoints were NIV failure and the percentage 
of patients requiring anxiolytics or sedative during NIV sessions. 
The comparison performed in a pre-specified fashion was between 
“musical intervention” group and “NIV-only” group. A total of 99 
subjects had to be randomized in order to show a 2-unit difference in 
respiratory comfort between two groups. This number was extended 
to 114 because of missing data on the primary endpoint.
Results Among the 114 subjects randomized (May 2015 to May 
2016—“musical intervention” group n  =  37; “sensory deprivation” 
group n  =  38, “NIV-only” group n  =  39), median age was 67  years 
(60–74), and 63 were men (55.3%). Mean baseline respiratory comfort 
for “musical intervention”, “sensory deprivation” and “NIV-only” was 
4.34  ±  3.01, 4.24  ±  2.59, 3.89  ±  3.03 respectively for the first NIV 
session (p  =  0.74). Mean change in respiratory comfort between T0 
and T30 for “musical intervention”, “sensory deprivation” and “NIV-only” 
was respectively 0.54 ± 3.57; 0.55 ± 2.33; 0.66 ± 2.9. The comparison 
between “musical intervention” and NIV-alone group yielded a p-value 
of 0.91. NIV failure during ICU stay was evidenced in 16.2%, 10.5%, 
12.8% (“musical intervention”, “sensory deprivation” and “NIV-only”, 
respectively, p  =  0.74). No subjects required the administration of 
anxiolytics or sedatives to cope with the first NIV session in all groups.
Discussion Our study failed to evidence a significant effect of a 
musical intervention on the reduction of respiratory discomfort during 
the first NIV session of acute respiratory failure ICU patients. One may 
hypothesize that the improvement provided by NIV (which patients 
received in all three groups) was such that it outweighed and/or 
masked a potential effect of the musical intervention. Further analysis 
are planned to investigate the respiratory comfort and the evolution 
of physiological parameters during the subsequent sessions.
Conclusion Applying a musical intervention early in the course of 
a treatment by NIV during acute respiratory failure did not modify 
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Introduction Tracheal intubation in the intensive care unit (ICU) is 
associated with severe life-threatening complications including severe 
hypoxemia [1]. Preoxygenation before intubation has been recom-
mended in order to decrease such complications. Noninvasive ventila-
tion (NIV)-assisted preoxygenation allows increased oxygen saturation 
during intubation procedure [2]. However, the NIV-mask has to be taken 
off after preoxygenation to allow the passage of the tube through 
the mouth. High-flow nasal cannula oxygen (HFNC) has a potential of 
apneic oxygenation during the apnea period following the preoxygena-
tion with NIV. We hypothesized that application of HFNC combined 
with NIV was more effective at reducing oxygen desaturation during 
the intubation procedure compared to NIV alone for preoxygenation in 
hypoxemic ICU patients with acute respiratory failure.
Patients and methods We did this randomised, controlled, single-
center trial with assessor-blinded outcome assessment in patients 
admitted to ICU. Hypoxaemic patients requiring orotracheal intu-
bation for respiratory failure were randomised to receive preoxy-
genation using HFNC [flow  =  60  L/min, fraction of inspired-oxygen 
(FIO2)  =  100%] combined with NIV (pressure support  =  10  cmH2O, 
positive end-expiratory pressure  =  5  cmH2O, FiO2  =  100%) in the 
interventional-group or using NIV alone in the reference-group (Fig. 6). 
The primary outcome was the minimal oxygen saturation (SpO2) 
during the intubation procedure. Secondary outcomes were intuba-
tion-related complications and ICU-mortality. The OPTINIV trial was 
registered with ClinicalTrials.gov, number NCT02530957.
Results Between July-2015 and February-2016, we randomly assigned 
25 and 24 patients in the interventional and reference groups. 
During the intubation procedure, median minimal SpO2 values were 
significantly higher in the interventional-group when compared with 
the reference-group (100 [95–100] vs 96 [92–99]%, p =  0.029). After 
exclusion from analysis of two patients for protocol violation, no (0%) 
patients in the interventional-group and five (21%) patients in the 
reference-group had a SpO2 below 80% (p = 0.050). We recorded no 
significant difference in intubation-related complications and ICU-
mortality between groups.
Conclusion A novel strategy of preoxygenation adding apnoeic high-
flow oxygen to NIV to perform orotracheal intubation in hypoxaemic 
patients is more effective at reducing oxygen desaturation in 
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Introduction Dyspnea is common and severe in intensive care unit 
(ICU) patients. In these patients, dyspnea is associated with a poorer 
outcome. The measurement of dyspnea involves a self-assessment 
by the patient with a visual analogic scale (VAS-Dyspnea), which 
by definition requires a certain level of communication. However, 
many intubated critically-ill patients are unable to reach this level 
of communication, which makes very difficult the assessment of 
dyspnea.
Recently, our team has developed, a behavioral score named IC-RDOS 
[1], which is reliable to predict severe dyspnea in ICU patients. This 
score has been only validated in non-intubated conscious ICU patients.
The objective of our study was to validate this score in intubated 
communicating and non-communicating (NC) patients. IC-RDOS 
was compared to VAS-Dyspnea in communicating patients 
and to electrophysiologic markers of dyspnea such as surface 
electromyographic (EMG) activity of extra diaphragmatic inspiratory 
muscles [2], in NC patients.
Materials and methods Between February and August 2016, 
invasively mechanically ventilated patients with clinical respiratory 
discomfort were included. The IC-RDOS and EMG activity of the 
Parasternal and Alae Nasi were measured before (baseline, BL) and 
after one or two interventions aiming at reducing dyspnea. These 
interventions consisted in an optimization of ventilator settings (Opt) 
followed, if necessary, by the injection of opioids. The VAS-Dyspnea 
was only recorded in communicating patients. Non-communicating 
state was defined by the impossibility to perform a VAS-Dyspnea. This 
work was supported by the “Fond de dotation Recherche en Santé 
Respiratoire” and the “Fondation du Souffle”.
Results 35 patients (age 67 [56–76], SAPS II 51 [35–61]; med [IQR]) 
were included; 17 were NC. Among the 18 communicating patients 
we observed a strong correlation between the IC-RDOS and the 
VAS-Dyspnea (rho = 0.545, p = 0.038). Among NC patients, IC-RDOS 
decreased from 6.2 [4.3–6.6] at BL to 4.4 [2.7–6.3] (p = 0.286) and to 
4.3 [2.9–4.8] (p = 0.024) after Opt and opioids injection, respectively. 
Among NC patients, we observed concomitantly, a significant 
diminution of the EMG activity (EMGAUC) of the Alae Nasi compared 
to to BL (−38% [p  =  0.003] and −64% [p  =  0.008] after Opt and 
morphine injection respectively) and a significant diminution of 
the EMGAUC of the Parasternal relative to BL (−65% [p  =  0.039]) 
after morphine injection. Among NC patients, we found a significant 
positive correlation between IC-RDOS and Parasternal EMGAUC 
(rho = 0.538, p = 0.060).
Conclusion IC-RDOS is a reliable surrogate of dyspnea in communicat-
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Introduction Pleural effusions are common in critically ill patients. 
Bedside lung ultrasonography (LU) outperformes chest radiograph for 
the diagnosis of pleural effusion. Pleural effusion drainage improves 
oxygenation and respiratory mechanics of patients under mechanical 
ventilation. However, the role of pleural effusion during the weaning 
process is unclear.
Patients and methods We performed a prospective multicenter study 
in six ICUs in France. We used ultrasonography to screen for pleural 
effusion during the weaning process. Weaning failure was defined as 
failure of spontaneous breathing trial (SBT) or extubation. Patients 
were included the day of a first weaning test after at least 24  h of 
mechanical ventilation. We assessed factors associated with pleural 
effusion and its evolution.
Results Two hundred and forty nine patients were included. Median 
duration of mechanical ventilation was 4 [2–8] days before a first 
SBT. Forty-seven patients (19%) failed a first SBT and 31 (15%) had 
extubation failure (reintubation or death within the 7  days following 
extubation). Pleural effusion was detected in 139 patients (56%) the 
day of SBT. Most of pleural effusions were homogeneously anechoic 
(98%) and associated with pulmonary condensation or atelectasis 
(70%). Interpleural distance was higher among patients with left 
ventricular diastolic dysfunction, cancer history, ARDS or dialysis 
before the first SBT. A higher interpleural distance was associated 
with SBT failure and weaning failure. Patient with weaning failure had 
more often large pleural effusion (34 vs 12%, p < 0.01). Among patient 
failing the first SBT and followed up during the weaning process, either 
diuretic nor fluid balance change altered the interpleural distance 
within 24–48 h.
Conclusion Pleural effusion is frequent during the weaning process 
and is associated with weaning failure. Further studies are needed to 
test whether a strategy aimed at draining large pleural effusions has 
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Introduction Recourses to the intensive care units (ICU) physicians by 
the emergency department (ED) physicians are frequent, estimated 
around once a day. Nevertheless, these recourses are inherently 
unpredictable. A good relationship seems very important for an 
adequate care of the patients and a rational use of hospital resources. 
The collaboration between these two entities remains poorly 
described. Therefore, we aimed to characterize those recourses.
Patients and methods This is prospective observational multicenter 
study conducted during 1 month (march 2016) in the ED and ICU of 
three hospitals of Paris suburb: Hôpital Antoine Béclère (398 beds 
university hospital), Hôpital André Mignot (702 beds) and Centre 
hospitalier intercommunal de Meulan les Mureaux (517 beds). We first 
conducted a preliminary survey describing the baseline evaluation 
of those recourses, with a questionnaire distributed to all physicians 
in the participating units. Therefater, we did a prospective work to 
characterize the reality of theses recourses. A questionnaire was 
fulfilled at each call, by the ED and the ICU physicians, blinded from 
his colleague. Finally, to evaluate the “non recourse” too, we recorded 
the characteristics of ICU patients admitted from another ward of the 
hospital, within seven days after triage in the ED.
Results Preliminary survey: 40 emergency physicians and 24 
intensivists answered (response rate: 87%). Intensivists declared that 
generally they estimate that the recourse is justified (87% of answers), 
in an appropriate timing (72%), and that they generally agree with the 
ED’s physician about the emergency level (92%).
- Recourse characterization: during the study period, there were 111 
recourses among the 12 674 patients admitted in the ED. We had 
bilateral data in 50% of cases. The mean recourse frequency was 1.2/
day, representing 1/114 patients admitted in the ED, with a great 
variation between hospitals: from 1/71 to 1/158 patients. 50% of these 
recourses occurred during daytime (8 AM to 6 PM).
Intensivist went to the ED in 81% of cases. For the remaining cases, 
a direct admission was decided in 40% of cases and a phone advice 
was given in 60%. The mean time of arrival to the ED was 10 min and 
the mean time spent in the ED was 32 min. Life sustaining treatment 
limitation was a frequent recourse’s reason (9.4%).
There was a non significant trend toward an estimation of higher 
severity by emergency physicians (37.3 vs 19.8%, p = 0.19).
The exchange’s climate was rated excellent or good in 81% of cases. It 
was more often “neutral” when an ED’s resident was calling (45 vs 5.7%, 
p =  0.048). In those cases (8% of recourses) intensivists complained 
about an insufficient supervision of the resident.
Main demand of the ED physician was an ICU admission (80%), and 
disagreement occurred in 36% of cases. Eventually, 55% of patients 
were admitted in ICU.
“Non recourse” involved 20 patients. It was estimated according to 
their file that 7 of them (40%) harbored severity signs at the initial 
ED evaluation, but the intensivist wasn’t solicited. ICU admission was 
denied for one patient despite intensivist’s evaluation and evidence of 
severity.
Discussion The ICU physicians seem to be solicited by the ED 
physicians roughly once a day. There is some “non-recourse” with 
delayed admission in ICU which could be deleterious for the patient.
The climate of medical exchanges is usually good, although this 
appreciation may be downgraded by a resident’s call.
Except for the Glasgow coma scale (which was suggested in our 
questionnaire), no severity or prognostic score was used as objective 
assessment of severity.
Life sustaining treatment limitation is a frequent reason for ICU 
recourse. These complex situations require a collegial discussion and 
recourses were estimated justified by the intensivists.
Conclusion Recourses to ICU physicians by ED physicians seem to be 
adapted and the medical exchanges happen in good relationship con-
ditions. The frequency of these recourses is very variable among hospi-
tals. ED physicians are mainly asking for an admission in ICU. Our work 
seems to point out some improvement ways, such as the use of sever-
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Introduction If French activity in emergency departments is similar 
to that of other countries, the concept of pre-hospital medicalization 
remains specific. Invasive mechanical ventilation (IMV) is a common 
practice in French pre-hospitals; however, few data is available.
Materials and methods An epidemiological study was conducted at 
two French pre-hospital departments throughout 2015 and 5 months 
of 2016. Eligible patients were those receiving IMV at pre-hospitals 
and aged >18 years. The aim was to define pre-hospital IMV practices 
and determine their consequences on mechanical and blood gases.
Results Eighty patients were included with 71.3% being men and 
middle-aged 55 years. J28 survival was 60%.
The aetiologies of intubation were 38.8% traumatic, 16.5% of cardiac 
origin, and 12.5% of brain vascular origin.
The preferred mode of ventilation was assist-control volume-control 
(98.75%). The median tidal volume was 6.9  ml/kg of predicted body 
weight (PBW; interquartile range (IQR) 6.4–7.7  ml/kg PBW) with a 
range of 5.1–10.4 ml/kg PBW. Lung protective volume ventilation was 
employed in 70.7% of patients (6–8 ml/kg PBW).
The median PEEP was 5 mmHg (IQR 5–5 mmHg). 34% of patients had 
a change of PEEP’s level compared to factory settings. The average 
respiratory rate was 15 cycles/min (SD 14–16 cycles/min).
The median FiO2 was 100% (IQR 60–100%), with 58% of patients 
exposed to FiO2 = 100%. In all, 56% of patients had hyperoxemia gases 
(PaO2: 126  mmHg, IQR 96–307  mmHg) and 56% hypercapnia gases 
(PaCO2: 46.3 mmHg, IQR 40.1–52.9 mmHg). Overall, 46.3% of patients 
needing brain protection (brain injury, stroke) had hypercapnia gases.
Discussion Lung-protective ventilation is not defined strictly by tidal 
volume between 6–8 ml/kg PBW, but is a strategy that includes PEEP, 
respiratory frequency, and FiO2 (1).
This study suggests infrequent use of PEEP titration in favour of 
delivery of a high level of oxygen and infrequent utilisation of lung-
protective ventilation in French pre-hospital medicalization.
ARDS is a syndrome that should be prevented by generalization of a 
lung-protective ventilation strategy for all of patients (2).
Conclusion French pre-hospital invasive mechanical ventilation must 
be optimized with a full strategy of lung-protective ventilation with 
regards to tidal volume, pressure, oxygenation or capnia.
A comparative study following a guided ventilation strategy is 
currently underway to determine if a ventilatory protocol would 
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Introduction Caring for patients during intra hospital transport (IHT) 
is a high-risk activity. Adverse events during transport are frequent 
and may have significant consequences for the patient. The aim of this 
study was to assess the incidence of complications occurring during 
the IHT and to analyze the causes of such complications.
Patients and methods We prospectively describe IHT from the 
emergency department, realized from January 2016 to March 2016. 
Were included in the study IHT of compromised patients for whom 
critical care monitoring was needed and emergency physician 
is required. Clinical characteristics of patient’s departure and 
technical equipments (mechanical ventilation, drugs) were noted. 
Complications were defined as follows: patient related problems 
(desaturation, haemodynamic instability, arrhythmia, extubation, 
acute change in mental status, death) and ventilator related problems 
(breakdown or defect of the material).
Results During the inclusion period, 102 IHT were carried out. The IHT 
were realized for imaging procedure in 41 cases and for transferring 
patients to the intensive care unit in 24 cases and to the other wards 
in 37 cases. The median IHT duration was 15  min [10–30]. Twenty 
patients (19%) were mechanically ventilated. The majority of IHT (60%) 
were performed by the night shift emergency team. The incidence 
of complications was 44% (45 patients). Most events were related 
to haemodynamic instability in 25 cases, desaturation in 22 cases, 
agitation in 14 cases and cardiac arrest in 2 cases and one death. 
Therapeutic interventions were volume resuscitation in 13 cases, 
optimization of sedation in 12 cases, vasopressor managment in 12 
patients and cardiopulmonary resuscitation in 3 cases.
The occurrence of complications during transport was significantly 
increased in mechanically ventilated patients (p  =  0.009), especially 
with inspiratory oxygen fraction >0.5 (p  =  0.00), sedation before 
transport (p  =  0.001), vasopressor requirement before transport 
(p  =  0.03) and with the night shift team (p  =  0.007). Sedation and 
mechanical ventilation were the independent risk factors of IHT 
complications.
Conclusion This study confirms that the intrahospital transport of 
compromised patients leads to a significant number of complications. 
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Introduction Shift work including night work is responsible for sleep 
deprivation and tiredness. The relationship between tiredness and the 
risk of medical errors is now commonly accepted. The main objective 
of this study was to evaluate the cognitive performance of emergency 
practitioners after night shift of 14 h and after work shift of 24 h and to 
compare them with tests performed after a rest night at home.
Materials and methods We conducted an observational, prospective, 
single-center, randomized and cross-over comparative study. 
Emergency practitioners (staff physicians and residents) were eligible 
if they worked at least one night from 6:30 p.m. to 8:30 a.m. (14  h) 
and a day followed by consecutive night from 8:30 a.m. to 8:30 a.m. 
(24  h) within three consecutive months. Emergency practitioners 
participated to three cognitive assessments separated by at least 
7  days: after a night of rest, after a night shift of 14  h and after a 
work shift of 24 h (including a night shift). The evaluation after night 
rest took place at least 3  days after the previous night shift. Three 
assessments were randomly assigned via sealed envelopes within 
a period of 3 months for each participant. Each participant was his 
own control and was evaluated by the same examiner. A psychologist 
formed four voluntary examiners to assess cognitive performance. 
Psycho-cognitive assessment began with self-evaluation of tiredness, 
attention, mood and lack of sleep (visual scales). Then an examiner 
evaluated participant’s cognitive performance according to the 
Wechsler Adult Intelligence Scale and the Wisconsin Card Sorting Test. 
Four cognitive skills were assessed: speed of processing information, 
working memory capacity, cognitive flexibility and perceptual 
reasoning. To test our main hypothesis, we performed an analysis of 
variance with repeated measures.
Results Forty emergency practitioners were included: 19 staff 
physicians and 21 residents. A staff physician and a resident declined 
to participate. Staff physicians were 36.2 ± 7.1 years old and residents 
were 26.8 ± 1.0 years old (p < 0.001). Average number of night shift 
per month was 4.4 ± 1.1 for staff physicians and 3.2 ± 0.6 for residents 
(p < 0.001). Amount of sleep, phone wakes up and stand ups were not 
different among staff physicians and residents. For all participants, no 
cognitive capacity was significantly altered after a night shift of 14 h 
when compared with performance after a night of rest. Conversely, 
three cognitive abilities were impaired after a work shift of 24 h when 
compared with performance after a night of rest: speed of processing 
information (11.2  ±  2.7 vs 12.4  ±  3.2; p  <  0.003), working memory 
capacity (10.1 ± 2.9 vs 11.6 ± 3.0; p < 0.001) and perceptual reasoning 
(8.4  ±  2.7 vs 10.6  ±  2.8; p  <  0.001). In absolute percentage, those 
performances were 10 to 20% lower after work shift of 24 h than after 
night of rest. Only cognitive flexibility scores were not significantly 
different in this condition. Working memory capacity was the only 
cognitive ability significantly altered after a work shift of 24 h versus 
a night shift of 14 h (10.1 ± 2.9 vs 11.6 ± 3.0; p < 0.01) whereas other 
cognitive abilities were all lower after a work shift of 24 h but without 
significant difference. Regarding the influence of medical experience, 
cognitive performance of staff physicians compared to residents were 
not statistically different after a night shift of 14  h and after a work 
shift of 24  h. There was no significant correlation between self and 
hetero assessment.
Conclusion The cognitive abilities of emergency practitioners were 
significantly altered following a work shift of 24 h whereas they were 
not significantly different from rest condition after a night shift of 
14  h. Limiting 24  h shift work for emergency department should be 
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Introduction Medical emergency team is called to provide acute care 
for compromised patients outside intensive care unit. While waiting 
for his arrival, medical ward’s physicians must initiate patient rescue.
The aim of this study was to describe clinical characteristics and out-
comes of patients who experience medical emergency team calls and 
to evaluate initial care provided in medical specialty wards.
Patients and methods It’s a two-months prospective study (03/2016–
04/2016) including all in hospital emergency calls. These calls were 
given by medical wards teams (dermatology, Gastroenterology, 
internal medicine, dermatology, cardiology and radiology) to the 
emergency physician when a deterioration in their patient’s condition 
was documented. Emergency and intensive care department 
emergency calls were excluded.
Results There were a total of 51 calls for 40 patients, principally 
hospitalized in internal medicine ward (21) and cardiology ward (14). 
Emergency calls were given by a physician in 47 cases and a nurse in 4 
cases, during the night in 32 cases (62%). The greater number of calls 
was received Monday (13) and the week- end (11). Cardiac arrest (7), 
respiratory distress (28) and hemodynamic instability (16) were the 
reason’s call. The median emergency team arrival time was 10  min. 
The majority of patients (88%) required acute care for on average 
35  min spent time. The vital signs were monitored and adequate 
therapy was initiated by the attending physician for 17 (33%) 
patients. Cardiovascular support was necessary for 24 (47%) patients, 
respiratory assistance was necessary for 3 patients. A transfer for the 
intensive care unit was indicated for 16 patients (31%) and delayed for 
13 patients because of a lack of beds. In hospital mortality was 23% 
(n = 12). In hospital cardiac arrest and coma (Glasgow coma scale ≤8) 
were the principal prognostic factors. Delayed emergency time arrival 
was not associated with a greater mortality.
Conclusion In hospital emergencies were associated with an 
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Introduction Reducing the heterogeneity of patients included in 
clinical trials for sepsis is essential. The aim of this study was to identify 
more homogeneous clusters of patients with sepsis and septic shock 
according to their initial clinical and biological characteristics.
Patients and methods All patients admitted for sepsis or septic 
shock, according to the new Sepsis 3.0 definition, were included 
from a national prospective multicenter ICU cohort. A first test set 
of patients was used in an unsupervised clustering to build clusters 
independently of patient’s prognosis. After description of mains 
characteristics of each cluster, 3  years mortality was compared with 
log rank test. A binary tree was built to assign new patients into cluster 
and evaluated using the validation set.
Results The test set included 4050 (67%) patients admitted for a first 
episode of sepsis. Six distinct clusters were identified (Fig.  7). Three 
years mortality was 21% [16–26%] for COPD exacerbation cluster, 26% 
[24–28%] for pulmonary sepsis cluster, 37% [33–40%] for surgical sep-
sis cluster, 27% [19–34%] for meningo-encephalitis cluster, 47% [41–
52%] for immunocompromised patients cluster and 47% [44–50%] 
for chronic diseases cluster (p  <  .001). Binary tree identified 6 discri-
minant variables to assign patients into clusters: lung infection, surgi-
cal admission, bronchial infection, meningeal infection, hematological 
malignancy and chronic heart failure. Identical patient profiles were 
found in the validation set.
Conclusion Six clusters of ICU patients admitted for sepsis or sepsis 
shock were identified. All clusters contained patients who met the 
new definitions of sepsis. Despite this, these clusters have a very high 
heterogeneity prognosis. Considering these clusters may improve 
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Introduction Legionnaires’ disease (LD) is an important cause 
of community-acquired pneumonia. A high mortality rate has 
been reported in the most severe LD cases, for which the optimal 
antimicrobial regimen remains controversial.
Patients and methods This is a retrospective, multicentre obser-
vational study including patients admitted to ten intensive care 
units (ICU) for severe LD over a 10-year period. Patients were strati-
fied according to the antibiotic strategy administered: (1) fluoroqui-
nolones versus no fluoroquinolones and (2) monotherapy versus 
Fig. 7 See text for description
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combination therapy. To evaluate the effect of antimicrobial strategy 
on ICU mortality, multivariable Cox model and propensity score anal-
yses were used.
Results 211 patients with LD requiring ICU admission were included. 
A fluoroquinolone-based and a combination therapy were adminis-
tered to 159 and 123 patients, respectively. 146 patients (69%) devel-
oped an acute respiratory distress syndrome, 111 (53%) a shock, 56 
(27%) an acute renal failure that required renal replacement therapy, 
and 54 (26%) died in the ICU. In-ICU mortality was lower in the fluo-
roquinolone group as compared to the no-fluoroquinolone group 
(21 vs. 39%, p = 0.01), as well as in the combination therapy group as 
compared to the monotherapy group (20 vs. 34%, p = 0.02). In mul-
tivariable analysis with covariate adjustment including a propensity 
score for fluoroquinolone treatment, a fluoroquinolone-based ther-
apy, but not a combination therapy, was independently associated 
with a reduced risk of mortality (HR 0.4, 95% CI [0.2–0.7], p = 0.002) 
(Table 7).
Discussion Our results, which suggest a beneficial effect on mortality 
of a fluoroquinolone-based therapy in patients with LD who required 
ICU admission, are consistent with previous studies showing a non-
significant trend in favor of fluoroquinolone use in patients hospital-
ized for LD [1]. The limited number of patients in our study precluded 
assessing the individual effects of distinct molecules within the fluoro-
quinolone class.
Conclusion Patients with severe LD receiving a fluoroquinolone-
based antimicrobial regimen in the early course of the management 
in ICU had a lower in-ICU mortality, which persisted after adjusting 
on significant covariates. A combination therapy did not provide 
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Introduction Data on necrotizing pneumonia in ICU are scarce. This 
potentially devastating condition is generally thought to be due to 
highly virulent bacteria such as Panton-Valentine leukocidin-secreting 
Staphylococcus aureus or to slowly-growing organisms such as 
mycobacteria and other Actinomycetales. The goal of this study was to 
describe the clinical, microbiological and radiological features of NP in 
intensive care unit.
Patients and methods Monocenter restrospective study. All patients 
hospitalized between January 1st 2009 and July 1st 2016 with an 
ICD-10-CM code for pneumonia (J1X) in an 18-bed medical ICU were 
included. All chest X-rays and CT-scans obtained during the stay 
were screened in order to select patients with NP, which was defined 
as a new cavity or a zone with no contrast enhancement within 
a pulmonary consolidation. Diagnosis was confirmed by a senior 
radiologist. Medical records of included patients were reviewed 
to describe clinical and radiological presentation, demographic 
characteristics, microbiological results and outcome.
Results Among 1009 screened pts, a definitive diagnosis of NP was 
made in 37 pts (3.7%). Median age was 57 [interquartile range 48–69] 
years, 68% were males, median SAPS2 was 43. Half of the pts were 
immunocompromised due to hematologic malignancy (7 pts), solid 
tumor (7 pts), immunosuppressive therapy (2 pts) or HIV infection (2 
pts). Eight pts had chronic respiratory disease, 8 had diabetes, 11 were 
alcoholic.
Pneumonia was community-acquired in 21 pts, including 3 pts with 
aspiration pneumonia. The remaining NP were nosocomial diseases, 
including 5 pts with ventilator-associated pneumonia. In 4 pts, 
pneumonia was considered to be acquired by hematogenous spread, 
including 1 patient with endocarditis.
Most pts had severe hypoxemia, with a median minimum PaO2/FiO2 
ratio of 153 [102–203] mmHg. Twenty-three pts were intubated, and 
median duration of mechanical ventilation was 4  days. Eighteen pts 
developed septic shock, and 3 had renal replacement therapy. In-ICU 
mortality was 32% (12 pts).
Chest CT-scan was performed in all pts but 1. One or more cavity was 
observed in 33 pts, whereas lung necrosis without excavation was 
present in 4 pts. Most pts (25) had more than one lesion, involving 
more than 1 pulmonary lobe in 22 pts and both lungs in 15 pts. 
Median size of the largest lesion was 42 [24–78] mm.
Broncho-alveolar lavage was performed in 25 pts, and bronchial 
aspirate in 18 pts. One or more pathogen was isolated in 29 pts; 
in 4 pts, the final diagnosis was non-infectious (neoplasia in 3 
pts and 1 crack lung), and all samples were sterile in 4 additional 
pts. Fifteen pts had polymicrobial infection. Overall, the most 
frequently isolated pathogen was Pseudomonas aeruginosa (9 pts), 
followed by Staphylococcus aureus (7 pts) and fungi (7 pts). Klebsiella 
pneumoniae and other Enterobacteriaceae were isolated in 5 and 6 
pts, respectively. All cases involving P. aeruginosa were diagnosed 
in immunocompromised patients. In contrast, most patients with S. 
aureus infection (6/7) and all patients with K. pneumoniae infection 
were immunocompetent.
Table 7 Univariable and  multivariable Cox model of  fac‑
tors associated with  day‑60 mortality in  patients (n =  211) 
with severe Legionnaires’ disease admitted in the ICU
I/NR included not retained, LODS Logistic Organ Dysfunction Score, HR hazard 
ratio
a Propensity score of fluoroquinolone-based treatment
Univariable analysis Multivariable analysis
HR (95% CI), p value HR (95% CI), p value
Combination therapy
 No 1 I/NR
 Yes 0.56 [0.32–0.97], 
p = 0.04
Fluoroquinolone therapy
 No 1 1




Age > 60 years
 No 1 1





 No 1 1













Page 29 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
Among pts with proven infection, none underwent surgical treatment, 
but percutaneous drainage was performed in 3 pts.
Conclusion NP was rarely observed in our ICU. In immunocompro-
mised patients, P. aeruginosa and fungi were the most frequently iso-
lated pathogens, whereas highly virulent bacteria such as S. aureus and 
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Introduction Symmetric peripheral gangrene (SPG) is a rare but 
severe complication of septic shock often leading to multiple 
amputations. Epidemiology of SPG and long-term outcome remain 
poorly known. Amputations are serious offense to body integrity but 
can benefit from rehabilitation and prosthetics. Our objectives were to 
describe epidemiology of SPG and to assess health-related quality of 
life (HRQOL) once rehabilitation was achieved.
Patients and methods A prospective and retrospective, multicentric 
study was performed. Adult patients hospitalised between 2005 
and 2015 were included. They must have undergone at least two 
major amputations (whatever the level) and been discharged in a 
specialised rehabilitation center. HRQOL was assessed with generic 
scale EQ-5D-3L by phone call. Epidemiologic data were extracted from 
hospitalization reports.
Results Nine centres on 13 participated, 30 patients were recruited 
and medical letters were available for 25 of them. SPR was observed 
in a majority of female (60%), aged around 50 yo. Mean intensive care 
unit (ICU) length of stay was 39 (±  21) days. Infectious agents were 
in majority Gram positive cocci (64%), but Escherichia Coli took an 
important part (20%), similar to Meningococcus (16%). All patients 
were amputated of the two lower limbs and 80% were quadruple 
amputees. HRQOL estimated wit EQ index was inferior to the French 
reference. However, patients rated themselves their health state as 
similar to the reference and even superior to the reference French 
value before SPG, using visual analogue scale (VAS). Main decrease 
in VAS was 22 points (95% CI 13–31). Intense pain due to phantom 
pain was the main factor of impaired EQ index. Painkillers use was 
statistically dependant of antidepressants use. All patient except one 
said they would be willing to be treated again for SPG.
Conclusion Symmetric peripheral gangrene is mainly due to Gram 
positive Cocci but also Escherichia Coli. It leads to severe amputations 
with impaired HRQOL which could be improved by better analgesic 
strategies. However patients consider themselves as being in good 
health and would be willing to be treated again. This should be taken 
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Introduction Early surgical intervention in bacterial infective 
endocarditis seems to increase survival compared with conservative 
management or delayed surgery [1]. However, in order to decrease 
the bacterial inoculum on valves, European society of cardiology 
guidelines suggest, in cases without emergency, to postpone surgery 
to allow 1 or 2 weeks of antibiotic treatment [2]. We looked for valve 
culture in a population of endocarditis in intensive care unit and we 
aimed to identify associated factor for positive valve culture and to 
study outcomes of those patients.
Patients and methods Retrospective study between 2002 and 2016 
for all consecutive adult patients who underwent cardiac surgery 
during the acute phase of definite left sided infectious endocarditis 
(Duke Criteria) in two referral centers and requiring intensive care 
unit (ICU) hospitalization. The following variables were recorded: 
demographic characteristics, echography findings before surgery 
(vegetation size, abscess…), cardiac timing surgery between the first 
adequate antimicrobial therapy and surgery and was classified as 
<7 days, 7–13 days and more than 14 days. Continuous variables were 
expressed as median and quartiles range and were compared by non-
parametric tests (Mann–Whitney U-test). Proportions were compared 
by a χ2 test. A descendant stepwise logistic regression analysis was 
performed to determine the variables independently associated 
with positive valve culture. The study was approved by the Rennes 
institutional review board (N°12–70).
Results During the study period, 165 patients underwent cardiac 
surgery. Among them, 13 had endocarditis without microbiological 
documentation and 4 had no information about valve culture. 
Finally, 148 patients were included in the study with a median age 
of 65 years [53–73], a majority of men (74%) and obesity in 23 cases 
(16%). In most cases, it was a native valve endocarditis (n  =  100, 
68%) with a predominance of methicillin susceptible Staphylococcus 
aureus (n = 50, 34%) and a majority of acute endocarditis began less 
than 1  month (n =  102, 69%). In 95 cases (64%), the vegetation size 
was measured >10  mm and abscess was noted in 74 cases (50%). 
Time between adequate antimicrobial therapy and surgery was 
14  days [5–26] and this latter was performed because of unstable 
hemodynamic condition in 102 cases (69%). Valve culture was positive 
in 46 cases (31%). Extra corporel circulation time was not significantly 
different in case of positive valve culture (120′ [97–173] vs 123′ [90–
159]). There was only 2 cases of new surgery for valve disinsertion and 
12 for tamponade.
The only factor independently associated with positive valve culture 
was the surgery performed in the week following the beginning 
of adequate antimicrobial therapy (OR 8.16, p  <  0.001) and there 
was a strong tendency for larger vegetations >10  mm (OR 2.39 
but p  =  0.066). Performing surgery in the second week was not 
significantly associated with positive valve culture. In our study, 
positive valve culture was not associated with death or post-surgical 
complications except for acute respiratory distress syndrome (ARDS) 
which was more frequent in case of positive valve culture (37 vs 
16%, p = 0.008). Overall in hospital mortality was 23%. The mortality 
of patients for which surgery was performed in the first week was 
16/50 (32%) versus 18/96 (18%) but this tendency was not significant 
(p = 0.156).
Discussion Performing early surgery was independently associated 
with positive valve culture which may be explained by the too short 
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time of antimicrobial therapy for reduction of bacterial inoculum. 
However, valve surgery in patients with positive valve culture was not 
associated with death or post-surgery complications except ARDS and 
clinicians must be aware of this risk.
Conclusion Our results suggest that valve cultures are more 
frequently positive when surgery is performed before 7  days of 
adequate antimicrobial therapy. We did not find that positive valve 
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Introduction The outcome of septic shock has undoubtedly 
improved over the last two decades, both in immunocomptetent and 
immunocompromised patients. The combination of anti-infective 
treatments and aggressive organ failure supports often allows 
stabilisation of the clinical condition, but patients become then 
exposed to intensive care unit (ICU)-acquired infectious and non-
infectious complications that significantly impact on prognosis. Whereas 
immunosuppression is commonly viewed as a major risk factor of death 
in septic shock, whether it is associated with an increased incidence 
of ICU-acquired complications is unclear. The present study aimed 
at addressing the course of septic shock across clinically significant 
subgroups of patients with and without immunosuppressive conditions.
Patients and methods This was a 8-year (2008–2015) monocenter 
retrospective study performed in a 24-bed medical ICU. All consecutive 
adult patients diagnosed for septic shock within the first 48  h of 
intensive care unit (ICU) admission were included. Septic shock was 
defined as a microbiologically proven or clinically suspected infection, 
associated with acute circulatory failure requiring vasopressors 
despite adequate fluid filling. Patients were considered either as non-
immunocompromised or immunocompromised, this latter subgroup 
being categorized in three subgroups according to the underlying 
immunosuppressive condition: solid neoplasm, hematological 
malignancy and HIV- or drug-induced cellular immunosuppression. 
Furthermore, administration of intravenous chemotherapy during 
the last 3 months and leuconeutropenia defined by leucocyte count 
<1000/mm3 and/or neutrophil count <500/mm3 were collected as 
well. Survival status was assessed at ICU and hospital discharge. We 
focused on the most likely infectious, hemorrhagic and ischemic 
complications occurring after the first 48 h in the ICU.
The impact of the underlying immune status on 3-day and late 
mortality was assessed using a cause-specific proportional hazard 
model. To assess the impact of immune status on ICU complications, 
we performed two competing risk analysis model (Fine-Gray and 
cause-specific proportional hazard model). A landmark analysis with 
the choice of a 3-day fixed landmark point was performed to correct 
for the substantial immortal time bias. The SAPS2 was used to adjust 
for admission severity.
Results Eight hundred one patients were included. Their median 
age was 59 [57–79] years. The main source of infection was the lung 
in 49.6%. About 38% of patients had underlying immunosuppressive 
conditions, distributed into solid neoplasms (15.2%), hematological 
malignancy (13.2%) and non malignant immunosuppression 
(9.6%). The overall in-ICU and in-hospital mortality rates were 
37.3% and 41.3%, respectively. With respect to the immune status, 
immunocompromised patients displayed worse outcome than 
immunocompetent ones, those with solid neoplasms having the 
highest risk of death. 113 patients died within the first 3  days, 
leaving 633 patients at risk of ICU-acquired complications. Among 
the 3-day survivors, the crude incidence rates of ICU-acquired 
infectious, ischemic and hemorrhagic complications were 27, 11 and 
9%, respectively. The incidence of secondary infections was similar 
across the immunocompetent and the three immunocompromised 
subgroups of patients. In contrast, non malignant immunosuppression 
was associated with an increased risk of ischemic complications while 
hematological malignancies were associated with an increased risk of 
bleeding.
Conclusion We herein show that patients with septic shock display 
various clinical courses in relation with their underlying immune 
status. The burden of ICU-acquired complications in septic shock calls 
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Introduction Neutropenic Enterocolitis (NE) occurs in about 5.3% 
[1] of patients hospitalized for hematological malignancies receiving 
chemotherapy. Data in critically ill patients with NE are scarce. The goal 
of this study is to describe the population of patient with NE admitted 
in ICU.
Patients and methods This retrospective study was performed in 
a 12-beds medical ICU between January 2010 and August 2016. 
All neutropenic patients hospitalized in the ICU with a diagnosis of 
enteritis and/or colitis were screened. Patients with a differential 
diagnosis (clostridium colitis, viral colitis, inflammatory enterocolitis, 
mesenteric ischemia, Graft-Versus-Host disease) were excluded. 
Univariate analysis between radiological findings, microbial 
documentation and outcomes were made with Fisher exact test 
(Software R v3.2.2).
Results We included 54 patients [male n  =  34 (63%)], aged of 53 
[31–63] years. The underlying malignancies were acute leukemia in 
26 (48.1%) patients, lymphoma in 19 (35.2%) patients, and solid tumor 
cancer in 7 (12.9%) patients. Two patients had idiopathic medullar 
aplasia. Median SAPSII and SOFA scores at admission in ICU were 
respectively 53 [44–66] and 10 [8–12]. Main reason of admission was 
sepsis [n  =  49 (91%)] with an increase in the Sepsis-related SOFA 
of 2 points or more for 51 (94%) patients. During ICU stay, 29 (54%) 
patients required mechanical ventilation, 37 (69%) patients required 
vasopressors and 13 (24%) patients required renal replacement 
therapy. Respective ICU and hospital mortality were 37 and 46.3%. 
Respective ICU and hospital median length-of-stay were 5.5 [3–15.75] 
and 39 [27–55] days.
NE occurred mainly after chemotherapy regimens containing 
cytarabine n  =  36 (66.7%) and anthracyclines drugs n  =  26 
(48.1%). Symptoms appeared after a median of 8 [5–11] days after 
chemotherapy. Median duration of aplasia was 15.5 [10–22] days. Main 
symptoms consisted in diarrhea [n  =  50 (92.6%)], abdominal pain 
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[n = 47 (87%)], oral mucositis [n = 36 (66.7%)], paralytic ileus [n = 17 
(31.5%)], nausea and vomiting [n = 14 (25.9%)]. Digestive hemorrhage 
occurred in 9 (16.7%) patients. Almost all patient had abdominal 
CT-scan (94.4%). The digestive inflammation involved ascending colon 
[n = 41 (75.9%)], transverse colon [n = 25 (46.3%)], descending colon 
or sigmoid [n =  25 (46.3%)], and small intestine [n =  12 (22.2%)]. A 
diffuse involvement (more than one segment) occurred in n  =  32 
(59.3%) patients. The other frequent signs were a peritoneal effusion 
n  =  37 (68.5%) and intra-abdominal fat infiltration n  =  19 (35.2%). 
Pneumoperitonea (n = 2) and parietal pneumatosis (n = 1) were rare.
Antibiotic therapy consisted in beta lactam (carbapenems [n  =  31 
(57.4%)], ureidopenicillins and inhibitors [n  =  18 (33.3%)], cefepime 
[n =  4 (7.4%)], ceftazidime [n =  1 (1.9%)] combined with aminosids 
[n = 41 (75.9%)], vancomycin [n = 44 (81.5%)], and ornidazole [n = 34 
(63%)]. Antifungal therapy was used for 33 (61.1%) patients. There 
was 33 (61%) bacterial and 8 (14.8%) fungal documented infections. 
Empirical antimicrobial therapy was effective in respectively 31 and 
3 cases. Most frequent pathogens were Escherichia coli (n  =  10), 
Enterococcus faecium n  =  8, Enterobacter cloacae (n  =  7), Klebsiella 
pneumoniae (n  =  6), Pseudomonas aeruginosa (n  =  3), Candida spp 
(n = 5). Infection was polymicrobial for n = 16 (29.6%). Involvement 
of small intestine including terminal ileum was associated with 
fungal infections (p = 0.01). ICU mortality was associated with fungal 
infections (p  =  0.003) and polymicrobial infections (p  =  0.03). Five 
patients underwent surgery (2 perforations, 1 digestive hemorrhage, 1 
abscess, 1 negative laparotomy), with a ICU mortality of 60%.
Conclusion NE is a life threatening complication in patients with 
malignancies who receive intensive chemotherapy. NE is associated 
with high mortality rates, especially in patients with fungal infections. 
Antifungal therapy should be systematically discussed in NE patients 
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Introduction Heart transplantation is the reference treatment of 
end-stage heart failure. National priority heart transplantation for 
severe acute heart failure has increased, leading to a change in the 
population of heart-transplant recipients (older patients with more 
comorbidities). Infectious complication is one of the biggest concerns 
after solid organ transplantation, with high rates of morbidity and 
mortality. The impact of early infectious complications has never been 
assessed in a large cohort of ICU patients. We aimed to determine 
the characteristics, the determinants and the impact of infectious 
complications after heart transplantation.
Patients and methods We retrospectively studied all consecutive 
heart-transplant recipients from Bichat university hospital, between 
January 1st, 2011 and June 30th, 2015. All infectious complications 
that occurred within 6 months after transplantation were considered 
for analysis. The early post-operative period was defined as the first 
8 days following heart transplantation. The primary endpoint was the 
rate of infectious complications at 6 months. We used multivariate 
logistic regression to identify independent risk factors for infections 
in the ICU. The impact of infectious complications on mortality 
at 3 months was determined by Cox regression analysis. Data are 
presented as median [interquartile range] or number (percentage).
Results One hundred and thirteen patients (53  years [40–62], male 
n =  86 (76.1%)) were included. At the time of heart transplantation, 
65 (57.5%) patients were hospitalized in ICU for severe acute heart 
failure and 28 (24.8%) patients were under extracorporeal membrane 
oxygenation (ECMO) support. The SOFA score on the day before heart 
transplantation was 4 [1–6]. A cytomegalovirus (CMV) mismatch 
was found in 15 (14%) recipients. Twenty-two (19%) patients had a 
multidrug-resistant bacteria (MRB) carriage before transplantation, 
and six (5.3%) acquired one during the first week in the ICU. There 
were 213 infectious complications within 6 months after heart 
transplantation in 90 (80.5%) patients. The first bacterial infection 
occurred in ICU for 66 (58.4%) patients. Pneumonia was the most 
frequent infection, accounting for 46.5% of the cases. Sixty-five 
pneumonia were diagnosed during the ICU stay, and 46 out of 65 
(70%) within the early post-operative period. By contrast, bloodstream 
infections (n = 31, 14.5%) and Scarpa infections (n = 22, 10.3%) were 
as frequent in the early post-operative period than after day eight. 
Sixty-three patients (55.8%) developed at least one infection due to 
Gram-negative bacilli, including 24 patients (21.2%) with an infection 
due to Pseudomonas aeruginosa. Thirty-five patients (31%) had a Gram 
positive cocci infection. Multi-resistant bacteria were responsible for 
infection in twenty-one (18.6%) patients. Within 6 months following 
heart transplantation, 44 (38.9%) patients had a viral complication, 
usually occurring after the early post-operative period and before day 
30 [n = 32 (28.3%)]. Fungal infection was found in 16 (14.2%) patients, 
including seven invasive aspergillosis, most of them diagnosed after 
day 30. In univariate analysis, we found that ECMO following heart 
transplantation (n = 10 (29.4%) vs n = 62 (49%) p < 0.01), day 1 SOFA 
score (8 [7–10] vs 9.5 [8–11] p  =  0.01) and mechanical ventilation 
duration (3 [1–8] vs 9 [5–15] p < 0.01) were associated with infectious 
complications in ICU. After adjustment, ECMO following heart 
transplantation was identified as the only independent risk factor for 
bacterial infection in the ICU (Odds Ratio: 3.1, 95% confidence interval 
1.4–6.9, p  =  0.006). Bacterial infection in ICU was associated with a 
longer stay in ICU (20 [13–29] days versus 12 [8–17] days, p < 0.001), 
but not with ICU mortality. Ninety-two patients (81.4%) were alive 6 
months after the transplantation, and 11 out of the 21 deaths (52.3%) 
were caused by an infectious complication. In an adjusted Cox model, 
the third not-viral infection was significantly associated with death 
at 3 months post transplantation (adjusted Hazard Ratio: 6.2, 95% 
confidence interval 1.2–31, p = 0.02).
Conclusion This study confirms the high rate of early infectious 
complications after heart transplantation. ECMO following 
transplantation is an independent factor associated with bacterial 
infections. Bacterial infection in ICU was associated with a longer stay 
in ICU. The risk of death at 3  months after transplantation increased 
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Introduction Cryptococcosis is a well-known opportunistic infection, 
especially in HIV-infected patients with profound immunosuppression. 
However, data regarding presentation and prognosis of severe forms 
of cryptococcosis requiring intensive care unit (ICU) admission are 
scarce.
Patients and methods We performed a retrospective multicenter 
study including all patients admitted for cryptococcosis from January 
1998 to March 2016 to one of the 11 participating ICUs. Admissions 
were identified through a systematic review of ICUs databases using 
ICD-10 code B45. Diagnosis was confirmed either by cryptococcal 
antigen detection in serum, cerebrospinal fluid, bronchoalveolar 
lavage or urine, or by the identification of Cryptococcus in the culture 
of a specimen of any site or by histology. Qualitative and quantitative 
values are expressed as number and percentage, and median and 
interquartile range, respectively. Comparisons between ICU-survivors 
and –non survivors were performed using Fisher’s exact test and 
Mann–Whitney test for qualitative and quantitative variables, 
respectively. A p-value <0.05 was considered to be significant.
Results Seventy-three patients (age 44 [37; 52] years, 58 (79.5%) male, 
SAPS II: 42 [31; 59], SOFA score at day one: 4 [1;7]) were included. 
Twenty-five (34.2%) of them reported previous opportunistic 
infection. HIV infection was the leading cause of immunosuppression 
(n =  58 (79.5%), median CD4 count: 12 [6; 40]/mm3) and was newly 
diagnosed in 30 (51.7%) patients. The remaining patients broke as 
follows: immunosuppressive therapy for auto-immune disease (n = 6) 
or solid organ transplantation (n = 4) or nephrotic syndrome (n = 1), 
cirrhosis (n  =  1), primary hypogammaglobulinemia (n  =  2) and 
diabetes mellitus as the only underlying comorbidity (n = 1). Impaired 
consciousness (68.5%) was the first reason for ICU admission, followed 
by acute respiratory failure (21.9%), shock (8.2%) and acute renal 
failure (1.4%). Time from first symptoms to diagnosis was 7 [3; 21] days, 
and was 9 [4;25] days from first symptoms to ICU admission.
Central nervous system was the most frequently infected site [n = 62 
(84.9%)] with meningo-encephalitis (n  =  60 patients) and brain 
abscesses (n = 8). Lung was the second more frequent site of infection 
(n = 14). Other localisations included skin, heart, urinary tract, pleura 
and spleen. In 23 patients (31.5%), at least two sites were infected. 
Fungemia was observed in 17 patients (23.2%).
Invasive mechanical ventilation was required in 34 (46.6%) patients, 
vasopressors in 18 (24.7%) and renal replacement therapy in 10 
(13.7%). Median ICU length of stay was 4 [3;12] days. ICU mortality was 
41.1%.
Factors associated with ICU death were: infection of at least 2 sites 
(OR 5.1 [1.8; 15.2], p  =  0.0038), SAPS II and SOFA score at day one 
(p  <  0.0001), need for invasive mechanical ventilation (OR 18.9 
[5.6;63.3], p  <  0.0001), need for vasopressors (OR 41.3 [10.3;769.6], 
p  <  0.0001) and renal replacement therapy (OR 7.5 [1.5;38.2], 
p =  0.013). Neither HIV status (p =  0.77) nor previous opportunistic 
infection (p = 0.80) was associated with ICU mortality.
Discussion Because of the limited number of non-HIV-infected 
patients, the study was not powerful enough to analyze clinical 
presentation according to HIV status.
Conclusion Severe forms of cryptococcosis requiring ICU admission 
are mostly observed among HIV-infected patients. However, one in 
five patients has another cause of immunosuppression, principally 
immunosuppressive therapy for auto-immune disease or solid organ 
transplantation. Central nervous system is the most common site 
infected. ICU mortality is high and associated with disseminated 
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Introduction Rare opportunistic (non-Candida, non-Cryptococcus) 
yeast bloodstream infections (ROYBSIs) are rare, even in intensive 
care unit ICU. Candida lipolytica candidemia is a rare but an emerging 
pathogenic yeast infection in humans. It can gain access to the 
bloodstream through intravascular catheterization, especially through 
central venous catheters in immunocompromised or critically ill 
patients during hospitalization.
Patients and methods We retrospectively reviewed all episodes of 
unusual cases of Y. lipolytica fungemia occurred between October 
2012 and June 2014 in the intensive care unit (ICU) of the UH Habib 
Bourguiba Sfax Tunisia. Underlying diseases, predisposing factors, 
laboratory data, and outcome were analyzed.
Results During this period, 55 cases of Y. lipolytica septicemia were 
diagnosed. There were 46 men and 9 women (sexratio  =  5). The 
median age was 44.8 ± 19.8 years. The SAPS II was 40, 22 ± 12, 85 
points. The catheterization (96%), mechanical ventilation (96%), the 
broadspectrum antibiotics (89%) and the prolonged hospitalization 
in ICU (78%) were the main risk factors. Patients were hospitalized 
in ICU, mostly, for polytraumatism (60%), acute respiratory failure 
(14.5%), and post-operative complications (9%). Fever unresponsive 
to broadspectrum antibacterial therapy was the predominant sign 
of infection (69%). Candida score was 1.85 ± 0.97 point. Pittet index 
was realized in 30 patients (54.5%). It was positive in 11 patients 
(36.6%). Preemptive treatment was indicated in 10 patients and 
was based on intravenous amphotericin B (50%) and fluconazole 
(50%).
The delay of fungemia was 18.73  ±  12.4  days. In our study, the 
most Y. lipolytica isolates are susceptible to fluconazole (73%) and 
amphotericin B (99%). The mortality rate in ICU was 45.5%.
Moreover, comparison between survivors and deceased showed 
that factors associated with deaths were: high SAPS II score on ICU 
admission, high SOFA score on the day of fungemia, a kidney failure 
and the presence of shock.
Conclusion In conclusion, although non-Candida fungemia is a rare 
clinical entity, it can develop in immunocompromised patients, and 
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Introduction Despite decades of research and significant 
improvement in medical management, septic shock remains a major 
health care burden and a leading cause of death worldwide. The aim 
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of this study is to determine recent national trends in occurrence of 
septic shock (SC) and SC-related deaths and costs.
Patients and methods We analysed the occurrence of sepsis from 
2009 to 2014, in adult patients, using the national French hospital 
Database PMSI (Programme de Médicalisation des Systèmes 
d’Information). This database collects annually, for each hospital stay 
in France, a uniform hospital discharge record including diagnostic 
codes according to the International Classification of diseases, Tenth 
revision, Clinical Modification (ICD-10th-CM) and procedure codes 
according to the CCAM (Classification Commune des Actes Médicaux).
Cases were identified from discharge records in the PMSI database. 
Septic shock was defined by a combination of a principal or 
accompanying diagnosis of infection (ICD-10thCM) plus a diagnosis 
code for septic shock (R572, R578, R579) or the procedure code 
EQLAFF03 (infusion of vasopressors). Charlson index were determined 
using diagnosis codes as previously described [1].
Costs were determined according to the National Reference Costs 
(ENC  =  Etude Nationale des Couts). Temporal trend were assessed 
by calculating the value of the entire variable by year and compared 
using linear regression variables or Cochran Armitage Trend Test for 
continuous and categorical variables respectively.
Results A total of 25,444,627 adults aged ≥ 18 years were hospitalized 
in France during 2009–2014. Among them we identified 419,597 
(10.3%) patients with SC. There was an annualized increase in the 
incidence of SC from 87 to 122/100,000 inhabitants p  <  0.001). 
Only 25% of the cases were hospitalized in an affiliated university 
centre. Sepsis was more frequent among men (62.8%) than among 
women (37.2%). Overall the SAPS2 score was (median [interquartile 
range  =  IQR] 49 [36–65]. Charlson comorbidities index decreased 
significantly over time (p < 0.001). 58.6% of the cases were considered 
as medical. Nearly all the patients were admitted from the emergency 
department (75.9%) or from wards (20.1%). About 80% of the 
patients were hospitalized at least 1  day in Intensive Care Units and 
of note this percentage decreased consistently over time from 85.6 
to 79.7%. Concomitantly admission at least 1  day in intermediate 
care unit (from 24.9% to 33.6%) or in specialized wards such as onco-
hematology (from 0.6% to 3.1%) increased over time. Overall, the 
main comorbidities reported were congestive heart failure (27.6%), 
cerebro-vascular disease (8.7%), Chronic Pulmonary Disease (15%), 
dementia (2.9%), renal disease (11.3%), diabetes without (6.3%) and 
with complications (5%) and cancer (16.9%), mild liver disease (8.5%). 
The main sources of sepsis were pulmonary (39.2%), abdominal (12%), 
urinary (15.6%), and cutaneous (3.2%), cardiac (3.1%), neurological 
(1.1%), and osteo-articular (1.6%). Gram-negative bacteria were 
the predominant organisms causing sepsis (from 27.6% to 38.8%) 
but gram-positive bacteria were reported most commonly in each 
subsequent year as well (from 20.8% to 26.4%). The length of ICU and 
hospital stays were 9 [3–19] and 18 [8–35] days respectively and both 
decreased over time (p  <  0.001). Mortality rates slightly decreased 
over the 6-year period (from 41.7% to 38.7%). However the in-hospital 
deaths related to sepsis increased over time from 433 to 571/10,000 
deaths in France (p < 0.001). The average costs per case were 14,453€ 
[7460–25,041] decreasing over time from 15,291 [7637–26,136] to 
14,171 [7593–24,194].
Conclusion SC incidence increased in France. Nearly 75% of the cases 
were managed in non-affiliated university centre. Although the overall 
mortality rates in patients with SC is slightly decreasing in France, the 
number of deaths related to SC in France is growing.
Results must be interpreted with caution because of the limits related 
to administrative databases. However, the trends are comparable to 
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Introduction Since 2015, Zika virus (ZIKV) infection is spreading across 
South and Central America. The outbreak reached the Caribbean in 
the early 2016. The aim of this study is to describe the characteristics 
and outcome of patients with severe complications of ZIKV requiring 
intensive care unit (ICU) admission.
Patients and methods We performed a prospective observational 
study in the ICU in the University Hospital of Guadeloupe from May 
15th to September 15th 2016. All patients with an acute ZIKV infection 
confirmed either by Real Time PCR (RT-PCR) or IgM detection in the 
serum were included. In patients presenting with an acute neurologic 
disease, extensive laboratory testing, CSF analysis, brain MRI and 
electromyography testing were performed according to a predefined 
protocol, in order to rule out others diagnosis. Patients with Guillain-
Barré syndrome (GBS) were treated with intravenous immunoglobulins 
0.4 mg/kg/day during 5 days.
Qualitative data are presented in percentage and quantitative data in 
medial [interquartile range].
Results During the study period, 19 patients with proven ZIKV 
infection were admitted to the ICU: 10 (53%) men, median age 59 
[37–73] years, SAPS-2 30 [21–37]. Main comorbidities were chronic 
hypertension (47%) and diabetes (32%). One patient (5%) was 
immunocompromised and 6 (32%) had no comorbidities.
Among the 19 patients, 15 (79%) were admitted for an acute 
neurological disease, namely GBS in 10 (53%) patients and encephalitis 
in 5 (26%) patients. The remaining 4 (21%) patients were admitted 
for COPD exacerbation, lupus exacerbation, myasthenia gravis and 
metformine intoxication complicated with auto-immune hepatitis.
Clinical symptoms of ZIKV infection such as fever, arthralgia, 
cutaneous rash, conjunctivitis were identified in 11 (58%) patients. 
The time between symptoms onset and ICU admission was 7 [5–10] 
days. Among the 15 patients with neurological diseases, the time 
between the onset of neurological symptoms and ICU admission was 
3 [2–5] days. ZIVK RT-PCR was positive in urine in 15 (79%) patients, in 
blood in 2 (11%) patients and in CSF in 1 (5%) patient. Serum IgM were 
detected in 10 (53%) patients.
CSF was obtained in the 15 patients with neurological diseases. For 
the 10 patients with GBS, white cell count was 3 [1–5]/mm3, protein 
level was 1.4 [0.8–1.9] g/L, glucose level 4.8 [4.3–5.3] mmol/l. For the 
5 patients with encephalitis, white cell count was 65 [24–180]/mm3, 
protein level was 0.6 [0.4–1.1] g/L, glucose level 5.5 [4.1–6.1] mmol/l.
Brain MRI abnormalities were observed in 4 (21%) patients, and 
myelitis was observed in one patient.
Fourteen patients (79%) had mechanically ventilation for median 
length of 12 [6–22] days. Among them 4 (21%) were tracheotomised 
because of prolonged mechanical ventilation. Six (32%) patients 
received vaso-active drugs, and 2 (11%) required renal replacement 
therapy. ICU length of stay was 12 [7–25] days. Five (26%) patients 
stayed more than 30  days in the ICU: 3 patients with GBS, 1 patient 
with encephalitis, 1 other patient. Three (16%) patients died in the ICU.
Conclusion As previously reported, ZIKV infection is responsible 
for neurological complications [1]. In particular, the GBS has been 
observed in a previous epidemic in French Polynesia [2]. Our data 
confirmed the association between ZIKV infection and GBS, as the 
annual incidence of GBS in our ICU is usually 3–5.
Interestingly, several cases of encephalitis were observed, which has 
not been reported previously.
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These are preliminary data. As the outbreak is still ongoing in the 
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Introduction Supplemental oxygen has been used in the 
management of patients with acute coronary disease and investigated 
for more than a century [1]. The rational for a systematic oxygen 
supply in patients with acute coronary syndrome is based on a 
limited number of data. The links between hypoxia and ischemic or 
arrhythmic electrocardiographic abnormalities have been known 
for a long time. The risks associated with hyperoxia have been well 
described in physiological studies (increased coronary resistances, 
decreased coronary blood flow). A recent large RCT demonstrated that 
liberal oxygen administration during the acute phase of myocardial 
infarction may increase the level of cardiac enzyme and the infarct size 
[2].
FreeO2 is a recently developed device that automatically titrates 
oxygen flowrate with the aim to maintain constant the SpO2, around 
the target set by the physician. We evaluated two SpO2 targets using 
automated oxygen titration with FreeO2 during acute coronary 
syndrome and evaluated oxygenation delivered with usual manual 
oxygen therapy. Our hypotheses were that high rates of hypoxemia 
and hyperoxia would occur with manual titration, and would be 
reduced with automated oxygen titration.
Patients and methods We conducted a pilot randomized controlled, 
single blind monocentric study to evaluate oxygen therapy 
administration at the acute phase of acute coronary syndrome. 
Patients with acute coronary syndrome were included (based on 
AHA criteria). Severe COPD patients were excluded. Patients were 
randomized one of the three arms: Automated oxygen titration 
with FreeO2 at two different SpO2 targets (92 and 96%) and manual 
administration of oxygen.
The study lasted a maximum of 24  h for each patient, including one 
night. All patients were continuously monitored with FreeO2 (set in 
recording mode in the manual group), continuous cardiac telemetry 
was performed for all patients, cardiac enzymes were collected as per 
usual care.
The primary outcome was the frequency of desaturation (SpO2 < 90% 
for 30 s). The secondary outcomes were the frequency of arrhythmias, 
the rate of tachycardia episodes and the level of cardiac enzymes in 
patients with acute coronary disease.
Results Sixty patients were included in the study, the mean age was 
63 ± 12 years, 73% of the patients were men. The average recording 
time was 11.5 ± 2.8 h. Preliminary data are presented here.
–21 patients were included in the control group (manual adjustment 
of oxygen therapy).
–20 patients were included in the FreeO2 group with SpO2 
target = 92%.
–19 patients were included in the FreeO2 group with SpO2 
target  =  97% (including one case of missing data due to technical 
issues).
Primary end point (rate of hypoxemia): The percentage of time with 
hypoxemia (SpO2 < 90%) was 4% of the recording time (equivalent to 
30  min) in the control group, 1.2% of the recording time (equivalent 
to 9  min) in the FreeO2 (92%) group and 0.4% of the recording time 
(equivalent to 2.5  min) in the FreeO2 (97%) group (manual vs. 92%, 
p = 0.58; manual vs. 97%, p = 0.001; 92 vs. 97%, p = 0.006).
57% of the patients in the control group, 30% in the FreeO2 (92%) and 
22% in the FreeO2 (97%) experienced desaturation below 90% for 
more than 30 s (manual vs. 92%, p = 0.08, manual vs. 97%, p = 0.027).
The rate of severe hypoxemia (SpO2 < 80 and 85%) were reduced with 
FreeO2 (97%).
The rates of ventricular extrasystoles were 43, 35, 6%, p  <  0.001 and 
atrial extrasystoles were 28, 20 and 17%, p = 0.15 for manual titration, 
FreeO2 (92%) and FreeO2 (97%) respectively.
The mean maximal heart rate was 96  ±  15, 86  ±  10 and 82  ±  13, 
p  =  0.018 for manual titration, FreeO2 (92%) and FreeO2 (97%) 
respectively.
There was no differences in hospital length of stay between the groups 
and the mortality was 0% in all groups. Other data are under analysis.
Conclusion Automated oxygen titration with FreeO2 with SpO2 target 
set at 97% reduced the rate of desaturation and severe desaturation in 
patients managed for acute coronary syndrome.
Automated oxygen titration with FreeO2 with SpO2 target set at 97% 
reduced the rate of ventricular extrasystoles.
SpO2 target set at 92% with FreeO2 may not be sufficient in this 
population.
With manual titration the risk of hypoxemia and severe hypoxemia was 
increased, however, the rate of significant hyperoxia was not increased 
in this study and could not be evaluated.
Additional data are required to evaluate intermediate levels of 
oxygenation target and potential impact in this population.
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Introduction During acute circulatory failure, volume expansion 
(VE) aims at increasing cardiac output (CO). However, CO is seldom 
measured to manage VE [1]. Increase in systolic, mean and pulse 
arterial blood pressure (ΔveSBP, ΔveMBP and ΔvePP) or decrease 
in heart rate (ΔveHR) are often used as surrogates for VE-induced 
increase in CO (ΔveCO) despite their poor performance.
VE-induced changes in end-tidal carbon dioxide (ΔveEtCO2) could be 
a surrogate for ΔveCO. Indeed, EtCO2, the amount of exhaled carbon 
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dioxide (CO2), depends on CO2 production by body tissues, its delivery 
by CO and its elimination by alveolar ventilation. If, during VE, alveolar 
ventilation is kept unchanged, i.e., during fully controlled ventilation, 
and if we hypothesize that CO2 production only mildly changes, then 
ΔveEtCO2 may reflect ΔveCO [2].
Other appealing surrogates were also scarcely evaluated: Doppler 
measurements of VE-induced increase in femoral artery flow 
(ΔveFemFlow) or, provided the absence of inspiratory efforts and 
arrhythmia, VE-induced decrease in respiratory pulse pressure 
variation (ΔvePPV).
The objective of this study was to compare ΔveEtCO2, ΔveFemFlow, 
ΔveSBP, ΔveMBP, ΔvePP and, when applicable, ΔvePPV and ΔveHR as 
surrogates for ΔveCO for the identification of patients who responded/
did not respond to VE.
Patients and methods Adult patients were prospectively included if 
(1) they already had an arterial line, (2) they were receiving controlled 
mechanical ventilation, (3) their blood pressure (BP) was stable over 5 
min, (4) the attending physician prescribed a VE and (5) presence of 
at least one criterion suggesting acute circulatory failure: hypotension 
(invasive systolic BP < 90 mmHg and/or mean BP < 65 mmHg), oliguria 
(<0.5 ml kg h−1) considered to be related to circulatory failure, arterial 
lactate >2.5 mmol L−1, skin mottling, or vasopressor and/or inotropic 
drug infusion.
CO was measured by trans-thoracic echocardiography and was 
the average of 2 sets of 3 (5 in case of arrhythmia) consecutive 
measurements started from the velocity time interval of highest 
magnitude. EtCO2, displayed on the ventilator, was collected at a 
glance, once at each study phase.
Femoral velocity time interval was measured with a 5-MHz linear 
echographic probe to quantify flow. Other definitions were tested for 
femoral flow: magnitude (peak) of the femoral pulse wave.
The ability to identify patients responding or not to VE (ΔveCO ≥ 15%) 
was evaluated by calculation of the areas under the receiver operating 
characteristic curves (AUCROCs).
Results In 109 patients included, poor thoracic insonation 
prevented CO measurements in 22 (20%). One patient was excluded 
because of change in minute ventilation >0.2 L/min during the 
study protocol.
In the 86 remaining patients, the AUCROC for ΔveEtCO2 was 0.82 
[0.73–0.90], significantly higher than for ΔvePP, ΔveSBP, ΔveMBP and 
ΔveFemFlow, whatever its definition (AUCROC 0.61–0.65, all p < 0.05). 
A ΔveEtCO2  >  1  mmHg had good positive (5.0 [2.6–9.8]) and fair 
negative (0.29 [0.2–0.5]) likelihood ratios. Arrhythmia was of little 
impact on the reliability of ΔveEtCO2: the 16 patients with arrhythmia 
had similar relationship between ΔveEtCO2 and ΔveCO than regular 
rhythm patients (r2 = 0.23 in both subgroups).
In 60 patients with no arrhythmia, ΔveEtCO2 (AUCROC =  0.84 [0.72–
0.92]) outperformed ΔveHR (AUCROC = 0.52 [0.39–0.66], p < 0.05) and 
tended to outperform ΔvePPV (AUCROC = 0.73 [0.60–0.84], p = 0.21). 
In the 45 patients with no arrhythmia and receiving a tidal volume 
<8  ml/kg of ideal body weight, ΔveEtCO2 was of significantly better 
performance than ΔvePPV: AUCROC = 0.86 [0.72–0.95] vs. 0.66 [0.49–
0.80], p = 0.02.
Conclusion ΔveEtCO2 outperformed ΔvePP, ΔveSBP, ΔveMBP, 
ΔveFemFlow and ΔveHR, and, in case of protective ventilation and/or 
arrhythmia, also outperformed ΔvePPV. ΔVEEtCO2 > 1 mmHg indicates 
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Introduction Patient admitted to the ICU for refractory cardiac arrest 
can currently be managed using peripheral veno-arterial extracorporeal 
life support (ECLS) [1]. Because of impaired venous in-flow, occurrence 
of intra-abdominal hypertension (IAH), that is, intra-vesical pressure (IVP) 
above 12 mmHg), can compromise ECLS efficiency [2]. We hypothesized 
that prompt diagnosis and treatment of IAH among patients under ECLS 
for refractory cardiac arrest may improve ECLS performance and clinical 
outcome. We aimed to describe critically ill patients requiring ECLS for 
refractory cardiac arrest and presenting with IAH.
Patients and methods This was a retrospective study of patients admit-
ted to the ICU of the Besançon University Hospital, between January 
2010 and August 2016, who develop IAH under peripheral veno-arterial 
ECLS for refractory cardiac arrest. We collected data about diagnosis and 
treatment of IAH, ECLS performance, and patient outcome. Descriptive 
analysis was performed. Quantitative variables were expressed as median 
[interquartile range] and qualitative variables as number (percentage).
Results During the study period, 202 patients (4% of the patients) were 
admitted to our ICU with femoral veno-arterial ECLS. Indication of ECLS 
was refractory cardiac arrest in 97 patients (48%), and among them, 
28 (29%) developed IAH. Data were available for 27 patients who were 
included in the analysis. Maximum IVP was 22 [17–25.5] mmHg, which 
was reached 12 [5–19.5] h after ECLS onset. IVP was above 20  mmHg 
in 56% of cases. Curarization was initiated in 22 patients (81%). Ten 
patients (45%) required additional rescue laparotomy which was per-
formed 2.5 [2–5] h after the diagnosis of abdominal compartment 
syndrome. ECLS parameters during maximum IAH and their improve-
ment after efficient treatment were presented in Fig. 8. Clinically, there 
was a transient improvement of hemodynamic status after treatment, 
but hepatic and renal failures persisted. In our cohort, in-ICU mortality 
reached 100%. Deaths occurred after a median duration of ECLS of 32 
[12–69] h, and because of refractory multi-organ failure in 82% of cases.
Conclusion Among patients under ECLS for refractory cardiac arrest, 
IAH is frequent, occurs early, and is associated with an extremely poor 
prognosis. IAH treatment is associated with an improvement of ECLS 
outflow and hemodynamic status. IAH among patients presenting 
with refractory cardiac arrest might be a strong prognostic factor per 
se. It’s not excluded that early and efficient treatment of IAH, before 
occurrence of abdominal compartment syndrome, might improve the 
overall prognosis of critically ill patients under ECLS for cardiac arrest.
Competing interests
None.
Fig. 8 Comparison of ECLS parameters during IAH and after efficient 
treatment of IAH
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Introduction Variable intensity systemic anticoagulation with 
unfractionated heparin is routinely used in patients undergoing extra 
corporeal membrane oxygenation (ECMO) to offset the increase risk 
of thrombosis in this population. Bleeding remains the most frequent 
complications and is independently associated with worse outcomes. 
Therefore, determining optimal anticoagulation to prevent thrombosis 
whilst minimising bleeding in adults on ECMO is a priority. This pilot 
study aims to evaluate the feasibility of allocating patients on ECMO in 
two different anticoagulation patterns group resulting in a difference 
in anti-coagulation level.
Patients and methods This is a randomised, controlled, unblinded 
pilot trial at two intensive care units. We enrolled critically ill patients 
who required ECMO (venous–venous [VV] or venous-arterial [VA]). We 
randomly assigned patients to therapeutic anticoagulation with heparin 
(target activated partial thromboplastin time [aPTT] between 50 and 
70  s) or low dose heparin (12,000 units/24  h aiming for aPTT  <45  s). 
Paired aPTT and anti-Xa assays were taken at a minimum once a day. The 
primary endpoints for feasibility were difference in mean heparin dose, 
aPTT and anti-Xa levels. All primary outcomes were log-transformed 
prior to analysis and reported as geometric means (95% CI) with overall 
differences determined using Repeat measures ANOVA.
Results Between May 2014 and March 2016, 31 patients who 
underwent ECMO (9 VA and 22 VV) were enrolled; 16 were randomised 
to low dose and 15 to therapeutic dose heparin. The groups were similar 
in age (mean 41 years [SD 16.8] vs 43 [SD 17.6] p = 0.75), gender (68 vs 
80% male, p = 0.47), type of ECMO (31 vs 27% VA, p = 0.78) and severity 
sepsis-related organ failure assessment score (mean 10 [SD 3.6] vs 10 
[SD 3.3], p = 1.0). The mean duration of ECMO support was 9.33 days 
(SD 5.97) in the low dose and 9.79  days (SD 4.77) in the therapeutic 
dose group (p = 0.82). For the primary outcomes, there was a significant 
difference in the daily mean aPTT (48.1 [95% CI 43.5–53.3] vs 56.2 [95% 
CI 50.7–62.3], p = 0.03), daily mean anti-Xa (0.11 [95% CI 0.07–0.18] vs 
0.30 [IQR 0.19–0.46], p =  0.003) and daily mean heparin dose (11,784 
units [95% CI 8693–15,972] vs 22,050 [IQR 16,262–29,899], p = 0.004) in 
the low dose compared to therapeutic group. There was no difference in 
thrombotic and bleeding complications between study groups.
Conclusion In this pilot trial, administration of a low dose heparin 
protocol was feasible, and resulted in a significant difference in 
mean heparin dose administered and daily aPTT and anti-Xa levels 
between groups. Our findings support the feasibility of a larger 
study to evaluate the safety and efficacy of low-dose anticoagulation 
compared with therapeutic heparin with regard to thrombotic and 
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Introduction Ventilator-associated pneumonia (VAP) is a frequent 
complication in Intensive Care Unit (ICU) patients.
In the specific case of patients treated with Veno-Arterial 
Extracorporeal Life Support (VA-ECLS), epidemiology and risk factor of 
VAP treatment failure (VAP-TF) have been incompletely investigated. 
The objective of this study was to describe the epidemiology of VAP 
and investigate the risk factors of treatment failure (VAP-TF) in a large 
cohort of ICU patients treated with VA-ECLS.
Patients and methods All patients treated with a VA-ECLS between 
January 2013 and December 2014 were systematically included in 
the SARIC database. We retrospectively investigated all patients who 
developed a VAP during VA-ECLS. Diagnosis of VAP was confirmed 
by a positive quantitative culture of a respiratory sample. VAP-TF was 
defined as composite of death attributable to pneumonia and relapse 
within 28 days of the first episode. Incidence, risk factors and impact 
on outcomes were analyzed.
To describe the population, Chi square test (categorical variables), 
Student t-test and Man Whitney tests (continuous variables) were 
used for statistical analysis. Statistical significance was defined as 
p < 0.05. Stepwise logistic regression was subsequently led to analyze 
risk factors for VAP treatment failure, with a threshold of p  <  0.1 for 
inclusion in the model.
Results At all, 162 patients underwent ECMO support for >48  h. 
During the VA-ECLS support, 86 (53%) patients developed a VAP. The 
ICU-mortality was 57%. The median time to onset of VAP was 3 days 
after the beginning of mechanical ventilation. The main pathogens 
identified were Gram-negative Bacilli, Pseudomonas aeruginosa or 
enterobacteriaceae being involved in 80% of cases.
VAP-TF occurred in 28 (32.6%) patients. The Pseudomonas aeruginosa 
infection was the only risk factor for VAP-FT identified, odds ratio (OR) 
3.7 (95% CI [1.4–10.6]; p = 0.02). The Renal Replacement Therapy (RRT) 
trended to increase the risk of VAP-TF, OR 3.4 (95% CI [1.0–12.0]; p = 0.05). 
In the subgroup of patients with Pseudomonas aeruginosa pneumonia 
(PA-VAP), neither the duration of antibiotic therapy nor the use of a 
combination of antibiotics was associated with VAP-TF. Changes in 
clinical or biochemical parameters from the VAP diagnosis (day 0) to day 
14, such as leukocytes, procalcitonin, temperature, blood oxygenation, 
VA-ECLS flow or pump rotational speed, were not able to predict VAP-T. A 
VAP relapse was associated with an increased of duration of mechanical 
ventilation, VA-ECLS support duration and length of ICU or hospital stay. 
With this sample size, mortality was not impacted by VAP.
Discussion In this large cohort, VAP occurs early during VA-ECLS 
support while identified pathogens are those known to be 
involved for late-onset VAP. It could be explained by a very 
co-morbid status of patients in cardiac surgery ICU. VAP-TF occurs 
in 30% of patients, especially in PA-VAP while no guideline exists 
for the adequate antibiotic regimen and duration in patients 
treated with VA-ECLS. In addition, renal replacement therapy 
trends to increase VAP-TF. Antibiotics pharmacokinetics variations 
related to VA-ECLS and/or RRT support may contribute to this poor 
efficacy of VAP treatment.
Conclusion VAP in patients treated with VA-ECLS is associated with 
an important morbidity, and infection by Pseudomonas aeruginosa 
appears as a strong risk factor of treatment failure. Further studies 
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Introduction ICU-acquired infections are common in critically ill 
patients and result in prolonged ICU-stay and increased healthcare 
costs. Moreover, the necessary antibiotic treatment may lead to a 
selection of multiresistant bacteria. Therefore, health authorities 
mandate the registration of specific nosocomial infections such as 
ventilator-associated pneumonia and catheter-related blood stream 
infections and wound infections. Unfortunately, there is no unified 
definition of nosocomial infection and its incidence depends on the 
screening intensity.
We therefore hypothesized that a computer algorithm using the 
prescribed antibiotic treatments may be an objective alternative for 
the detection of nosocomial infections.
Patients and methods As a gold standard, infections were scored by 
an infectious disease specialist.
The Java algorithm uses the following inputs: patient identifier, admis-
sion/discharge day, antibiotic name/dose/route of administration, 
administration days of antibiotics. The algorithm distinguishes infec-
tions on admission and nosocomial infections.
The algorithm was trained and validated in data sets of critically ill 
adults (ICU) and children (PICU) admitted to the ICU of the University 
Hospitals Leuven between 2012 and 2015.
Results In the training sets 314/335 PICU-patients and 352/383 
ICU-patients received antibiotics. Gold standard scoring yielded a 
nosocomial infections rate of 11% in the PICU and 16% in the ICU-
population. When the criterion of at least 2 days of antibiotics beyond 
the prophylactic spectrum, the algorithm yielded a nosocomial 
infection rate of 23% (PICU) and 21% (ICU). A True Positive Rate of 
0.917, a False Positive Rate of 0.084, a Positive Predictive Value 0.671 
and a Negative Predictive Value of 0.983 were achieved.
In the validation set only adult data were used. 384/408 patients 
received antibiotics. 55 had a nosocomial infection and 91 an infection 
on admission by gold standard measurement. Here a True Positive 
Rate of 0.873, a False Positive Rate of 0.067, a Positive Predictive Value 
0.705 and a Negative Predictive Value of 0.976 were obtained. For 
scoring infections on admission the algorithm had a True Positive Rate 
of 0.785, a False Positive Rate of 0.058, a Positive Predictive Value 0.843 
and a Negative Predictive Value of 0.917.
Discussion Sensitivity (TPR) and specificity (1-FPR) are comparable 
and acceptable around 0.85–0.90 for an algorithm that scores 
nosocomial infections with limited input variables. In its current 
settings it could serve as elimination tool for patients who definitely 
do not have a nosocomial infection. Infectious disease specialists 
can then focus on remaining patient files for scoring nosocomial 
infections.
Sensitivity needs to be increased while maintaining specificity for 
actual use in an environment with varying antibiotic prescription prac-
tices. The algorithm should also be further validated in lager datasets 
for different ICUs.
Conclusion In this proof-of-concept study, a computer algorithm was 
shown to be an acceptable alternative to trained infectious disease 




Temporal trends in ICU‑acquired bacteremia due to Staphylococcus 
aureus annual incidence in a French national ICU network
Sébastien Bailly1, Jc Lucet2, Alain Lepape3, François L’hériteau4, Martine 
Aupée5, Caroline Bervas6, Sandrine Boussat7, Anne Berger‑Carbonne8, 
Anaïs Machut9, Anne Savey10, Jean‑François Timsit11, REA‑RAISIN study 
group 
1Iame team 5, INSERM UMR 1137, Paris, France; 2Hygiène hospitalière, 
Hôpital Bichat‑Claude Bernard (AP‑HP), Paris, France; 3Réanimation, 
Hospices Civils De Lyon, Lyon, France; 4Médecine interne, Hôpital 
Bichat‑Claude Bernard (AP‑HP), Paris, France; 5Hygiène hospitalière, C.H.U 
de Rennes, Rennes, France; 6Pharmacie, CHU ‑ Hôpitaux de Bordeaux, 
Bordeaux, France; 7Réanimation, CHRU Nancy, Nancy, France; 8Dgos, 
Ministère des Affaires sociales et de la Santé, Paris, France; 9Cclin sud 
est, Hospices Civils De Lyon, Lyon, France; 10Cclin, Hospices Civils De 
Lyon, Lyon, France; 11Réanimation médicale et infectieuse, Hôpital 
Bichat‑Claude Bernard, Paris, France
Correspondence: Sébastien Bailly ‑ sbailly@chu‑grenoble.fr
Annals of Intensive Care 2017, 7(Suppl 1):O68
Introduction Staphylococcus aureus (SA) is the most common isolated 
Gram-positive organism responsible for infection in ICU settings. The 
objective of this study was to assess in a French national network 
of ICU surveillance, the incidence of SA ICU-acquired bloodstream 
infection (BSI) overall and according to resistance profiles, either 
methicilin-susceptible (MSSA) and methicilin-resistant SA (MRSA), 
and the temporal trends of the incidence over 10 years, adjusted for 
patients’ case mix and ICUs’ characteristics.
Materials and methods Data from 2005 to 2014 were used. The 
incidence of BSI due to SA was assessed as the yearly ratio of ICU-
acquired (>48 h.) SA BSI per 10,000 ICU patients. Only the first SA BSI 
occurred during one ICU stay for a patient was taken into account. 
Univariable autoregressive models were performed to assess the 
temporal trend in the evolution of the annual incidence during the 
study period. Multivariable autoregressive model were performed to 
adjust on case-mix and other centers’ characteristics with a significant 
annual trend selected in the univariable analysis.
Results Of 265,035 patients included from an annual median number 
of 158 participating ICUs (144 in 2005, 213 in 2014), 9553 (3.6%) had 
an ICU-acquired BSI, and 1476 (15%) of them had at least one SA BSI 
(56 per 10,000 ICU patients). One-third of SA BSI (n = 491, 33%) was 
MRSA and 907 (67%) were MSSA. There was a significant decrease of 
annual incidence for all SA BSI from 2005 to 2014 (64 to 48/10,000 
ICU patients; −1.8/10,000 ICU patients per year; p  =  0.02). The raw 
annual incidence of MRSA BSI decreased significantly from 34 to 
11/10,000 ICU patients between 2005 and 2014 (−2.21/10,000 per 
year; p = 0.001). There was no significant change in the incidence of 
MSSA from 28 to 35/10,000 between 2005 and 2014 (+0.35/10,000 
per year; p = 0.53) (Fig. 9). By adjusting on annual ICUs variables sig-
nificant in the multivariable model (percent of medical-surgical ICU, 
public hospital, percentage of patients with antibiotic therapy at ICU 
admission, central venous catheter exposure, medical admission and 
annual median of age) there was no significant change in the overall 
incidence of SA BSI, but a significant decrease of MRSA (p = 0.02). The 
temporal trends were similar in all French regions.
Conclusion After adjustment on center variables, there was neither 
significant change in the overall incidence of S. aureus BSI nor in the 
incidence of MSSA BSI in ICU. However, the incidence of MRSA BSI 
decreased significantly. Moreover MSSA BSI did not significantly 
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increase. MRSA rate trends in the ICUs participating to the network 
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Introduction Hemophagocytic lymphohistiocytosis (HLH) is a life 
threatening condition characterized by NK/T cells/macrophage 
overactivation resulting in a cytokine storm with multiorgan 
dysfunction. In adults, HLH is mostly secondary to cancers (mainly 
hematological neoplasms), infections or auto-immune diseases.
HLH-etiology can be difficult to assess, especially in the critical care 
setting. Clinical and biological symptoms of HLH, its etiology and 
underlying immune deficiency being often mixed. Yet, targeting 
HLH-etiology is part of the ICU management in which supporting 
organ failure, early etoposide and empirical anti-infectious agents are 
routine. In this work, we assessed diagnostic yield of tissue biopsies to 
identify HLH-etiology.
Patients and methods This single center retrospective study was 
conducted between 2007 and 2016. Medical records of all consecutive 
patients admitted with a HLH diagnosis (defined using HLH 2004 
criteria) were reviewed. The performance of each diagnostic procedure 
was established. Rstudio software was used for analysis.
Results Over the study period, 142 patients (45 women, 32%; median 
age 47 years [37–57]) were recorded. Acute respiratory failure was the 
main reason for ICU admission (40 cases, 28%). Ninety-six patients 
(68%) had a known immune deficiency (HIV 36%, other 32%). Median 
SOFA at admission was 7 [5–10]. All patients met at least 5/8 HLH 
criteria. HLH-etiology was identified in 137 patients (96%): malignancy 
in 102 (74%), infection in 28 (20%), autoimmune disease in 7 (5%). 
Life sustaining therapy was needed in 80 patients (56%): mechanical 
ventilation (52%), vasopressors (44%), or renal replacement therapy 
(37%). Hospital mortality was 42%, with no difference between 
patients with or without identified HLH-etiology.
Bone marrow smears were performed in the ICU in 77 cases and were 
mostly useful to contribute to HLH diagnosis (83% hemophagocy-
tosis). However, only 23 (30%) identified HLH-etiology. Among tis-
sues that were sampled, the highest and the lowest diagnostic yields 
were provided by spleen resection and liver biopsy, respectively (7/8 
[87.5%] splenectomies and 11/30 [37%] liver biopsies allowed to 
establish a definite diagnosis).
Figure  10 displays respective contributions of other tissue examina-
tion. Interestingly, the best feasibility/contribution ratio was achieved 
by minimally invasive lymph node biopsy. Namely, among 97 patients 
with clinically relevant lymph nodes, 57 (59%) could be explored 
under echography or CT, and diagnostic yield was 74%.
Severe adverse events included two cases of reversible hemorrhagic 
shocks, one following transjugular liver biopsy and one after splenec-
tomy. No post-procedure infection was recorded.
Discussion Identifying HLH-etiology is a mandatory step for short and 
long term recovery. Moreover, when HLH patients are critically ill, iden-
tifying and targeting HLH etiology is the cornerstone of ICU manage-
ment. However, in patients with multi-organ dysfunction, clinicians 
need guidance to understand which procedure is likely to identify 
HLH-etiology. In patients with HLH, pancytopenia or spleen enlarge-
ment are the rule. However, other organ involvement has to be sought 
in each specific case.
Even if splenectomy achieves the highest diagnostic yields, minimally 
invasive lymph node biopsy or skin biopsy are of value based on their 
feasibility/diagnostic yield ratio. Only few complications were identi-
fied in this work and minimally invasive procedures seem to be safe.
Conclusion This study provides important guidance to establish HLH-
etiology. Timing for identifying HLH-etiology has nevertheless not 
been associated with mortality. Studies to assess whether targeting 
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Introduction In patients with haematological malignancies, 
neutropenia recovery is a situation where respiratory status may 
deteriorate. It has been previously demonstrated that granulocyte 
colony-stimulating factor (G-CSF) administration increases the risk of 
lung injury. ICU physicians are reluctant to use G-CSF in neutropenic 
patients with respiratory symptoms. However, data supporting this 
strategy are limited, consisting mainly of case series, retrospective 
data and experimental data. The aim of this study is to evaluate the 
impact of G-CSF administration on respiratory status in neutropenic 
patients with haematological malignancies admitted in ICU.
Patients and methods TRIAL-OH is a prospective, multicenter 
observational study that included 1011 patients with hematological 
malignancies who required ICU admission in 2010–2011 in 17 French 
and Belgian centers [1]. 288 patients who were neutropenic at ICU 
admission were included. The main endpoint was respiratory status 
deterioration at day 7, defined as any increase in respiratory SOFA score 
or death within the first 7 days of ICU stay. Using a propensity score (PS) 
based on the probability of receiving G-CSF during the first 48 h of ICU 
stay, we estimated the association between GCSF administration and 
respiratory function at day 7 on the matched sample, using a logistic 
regression model, adjusted on respiratory SOFA score at admission.
Results 288 neutropenic patients were included in the study. 201 
(70%) did not receive G-CSF during the first 48  h of ICU stay. 87 
(30%) received G-CSF at day 1 or day 2. 142 patients were selected 
by PS-matching. 57 (40%) were male, the median age was 58 (46–
65) years. The most frequent malignancy was acute leukemia in 60 
(42%) patients. The median SOFA score at admission was 6 (4–9). The 
respiratory SOFA score at admission was 0 for 103 patients (73%), 1–2 
for 18 patients (12%) and 3–4 for 24 patients (15%). 11 (8%) patients 
had an invasive pulmonary aspergillosis.
After propensity score matching (71 patients/group), there was no 
significant association between G-CSF administration and respiratory 
status deterioration during the following 7  days (OR 1.08; 95% CI 
0.55–2.13; p = 0.83), even though neutropenic patients who received 
G-CSF had better neutrophil recovery at day 7. 70 (49%) patients died 
or showed an increase of the respiratory SOFA score. Among them, 
37 (53%) received G-CSF and 33 (47%) did not. Additional sensitivity 
analysis in patients admitted for acute respiratory failure showed 
similar results (OR 0.96; 95% CI 0.36–2.55; p = 0.93).
Discussion This is the largest study focusing on the association 
between G-CSF administration and respiratory status in critically 
ill neutropenic patients. Although the benefit of G-CSF in terms of 
mortality has never been demonstrated in this population, our data do 
not confirm G-CSF related pulmonary toxicity.
Conclusion In this study, G-CSF administration was not associated 
with deterioration of respiratory status in critically ill neutropenic 
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Introduction Short term prognosis of thrombotic microangiopathies 
(TMA) has improved over the last decades with a mortality rate 
smoothing out to 10%. Main advances include management 
guidelines, improved understanding of the pathophysiology of 
most TMA syndromes and the development of targeted treatments. 
Acquired thrombotic thrombocytopenic purpura (TTP) in adults, 
an element of the TMA syndromes, is caused by a severe ADAMTS13 
activity deficiency chiefly through anti-ADAMTS13 auto-antibodies. 
Rituximab, a chimeric anti-CD20 monoclonal antibody, has shown 
effectiveness for the treatment of refractory or recurrent TTP. In 
this study we focused on the short and long term complications of 
Rituximab administration in critically ill patients with severe TTP.
Patients and methods All TMA patients requiring admission to St 
Louis hospital ICU from 2006 to 2015 were enrolled in the study. 
Clinical, biological and follow-up data were retrieved from the 
patients’ medical chart and the hospital’s electronic database. Specific 
complications of TMA-therapies were specifically sought. Data are 
presented as numbers (%) and medians (interquartile range). Groups 
were compared using non-parametric statistical tests (Chi square test 
or Mann–Whitney).
Results During the study period, 124 critically ill TMA patients were 
recruited. There were 79 (64%) females, aged 44 years old (32–55). 
The TMA etiology included TTP in 81 (65%) cases, HUS in 24 (19%) 
and other TMA in 19 (15%) cases. Among the 81 TTP patients, 58 
(72%) were females aged 42  years old (27–53). At diagnosis 66 
(83%) patients presented with neurological symptoms, 50 (62%) 
with cardiac anomalies (whether clinical, EKG or biological anom-
alies), 46 (56%) with renal dysfunction, 28 (35%) with digestive 
symptoms. Day-1 hemoglobin was 7.4  g/dl (6.2–8.7), platelet rate 
was 11 G/l (8–19), creatinine was 96 µmol/l (73–148) and LDH rate 
was 1880 U/l (1410–2638). ADAMTS13 activity was undetectable in 
all patients, with auto-antibodies in 61/70 (87%). Day-1 SOFA was 
6 (5–9) with 23 (28%) patients requiring mechanical ventilation, 
12 (15%) requiring extra-renal epuration and 14 (17%) requiring 
vasopressors throughout the ICU stay. All patients received daily 
plasma-exchange (PEX) therapy, 78 (96%) corticosteroids, 55 (69%) 
2 (1–2) anti-hypertensive drugs, 70 (86%) low dose Aspirin, and 62 
(77%) received anticoagulation. Other therapies were administered 
in half the patients (n = 39) including Rituximab in 33 (41%) cases, 
pulse steroids in 23 (28%), Vincristine in 13 (16%), and other thera-
pies in 11 (14%) (splenectomy, cyclophosphamide, twice daily PEX 
and vinblastine). ICU stay was 8  days (5–16) and 5 patients (6%) 
died in the ICU. The 33 patients receiving Rituximab in the ICU did 
not exert any benefit in terms of ICU or long term mortality. Rituxi-
mab administration was not associated with significant increase 
of ICU-acquired infections (9/33 (27%) vs 8/48 (17%), p =  0.2). No 
adverse reaction was noted following Rituximab infusion during 
the ICU period. Follow up was 1126  days (271–2001) and 3 addi-
tional patient died during follow-up. Eleven (14%) patients had 
TMA recurrence within 585  days (125–858). There was a trend 
toward a longer time to recurrence in Rituximab-treated patients 
(1475 days (427–2530) vs 136 days (80–749), p = 0.09). In addition, 
22 TTP patients subsequently received Rituximab during follow-
up either for TTP clinical recurrence or as maintenance therapy for 
persistent or recurrent ADAMTS13 undetectable activity. Long term 
complications potentially attributable to Rituximab included tran-
sient decrease in IgM levels (3 patients), serum disease in 1 patient, 
mild cognitive dysfunction in 1 patient and asymptomatic hepatitis 
B virus reactivation in 1 patient.
Discussion Rituximab, when used in patients with severe/refractory 
TTP, seems safe at short and long term. This apparently low compli-
cation rate may be due to the relatively low Rituximab dosage used 
as compared to regimen applied to patients with lymphoma. High 
dose steroids might also have been protective against acute cytokinic 
reactions. Last, the retrospective nature of this study might also have 
undermined transient or mild Rituximab-related toxicity.
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Conclusion In critically ill patients with severe/refractory TTP, safety 
profile of Rituximab is good. Studies to assess its efficacy as early 
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Introduction Outcome of critically ill patients with hematological 
malignancies has substantially improved over the last decade. 
However, data regarding the long term Quality of Life (QOL) of these 
patients are scarce. The purpose of this study is to assess post ICU 
burden and health related QOL, and to identify risk factors for long 
term QOL impairment.
Patients and methods TRIAL-OH is a prospective, multicenter 
observational study that included 1011 patients with hematological 
malignancies who required ICU admission in 2010–2011 in 17 French 
and Belgian centers. Ninety days and 1  year after ICU discharge, 
HRQOL was was determined by applying the interview form of the 
short-form 36 questionnaire (SF-36), which measures HRQOL in 8 
separate dimensions (0 = worst health state, 100 = best health state). 
Psychological distress symptoms were evaluated using the Hospital 
Anxiety Depression Score (HADS) and the Impact of Event Scale (IES). 
All datas were collected prospectively
Results Two hundred and seventy-nine patients were evaluated 
at 3  months and 117 patients were evaluated at 1  year after ICU 
discharge.
At 3  months global median Physical (PS) and Mental scores (MS) 
were respectively 51.6 [48.0–55.3] and 49.7 [46.1–53.2], and at 1 year 
median PS and MS were respectively 63.8 [59.9–67.6] (p =  0.92) and 
56.3 [52.5–60.0] (p = 0.05).
Physical functioning, general health, social functioning, mental health 
did not significantly change between 3  months and 1  year. Role 
Limitation due to physical problems (0.0 [0–6.2] vs 25.0 [17.7–32.3], 
p  =  0.0008) and Vitality Score (40.0 [36.1–43.9] vs 46.7 [43.3–50.0] 
p  =  0.018) significantly improved at 1  year. Role limitation due to 
emotional problems (72.4 [93.4–106.6] vs 66.7 [59.2–74.1], p = 0.001) 
and bodily pain (70.0 [64.2–75.8] vs 67.5 [63.0–72.0] were significantly 
worse at 1 year. At 3 months, 49 (17.5%) patients had an IES score at 20 
and 139 (49.5%) patients had a HADS at 8
Discussion This multicentric study is the first to assess long term 
QOL in a large cohort of critically ill patients with hematological 
malignancies. Significant improvement in terms of short term 
mortality in this population do not fully reflect the impact of ICU stay. 
Prompt recognition of risk factors for impaired QOL and adapted 
therapy for anxiodepressive symptoms may improve their outcome
Conclusion Critically ill patients with hematological malignancies 
have impaired QOL at 3  months and recovery is incomplete 1  year 
after ICU discharge. Long term QOL should be taken into account in 
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Introduction Over the last two decades, advances in hematology and 
critical care management have translated into improved outcomes for 
critically ill hematological patients. Concerns have been raised about 
delayed admission to the ICU, however, the strength of evidence 
remains weak.
Patients and methods In a substudy from Trialoh led by the GRRR-OH 
and published in 2013, we sought to assess how time from hospital 
to ICU admission is associated with hospital mortality. Data were 
collected from 17 ICUs from France and Belgium between January 
2010 and May 2011. We used non parametric Wilcoxon tests and Fisher 
exact tests for baseline univariate comparisons across groups, p-value 
equal or below 0.05 were considered statistical significant. Regression 
logistic models were used to summarize predictive information for ICU 
mortality.
Results Based on non-parametric estimation, the cutoff value of 3 days 
for time between hospital and ICU admission was best associated 
with mortality (OR 1.66 (1.28–2.15), P  =  0.0001). Among the 1007 
included patients, 592 were admitted before day-3 and 415 after day-
3. Non-Hodgkin’s lymphoma, acute myeloid leukemia, and myeloma 
represented about 70% of admissions in the two groups. Patients 
admitted earlier were older [62 (50–71) vs. 59 (48–67), p = 0.01], more 
frequently women (35 vs. 45%, p = 0.003), had higher Charlson scores 
[4 (3–6) vs. 3 (2–5), P  =  0.007 mostly from diabetes, cardiovascular 
diseases and chronic kidney diseases], but less altered performance 
status 1 (0–2) vs. 2 (1–3), p  <  0.0001). Early admitted patients, were 
more frequently admitted to the ICU from the ED/SAMU (43 vs. 2%, 
p < 0.0001) and less frequently enrolled in a hematology trial (23 vs. 
33%, p  =  0.0004). Patients admitted before day-3, more frequently 
carried a newly diagnosed malignancy (28.69 vs. 15.74%; p < 0.0001) 
and were less frequently acute myeloid leukemia patients (23 vs. 
33%, p  =  0.0009), recipients of hematopoietic stem cell transplants 
(both for autologous (18.16 vs. 11.53%, p  =  0.004) and allogeneic 
(20.29 vs. 10.34%; p < 0.001)) or patients not in remission (36 vs. 46%, 
p  <  0.0001). Delayed ICU admission occurred more frequently in 
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patients with acute respiratory failure (70.3 vs. 57.2%, p  <  0.0001) or 
coagulation disorders (23.7 vs. 16%, p = 0.003). Patients admitted after 
day-3, developed more frequently multiple organ failure (59.5 vs. 51%, 
p = 0.009).
By multivariable analysis with mortality as the outcome variable, 
admission after day-3 tended to be associated with mortality but did 
not reach significance when adjusted on patient’s characteristics and 
processes of care. An ongoing analysis to adjust on severity at ICU 
admission will be communicated in January.
Conclusion Patients admitted to the ICU more than 3  days after 
hospital admission have an increased mortality. As one-third of these 
patients were admitted after an initial refusal, these results identify 
the typology of patients for whom delayed ICU admission impacts on 
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Introduction Volume expansion is aimed at increasing cardiac output. 
Nevertheless, a cardiac output monitoring technique is not always 
available. The perfusion index (PI) (Masimo Corp., Irvine, CA, USA), 
is automatically calculated from the plethysmographic waveform 
of oxygen saturation as the ratio of the pulsatile fraction, caused by 
blood flow, and the non-pulsatile fraction. We hypothesized that 
PI could be proportional to stroke volume and that it could detect 
changes in cardiac output during passive leg raising (PLR) and volume 
expansion (VE).
Patients and methods We included patients for which a PLR test 
was planned. We measured the changes in cardiac index (CI, PiCCO2 
device, Pulsion Medical Systems, Munich, Germany) and PI before and 
during the PLR tests. If a VE (500 mL of saline infusion over 10 min) was 
performed, we also measured its effects on CI and PI.
Results Fifty-five PLR tests were performed in 30 patients. One 
case was excluded because of a poor oxygen saturation signal. 
Norepinephrine was administered in all cases at a mean dose of 
1.6 ± 1.0 mg/h. The PLR test was positive (increase in CI ≥ 10%) in 26 
“preload responsive” cases and negative in 29 “preload unresponsive” 
cases. During PLR test, in preload responsive cases, CI significantly 
increased by 30  ±  15% and PI significantly increased by 79  ±  45%. 
During PLR test, in preload unresponsive cases, neither CI nor PI 
changed significantly. PI was able to detect a positive PLR test with 
good accuracy (area under the receiver operating characteristic curve: 
0.99 (95% confidence interval 0.90–1.00, p  <  0.001). If PI increased 
>23%, a positive response to PLR could be diagnosed with a sensitivity 
of 100% (84–100%) and a specificity of 90% (74–98%). Volume 
expansion was administered in 15 cases with a positive PLR test. 
Taking into account both PLR and volume expansions, the changes 
in CI and PI (27 ±  11% and 73 ±  47%, respectively) were correlated 
(r = 0.73, p < 0.001). The PI value at baseline was <2 in 15 patients, but 
the ability of PI to track changes in CI was not poorer in these patients 
than in the other ones.
Conclusion The results of this preliminary study are that the perfusion 
index using pulse oximetry seems to accurately reflect changes in CI 
during PLR test and volume expansion. This could be a reliable way to 
assess preload responsiveness in a totally non-invasive way.
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Introduction Mechanical ventilation is a common organ support 
therapy in critically ill patients. Mechanical ventilation initiation could 
have several hemodynamic consequences, ranging from tachycardia 
to life-threatening collapse. The objectives of this study were (i) to 
describe the microcirculatory and macrocirculatory changes following 
emergency tracheal intubation (TI) and (ii) to identify predictors of 
hemodynamic instability.
Patients and methods Prospective observational monocenter study 
conducted in a 18-bed medical ICU. Consecutive patients requiring 
tracheal intubation were eligible for the study. Data collection 
included general demographic parameters and comorbidities, 
indication for tracheal intubation and presence of sepsis. Global 
hemodynamic parameters (blood pressure, heart rate, cardiac index) 
and tissue perfusion parameters (mottling score, capillary refill time 
[CRT], toe-to-rectal gradient temperature) were recorded before, 5 min 
and 2 h after TI. Cardiac function parameters (left ventricular ejection 
fraction, right ventricular to left ventricular diameter ratio, presence of 
paradoxical septum), arterial blood gas and arterial lactate level were 
measured before and 2 h after TI. Hemodynamic instability requiring 
intervention (HII) was defined as any hemodynamic status degradation 
requiring intravenous fluid resuscitation (≥500 ml) or the introduction 
of vasopressors or an increase in vasopressor dose ≥20%. Difficulty of 
tracheal intubation was assessed using the Intubation Difficulty Scale.
Results Seventy-seven patients were included (male gender 61%) with 
a median age of 69 [interquartile range 56–81] years. Median SOFA 
score and SAPS2 were 7 [4–10] and 51 [41–64], respectively. Indication 
for tracheal intubation was hypoxemia (44%), hypercapnia (14%), and 
coma (32%). Most of the patients had sepsis (64%), including septic 
shock patients (22%).
Tracheal intubation had no significant impact on cardiac index, heart 
rate and tissue hypoperfusion, whereas median mean arterial pressure 
decreased from 82 [71–93] mmHg before intubation to 73 [66–84] 
mmHg 2 h after TI (P = 0.005, Wilcoxon signed rank test).
HII occurred in 38 patients (48%). Univariate comparison (Fisher’s exact 
test for discrete variables and Mann–Whitney U test for continuous 
variables) of these patients with those who did not experience HII 
indicated that male gender (P  =  0.035), intubation for hypoxemia 
(P  =  0.006), administration of norepinephrine before TI (P  =  0.002), 
sepsis (P  <  0.0001), higher SOFA score (P  =  0.0005), higher SAPS2 
(P =  0.006), mottling score ≥3 before TI (P =  0.046), higher baseline 
serum lactate level (P  =  0.038) and higher baseline knee CRT 
(P  =  0.029) were predictors for HII. In contrast, cardiac index, mean 
arterial pressure, baseline temperature gradient, index CRT before TI 
and Intubation Difficulty Scale were not associated with HII.
Sepsis patients had a relative risk (RR) of HII of 2.8 [95% confidence 
interval 1.8–4.4]. Among sepsis patients, a mottling score ≥3 was 
associated with a RR of HII of 9.8 [1.3–73.4], serum lactate level with a 
RR of 2.6 [1.2–5.6], and intubation for hypoxemia with a RR of 2.1 [1.2–
3.8], as compared with the entire study population.
Conclusion In a non-selected ICU population, half of the patients required 
fluid resuscitation or vasoactive drugs in the 2 h following TI. Sepsis was 
the strongest predictor of hemodynamic instability. Tissue hypoperfusion 
parameters, especially mottling score, identified a subpopulation of septic 
patients with a high risk of hemodynamic instability. In contrast, global 
hemodynamic parameters such as cardiac index before TI did not predict 
bad hemodynamic tolerance of the procedure.
Competing interests
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Introduction Elevations of cardiac troponin values, suggesting a 
myocardial necrosis, are common in critically ill patients with sepsis 
and are associated with a poor prognosis. In this context, myocardial 
ischaemia is one of the main underlying mechanisms leading to 
necrosis of myocardial cells defining the myocardial infarction (MI). 
However identifying which septic patients with suspected myocardial 
infarction are at risk of mortality and major cardiac events is a clinical 
challenge [1]. Clinical evaluation may lack sufficient precision, leading 
to inappropriate medication and discharge. It is uncertain whether 
risk scores derived from cardiologic populations apply in this context. 
We aimed to assess whether the  «Global Registry of Acute Coronary 
Events»  [2] score (GRACE) may predict mortality in the intensive care 
unit (ICU) for septic patients with a suspected MI.
Patients and methods We conducted a prospective monocenter 
observational study from June 2012 to August 2016 in the medico-
surgical ICU of Tenon Hospital, Paris, France. All patients with a 
suspected MI [significant cardiac troponin elevation with at least one 
of the following: symptoms of ischaemia, new significant ST-segment 
or T wave changes at electrocardiogram, acute left ventricular systolic 
dysfunction (1)] on ICU admission or during their ICU stay, were 
screened. Patients admitted for sepsis were included. The primary 
endpoint was to assess the performance of the GRACE score to 
predict ICU mortality. The secondary endpoints were to describe the 
respective occurrence of major cardiovascular events (stroke, cardiac 
arrest and reinfarction), major bleedings and cardiogenic shock during 
ICU stay.
Results During the study period, 238 out of 3774 patients (6.3%) had 
a suspected MI. Among them, 122 (51%) were admitted for sepsis (75 
men, 66 years [IQR 25–75: 56–76], 80 with invasive ventilation, 78 with 
septic shock, median Simplified Acute Physiology Score II 50 [37–62]). 
Principal sources of infection were pulmonary (60%), urinary (19%), 
and abdominal (16%). The pathogen was identified in 78 patients 
(64%). 75% of suspected myocardial infarction occurred at admission 
or during the first day after admission (median time: 0 day [IQR 0–0]) 
either on ST-elevation (n = 23) or non ST elevation (n = 99). At the time 
of suspected MI, the median Sepsis-related Organ Failure Assessment 
Score was 8 [5–12]. The ICU length of stay was 8.5 days [4–15]. The ICU 
mortality rate was 0.30 (95% CI 0.22–0.39). At the time of suspected 
MI, the GRACE score was higher in the non-survivor group (201 
[160–226]), as compared with the survivor group (176 [149–211]; 
p =  0.053). A cut-off value of 200 was associated with ICU mortality 
(OR 2.53, 95% CI 1.14–5.61; p = 0.022). The symptoms of ischaemia (13 
vs 8%, p =  0.441), the level of high sensitivity cardiac troponin peak 
(1093  pg/mL [381–4054] vs 1248  pg/mL [554–2973], p  =  0.66), and 
the left ventricular ejection fraction at echocardiography (29% [20–41] 
vs 35% [20–50], p  =  0.21) were similar between non-survivors and 
survivors. The electrocardiogram ST-segment or T wave changes were 
less frequent in the non survivors than in the survivors (50 vs 69%, 
p = 0.041). Major cardiovascular complications, major bleedings, and 
cardiogenic shock occurred more frequently in the non-survivors than 
in the survivors (19 vs 4%, p = 0.012; 16 vs 7%, p = 0.086; 76 vs 36%, 
p < 0.001; respectively).
Discussion Critically ill septic patients with suspected MI had a high 
risk of cardiovascular events and bleeding. In this population, the 
GRACE scoring system was more accurate for predicting ICU death 
than symptoms of ischemia, troponin elevation, and left ventricular 
dysfunction. The systematic application of a validated risk score 
to septic ICU patients with a suspected MI could enable an early 
appropriate management, and provide a more reliable basis for 
adequate discharge and follow-up. These findings require validation in 
larger prospective studies.
Conclusion The GRACE risk score could be a promising score to help 
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Introduction Systemic Capillary Leak Syndrome (SCLS) is a rare 
disease characterized by recurrent life-threatening attacks of capillary 
hyper permeability in the presence of a monoclonal gammopathy 
(MG). During acute episodes, the leak of fluid and proteins from the 
intravascular compartment to the interstitium results in clinical signs 
of both acute hypovolemia and interstitial edema. Biological profile 
is pathognomonic with marked hemoconcentration and paradoxal 
hypoproteinemia. There are few data available about natural history 
and prognosis of severe SCLS attacks. The objectives of this study were 
to precisely describe natural history, outcome and mortality associated 
factors in severe SCLS attack.
Patients and methods Multicenter retrospective analysis of data from 
the European Clarkson registry (EurêClark). Criteria to retain SCLS’s 
diagnostic were; presence of a MG; ≥1 typical attack with clinical 
manifestations of hypovolemia and capillary leak; hemoconcentration 
with paradoxal hypo protidemia; exclusion of secondary capillary 
leak syndrome causes. Patients with severe attacks admitted in ICU 
were identified in EurêClark registry. Physician were contacted and 
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offered to include the attack using a pre-established case report form. 
Categorical variables are expressed: n (%) and continuous variable: 
mean ± SD or median [IQR].
Results Between May 1992 and February 2016, 59 attacks in 
37 patients were included. Sex ratio was 1.05 with an age of 
51 ±  11.4  years. In ten patients, more than one attack was included. 
Thirty-four (92%) patients had an IgG MG with Kappa light chain in 
20 (59%) patients. A trigger of the attack could be found in 34 (58%) 
patients with flu-like syndrome being the most frequent (89%). SAPS II 
score at admission was 54 [38–67] and SOFA score 6 [3–9]. Admission 
heart rate was 128 ±  21  bpm, admission arterial systolic, mean and 
diastolic blood pressure were respectively 75 [55–94], 60 [44–70] and 
45 [36–60] mmHg. Frequent clinical manifestations at admission were; 
unaltered consciousness despite profound arterial hypotension (83%), 
asthenia (78%), faintness (64%), nausea and vomiting (53%), edema 
(51%), dyspnea (46%), marbles (42%), myalgia (39%) and abdominal 
pain (36%). Admission hemoglobin, protidemia, serum creatinine and 
arterial lactate were respectively 20.2 [17.9–22] g/dL, 50 [36.5–58.5] 
g/L, 176 [121–244.5] µmol/L and 4.6 [3.3–6.5] mmol/L. Five patients 
underwent phlebotomy for mistaken hyper viscosity syndrome 
and 57 (97%) received fluid therapy with a cumulated volume of 4.5 
[2.8–10.6] L over 1 [1–2.5] days. Norepinephrine was administered in 
28 (47.5%) patients, epinephrine in 10 (17%) and corticosteroids in 
19 (32%). Twenty-two (37%) patients required mechanical ventilation 
and 18 (30.5%) underwent renal replacement therapy. Fifteen 
patients (25%) were treated with intravenous immunoglobulins (IgIV) 
during the attack. Compartment syndrome occurred in 12 (32%) 
patients and 11 (30%) died in ICU. In univariable analysis (over 37 
unique patients) main factors associated with mortality were SAPS II 
(p =  0.006) and SOFA score (0.005), neurological dysfunction (neuro 
SOFA score ≥3, p  =  0.003), high ICU maximum weight (p  =  0.008), 
high cumulated volume of fluid therapy (p  =  0.017), mechanical 
ventilation (p < 0.0001) and renal replacement therapy (p = 0.002) but 
not treatment with IgIV (p  =  0.12). Multivariable analysis retained a 
SOFA > 10 (OR 10.4 [1.1–91], p = 0.04) and a cumulated volume of fluid 
therapy >8 L (OR 16.4 [1.2–230], p = 0.038) as independent factors of 
mortality. Treatment with IgIV (OR 11.5 [0.85–155], p = 0.066) was not 
independently associated with mortality.
Conclusion Our study presents the first large cohort of SCLC attacks 
admitted to ICU. Compartment syndrome was a particularly frequent 
complication and mortality over 59 attacks was 18.6%. High cumulated 
volume of fluid therapy seems to be associated with poorer outcome. 
There was a trend toward mortality in patients treated with IgIV during 
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Introduction Acute right heart failure (RHF) remains the leading 
cause of death in patients with precapillary pulmonary hypertension 
(PH). However, no recent data on this life-threatening condition are 
available since the progress in severe PH management, the changes in 
lung graft allocation rules and the development of extracorporeal life 
support as bridge to transplantation.
Patients and methods The aim of this prospective, observational, 
single-centre study was to determine the characteristics and survival 
of patients suffering from pulmonary arterial hypertension (PAH), 
pulmonary veno-occlusive disease (PVOD) or chronic thromboembolic 
PH (CTEPH) and admitted to intensive care unit (ICU) for acute RHF. 
Risk factors associated with an increased likelihood of 1-month 
mortality were identified.
Results From March 2015 to April 2016, 83 patients (median 
age 59  years, female 53%, PAH 59%) were included in the study. 
Precapillary PH was diagnosed at the same time as acute RHF in 
32.5% of cases. All patients were treated with intravenous diuretics. 
Catecholamines were initiated in 57 (68.5%) patients (dobutamine 
alone in 36% of cases and dobutamine  +  noradrenaline in 32.5% 
cases). Urgent lung transplantation was performed in 11 patients with 
PAH or PVOD including 4 after extracorporeal life support initiation. 
Urgent endarteriectomy was performed in 9 patients with CTEPH. 
Overall mortality rate in ICU, at 1 and 3  months was respectively 18, 
20 and 28%. Mortality rate at 3  months of patients <50  years, 50 to 
65  years and >65  years and treated with catecholamines was 7, 36 
and 52% respectively. Risk factors for death at 1 month were: known 
PH (HR 4; p  =  0.05), catecholamines initiation (HR 5; p  =  0.03), 
identification of a triggering factor (HR 2.8; p = 0.04), average blood 
pressure at third day (HR 0.9; p = 0.001), weight loss in the first 3 days 
(HR 9; p  =  0.01), urea at admission (HR 1.2; p  <  0.01) and third day 
(HR 1.1; p = 0.003), creatinine at admission (HR 1; p = 0.05) and third 
day (HR 1.1; p = 0.047), BNP (HR 1; p = 0.002) and natremia (HR 0.9; 
p = 0.037) at third day.
Conclusion In the past 10 years, the phenotype of PH patients 
hospitalized in ICU for acute RHF has changed with a median age 
significantly higher in comparison with previous studie1. The risk 
of death at short-term remains high especially in patients treated 
with cathecholamine (35%). However, recent progress in lung graft 
allocation rules and management of acute RHF dramatically reduced 
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Introduction Optimization of antibiotic therapy for extracorporeal 
Life Support (ECLS) patients remains a pharmacological challenge. 
Clinical studies suggest that individualized dosing strategies and 
therapeutic drug monitoring could facilitate the achievement of 
adequate antibiotic concentration. The objective of this pilot study 
was to observe the pharmacokinetic characteristics of commonly used 
antibiotics in intensive care unit (ICU) for patients treated with ECLS.
Patients and methods The PHARMECMO study was a pilot, 
prospective, pharmacokinetic study, conducted in ICU cardiac 
surgery. All patients treated with ECLS, with known or suspected 
sepsis and receiving antibiotic therapy, were eligible for inclusion. The 
concentration of each antibiotic was measured by a combination of 
liquid chromatography and mass spectrometry from blood samples. 
For intermittent administration of antibiotic, two successive measures 
were performed, under steady state conditions, both at 50% (CT50) 
and 100% (Cmin) of the dosing interval.
Results Forty-five eligible patients were enrolled for 68 inclusions 
allowing 114 analysed samples during 1 year. The median age 
was 63 years [interquartile range (IQR) 58–67], 84.4% of inclusions 
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were male, with a median weight of 74.5  kg (IQR 70–86.75). 
Among the 68 inclusions, 39.7% received continuous veno-venous 
hemofiltration. ECLS therapy was veno-venous (n =  2), peripheral 
venoarterial (n  =  51) or central venoarterial (n  =  15). The most 
frequent causes of infection were pneumonia (n = 36), infection of 
femoral triangle (n =  5) and catheter-associated infection (n =  5). 
Of the pathogens identified, Pseudomonas aeruginosa was the most 
frequent (n = 20).
The main studied antibiotics were piperacillin-tazobactam (n  =  17), 
cefotaxime (n = 12), imipenem (n = 10) and amikacin (n = 6). For the 
association piperacillin-tazobactam, the median CT50 was 87.00 mg/L 
(IQR 57.93–158.71) and the median Cmin 61.24  mg/L (IQR 44.92–
90.51) for a dose of 4 g four times a day, with a MIC target of 16 mg/L. 
For cefotaxime, median concentrations were respectively, CT50 and 
Cmin of 64.69  mg/L (IQR 20.17–97.52) and 28.61  mg/L (IQR 7.28–
42.12) for a MIC target of 1  mg/L and a median dose of 7  g per day. 
Regarding imipenem, at a dose of 1 g three times a day, the median 
concentrations were respectively, CT50 and Cmin, of 7.30  mg/L (IQR 
4.07–14.59) and 3.28 mg/L (IQR 1.84–5.43) for a MIC target of 4 mg/L. 
Only one patient had a CT50 greater than 4 MIC, and 60% of measured 
Cmin were under the MIC. Finally, for amikacin, the median Cmax was 
51.14  mg/L (IQR 32.36–78.26) at a median dose of 24.3  mg/kg, for a 
target between 60 and 80 mg/L.
Conclusion These preliminary data suggest that therapeutic drug 
monitoring could optimize the achievement of pharmacokinetic 
objectives associated with an effective antibiotic therapy. These 
data also suggest that, in most patients, the recommended doses of 
imipenem at 1 g three times a day and aminoglycoside at 20 to 25 mg/




Variation in screen and isolate policy for multidrug‑resistant 
bacteria (MDRB): a national survey in French adult ICUs
Zoé Coppere1, Guillaume Voiriot1, Aude Gibelin1, Clementine Taconet1, 
Vincent Labbe1, Muriel Fartoukh1, Michel Djibre1 
1Réanimation médico‑chirurgicale, Hôpital Tenon ‑APHP, Paris, France
Correspondence: Michel Djibre ‑ michel.djibre@aphp.fr
Annals of Intensive Care 2017, 7(Suppl 1):P2
Introduction The control of health-care associated infections and 
multidrug-resistant bacteria (MDRB) is a public health priority. The 
MDRB prevalence rate has dramatically increased, mainly extended-
spectrum beta-lactamase producing Enterobacteriaceae (ESBLE). The 
aim of this study is to describe and to analyse the different screen and 
isolate policies regarding MDRB in French adult ICUs.
Patients and methods This is an observational, descriptive, multi-
center online survey performed in French adult ICUs. The questionnaire 
included 63 questions divided into 4 parts: characteristics of the unit, 
MDRB screening policy, policy regarding contact precautions and 
ecology of the unit.
Results From April 2015 to June 2016, 73 of 301 French adult ICUs 
responded to the survey (24% response rate). A screening upon 
admission was performed in 96% of cases, mostly in a systematic 
way for at least one MDRB (78%). Screening was commonly used for 
ESBLE (98.6%), methicillin-resistant Staphylococcus aureus (89.8%) 
and, to a lesser extent, imipenem resistant Acinetobacter baumanii 
(47%). A targeted screening upon admission of highly resistant 
bacteria (HRB) was performed on high-risk patients in 86.3% of cases. 
A periodic MDRB screening during the ICU stay was performed in 83% 
of cases usually weekly (90%). Preemptive isolation of patients on ICU 
admission was performed in 82% of cases, and mostly in a targeted 
way (71%). Participants varied on gown and gloves wearing from 
standard precautions to consolidated additional contact precautions. 
About 23% of units used one or several specific decontamination 
methods. Imported and acquired MDRB rates >10% were noted in 
44% and 27% of cases, respectively. Almost half of the units (48%) had 
already experienced a MDRB epidemic situation in the 3 preceding 
years.
Discussion French adult ICUs vary significantly in their MDRB 
screening and isolate approach, and about 10 combinations were 
encountered in the survey. The different approaches practiced were 
not always in agreement with the 2009 national guidelines for the 
prevention of MDRB transmission. Very few ICUs proceeded without 
screening and isolation at admission.
Conclusion Substantial variations exist in French ICUs practices 
regarding MDRB screening and isolation. The growing impact of 
imported and acquired MDRB rates and the frequency of epidemic 
situations in the ICUs may induce to reconsider and clarify the 
recommendations for prevention of “cross-transmission” of the French 
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Introduction Selective decontamination with various regimens using 
topical antimicrobials has been reported to reduce acquired infections 
(AIs) and mortality in the ICU. The efficacy of decontamination on the 
prevention of P. aeruginosa AIs is controversial [1] and potential impact 
on the emergence of antimicrobial-resistant strains is a concern. We 
assessed the incidence of P. aeruginosa AIs (PAAIs) with the routine 
use of a multiple decontamination regimen with oropharyngeal and 
digestive tobramycin/colistin/amphotericin B and nasal mupirocin/
chlorhexidine body wash over 5  years with a special attention to 
antimicrobial resistance.
Patients and methods This was an observational single center study 
of all patients admitted to an ICU 2008–2012 (study population). 
Decontamination was given for the period of intubation and standard 
care otherwise. PAAIs were prospectively recorded. Rates of PAAIs 
(proportion of patients) were first compared between the study 
period and a 4-year pre-intervention period (2003–2006). During 
study, trends were analyzed by year using a logistic regression model. 
Categories were compared by Chi square test or Fisher’s exact test 
when appropriate. Continuous variables were expressed by median 
(25th–75th percentile) and compared using non-parametric test.er the 
text
Results Of the 5250 patients admitted to the ICU during the 5-year 
study period, 69 (1.3%) acquired 77 episodes of PA infection (vs 112 
of 3603 patients [3.1%] during the pre-intervention period, p < 0.001). 
The incidence of PAAIs declined over time (OR 0.81 [0.68–0.96], 
p = 0.02). The proportion of patients who had clinical samples positive 
for PA at admission was 1.3% (70/5250) and did not vary with time (OR 
1.03 [0.87–1.22], p  =  0.75). Baseline characteristics of PAAIs patients 
were: SAPS II 55 (44–68), SOFA score 9 (7–12), prior antimicrobials 
exposition (number of molecules): 4 (2–5). AIs sites (n  =  80) were 
respiratory (n  =  52, ventilator-associated in 50), bloodstream 
(n  =  15), genitourinary (n  =  5), abdominal (n  =  4) and other 
(n =  4). The delay of onset after admission was 13  days (7–22). Prior 
decontamination duration was 10 days (5–18). The susceptibility rate 
to 10 antimicrobials of the 80 isolates tested was as follows: ticarcillin 
(66.3%); piperacillin/tazobactam (82.5%); ceftazidime (93.8%); 
imipenem (52.5%); gentamicin (57.5%); tobramycin (97.5%); amikacin 
(96.3%); ciprofloxacin (67.5%]; fosfomycin (61.3%); colistin (98.8%). 
Susceptibility to all antimicrobials remained unchanged with time 
except for fosfomycin (susceptibility rate increased with time, OR 1.59 
[1.05–2.39], p = 0.03). Antimicrobial therapy of 77 episodes consisted 
of a β-lactam agent (89.6%), ciprofloxacin (36.3%), aminoglycoside 
(31.1%). 6 episodes were not treated.
The mortality rate in ICU was similar in the patients with PAAIs (30.4%) 
and in those (n  =  166) who acquired AIs not due to PA (31.3%, 
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adjusted odds ratio  =  0.84 [0.44–1.57], p  =  0.58). The ICU mortality 
rate differed according to the site of the first episode: bloodstream 
5/12 (41.6%); lung 16/46 (34.8%); other 0/11 (p = 0.03). In the patients 
with bloodstream or respiratory PAAIs, in multivariate analysis, SAPS II 
(per one unit increase OR 1.05 [1.00–1.10]) and non-susceptibility to 
piperacillin/tazobactam (OR 5.46 [1.04–27.77]) were independent risk 
factors for death in ICU (both p < 0.05). Aminoglycoside combination 
therapy was not associated with a higher cure rate (41%, vs no 
aminoglycoside 63%; p = 0.12).
Discussion Although all-cause AIs are declining in our ICU and the 
incidence rate has become low [2], PA remains the most common 
agent of AIs. 65% of PAAIs were ventilator-associated pneumonia. 
PAAIs were not associated with a higher ICU mortality rate than AIs 
due to other organisms.
Conclusion With the routine use of a decontamination regimen, AIs 
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Introduction The incidence of resistance of Staphylococcus aureus to 
methicillin has decreased in France during the past decade leading to 
an increase use of methicillin and antistaphylococcal cephalosporins. 
It is usually stated that about 5% of methicillin-susceptible 
Staphylococcus aureus (MSSA) isolates are sensitive to penicillin G 
and penicillin G is unfrequently used to treat Staphylococcus aureus 
related infection. The aim of this retrospective observational study 
was to assess the rate of susceptibility to penicillin G among clinical 
Staphylococcus aureus strains isolated from ICU patients.
Patients and methods For a 10  years period, methicillin and 
penicillin susceptibilities of all Staphylococcus aureus strains isolated 
from clinical samples were analyzed. Repeat episodes and screening 
samples were excluded. Demographic data (age, sex), SAPSII score and 
in-ICU survival were recorded and analyzed according to penicillin G 
susceptibility.
Results From 01/2006 to 12/2015, 584 Staphylococcus aureus strains 
were isolated, 136 of whom being obtained from blood cultures, 
327 from respiratory samples, 25 from urines 8 from arthritis. One 
hundred and three (17.6%) were susceptible to penicillin. Among 
all strains of Staphylococcus aureus isolated, the annual incidence of 
penicillin -susceptible strains varied from 5 to 24%. Over this period, 
global methicillin-resistant strains incidence was 15% with annual 
rate ranging from 4 to 31%. No difference was observed between age, 
sex of patients, SAPSII score or prognosis according to penicillin-G 
susceptibility (Table 8).
Conclusion This retrospective study suggests that penicillin suscepti-
bility among clinical isolates of Staphylococcus aureus is not negligible 
and more frequent than the classical 5%. Microbiological laboratories 
should continue to test penicillin on Staphylococcus aureus strains. In 
this era of oxacillin shortage, penicillin G could be an appealing alter-
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Introduction Multiple-drug resistant bacteria carriage in general pop-
ulation and nosocomial infections are increasing in France and Europa 
even efficience of hands hygiene and antibiotic stewardship to control 
major hospital pathogens. Otherwise, antibiotics use have different 
consequences on bowel bacteria selection pressure. High biliary excre-
tion of ceftriaxone and its long acting properties are responsible for a 
higher selection pressure in comparison with cefotaxime, an antibiotic 
drug with the same microbial spectre, lower biliary excretion, shorter 
action and a negligible effect on the bowel microflora.
Patients and methods Consequently, a new antibiotic policy was 
implemented in a 350-bed general hospital in Lyon (France) with the 
promotion of cefotaxim use instead of ceftriaxone from 1st January 
2014 after an educational campaign in December 2013.
Hospital-acquired (HA) bloodstream meticillin-resistant Staphylococcus 
aureus (MRSA), third-generation cephalosporin-resistant Enterobacte-
riaceae (3GCRE), Candida infections and Clostridium difficile colitis cases 
per month/1000 patient-beds were identified and reviewed through-
out our 12 beds-intensive care unit (ICU).
Monthly consumption of several antibiotics was monitored in defined 
daily doses (DDDs) per 1000 patient-occupied bed-days (1000 pt-bds) 
24  months before (2012–2013) until 24  months after new antibiotic 
policy introduction (2014–2015).
Results Physicians have quickly followed new antibiotic policy and 
average monthly consumption of ceftriaxone reduced by 82% (from 
119.6 to 26.6 DDDs/1000 pt-bds, p < 0.001) and cefotaxime increased 
in 40% (from 27.7 to 68.8 DDDs/1000 pt-bds, p < 0.001) between the 
first and final 24 months of the study in ICU.
Over the same periods, HA bloodstream infections rates were stable 
between the period before and after intervention for 3GCRE (1.71 vs 
1.10 cases/1000 pt-bds, p = 0.33), MRSA (0.24 vs 0.08 cases/1000 pt-
bds, p = 0.41), Candida (2.09 vs 2.76 cases/1000 pt-bds, p = 0.45). And 
HA C. difficile infections were similar between the two periods (0.60 vs 
0.67 cases/1000 pt-bds for the second period, p = 0.82) in ICU.
Table 8 Age, sex ratio, SAPSII score and in‑ICU survival according 
to PeniG susceptibility
All strains Peni G-S Peni G-R P
N = 584 N = 103 N = 481
Age 64 ± 17 64 ± 18 66 ± 17 NS
Male 58% 58% 60% NS
SAPSII 48 ± 21 49 ± 19 48 ± 2 NS
Survival 70% 70% 69% NS
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Hand-hygiene compliance with alcoholic formulation (7.9 vs 10.31 ml 
per patient-days, p =  0.12) and consumption of all antibiotics (3936 
vs 4520 DDDs/1000 pt-bds, p  =  0.12) haven’t significantly changed 
before and after new antibiotic policy in our ICU and hospital.
Discussion While multiple-drug resistant bacteria nosocomial 
infections dramatically increase in France and Europa, trends in 
bloodstream 3GCRE, MRSA, Candida infections and Clostridium difficile 
colitis rates were stable in our ICU 2 years after introduction of a new 
antibiotic policy for third-generation cephalosporins. And our results 
seem different to some previous studies because only boodstream 
infections were considered in order to affirm multiple-drug resistant 
bacteria infections. But this method induced lower HA infections 
rates. Our results have to be analyzed after adjustment with multiple-
drug resistant bacteria carriage at admission in ICU between the two 
periods. About 20% of patients carriers of multiple-drug resistant 
bacteria will be infected by the same bacteria during hospitalization 
indeed. A Poisson regression model (adjusted for overdispersion) will 
be used with log occupied bed-days as an offset. Linear trend terms 
were used to assess temporal changes. The main hypothesis was to 
see whether the trend in HA infections rates following antibiotic policy 
change was the same as the trend before the intervention. Poisson 
regression will be again used to assess which of the antibiotics was the 
better predictor of HA bloodstream 3GCRE, MRSA, Candida infections 
and Clostridium difficile colitis cases.
Conclusion Hospital new antibiotic policy promoting cefotaxime 
use instead of ceftriaxone didn’t seem to impact hospital-acquired 
bloodstream meticillin-resistant Staphylococcus aureus, third-
generation cephalosporin-resistant Enterobacteriaceae and Candida 
infections and Clostridium difficile colitis rates after 2 years-monitoring 
in our intensive care unit. Further investigations are needed to precise 
the impact of dramatic increase in third-generation cephalosporin-
resistant Enterobacteriaceae carriage on our results and the best 
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Introduction Staphylococcal infections affect almost 30% of 
patients in intensive care units (ICU) in Western Europe (19.6% of 
Staphylococcus aureus (SA) infections and 11.2% of coagulase-negative 
Staphylococcus (CNS) infections). These infections are associated with 
increased risks of mortality, and increased prevalence of meticillin-
resistance. During the last decade, new active antibiotics against 
meticillin-resistant Staphylococcus (MRS), linezolid and daptomycin 
appeared which changed the management of these infections. The 
objective of this study is to characterize patients infected with SA and 
CNS and assess prescribing habits concerning with antistaphylococcal 
antibiotics in ICU, 10 years after the advent of the new anti-MRS.
Patients and methods It is an observational retrospective study in 
a medical and surgical ICU. All patients with at least one SA or CSN-
documented and treated infection between January 1st, 2006 and 
February 1st, 2015 have been included. A staphylococcal infection 
was defined by clinical, biological and microbiological criteria (based 
on thresholds of clinical guidelines). Antistaphylococcal antibiotic 
treatment was considered to be appropriate if at least one of the 
antibiotics used was effective against the germ according to the 
antibiogram. A descriptive analysis of the results was conducted.
Results Sixty-seven patients had at least one staphylococcal infection, 
corresponding to 74 infectious events including 63 SA infections 
(85%) and 11 CNS infections (15%). The average age of patients 
was 62  ±  15  years with a majority of men (62%) with numerous 
comorbidities (average Charlson of 4  ±  2). Average IGS and SOFA 
scores at 24 h were 60 ± 22 and 11 ± 5 respectively. There were mainly 
low respiratory infections (46 of 74, 62%) then 12 endocarditis and 
septicemias (16%) including 4 intravenous device infections. There 
were 47 nosocomial infections (64%) and the overall prevalence 
of MRS was 23.8% including 34% among nosocomial infections 
and only 4% among community-acquired infections. An empiric 
antibiotic therapy was prescribed in 89% of cases, and active against 
Staphylococcus spp. in 92% of cases. The empiric antibiotic therapy 
was effective against MRS for 48% of community-acquired and 43% 
of nosocomial infections. After the antibiogram reception, penicillin 
M was used for 46% of meticillin-sensitive staphylococcal infections, 
followed by amoxicillin-clavulanic acid (22%), and then vancomycin 
and linezolid (10% each). Vancomycin was the first used antibiotic in 
MRS infections (77%) with a vancomycin serum concentration at 48 h 
of 18 ± 8 mg/l, followed by linezolid (15%), mainly for the treatment of 
low respiratory infections. Daptomycin has never been used. Mortality 
rate at 28 and 90 days was 79% and 87% respectively, and the average 
length of stay in ICU was 15 days ([5; 27]).
Conclusion Staphylococcus spp. is essentially responsible for low 
respiratory infections, septicemias and infectious endocarditis, mostly 
nosocomial. These infections concern severely ill patients, with a low 
survival rate, without any causal link proved in this study. Empiric anti-
MRS antibiotic therapy must be improved, particularly in a nosocomial 
condition. Vancomycin is still the first anti-MRS used 10 years after the 
provision of linezolid in France. Easier to use, empiric prescription of 
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Introduction Ventilator-associated pneumonia (VAP) is the leading 
cause of nosocomial infections in intensive care units. In case of VAP 
with shock, most recent international guidelines still recommend 
an early and broad-spectrum empiric antibiotic therapy focused on 
any infection due to Gram negative bacillus, including extended-
spectrum β-lactamase–producing enterobacteriaceae (ESBL-EB), 
and MRSA. However, in recent years, there has been a change in the 
bacterial ecology, particularly a lower MRSA incidence. This study 
aims to demonstrate that, in patients with VAP and septic shock, an 
empiric antibiotic therapy with anti-MRSA activity without prior MRSA 
colonization is inappropriate.
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Patients and methods Retrospective cohort study of patients with 
documented VAP in two intensive care units (ICU). All patients admit-
ted to our ICU’s between January 2010 and December 2014 were 
included with the following criteria (1) mechanical ventilation for more 
than 48  h; (2) quantitatively significant culture of lower airways; (3) 
CPIS > 6. At admission and weekly thereafter, in all patients, was rou-
tinely performed multidrug-resistant bacterial species colonization by 
rectal or nasal swab collection.
Results Among 3629 patients under mechanical ventilation hospital-
ized in our ICU’s, 284 (7.8%) had a confirmed VAP, 172 (60.6%) with 
septic shock and 112 (39.4%) without. In the septic shock VAP group, 
11 patients (6.4%) presented a VAP caused by MRSA. Among them, 10 
were colonized by MRSA before VAP occurrence. No infection or colo-
nization by MRSA were found in non septic shock VAP group. Interest-
ingly, among the 284 patients with confirmed VAP, 141 (49.6%) (109 in 
the septic shock VAP group vs 32 without shock) were treated by anti-
MRSA antibiotherapy (vancomycin or linezolid).
Conclusion MRSA colonization screening at admission and weekly 
thereafter is essential to avoid useless anti MRSA antibiotherapy in VAP 
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Introduction Emergence of multidrug resistant (MDR) bacteria is a 
real problem worldwide and becoming increasingly important. The 
aim of this study was to describe the frequency and patterns of MDR 
bacteria following the implement of a systematic screening process at 
ICU admission in a Tunisian ICU.
Patients and methods Between 1st March 2016 and 31st August 2016, 
consecutive patients admitted to our ICU following more than 24  h 
length of stay in another hospital ward, systematic screened for MDR 
bacteria. Specimens were recovered from nasal, axillary and rectal 
swabs. Micro-organisms cultures were made onchromogenic media.
Results During the study period 127 patients were admitted to the 
ICU, 32 of them were transferred from other wards and fulfilled the 
inclusion criteria. Colonization with MDR bacteria was present in 11 
patients (34.3%) (median age 64 [IQR 39–75], 62% males, mechanical 
ventilation in 59.4%). 72% of patients were referred from the 
emergency department. During the study period 127 patients were 
admitted to the ICU, 32 of them were transferred from other wards 
and fulfilled the inclusion criteria. Colonization with MDR bacteria 
was present in 11 patients (34.3%) (median age 64 [IQR 39–75], 
62% males, mechanical ventilation in 59.4%). 72% of patients were 
referred from the emergency department. During the study period 
127 patients were admitted to the ICU, 32 of them were transferred 
from other wards and fulfilled the inclusion criteria. Colonization with 
MDR bacteria was present in 11 patients (34.3%) (median age 64 [IQR 
39–75], 62% males, mechanical ventilation in 59.4%). 72% of patients 
were referred from the emergency department.
100% of the MDR bacteria were extended-spectrum beta-lactamase-
producing enterobacteriacae (Table 9).
No meticillin resistant staphylococcus aureus, nor carbapenemase 
producing pseudomonas aeruginosa or acinetobacter baumanii were 
isolated.
Conclusion MDR bacteria (100% extended-spectrum beta-lactamase-
producing enterobacteriacae) is present in more than one-third 
patients transferred from the emergency department. The risk factors 
forMDR bacteria acquisition and a strategy to contain this phenom-
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Introduction Vancomycin-resistant Enterococcus faecium (VREF) is cur-
rently one of the most important etiologies of nosocomial infections in 
critically ill patients. In the continuum of VREF infections, bacteremia 
is of special interest, given that overall mortality rates may reach val-
ues higher than 60% with an attributable mortality of around 40%. The 
aim of our study was to determine incidence and risk factors associ-
ated with VREF bacteremia in an intensive care unit (ICU).
Patients and methods A retrospective case–control study was 
performed in the ICU of an university hospital in Tunisia from March 
2008 to march 2016. Cases were defined as septic patients with 
VREF isolated from a blood culture (VREF group). Blood isolates were 
identified according to standard techniques and Vitek2 (bioMerieux).
VREF was defined as an Enterococcus faecium isolate with an MIC of 
vancomycin ≥32  μg/mL by the Etest (bioMerieux) according to the 
standards of the Clinical and Laboratory Standards Institute (CLSI).
Control patients were randomly drawn from 65 hospitalized patients 
with vancomycin-susceptible Enterococcus faecium isolated from 
a blood culture (VSEF group). Medical records of the patients were 
reviewed. If patients developed several episodes of VREF bacteremia 
during the study period, only the first episode was investigated.
Results A total of 20 case patients (4.89 per 1000 admissions) and 20 
control patients with at least one positive E. faecium blood culture 
were identified. The demographic and clinical characteristics of the 
case and control groups were similar, except for mean duration of 
length of stay, with values being significantly greater in the case 
group (66 ± 12 vs 24 ± 8, p < 0.001). In 14 cases, VREF bloodstream 
infections were related to intraabdominal infections; six cases had 
catheter-related VREF bloodstream infections. Mortality among these 
bacteremic patients did not differ significantly between those with 
VREF (14%) and those with VSEF (10%) isolates (p  =  0.36). In the 
univariate analysis, the significant risk factors for VREF bloodstream 
infections included diabetes mellitus, arterial hypertension, end-stage 
renal disease, prior exposure to immunosuppressive agents notably 
corticosteroids, prior receipt of vancomycin before VREF identification 
and a prolonged length of stay in ICU (Table 10).
Discussion Enterococcus is the third most common cause of nosoco-
mial bloodstream infection. Vancomycin-resistant Enterococcus (VRE) 
is an important problem in Europe, USA, and Latin America and has 
been isolated in many other countries. Infections due to VRE have 
been shown to be associated with significant in-hospital mortal-
ity and morbidity. Despite the fact that 80- 90% of clinical isolates of 
enterococci are E. faecalis, most VRE are E. faecium [1]. Similarly, in our 
Table 9 Micro‑organisms isolated with  systematic (MDR) bacte‑
ria screening
N = 11
Escherichia coli [n (%)] 4 (36.3%)
Klebsiella pneumoniae [n (%)] 4 (36.3%)
Klebsiella oxytoca [n (%)] 1 (9%)
Citrobacter freundii [n (%)] 2 (18.1%)
Page 48 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
institution, the vast majority of VRE bacteremia cases are caused by E. 
faecium.
Conclusion The incidence of VREF bloodstream infections was high 
compared with literature data.
Several risk factors have been identified and they should be 
considered in infection control practice to prevent VREF infection or 
colonization and to reduce they duration. This association has been 
previously suggested only in studies that have been limited by small 
numbers of patients and a failure to perform multivariate analysis. The 
retrospective analysis of a relative small cohort of patients is the major 
limitation of our study considering that we cannot be certain that we 
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Introduction The convulsive crisis is a symptom indicating a hyper 
synchronous discharge of a more or less extensive portion of the 
cerebral cortex. It is a frequent disease in the emergency (0.3 to 1.2%) 
[1]. The aim of our study was to report the epidemiological, clinical, 
therapeutic and evolutionary aspects of the convulsive crisis in the 
emergency.
Patients and methods Prospective study extending on year 
(01/01/2015 - 31/12/2015), including all patients aged over 18 
consulting in the emergency for convulsive crisis.
Results We included 41 patients. The average age was 45 ± 19 years 
with a sex ratio of 1.5. The convulsive crisis occurred at a known epi-
leptic in 53.6% of cases. The average duration of crisis was 10 ± 4 min. 
The average time of consultation was 54  ±  21  min. Generalized 
tonic–clonic seizures were observed in 30 patients. Partial seizures in 
11 patients. The status epilepticus has been reported in 12 patients 
(29.2%). Discontinuation of antiepileptic therapy was noted in 20 
cases (48.7%), intoxication in 6 cases (14.6%), hypoglycemia in 5 cases 
(12.1%), head trauma in 5 cases (12.1%), accident cerebrovascular in 
3 cases (7.3%) and preeclampsia in 2 cases (4.8%). The convulsive cri-
sis was accompanied by a post-critical deficit in 6 patients (14.6%) 
and a head injury in 2 patients (4.8%). A brain imaging was indicated 
in 18 patients (43.9%). Benzodiazepines were prescribed in 78% of 
cases and barbiturates in 24.3% of cases. The use of invasive mechani-
cal ventilation was reported in 12 patients (29.2%). Thirteen patients 
were hospitalized in intensive care, 12 in neurology and 6 in medicine 
department. There were no deaths.
Conclusion The management of convulsive crisis in the emergency is 
multidisciplinary. It is based on a good mastery of the definitions and 
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Introduction Stroke is a frequent and serious disease. Stroke units 
(SUs) have demonstrated efficiency in reducing death and disability 
after stroke. In France, public health autorities’s reports recommended 
that every patient presenting with stroke symptoms should be 
admitted in SUs. But beds in these units are still insufficient, so triage 
seems unavoidable. We aimed to explore admission criteria in SUs in 
case there is only one bed left. In this situation, is the time window 
allowed thrombolysis the main criteria for neurologists to accept a 
patient?
Patients and methods This was a postal and e-mail survey that took 
place from January 1st to July 31st 2016. An anonymous questionnaire 
was sent to the 164 neurologists who usually work in the 21 SUs 
in the region of Ile de France. The survey was in two parts: the first 
one encompassed questions about the physicians themselves (age, 
professional status, current job tenure), and, then, in the second part 
we presented different clinical cases including the type of stroke 
(ischemic, hemorrhagic, or transient ischemic attack), age ranges of 
the patients, and different time slots during nyctohemeral period. 
Finally, data were collected in July 2016.
Results were expressed as absolute numbers and percentages, and 
for statistical analyses, we used the Fisher’s exact test from the on-line 
software BiostaTGV.
Results One hundred four questionnaires were completed, 
representing 63% of all. Majority of physicians were hospital 
practitioner (53%), and 56% have been working in SUs for more than 
5 years. We asked to neurologists if they already refused a patient 
when it stay one bed in their unit, to keep it for a patient who could be 
eligible for thrombolysis, and the answer was positive in 64%.
There was no significant difference in accepting or denying regardless 
of the type of stroke or the different time slot. Concerning the age 
ranges, we found a significant relationship only with ischemic stroke 
(p  =  0.014), as the oldest patients above 90  years old were more 
refused than the youngest.
Discussion Our study has several limitations, and probably the main is 
the risk of declarative biases due to descriptions of practices that differ 
from those encountered in real life. A more rigorous methodologic 
analysis, including a prospective study following patients suffering 
from stroke, would perhaps more reflect the reality.
Conclusion In case there is one bed left in their SUs, neurologists seem 
to accept most patients, even if thrombolysis is off limits. Only the age 
ranges may influence their decision if the patient suffers from ischemic 
stroke. More studies are necessary to confirm or not these results.
Competing interests
None.
Table 10 Risk factors for VREF by univariate analysis
EFRV (n = 20) EFRV (n = 20) p
Diabète 15 0 0.006
HTA 15 0 0.006
I Rénale C 15 5 0.03
Corticothérapie 17 5 0.04
Prise de Vanco 15 2 0.048
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Introduction The management of hemorrhagic stroke (AVCH), consid-
ered the second cause of death in the world, has in recent years major 
changes. Early diagnosis and optimization of Early and specialized 
load have also shown their interest on the prognosis of patients
Purpose Through this analytical study, we emphasize the quality of 
the management of the hemorrhagic stroke.
Materials and methods We realized a retrospective study about 50 
patients hospitalized at the resuscitation department of the surgical 
emergencies at the UHC Casablanca during a period of 4  years from 
January 2012 to December 2015. It included 31 men and 19 women, 
the meanagewas51  ±  15  yearsold. The epidemiological, clinical, 
paraclinical, therapeutic, and evolutive data were collected and 
gathered on a card then entered and analyzed on Epi Info software.
Results 50 patients were collected whose average age is 52 plus or 
minus 15 years male predominance is noted.
Hypertension is the most common risk factor for 41% followed by 
diabetes with a rate of 26%.
In our study, the recruitment rate was highest in autumn period 33.33%.
The mode of early neurological symptoms was brutal in 74% of 37 
patients.
On admission clinical examination showed impaired consciousness 
with a Glasgow score ≤10 33 patients or 66%. Hemiplegia is the 
main focal neurological signs met the most common site of cerebral 
hemorrhage is lobar.
Brain CT showed an intra-parenchymal hemorrhage in 40 patients or 
79% of cases with a predominance of the parietal location (23%). A 
pure subarachnoid hemorrhage was noted in 4 patients 10% of cases. 
46% of patients had ventricular flooding.
Mechanical ventilation was required in 37 patients or 74%. 
Antihypertensive therapy was prescribed in 30 patients or 59%. 
Antiepileptic therapy was indicated in all patients.
The surgical indication was raised in 22 patients or 44%. 14 patients 
died after surgery.
The outcome was favorable in 14 patients or 28%, and negative in 36 
patients or 72% of cases.
Conclusion In the literature, various predictive factors of mortality 
are observed. The prognosis of the hemorrhagic stroke in the units 
of intensive cares is still dark, hence the importance to develop 
specialized centres in order to improve the management of the 
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Introduction Optic nerve sheath diameter (ONSD) is an easy to 
obtain parameter, which has been associated to absolute value and 
variation of intracranial pressure. However, the normal value of this 
parameter (observed in patients without raised intracranial pres-
sure) remains debatable (from 5 to 5.9 mm) highlighting the impor-
tance measurement precision. Is this pilot observational study, we 
aimed to compare the ONSD values obtained with two different US 
device.
Patients and methods During a 2-month period, all consecutive 
patients recovering from acute disease, orientated, spontane-
ously breathing, without vasocative support were deemed to be 
included. Age sex, height, weight, BMI, SAPSII, myopia and other 
relevant ophtlamologic diseases were recoreded. After oral con-
sent, ONSD of both right and left eyes were measured with two 
distinct US devices: Vivid 7 (GE, equipped with a 8 MHz (4–11 MHz) 
microconvex probe and a M Turbo, (Sonosite, Bothwell, MA) 
equipped with a HFL38 probe (6–11  MHz). Patients characteristics 
are expressed as qualitative or quantitative non parametric value as 
appropriate. The ONSD values obtained with the two devices were 
compared using Wilcoxon matched-paired test. The bias between 
the two measurements was expressed according to the Bland–Alt-
man method.
Results During the study period, 25 patients (age: 59  years [50–66], 
SAPSII: 47[30–64], weight 69 kg [52–86], height 168 cm [158–175]; BMI 
23 [20–29], myopia 3/25) were studied. Measurements, performed by 
a senior intensivist skilled in ultrasonography, were always possible 
with acceptable discomfort. Maximum values observed were 7.9 mm. 
ONSD values were similar between right and left eyes with the Vivid7 
device (5.8  mms 5.7  mm, p  =  .9) and with MTurbo (4.6 vs 4.7  mm, 
p =  .7) but were significantly greater with the Vivid device (p =  .002 
and p =  .003 for right and left eye respectively). The values were sig-
nificantly correlated (Spearman coeff r = 0.39 p = .003). No correlation 
was observed between ONSD values and height, weight or BMI. Myo-
pia was not associated with greater values. The bias (difference mean) 
1.16 m provided limits of agreement (±2SD) [−0.0589462, 0.291990) 
which included all except 3 patients.
Discussion In this small unselected medical ICU patients population 
with no neurological injury and unlikely to have raised intracranial 
pressure, the two US devices provided statistically different values 
with higher values with one of the devices.
Conclusion The ONSD is an easy to obtain parameter but depends on 
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Introduction Delayed cerebral ischemia (DCI) is the main 
cause of disability after subarachnoid hemorrhage (SAH) but its 
pathophysiology remains unclear. We currently have no effective 
treatment to reduce the incidence of DCI. Study of pathophysiology 
has long suffered from a lack of consensus definition of DCI. It is only 
recently that experts have proposed that in observational studies 
and clinical trials aiming to investigate strategies to prevent DCI, the 
2 main outcome measures should be: (1) cerebral infarction identified 
on CT scan or magnetic resonance imaging or proven at autopsy, after 
exclusion of procedure-related infarctions; and (2) functional outcome 
[1]. Currently, experimental studies must therefore meet this new 
definition. The aim of our study is to identify the extent preclinical 
studies using this new definition of DCI.
Materials and methods Systematic review from PUBMED using key 
words. Consulting additional bibliographic databases including gray 
literature, scientific meeting abstracts and review of the bibliography 
of selected articles completes the research. Inclusion criteria: (1) 
description and/or modification of an SAH model in rats or mice; (2) 
study of cerebral vasospasm and/or DCI. This research is performed in 
accordance with the PRISMA recommendations [2].
Results Seventy-one publications from 47 teams are included. 11 
teams are responsible for 77% of publications. 8 different methods are 
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used for induction of SAH. The most used model is the direct blood 
injection into the cisterna magna. Vasospasm is studied by brain imag-
ing (n =  18) mainly in the first 72  h and histology (n =  32) until the 
tenth day. A positive diagnosis of vasospasm is placed in histology 
in 28 of 32 studies. Cerebral ischemia is sought in 24 publications 
including one in cerebral imaging. Neurological deficit is wanted by 
sensorimotor tests in 13 publications. Three models use animals with 
comorbidities (hypertension, obesity and chronic inflammation). No 
model uses female population. Among the 10 most cited studies, 
none of them is studying cerebral ischemia by imaging.
Discussion Differences with human pathology of SAH are raised 
about the pathophysiology leading to SAH and its anatomoclinical 
characteristics. In particular, there is an over-representation of 
models of posterior circulation. Similarly, study of vasospasm remains 
the most studied criteria to the detriment of the ischemia and 
neurological deficit, even though it is the first cause of disability after 
SAH (Table  11). Furthermore, we can note an over-estimation of the 
incidence of vasospasm in the included publications compared to 
the clinical epidemiological data. Study methods of vasospasm and 
cerebral ischemia may be criticized.
Conclusion Currently we don’t have a murine model of SAH meeting 
the diagnostic DCI criteria retained in humans. The development of 
such a model in agreement with the pathophysiological data known 
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Introduction Pediatric transplants suffer from organs shortage. 
Children’s potential organs donors should be enhanced by awareness 
of the healthcare team and their families, given the socio-economic 
impact of the transplant. Our study’s aim was to evaluate our potential 
organs donors from deceased patients in pediatric intensive care 
during 2015.
Materials and methods We led a retrospective study in pediat-
ric intensive care unit of UHC Ibn Rochd child hospital Abderahim 
Elharouchi of Casablanca, over 1 year from 1 January 2015 until 31 
December 2015. Were Included all patients in clinical brain death. Our 
study excluded newborns.
Statistical analysis used the epi-info test with significance level P ˂0.05.
Results 25 cases were collected, 12% of deaths during 2015, with aver-
age age of 7, 32 ± 6, sex ratio was M/W 1.5, the average weight of our 
population was 34, 72 ± 32 kg, reason for admission was head injury 
following an PRA for 8 cases, cranial traumatism following defenestra-
tion for 2 cases, stroke for 10 cases, and epilepsy for 6 cases.
The Glasgow Average on admission was 6.88  ±  3, mean hospital 
duration was 6.75 days. All patients were ventilated on admission, use 
of vasoactive drugs were needed for 20 patients.
Brain death diagnosis was made by two intensive anesthetist doctors 
for each patient looking for brain death clinical signs. Cerebral 
angiography was made for 10 patients. The procedure of organ 
donation has been discussed in 17 cases, parents have accepted 
donation in two cases, refusal of both parents in 9 cases, refusal of 
one parent in 6 cases. In 8 cases the patient died before starting the 
procedure.
We successfully removed both kidneys and liver for our first donor and 
just one kidney and cornea for the second one.
Discussion In front of persisting imbalance between the needs 
and the number of grafts, removal of pediatric organs should be 
enhanced by optimizing children potential donors and their families 
management. It is important to encourage the involvement of a health 
care team and humanly participate with the coordination teams to 
deal with parents and dare to seek their consent to donate.
Conclusion This study shows out a significant pool of potential organ 
donors in pediatric intensive care. Hence the need to lead out activities 




Interest of lung ultrasound in an intensive care unit
Walid Sellami1, Zied Hajjej1, Soumaya Ben Yedder1, Iheb Labbene1, Musta‑
pha Ferjani1 
1Department of critical care medicine and anesthesiology, Military Hospi‑
tal of Tunis, Tunis, Tunisia
Correspondence: Walid Sellami ‑ drsellamiwalid@yahoo.fr
Annals of Intensive Care 2017, 7(Suppl 1):P18
Introduction Interest in bedside lung ultrasound in the intensive 
care unit has exploded in recent years [1]. The aim of this study was to 
evaluate the contribution of lung ultrasound in an intensive care unit 
and its place as a diagnostic tool and therapeutic implication.
Patients and methods Retrospective study extending over 6 months. 
It included ICU patients who underwent lung ultrasound.
Table 11 Table of ten most cited studies
NA not available
Studies Models Vasospasm Delayed cerebral ischemia
Imaging Histology Behavioral study
Bederson (1995) Endovascular perforation NA NA NA No focal neurological deficit
Bederson (1998) Endovascular perforation Yes NA NA NA
Delgado (1985) Direct injection Yes NA NA NA
Solomon (1985) Direct injection NA NA NA NA
Prunell (2003) Direct injection NA NA Yes Yes
Jackowski (1990) Direct injection Yes NA NA NA
Sugawara (2008) Endovascular perforation Yes NA NA Yes
Veelken (1995) Endovascular perforation NA NA Yes NA
Gules (2002) Direct injection Yes NA NA No focal neurological deficit
Doczi (1986) Direct injection NA NA NA NA
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Results Forty patients underwent a lung ultrasound due to various 
respiratory etiologies: 60% patients for acute respiratory failure, 
30% for ultrasound-guided pleural punctures, 20% for exploration 
of a white lung on chest radiograph. Ultrasonography consists in 
exploration the chest over the six regions. Of the 24 (60%) acute 
respiratory failure, the review found: 15 (62.5%) fluid pleural effusions, 
2 (8%) pneumothorax, 4 (16%) alveolar-interstitial syndrome 
and 3 (13.5%) pulmonary condensation. Clinical and gasometric 
improvement was observed in 70% of patients. Lung ultrasound has 
allowed a change in management in 43% of patients and has provided 
new information in 72% of cases and led to successful ultra sound 
guided pleural drainage.
Discussion Lung ultrasound has allowed a major improvement 
of routine practice in intensive care unit. Once the appropriate 
equipment and training acquired, lung ultrasound has advantages: 
Safety, speed, acuity, reduced costs and increased patient comfort
Conclusion Responding immediately to questions for which only 
sophisticated approaches were used, lung ultrasound untangles these 
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Introduction The use of large tidal volume ventilation can be 
deleterious and lead to Ventilator Induced Lung Injury. It has been 
suggested that Lung-protective ventilation using low tidal volume 
should be used in all critically ill patients. We conducted a study 
to evaluate the tidal volumes related to body weight prescribed 
during Assist Control Mechanical Ventilation (ACV) in our Unit and 
to determine the proportion of patients receiving Low Tidal Volume 
Ventilation (LTVV).
Patients and methods Retrospective study conducted in a single 
12 bed adult intensive care unit (ICU). Patients requiring mechanical 
ventilation admitted from January to June 2014 were included. 
Medical files were reviewed to determine the minimal and maximal 
tidal volumes related to predicted body weight (Vt min and Vt max) 
delivered during Assist Control Ventilation. LTVV was defined as 
Vt ≤ 8 ml/kg of predicted body weight (PBW).
Results We included 129 patients (63.5% men) with a median age of 
64 years (IQR 52.5–71), a mean SAPS II Score of 46 ± 16 and a median 
length of mechanical ventilation of 6 days (IQR 2–14.5). Patients were 
predominantly non-surgical (77.5%) and 18.6% had a diagnosis of 
ARDS. Mean height was 168.4  ±  9.3  cm, actual and predicted body 
weight were 75.5  ±  21.7  kg and 63.1  ±  9.8  kg. Median Vt max was 
7.9 ml/kg (IQR 7.3–8.9) and 72 patients (56%) had permanent LTVV (Vt 
max ≤  8  ml/kg). Median Vt min was 7.4  ml/kg (IQR 6.9–8.2). Women 
had Vt max and Vt min significantly higher than men [median respec-
tively 9.4 (IQR 8.3–9.8) vs 7.4 ml/kg (IQR 7–8) and 8.4 (IQR 7.5–9.3) vs 
7.2 ml/kg (IQR 6.7–7.6); p < 0.0001] (Fig. 11). Only 17% of women had 
permanent LTVV versus 78% of men.
Discussion Even though the benefit of LTVV applied for all ICU 
patients is still to be demonstrated, our results show that women 
are exposed to much more “aggressive” mechanical ventilation with 
potentially harmful consequences. LTVV seems to be achievable for 
all intensive care patients since 78% of men admitted in our unit are 
ventilated with maximal Vt ≤ 8 ml/kg of predicted body weight.
Conclusion A large proportion of patients in our unit are ventilated 
with LTVV but Mechanical Ventilation could be another example of 
gender discrimination. Particular attention should be paid when 
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Introduction Bench test studies are performed to evaluate or 
compare ventilators. Setting of respiratory mechanics of the lung 
model should simulate realistic conditions [1]. However, there is no 
standard for respiratory mechanics properties for normal lung, COPD, 
and ARDS. Consequently, bench studies use different respiratory 
mechanics variable which have a big impact on results [1]. This 
prospective observational study measured respiratory mechanics of 
passive ventilated ICU patients in order to provide realistic values for 
bench test studies.
Patients and methods This study was performed in adult mixed ICU 
of Sainte Musse hospital in Toulon between May 2015 and September 
2016. Patients deeply sedated and passively ventilated were included. 
Exclusion criteria were mixed lung condition, presence of chest tube, 
prone position, and severe hemodynamic impairment. Patients were 
classified according to standard definition in: normal lungs, COPD 
or ARDS. Patients were ventilated in INTELLIVENT-ASV® mode and 
positioned in semi-recumbent. Respiratory mechanics variables were 
measured once per patient during the first 24  h after ICU admission 
together with arterial blood gases. Airway pressure and flow was 
measured by a proximal pneumotachograph. Static compliance 
(CSTAT) and inspiratory resistances (RINS) were measured using the 
least square fitting method [2]. CSTAT was also calculated as the ratio 
between tidal volume and driving pressure. Expiratory time constant 
(RCEXP) was measured as the ratio between volume and flow at 75% 
of maximum expiratory flow and calculated as the product of CSTAT 
MEAS and RINS. Anova was performed to compare results between 
each lung condition. Data are presented as median [25th–75th 
quartiles].
Fig. 11 Box‑plot of tidal volumes according to gender
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Results Two hundred fifty-seven patients were included: age: 66 [54–
74] years; BMI: 25 [22–28] kg/m2, SAPS II: 56 [44–66]. The main results 
are shown in Table 12.
Conclusion This study reports clinically-based values of respira-
tory mechanics for passive mechanically ventilated ICU patients. 
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Introduction Although Neurally Adjusted Ventilatory Assist (NAVA) 
is currently used in many intensive care units, the best method for 
setting the optimal level of assistance in this proportional ventilatory 
mode is not yet established. In order to determine a method based on 
aiming the best respiratory comfort of the patient, the authors studied 
the impact of several levels of assist in NAVA, on the respiratory 
behaviour and comfort, of patients undergoing weaning of the 
mechanical ventilation.
Patients and methods This study was single-center prospective, 
open, randomised, of current care. Patients staying in a critical 
care unit, undergoing invasive mechanical ventilation for an acute 
respiratory failure, and recovering spontaneous ventilation, were 
included. For every patient, an optimal level of assistance in pressure-
support ventilation was determined and called AI 100, with which 
an equivalent level of assistance in NAVA called NAVA 100 was set. 
From this level, six other NAVA levels were determined, by increase 
or decrease of 25% stepwise, respectively called NAVA 25, NAVA 
50, NAVA 75, NAVA 125, NAVA 150 and NAVA 175, and applied in a 
randomized order. For every situation, after obtaining a stability of 
the end-tidal carbon dioxide pressure (ETCO2), pressure, volume, flow, 
and electromyographic activity of the diaphragm (Edi) were recorded 
during 5  min. An arterial gazometry was performed, and respiratory 
comfort was assessed by using the dyspnea numeric scale, the Multi-
dimensional Dyspnea Profile (MDP) by Banzett, and the Respiratory 
Distress Observational Scale (RDOS). All parameters were compared 
between ventilatory modes, by using variance analysis ANOVA.
Results Ten patients were included. Between NAVA levels, no differ-
ence was observed regarding tidal volume (Vt, p = 0.143) and arterial 
carbon dioxide pressure (PaCO2, p = 0.141). The Ti/Ttotneu ratio and 
AUC Editot (the area under curve of Edi superior to trigger) raised sig-
nificantly for NAVA 25, the lowest NAVA level, respectively p = 0.005 
and p < 0.001. The dyspnea numeric scale and MDP by Banzett showed 
no significant difference along the NAVA levels, respectively p = 0.412 
and p = 0.107. However, RDOS score was significantly higher for the 
low levels of assistance NAVA 25 and NAVA 50; p < 0.001.
Conclusion With variation of the NAVA level, our patients showed 
a respiratory behaviour similar to the findings described previously 
in the litterature. The level of assistance did not seem to influence 
the patient’s feeling of dyspnea, despite an obvious raising of the 
ventilatory demand. However, Ti/Ttotneu ratio, AUC Editot and 
RDOS clinical score appear as potential useful tools to detect under-
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Introduction The aim of the study is to assess the usefulness of 
the Full Outline of Unresponsiveness (FOUR) score in predicting 
extubation failure in critically-ill intubated patients admitted with 
disturbed level of conscious in comparison with the Glasgow Coma 
Scale (GCS).
Materials and methods All intubated critically-ill patients with 
disturbed level of consciousness were assessed using both the FOUR 
score and the GCS. The FOUR score and the GCS were compared 
regarding their predictive value for successful extubation at 14  days 
after intubation as a primary outcome measure. The 28-day mortality 
and the neurological outcome at 3  months were used as secondary 
outcome measures.
Results Eighty-six patients were included. Median age was 63 [50–77] 
years. Sex-ratio (M/F) was 1.46. Median GCS was 7 [3–10] while median 
FOUR score was 8.5 [2.3–11]. A GCS ≤ 7 predicted the extubation fail-
ure at 14 days after intubation with a sensitivity of 88.5% and specific-
ity of 68.3% (Youden index = 0.57 95% CI [0.35–.7]) whereas a FOUR 
score <10 predicted the same outcome with a sensitivity of 80.8% 











COPD (n = 28) P ANOVA
CSTAT MEAS (mL/
cmH2O)
46 (42–59) 34 (29–45) 37 (30–46) 35 (29–43) 33 (29–43) 50 (37–70) <.001
CSTAT CALC (mL/
cmH2O)
52 (43–64) 40 (32–49) 41 (32–51) 41 (33–49) 38 (30–45) 56 (42–72) <.001
RINS (cmH2O s/L) 13 (11–15) 12 (10–14) 11 (9–13) 12 (10–15) 11 (9–12) 22 (16–33) <.001
RCEXP MEAS (s) 0.60 (0.52–0.72) 0.47 (0.41–0.57) 0.46 (0.41–0.54) 0.47 (0.39–0.57) 0.45 (0.38–0.57) 1.04 (0.65–1.82) <.001
RCEXP CALC (s) 0.62 (0.51–0.80) 0.41 (0.32–0.55) 0.44 (0.35–0.57) 0.43 (0.30–0.58) 0.37 (0.30–0.51) 1.17 (0.69–1.70) <.001
Page 53 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
and a specificity of 81.7% (Youden index =  0.62 95% CI [0.44–0.77]). 
The AUC was significantly higher with the FOUR score than with GCS 
(respectively 0.867 95% CI [0790–0.944] and 0.832 95% CI [0.741–
0.923]; p  =  0.014). Both scores had similar accuracy for predicting 
28-day mortality and neurological outcome at 3 months.
Conclusion The FOUR score is superior to the GCS for prediction of 
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Introduction Spontaneous breathing trial (SBT) is used to test 
patient’s readiness for separation from the ventilator. The most appro-
priate method for SBT (t-tube vs pressure support ventilation, PSV) is 
still a matter of debate. The aim of the present study was to assess SBT 
and patients outcomes with these two methods in a Tunisian ICU.
Patients and methods This was a cohort study including patients 
consecutively admitted between 1st July 2014 and 31st August 2016 
and ventilated more than 48 h, who underwent their first SBT accord-
ing to clinical criteria. SBT was performed in our ICU with T-tube before 
March 2016 and with PSV since then. Clinical characteristics and out-
comes were compared between both groups. A multivariate analysis 
with adjustment on variables significantly different at baseline was 
made for the prediction of extubation success.
Results During the study period 84 patients under went first SBT (55 
patients with T-tube and 29 with PSV). Table 13 summarizes patients 
characteristics and outcomes.
Multivariate analysis showed no relation between SBT modality and 
extubation success (extubation without reintubation in the following 
48 h) (OR 0.89, 95% CI 0.33–2.38). We also matched 28 patients in PSV 
group with 28 others from T-tube group (on age, gender and SAPS 
III), and observed that the rate extubation success was not different 
(53.6% T-tube vs 57.1% PSV, p = 1.000). ICU mortality was significantly 
higher among reintubated patients than in successfully extubated 
patients (75 vs 11.3%, p < 0.001).
Conclusion In our cohort, SBT with PSV or T-tube provided compara-




First‑year experience of a French mechanical ventilation weaning 
centre
Françoise Haniez1, Hélène Jaillet1, Henri Maas1, Pierre Andrivet1, Christian 
Darné1, François Viau1 
191, C.H. Bligny, Briis‑sous‑Forges, France
Correspondence: Françoise Haniez ‑ f.haniez@chbligny.fr
Annals of Intensive Care 2017, 7(Suppl 1):P25
Introduction Economic pressure to maximize resource utilization has 
resulted in the creation of post-ICU care centers dedicated to patients 
with weaning failure.
Patients and methods Prospective observational cohort study of 
patients admitted to a French mechanical ventilation centre located in 
Essonne; first year experience (January 2015 to December 2015). The 
12-bed unit is staffed by nurses with special pulmonary and ventila-
tion expertise, and it features 24-h respiratory therapy supervision and 
non invasive monitoring (that is ventilator alarms) with signal outputs 
at each bedside. Pulmonary and critical care specialists are in charge of 
patients’ treatments and weaning plans. Dietitians and physical thera-
pists are all part of the care team.
Participants 106 patients admitted with a median age of 66.9 years; 
60% were male.
70 patients (66%) had tracheostomy before they were transferred in 
our unit, 54 of them with prolonged mechanical ventilation;
27 patients (25.5%) had non invasive ventilation;
9 patients (8.5%) were dependent on high oxygen flow (>6  l/mn) 
without mechanical ventilation. All patients came from the ICU.
The duration of ICU stay preceding admission was 236 days.
Results The duration of total unit stay was 29  days (6–74  days). The 
mean IGS score at admission was 29. The mortality rate was 4.7% (3 
patients with fibrosis dependent on high oxygen flow, 2 patients—1 
with polymetastatic cancer—with tracheostomy and 24  h/24 
ventilator support). 16 patients (15.1%) with worsening conditions 
returned to the ICU. Among the 85 remaining patients (80.2%), 46 
were transferred to a rehabilitation centre, 10 were transferred in acute 
care hospital in step-down unit, 29 were discharged directly to home.
Weaning success was observed in 3 patients with NIV at admission and 
24 were educated to self use of NIV.
Of the 16 patients without mechanical ventilation at admission 
only 3 patients with tracheostomy were discharged with long-term 
tracheostomy.
Of the 54 patients with invasive mechanical ventilation and 
tracheostomy at admission:
  • 30 were weaned and decannulated
  • 7 were discharged with long-term tracheostomy without ventilation
  • 14 with long-term tracheostomy were only partially weaned from 
invasive ventilation
 • 1 with tracheostomy and 24/24 ventilator support.
Of the patients who were dependent on high oxygen flow (>6 l/mn) at 
admission 4 were weaned from high oxygen flow at discharge.
Discussion The current data demonstrate that, in our centre, most of 
the patients with weaning failure can be successfully weaned. Despite 
a prolonged ICU stay before referral, weaning outcomes were similar 
to those reported in other countries and organizational models.
Table 13 Characteristics and  outcomes in  the two SBT 
modalities groups before adjustment
PSV (n = 29) T-tube (n = 55) p
Age (med [IQR]) 67 [48–74] 55 [36–67] 0.044
Gender (M/F) 21/8 32/23 0.240
SAPS III (med [IQR]) 75 [66.5–80.5] 67 [60–77] 0.021
SOFA (med [IQR]) 8 [7–10] 7 [5–10] 0.172
Reason for mechanical ventilation
 ARF on CRF [n (%)] 14 (48.3) 16 (29.1) 0.101
 ARF de novo [n (%)] 8 (27.6) 17 (31)
 Septic shock [n (%)] 5 (17.2) 6 (11)
 Neurologic [n (%)] 2 (6.9) 16 (29.1)
 Ventilation duration before 1st 
SBT (days) med [IQR]
5 [3–8] 5 [3–8] 0.854
SBT outcome
 SBT duration, med [IQR] 60 [30–80] 60 [30–90] 0.489
 SBT success [n (%)] 20 (68.9) 41 (74.5) 0.614
 Reintubation [n (%)] 3 (10.3) 5 (9.1) 0.852
 ICU LOS (days) (med [IQR]) 16 [8.5–27.5] 12 [7–30] 0.486
 ICU mortality [n (%)] 6 (20.7) 10 (18.2) 0.778
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Conclusion Patients with weaning failure should be considered for 
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Introduction Chronic Obstructive Pulmonary Disease (COPD) exacer-
bations are now the third leading cause of mortality all over the world 
and in Tunisia. There still are many controversies in their management 
and mainly the indications of antibiotic treatment and corticotherapy. 
In Tunisia and despite many valuable studies, only few studies were 
focused on the “Tunisian” daily practice in case of acute and severe 
exacerbations of COPD. Thus; we decided to perform this study. We 
aimed to describe the clinical characteristics of our patients, the blood 
gas exchange findings, the medical treatment, the ventilator support 
and to analyze their outcome.
Materials and methods It was a Single-center retrospective study 
performed in the teaching department of emergency and intensive 
care medicine in Zaghouan in Tunisia conducted between 1st January 
2015 and 31th December 2015. All patients admitted in our ICU for 
acute exacerbation of COPD were enrolled in the study. Anamnestic 
characteristics, primary diagnosis, mode of mechanical ventilation 
were noted. The results of laboratory tests, blood gas data and the 
outcome of patients were also collected.
Results 40 patients were included in the study. The mean age was 
68 ± 11 years with a sex ratio of 4 (32 males and 8 females). The mean 
SAPS II score was 35 ± 10 with an APACHE II mean score of 22 ± 5. The 
most common cause of COPD in our patients was tobacco smoke with 
a mean consumption of 32  ±  10 pack-year history of smoking. The 
most frequent COPD condition in our patients was chronic bronchi-
tis (n = 29; 72.5%). Six patients received home oxygen therapy. Three 
patients had lung emphysema and one patient had both restrictive and 
obstructive syndrome. At admission, the mean Glasgow coma scale 
score was 12 ±  3. The mean Ph was 7.21 ±  0.13 with a mean bicar-
bonate level of 32 ± 10 mEq/l. Lung infection was the most common 
cause of exacerbation (n = 26; 65%). The other recorded causes were: 
pulmonary edema (n =  3), pulmonary embolism (n =  2) and pleural 
effusion (n = 5). Twenty-two patients (55%) received systemic cortico-
therapy and 33 patients received antibiotic therapy. Sixteen patients 
(40%) did not receive bronchodilator medicines. Fifteen patients 
(37%) required noninvasive ventilation (NIV). Eighteen patients (45%) 
was intubated and required invasive mechanical ventilation. Ventila-
tory support was not necessary in the other seven patients (17.5%). 
The mean duration of hospital stay in our ICU was 111 ± 98 h. Sixteen 
patients died in our ICU with a mortality rate of 40%. The most frequent 
causes of death were septic shock (n  =  5), acute respiratory distress 
syndrome and multiorgan failure (n  =  2). Four patients were trans-
ferred and twenty patients were discharged from hospital. Only SAPS II 
was independently associated with poor outcome (p < 0.001).
Conclusion Our patients may be classified severe COPD according to 
GOLD recommendations. There is a big gap between our daily practice 
and the international recommendations. We still have a widespread 
use of corticotherapy and antibiotic therapy. We need effective inter-
ventions to implement existing evidence-based guidelines into daily 
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Introduction Acute exacerbation of chronic obstructive pulmonary 
disease (AECOPD) is linked to morbidity and mortality increase; 
high bicarbonate levels are linked to chronic hypercapnia and 
hypoventilation in this population. The consequences of bicarbonate 
levels change during ICU stay are not well studied. The aim of the 
present study is to investigate the association between bicarbonate 
concentration change during ICU stay for AECOPD and long-term 
survival.
Patients and methods In a prospectively collected database 
including consecutive patients admitted between 2000 and 2012 for 
hypercapnic COPD exacerbation in our ICU, we calculated bicarbonate 
concentration change during ICU stay as follows: ΔHCO3− =  [HCO3−] 
at admission − [HCO3−] at discharge. Patients were split into 3 groups:
  • Group 1: Decreased bicarbonate levels: ΔHCO3− ≤ −5 mmol/l,
  • Group 2: Small change in bicarbonate levels: −5  <  ΔHCO3−   
< +5 mmol/l,
 • Group 3: Increased bicarbonate levels: ΔHCO3− ≥ +5 mmol/l.
Long-term patient’s status (surviving or deceased) was checked by 
consulting the register of civil status.
Results During the study period 440 patients were consecutively 
admitted for hypercapnic COPD exacerbation (84.5% males, median 
age: 68 years, median pH at admission: 7.28 and median HCO3−: 30.6, 
NIV was the first ventilation modality in 65% and survival at ICU dis-
charge: 84.3%). Blood gas analyses (at ICU admission and discharge), 
and long-term vital status were available in 239 patients (survival at 
a median follow-up of 7 years was 31.2%). Bicarbonate levels change 
were inversely associated with the long-term survival (Table  14; 
Fig. 12).
Conclusion Our study suggests that bicarbonate levels change during 
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Introduction Dyspnea is frequent and intense in intubated patients. 
It is one of the worse experiences of the intensive care unit (ICU) stay 
and is associated with adverse outcomes. Despite the increasing 
use of non invasive ventilation (NIV) as the cornerstone therapy of 
acute respiratory failure (ARF), little attention has been given to that 
threatening sensation.
The objectives were: (1) To quantify the prevalence and intensity 
of dyspnea in patients receiving NIV for ARF, at admission and in 
response to NIV; (2) To examine the factors associated with dyspnea; 
(3) To investigate the impact of dyspnea on NIV success or failure and 
on the quality of life and post-ICU burden.
Patients and methods Second analysis of a prospective observational 
cohort study in patients who received NIV for ARF in 54 ICUs in France 
and Belgium, in 2010/2011. Dyspnea measurement was assessed 
with a modified Borg scale at admission and in response to the first 
NIV session. Patients with a dyspnea intensity <4 (defined as light to 
moderate) were compared to those with dyspnea intensity ≥4 defined 
(moderate to severe).
Results Among the 426 patients included the median dyspnea on 
admission was 4 [3–5] and decreased to 3 [2–4] in response to the 
first NIV session (p = 0.001). Moderate to severe dyspnea in response 
to NIV was independently associated with severity as assessed by the 
SOFA (OR 1.09, p = 0.023), anxiety (OR 1.84, p = 0.009), leaks (OR 2.15, 
p =  0.002) and poor NIV tolerance (OR 2.01, p =  0.012). In addition, 
moderate to severe dyspnea was an independent risk factor of NIV 
failure (OR 2.24, p  =  0.001). Finally, dyspnea was associated with 
higher length of stay and mortality (7 vs. 18%, p = 0.001) but was not 
associated with higher post ICU burden and quality of life.
Conclusion In patients receiving NIV, dyspnea is frequent, intense and 
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Introduction COPD patients have often polyglobulia because of 
associated hypoxemia especially in patients at the stage of chronic 
respiratory failure. Little is known about the prevalence of anemia and 
its impact on prognosis in patients with severe AECOPD admitted to 
ICU. The aim of this study was to determine the prevalence of anemia 
in AECOPD patients and its impact on prognosis.
Patients and methods In a prospectively collected database 
including consecutive patients admitted between 2007 and 2015 for 
AECOPD in our ICU, we retrospectively assessed hemoglobin levels 
at ICU admission. Anemia was defined according to WHO criteria: 
Hb < 13 g/dl in males; Hb < 12 g/dl in females. Continuous variables 
expressed as median (25–75 percentiles interquartile ranges, IQR) and 
compared with the Mann–Whitney test.
Results The cohort included 210 patients (median age 67, median 
pH 7.30, 87.6% males, NIV as first ventilator mode in 86.2%). Anemia 
was observed in 77 of the 210 patients (36.6%). Median haemoglobin 
levels were at 10.7 and 14.5  g/dl, in patients with and without 
anemia, respectively, Table 15 summarizes characteristics and clinical 
outcomes in the two study groups.
Table 14 Bicarbonate levels change and long‑term survival
ΔHCO3− ≤ −5 (n = 53) −5 < ΔHCO3− < +5 (n = 142) ΔHCO3− ≥ +5 (n = 44) p
ΔHCO3− [med (IQR)] −8.2 (−11.4;−6.05) 0 (−2.1; 2.05) 7.2 (6.2; 9.8) <0.001
Long‑term survival [n (%)] 26 (49.1) 57 (40.1) 10 (22.7) 0.027
Fig. 12 Kaplan Meier curve, bicarbonate levels change and long‑
term survival







Age [med (IQR)] 64 (57–72) 71 (65–75) <0.001
Male [n (%)] 117 (88) 67 (87) 0.831
Time course of COPD (years) 
[med (IQR)]
7 (4–12) 8.5 (4.2–15) 0.212
pH [med (IQR)] 7.30 (7.26–7.34) 7.30 (7.27–7.35) 0.205
HCO3− (µmol/L) [med (IQR)] 32.8 (28–36) 31.8 (27.7–35.5) 0.749
Creat (µmol/L) [med (IQR)] 83 (66–91) 101 (78.2–133.5) <0.001
GFR (MDRD) [mL/
min/1.73 m2, med (IQR)]
83 (70.1–104.5) 58.1 (42.1–76.1) <0.001
NIV [n (%)] 114 (85.7) 67 (87) 0.839
 Diabetes [n (%)] 22 (16.5) 15 (15.5) 0.580
 Hypertension [n (%)] 33 (24.8) 24 (31.2) 0.337
 Heart failure [n (%)] 13 (9.8) 10 (13) 0.497
Ventilation duration (days) 
[med (IQR)]
8 (5–11.5) 7 (4–10) 0.298
LOS (days) [med (IQR)] 10 (7–14) 9 (6–11.5) 0.138
ICU mortality [n (%)] 17 (12.8) 8 (10.6) 0.665
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In multivariate analysis anemia was not identified as independent fac-
tor associated with ICU mortality.
Conclusion Anemia was observed in one-third of patients admitted to 
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Introduction The identification of specific prognostic factors that 
predict long-term mortality in COPD patients is paramount for the 
management of these patients. The objective of this study was to 
evaluate the performance of the right ventricle (RV)/left ventricle (LV) 
ratio measured at exacerbation requiring mechanical ventilation in 
predicting the long-term prognosis in patients with severe COPD.
Patients and methods Prospective collection of data on 
demographics and echocardiography in COPD patients hospitalized 
in the Intensive Care Unit for hypercapnic decompensation between 
December 2010 and March 2013. Recorded variables are: age, sex, BMI, 
medical history, clinical characteristics of the index exacerbation, and 
blood gas, biological, echocardiographic variables and the mortality at 
6 years.
Results During the study period 108 were included in this study. The 
average age was 69  years (range: 43–92  years), 68% were male; the 
average SAPSII was 27 and average BMI was 26.8  kg/m2. The Mean 
PaCO2: 8.68  ±  1.69  kPa, and pH at admission was: 7.30  ±  0.04. All 
patients were ventilated with NIV initially. RV was frequently enlarged 
with a mean value of RV/LV at admission: 0.75 (±0.16). Overall mortal-
ity at 6 years was 35.5%. The ROC curve depicting the performance of 
RV/LV in predicting long term mortality is shown in Fig. 13 (AUC: 0.9, a 
cut-off of 0.7 had the best operative characteristics).
Conclusion RV/LV ratio seems a good indicator of long term prognosis 
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Introduction Severe acute exacerbation of COPD (AECOPD) reduces 
quality of life and represents a major burden for health care systems. 
SUA is well known to increase during hypoxia and systemic inflam-
mation. This final product of purine degradation is one of biomarkers 
showing promise in the prediction of outcomes in AECOPD [1].
The aim of this study was to assess the possible role of SUA and SUA/
creatinine ratio as biomarkers for the prediction of mortality and 
future exacerbations of patients hospitalized in intensive care unit 
(ICU) for severe AECOPD.
Patients and methods SUA levels were measured in 59 consecu-
tive eligible patients on ICU admission for severe AECOPD between 
April 2015 and April 2016. Clinical and functional characteristics 
were compared between patients with levels below and above 
the median values of SUA and SUA/creatinine ratio. The primary 
end-point was all-cause mortality at 30 and 90  days. Secondary 
outcomes included duration of ICU stay, duration of mechanical 
ventilation and the number of AECOPD in the 6 months period after 
ICU discharge.
Results On ICU admission, age was 69  ±  11  years; SAPS II, 30  ±  9; 
SOFA score, was 5.0  ±  2.9. Median [IQR] pH was 7.31 [7.28–7.33]; 
PaCO2, 57 [53–69] mmHg; PaO2, 100 [73–203] mmHg; PaO2/FIO2, 
239  ±  101. 52.5% had NIV with 45% NIV failure. Overall 71.2% had 
invasive mechanical ventilation and 59.3% received vasopressors.
Mean SUA was 342  ±  90  µmol/L; SUA/creatinine ratio, 4.5  ±  2.1. 
SUA levels were higher in patients presenting acute heart failure on 
admission (p = 0.035).
In addition, SUA/creatinine ratio levels were higher in patients having 
extended evolution time prior to ICU admission (p = 0.05) and those 
having high SOFA score (p = 0.05).
SUA levels were not associated with increased risk for AECOPD in the 
6 months period after ICU discharge.
High SUA was an independent factor associated to circulatory failure 
in multivariate Cox regression analysis (HR = 12.32, p = 0.037).
In multivariate Cox regression analysis, high SUA/creatinine ratio was 
an independent predictor of 30-day mortality (HR = 15.03, p = 0.032), 
and it was also independently associated with acute heart failure 
(HR = 7.08, p = 0.046).
Discussion SUA is considered as a useful biomarker in the 
identification of high-risk patients admitted for mild AECOPD [1–2]. 
The present study suggests a role of SUA in the prediction of mortality 
in severe AECOPD associated with heart failure or shock requiring ICU 
admission
Conclusion High SUA was only independently associated to 
circulatory failure among patients with severe AECOPD. High SUA/
creatinine ratio on ICU admission was associated with acute heart 
failure and was an independent predictor of 30-day mortality in ICU 
patients with severe AECOPD.
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Introduction Long-term home NIV is still a matter of debate in 
patients with obstructive pulmonary disease. Recent studies showed 
a positive effects on exacerbations frequency and less obvious 
effects on the survival rate. The objective of this study is to assess the 
impact of long-term NIV in the long term in patients with persistent 
hypercapnia at the end of ICU admission for hypercapnic respiratory 
failure.
Patients and methods Prospective collection of data in patients 
hospitalized in the intensive care unit for acute hypercapnic respiratory 
failure requiring mechanical ventilation between October 2005 and 
October 2015. Patients with persistent hypercapnia and a diagnosis of 
COPD, obesity-hypoventilation syndrome, or obstructive sleep apnea 
had the following recorded data: age, sex, BMI, echocardiographic 
data, apnea/hypopnea index in the case a polygraphy was performed, 
long-term NIV duration and observance, the quality of life and the 
outcome with emphasis on frequency of exacerbations and survival.
Results During the study period, 110 patients received long-term 
NIV including 28 COPD, 45 OSA and 37 overlap syndrome. The 
average age was 65 ± 11 years, BMI: 27. The main comorbidities were: 
hypertension, diabetes and ischemic heart disease. The baseline 
pH was 7.38, baseline PaCO2:55  mm Hg. The mean daytime duration 
of NIV use: 5–6  h/day. The use of NIV in the long term is associated 
with a significant reduction in PaCO2, improved quality of life, and 
exacerbations’ frequency. Overall mortality at 10 years was 33%.
Conclusion This study shows the feasibility of NIV in long-term care of 
patients with persistent hypercapnia following ICU hospitalization for 
hypercapnic respiratory failure. It also suggests beneficial effects on 
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Introduction Central venous catheters constitute invasive devices 
that are important for patients in intensive care units. They expose 
to multiple complications such as: infectious, traumatic and thrombo 
embolic complications [1].
The aim of our study is to look for the incidence of thrombo embolic 
events and to target its predictive factors.
Materials and methods It’s a prospective study lead in the intensive 
care unit department during 3 months.
Patients included: Every patient admitted in our department needing 
a central venous catheter for therapeutic use.
Exclusion criteria: Patient admitted with a central venous catheter 
(CVC), a long term CVC (for dialysis), Presence of thrombo embolic 
event before catheterization.
All CVC were placed with the help of echoguidance.
Each day, we realized a Doppler on the catheter estimating: 
permeability, Doppler velocity, the presence of thrombus. If this last 
was detected, we evaluate its length, mobility and adherence to the 
vein. The entire limb was explored through Doppler echography.
Patients were randomized into 2 groups: with and without thrombus.
Data was exploited by SPSS software by univariate then multivariate 
analysis.
Results 122 catheters were analysed, thrombus incidence was 24.5%.
The comparison between the two groups is mentioned in Table 16.
The thrombus was mobile in 83% with a mean length of 4.1 mm.
Conclusion Thrombo embolic events on CVC are frequent, varying 
from 8% to 25% of cases and depend on the site.
The Doppler helps us to diagnose it quickly and to prevent heavy 
complications.
In our study, predictive factors were: the neoplasy (p  =  0.045), 
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Introduction The primary goal of volume expansion in acute 
circulatory failure is to increase cardiac output. Nevertheless, 
techniques that measure cardiac output are not available in every 
patient. Changes in heart rate could be used instead of cardiac output, 
since increases in cardiac output induce a decrease in the reflex 
Table 16 See text for description
ATB antibiotics, PAR parenteral feeding, VAD Vaso active drugs
Thrombus+ Thrombus− OR (95% CI) p
Age (ans) 49.9 48.6 – 0.757
Sex (n, %)
 Male 23 (25.6) 67 (74.4) 1.23 (0.47–3.21) 0.678
 Female 7 (21.9) 25 (78.1)
Neoplasy (n, %) 15 (50.0) 28 (30.1) 2.32 (1.00–5.39) 0.047
Complication (n, 
%) (slough or 
sepsis)





15 (50.0) 55 (59.1) 0.69 (0.30–1.58) 0.379
PAR (n, %) 28 (93.3) 62 (66.7) 7.00 (1.56–
31.31)
0.004
VAD (n, %) 16 (53.3) 35 (37.6) 1.89 (0.82–4.35) 0.129
Type of catheter (n, %)
 Double 5 (16.7) 47 (50.5) 1 0.001
 Triple 25 (83.3) 46 (49.5) 5.11 (1.80–
14.49)
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sympathetic stimulation that may be reflected by significant decreases 
in heart rate. Our goal was to test whether the changes in heart rate 
could be used to differentiate positive and negative response to 
volume expansion.
Materials and methods We measured heart rate and cardiac output 
before and after volume expansion (500  mL saline over 10–30  min) 
performed in patients with acute circulatory failure. We tested the 
ability of changes in heart rate to detect fluid responsiveness, defined 
by an increase in cardiac output by more than 15% with volume 
expansion.
Results We analysed 542 volume expansions performed in 242 
patients (age 63  ±  14  years old, SAPSII 63  ±  13). The origin of 
shock was septic in 375 (69.2%) cases, cardiogenic in 24 (4.4%) 
cases, hypovolemic in 114 (21%) cases, vasoplegic without sepsis 
in 21 (3.9%) cases and unknown in 8 (1.5%) cases. Cardiac index 
increased from 3.0 ± 1.1 L/min/m2 to 3.7 ± 1.3 L/min/m2 (p < 0.01) 
and heart rate decreased from 96 ± 35 beats/min to 95 ± 31 beats/
min (p  <  0.01). Cardiac index increased ≥15% in 302 (56%) cases, 
≥30% in 142 (26%) cases and ≥50% in 61 (11%) cases. Changes in 
heart rate were not able to detect increases in cardiac index, neither 
≥15%, nor ≥30%, nor ≥50% (area under the Receiver Operating 
Characteristic curves not different from 0.5). Nevertheless, if heart 
rate decreased ≥20%, which occurred in 15 cases only, an increase 
in cardiac index ≥30% could be predicted with a sensitivity of 1% 
(95% confidence interval (CI) 0–5%) and a positive predictive value 
of 25% (3–65%)%, but with a specificity of 98% (97–99%) and a neg-
ative predictive value of 74% (70–78%). Also, if heart rate decreased 
≥20%, an increase in cardiac index ≥50% could be predicted with 
a sensitivity of 2% (0–9%) and a positive predictive value of 1% 
(1–1%), but with a specificity of 99% (97–99%) and a negative pre-
dictive value of 90% (86–92%).
Conclusion Except for changes of very large amplitude, decreases in 
heart rate cannot reliably detect a positive response of cardiac output 
to volume expansion. Changes in heart rate only allow the detection 
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Introduction Mean systemic filling pressure (MSFP) defines the 
pressure measured in the veno-arterial circulatory system when 
the cardiac output is nil. Representing the upstream pressure of the 
venous return gradient, it is considered as a major hemodynamic 
parameter. Because of the difficulties of its measurement, it is not 
routinely used in clinical practice but some authors proposed to use 
heart–lung interaction under mechanical ventilation for its estimation. 
Our objective was to demonstrate how MSFP is modified by positive 
pressure ventilation.
Patients and methods We conducted a bi-centric non interventional, 
prospective and observational study to measure the pressure 
encountered in the circulatory system at the time of death in critically-
ill patients on an arterial catheter and a central venous catheter. 
We included 112 patients with previously inserted catheters and 
mechanical ventilation with a positive end-expiratory pressure (PEEP) 
at the time of death. After calibration and supine positioning, arterial 
and venous pressures were recorded in five conditions: at end-
expiration and end-inspiration with and without PEEP and finally after 
disconnection from the ventilator.
Results Pressure measured on arterial and central venous cath-
eters did not differ, both representing MSFP. Both arterial and cen-
tral venous pressures increase with tidal ventilation and with PEEP 
(Fig. 14). The position of the arterial or the venous central catheters did 
not have any impact on these results.
Conclusion MSFP measured both on arterial and central venous 
catheters is altered by mechanical ventilation, with a tidal volume and 
PEEP effect, questioning the use of cardio-pulmonary interactions 
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Introduction Hemodynamic monitoring is an indubitable device in 
the diagnostic and therapeutic management in critically ill patients. 
The pulmonary artery catheter (PAC), since 1970, is the gold standard 
of recommended devices due to the diversity and relevance of 
provided parameters. Pulse contour cardiac output (PiCCO) represents 
an interesting alternative to the PAC. However invasiveness and 
delicacy in the collection and interpretation of data make that the risk/
benefit ratio of these techniques is to be worrying.
Our purposes were to assess the diagnostic, therapeutic and 
prognostic utility of invasive monitoring by PAC and PiCCO compared 
to non-invasive or less common tools.
Patients and methods Evaluative retrospective study comparing two 
arms of ICU patients with invasive versus non-invasive hemodynamic 
monitoring. Were included, the ICU patients who had hemodynamic 
and/or respiratory failure and how required the use of hemodynamic 
exploration. Exclusion criteria were age less than 18 years and the lack 
of data on the medical record. Outcomes: diagnostic utility was judged 
on the consistency and quality of data interpretation, therapeutic 
usefulness on the therapeutic changes and favourable response 
following these therapeutic adjustments during the 1st 24  h of 
monitoring, and prognostic assessment was judged on the ventilation 
period, length of stay and mortality.
Results 131 cases of hemodynamic monitoring were included 
(PAC/PiCCO: n  =  71 and common tools: n  =  60). The superiority of 
the invasive monitoring was objectified with the consistency of 
interpretation of the collected parameters (91.5 vs 78.4%, p = 0.044) 
and therapeutic changes derived by interpretation (83 vs 66.7%, 
p =  0.041). No benefit found on the clinical improvement following 
the modifications guided by monitoring (50 vs 57%, p = 0.72) and (31 
vs 47%, p  =  0.074) for the hemodynamic and respiratory responses 
respectively. The duration of ventilation and stay-length did not differ 
with those of the standard group. A higher mortality was found with 
age >50 years (OR 1.54, 95% CI [1.05–2.27], p = 0.02) and SAPS II score 
>35 (OR 1.8, 95% CI [1.09–3.35], p = 0.049).
Fig. 14 Effect of tidal ventilation and positive expiratory‑end pres‑
sure one MSFP measured on central venous catheter and arterial 
catheter
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Conclusion the diagnostic value and therapeutic changes guided by 
monitoring were significantly in favour of PAC/PiCCO technical. No 
benefits on hemodynamic and respiratory efficiency following these 
changes with a higher mortality. The invasive techniques keep their 
interest in intricate situations and where the contribution of non-
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Introduction Septic cardiomyopathy is commonly encountered 
in patients with septic shock. Most studies suggest no correlation 
between left ventricular ejection fraction (LVEF) and mortality in 
patients with septic shock. In the other hand, the initial left ventricle 
global longitudinal strain (LVGLS) seems to be a better prognostic 
factor. However its time course evolution remains to be precisely 
defined.
The present study aims to describe the evolution during the first days 
of the septic shock and to establish the prognostic value of this novel 
parameter in critically ill patients.
Materials and methods A prospective observational single center 
study was performed in the ICU.
After approval of the local ethics committee, all patient admitted to 
the ICU for septic shock without known pre-existing heart disease 
were eligible. In these preliminary results, 13 of the 100 planned 
patient were included and analysed.
Echocardiography was performed on the first day, and repeated daily 
during ICU stay until norepinephrin was stopped. LVEF and LVGLS were 
acquired in apical two-chamber, four-chamber and long-axis views. 
Patients were divided into two groups: survivors and non survivors.
Results Of the first 13 patients included mortality in the ICU was 23%. 
Left ventricular ejection fraction at admission (LVEF) was not signifi-
cantly different among the survivors and non survivors (respectively 
53%  ±  12 vs 28%  ±  9; p  =  0.089). Initial LVGLS was lower (which 
indicates better function) in survivors as compared to non survivors 
(−13% ± 12 vs −6% ± 0.5; p = 0.044). Time course evolution of LVGLS 
is displayed in Fig. 15.
Conclusion The preliminary results of the present study suggest that 
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Introduction Left ventricular diastolic dysfunction (LVDD) represents 
about 50% of the causes of heart failure [1]. However little is known 
about LVDD in the intensive care unit (ICU) setting. The purpose of 
our study was to determine the prevalence, clinical characteristics and 
outcome of LVDD in the ICU.
Materials and methods We performed a prospective monocentric 
study in a medical ICU. Between august 2014 and December 2014, for 
all consecutively admitted patients, transthoracic echocardiography 
was realized during the first 24  h after ICU admission. LVDD was 
established according 2 definitions: 1 complete definition based on 
American Society of Echocardiography criteria [2], and 1 simplified 
definition.
Results LVDD prevalence was 61.4% (102/166) according to the 
complete definition and 56.0% (93/166) according to the simplified 
definition. LVVD patients were older (66.5 vs 55  years, p  <  0.0001). 
Male sex predominated (67.6 vs 48.4%, p  <  0.0001). LVVD was more 
associated with cardiogenic pulmonary oedema, diuretics use, and 
new onset of atrial fibrillation, whether the full definition (25.5 vs 0%, 
p  <  0.0001; 52.9 vs 34.4%, p  <  0.0001; and 27.5 vs 14.1%, p =  0.044 
respectively) or the simplified definition (28 vs 0%, p < 0.0001; 53.8 vs 
35.6%, p = 0.002; and 29 vs 13.7%, p = 0.018 respectively). Unlike the 
full definition, LVDD patients detected with the simplified definition 
were associated with more important intra-hospital mortality (28 vs 
12.5%, p = 0.016).
Discussion LVDD prevalence found in our study is similar as in previ-
ous works in the cardiology setting. Higher incidences of atrial fibril-
lation and cardiogenic pulmonary oedema in the LVDD patients can 
be explained by a more important left atrial dilation, and a higher inci-
dence of other cardiomyopathies in the LVDD cohort.
Conclusion LVDD is a frequent abnormality in the ICU setting, asso-
ciated with an important morbi-mortality. LVDD identification should 
alert the physician for an higher risk of new onset of atrial fibrillation 
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Fig. 15 Time course evolution of LVGLS
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Introduction We wanted to determine the precision of 
echocardiographic measurements performed in critically ill patients.
Patients and methods We included 100 hemodynamically stable 
patients (age 67  ±  16  years, SAPSII 52  ±  19, 54% mechanically 
ventilated, 16% with atrial fibrillation and 34% under norepinephrine). 
Three successive echocardiography examinations were performed by 
two different operators with a national echocardiographic diploma, 
the first and the third by one operator and the second one by the other 
one. Within each examination, three measurements were performed 
for each variable without moving the probe from the patient at the 
end of expiration and averaged. For every echocardiographic variable, 
we calculated the precision and the least significant change (LSC), i.e. 
the minimal change in variable that could be trusted to be significant.
Results When calculated from the two examinations performed by 
the same operator, the precision of an echocardiographic examination 
was 10 ± 9% for velocity time integral (VTI). It is exactly equal to the 
limit that is usually regarded as acceptable for measures estimating 
cardiac output. For LV ejection fraction (LVEF), early peak velocity of 
transmitral flow (E) at pulsed Doppler, early diastolic peak velocity 
of the lateral mitral annulus (e’) at Tissue Doppler Imaging and 
LV end-diastolic area (LVEDA), the precision was 7  ±  5%, 8  ±  9%, 
17 ± 16% and 10 ± 8%, respectively. In this condition also, LSC of VTI 
was14 ± 13%. For LVEF, E, e’ and LVEDA, LSC was 10 ± 8%, 12 ± 12%, 
24 ± 23% and 15 ± 11%, respectively. When calculated from the two 
examinations performed by the two different operators, the precision 
of an echocardiographic examination was 13 ± 12% for VTI. For LVEF, 
E, e’ and LVEDA, it was 8 ± 7%, 10 ± 8%, 19 ± 19% and 13 ± 11% for 
LVEF, E, e’ and LVEDA, respectively. In this condition also, the LSC was 
19 ± 17% for VTI. It was 11 ± 10%, 14 ± 12%, 28 ± 27% and 18 ± 15% 
for LVEF, E, e’ and LVEDA, respectively.
Conclusion When an echocardiographic examination is performed 
by averaging three measurements, the precision of echocardiography 
is almost acceptable for VTI. It is better for LVEDA and LVEF. We are 
currently investigating the number of measurements that must be 
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Introduction Hypovolemia is common in intensive care patients. 
It may reduce cardiac output and O2 delivery relative to tissue need. 
Low mixed Central venous O2 saturation (ScvO2) has been used to 
optimize cardiac output and O2 delivery relative to tissue needs. The 
use of ScvO2 to predict fluid responsiveness is unclear. Objective: To 
determine whether ScvO2 is a good indicator of fluid responsiveness.
Patients and methods We carried out a prospective study in the 
medical intensive care unit of the teaching hospital in Mahdia over 
a period of 48  months. All patients with circulatory failure were 
enrolled. At baseline (t  =   0 min), hemodynamic measurements were 
performed with a PICCO. After baseline measurements and blood 
sampling, 500 cc of fluids were given over 30 mn and hemodynamic 
measurement were performed at the end of fluid perfusion. Concomi-
tant vasoactive and sedative drugs and ventilatory settings remained 
unchanged. Fluid responsiveness was defined as an increase in cardiac 
index >15%.
Results A total of 68 patients requiring volume expansion were 
included. The causes of acute circulatory failure were septic shock 
(n  =  45), cardiogenic shock (n  =  11), and dehydration (n  =  12). 
Among the 68 included patients, 33 (49%) were responders. ScvO2 
was significantly lower in no responders group (62 ±  11 vs 68 ±  12, 
p  =  0.046). However ScvO2 variation was significantly higher in 
responders group (10 ±  8 vs 6 ±  7, p =  0.041). The area under the 
ROC curve for ScvO2 was 0. 37 (95% CI 0.23–0.5). The best cutoff value 
of ScvO2 was <55% (sensibility  =  36%, specificity  =  8 8%, positive 
predictive value  =  75% and negative predictive value  =  60%). The 
area under the ROC curve for ScvO2 variation was 0.65 (95% CI 0.52–
0.78). The area under the ROC curve for delta ScvO2 was 0.5 (95% CI 
0.43–0.7).
Conclusion In this study, we can’t recommend strongly the use of 
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Introduction The application of tactical tourniquet is one of the 
most important lifesaving intervention (LSI) on the battlefield and 
in theaters of terrorist attacks. Despite its apparent simplicity, the 
failure rate of tactical tourniquet application remains high in real life 
experience. Some personality traits of the combat lifesavers could 
explain this high failure rate. The aim of this study was to analyze the 
association between different personality traits and the performance 
for applying the tactical tourniquet.
Materials and methods This observational, cross-sectional study 
concerned French soldiers of two theaters of operations in Africa 
(SANGARIS in Central African Republic and BARKHANE in Malia), 
between October 2015 and April 2016. The performance for 
application of the tactical tourniquet SOFFT® was evaluated during 
simulation sessions and included the time for application and its 
effectiveness, demonstrated by the elimination of the popliteal pulse 
Doppler signal. A performance score included both an application 
time shorter than 60  s and the interruption of the Doppler signal. 
Personality traits were assessed using validated questionnaires: 
the Self-Esteem Scale of Rosenberg (SES), the HEXACO personality 
inventory for empathy (HEXACO), the Freiburg Mindfulness Inventory 
(FMI) and the Büssing Altruism Scale (BAS).
Results A total of 72 participants (mean age 27 ± 4) were included in 
the study. The effectiveness rate of tactical tourniquet use was 51%. 
Only 26% of the participants performed this LSI in accordance with the 
performance score criteria. Some of the personality traits were asso-
ciated with significant differences in the performance of the SOFFT® 
application. Thus, the most empathetic soldiers (high HEXACO levels) 
had weak performance scores, in comparison with those with a lower 
HEXACO level (p = 0.016). Participants with a high BAS level were also 
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less performant for application of the tactical tourniquet. However, 
combattants with a high SES applied more quickly and more effi-
ciently the tactical tourniquet (Fig. 16).
Conclusion Personality traits are associated with significant 
differences for the performance of tactical tourniquet application, a 
crucial LSI in setting of both combat and terrorist attacks. Personality 
traits can be evaluated easily, using validated questionnaires. Finally, 
the “adaptive learning” could represent an adequate approach to 
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Introduction Delivering bad news regarding prognosis or care-related 
damages are difficult situations generating anxiety for patients but 
also for the medical teams who feel generally insufficiently prepared 
and trained. We have studied the interest of training paediatric and 
anaesthesiologist residents and fellows in difficult communication 
through simulation.
Materials and methods This multimodal training with multidiscipli-
nary teachers (psychologists and doctors) included theoretical inter-
active sessions (behaviour and environment to inform parents in an 
acute situation, modalities of communication, and knowledge about 
the defense mechanisms…) and simulation sessions with professional 
actors playing child’s parents. The scenarios promoted situations after 
significant events involving a child in PICU or in the operative room. 
Each scenario was created from real case. Standardized debriefing by 
teachers and a psychologist was done after each scenario with actors 
and every participant. A pre and post-test using Lickert scale was ful-
filled to evaluate the interest of this program and the confidence in this 
kind of meeting. The results are expressed in median [interquartile] and 
comparison used the U Man-Whitney test. A p value <0.05 was consid-
ered significant.
Results Thirty-one medical residents (17 anaesthesiologists, 14 pae-
diatricians) and 5 fellows (1 anaesthesiologist and 4 paediatricians) 
have participated at this 1 day course training. 44% declared to have 
previously received a course on communication, and 80% had already 
experienced, alone, situations with the announcement of bad news.
PreTest
  • How you consider important the communication with families?5 
[5–5]
  • Do you feel trained in communication with the patient or relatives? 
2 [2–3]
 • Do you feel anxious in  situations requiring breaking bad news? 3 
[2–3]
Post Test
  • How do you evaluate this training course? 4 [4–4]
  • Does this training course meet your expectations? 4 [4–4]
  • Do you feel anxious in  situations requiring breaking bad news? 3 
[3–3]
 • 97% of participants declared they recommend the training to their 
colleagues.
See Fig. 17
Discussion The participants reported a significant lack of initial training 
and a lack in confidence in communication skills with relatives’ despites 
their strong interest for this topic. The majority has still encountered 
such a situation. The post test evaluation showed a significant improve-
ment in confidence even though the level of anxiety remained high 
after the session. The multimodal aspect of the program combining 
theoretical courses and realistic simulation with professional actors in a 
“secured” environment was emphasized by the learners.
Conclusion This study confirms the feasibility, the realism and the 
learners’ satisfaction. It’s of major interest to pursue development of 
such interprofessional training with others caregivers (nurses…) and 
other medical and surgical specialists.
Competing interests
None.
Fig. 16 See text for description
Fig. 17 Confidence before and after training
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Introduction International guidelines strongly recommend ultra-
sound (US) guidance for central venous catheter (CVC) insertion. Com-
pared to anatomical landmark technique, US guidance reduces the 
number of attempts, and time to successful cannulation of internal 
jugular (IJ) vein [1]. However, adequate studies to prove this benefit 
for subclavian/axillary vein catheterization are lacking [2]. This could 
be explained by anatomical issues but also by technical difficulties. 
In-plane (IP) technique allows seeing the whole needle’s course but 
needs to place the needle in the exact middle of the probe in its long 
axis. If not achieved, no or only part of the needle is visualized. In the 
out-of-plane (OOP) method, only the needle’s tip is visualized, and the 
course of the needle is not controlled. Needle guidance systems are 
aimed at improving needle visualization but data supporting their 
advantage over conventional US guidance are scarce in the setting 
of axillary vein cannulation. We conducted the present study to com-
pare a sterile in-plane needle-guide (Infinity Pro; CIVCO Medical Solu-
tions) to standard freehand US guidance during IJ and axillary veins 
cannulation.
Materials and methods For both sites, each operator performed 
venipuncture using three methods: (1) standard OOP, (2) standard IP, 
and (3) IP with tested guide. Procedure was stopped at 180  s when 
the operator failed to cannulate vein. Punctures were performed on 
an inanimate manikin (Blue Phantom II, CAE Healthcare St. Louis, MO) 
using the M-Turbo® device (Sonosite, Bothewell, MA) with a 7.5 MHz 
linear probe equipped or not with the tested guide. The order of 
punctures—site (IJ or axillary) and method—was randomized using 
a 2-by-3 design in a 1:1:1:1:1:1 ratio. The random allocation sequence 
was generated using a random number table.
The number of attempts (needle passes) before success and time 
between first skin puncture and successful venous puncture were 
recorded. Qualitative and quantitative values are expressed as number 
(percentage), and median (range), and were compared using the 
Wilcoxon matched pairs test and the Fisher exact test, respectively.
Results Twenty physicians [median age 22 (22; 27) years, 7 senior 
physicians, graduated in intensive care medicine, 6 residents, and 3 
medicine students] participated to this randomized controlled study. 
Twelve (60%) declared prior experience in US-guidance for CVC 
insertion, and none had previously used the tested device.
At the axillary site, the tested device significantly reduced the number 
of attempts compared to both standard techniques (median 1 [1; 
1] attempts vs 1 [1; 2.8] for OOP standard, p = 0.021, and vs 1 [1; 2], 
p  =  0.035 for IP standard). Time between first skin puncture and 
success was also significantly reduced with tested guide (median 
16.5 [9.8; 39.3] s) compared to OOP standard (median 32.5 [9; 180] s, 
p = 0.029) and tended to be shorter than IP standard method (median 
29 [9.5; 96.3] s, p = 0.079). Success rate at first attempt was 85.5% using 
needle guidance, whereas it was 45% with OOP standard (p = 0.0057) 
and 55% with IP standard (p  =  0.031) methods. No significant 
difference was observed between needle-guidance and standard 
methods for IJ cannulation. Compared to IP standard, seventeen (85%) 
operators preferred in-plane needle guidance device for axillary vein 
puncture, whereas only 5 (25%) preferred tested device for IJ puncture.
Discussion These results have yet to be confirmed on a larger sample 
size and for bedside procedures on patients.
Conclusion Consistently with previous findings, these results suggest 
the interest of needle-guidance devices over freehand method for US-
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Introduction Though efforts have been made in the previous decades 
to teach medical students the basics of clinical research, their own 
involvement in such studies infrequently occurs before they become 
residents or assistants. The medical courses include lessons on 
experimental and clinical research methods, which may be difficult to 
integrate out of a concrete context. On the other hand, much has to 
be learned for medical students in ICU within a short training period. 
Involving medical students in research could increase their workload, 
and may affect their evaluation of the training period. We therefore 
aimed to have medical students making their first foray in clinical 
research through a practice evaluation. We asked them to evaluate the 
change in workload and their global satisfaction afterward.
Patients and methods Four medical students (4th year of medicine) 
agreed to participate to a clinical trial through an evaluation of medi-
cal practices. None of them had had a previous experience in this field. 
Gastric stress ulcer prophylaxis (SUP) was chosen by the students 
among other subjects. Two references were provided, in French, to 
give them clues on how to conduct the research. The first one was a 
free web access medical thesis exploring the medical practice on ulcer 
prophylaxis in three ICU in Toulouse. The second was a chapter of a 
reference textbook. Three weeks thereafter, it was decided in a meet-
ing to have a 2 steps approach. First, they realized an evaluation of the 
local practices through a daily monitoring of patients admitted dur-
ing a 2  weeks period. All patients admitted for an estimated period 
of more than 48 h were eligible. Exclusion criteria were baseline ulcer 
treatments and active gastrointestinal bleeding. Second, a brief survey 
of seniors and residents’ knowledge on the subject of matter was per-
formed. In both steps of investigation, the recorded criteria were those 
described in the French health authority’s recommendations. At the 
end the study period students participated to statistical analysis and 
interpretation of results. The study was presented to the department’s 
staff by the students. A few weeks later, they were asked to evaluate 
this experience.
Results During the study period, 27 patients were screened and 14 
patients (Mean age 57.4 ±  23.5  years, 4 female, 10 men, mean SAPS 
II 48 ±  25) were included and observed during a total 105 ICU days 
(7.5  ±  6.4  days/patient). 6 (42.9%) patients received stress ulcer 
prophylaxis at least once, and during 71.6 ±  32.6% of their ICU stay. 
According to French recommendations, SUP was not justified at least 
once in 5 out of the 6 patients. In 29% of SUP days, no criteria sup-
ported this prescription. 8 patients did not receive SUP. These patients 
were observed during 66  days. According to guidelines, SUP should 
have been offered in 2 patients during 15 ICU days. In this subgroup of 
patients no criteria for SUP was found in only 13 (19.6%) days. Among 
the studied criteria, a strong link between SUP and enteral nutrition 
was found (p  <  0.0001, Fisher exact test). 8 senior intensivists and 
6 residents answered the survey. The estimated prevalence of this 
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condition was evenly distributed between less than 1% and more 10% 
among responders. 30% of them ignored whether guidelines were 
available, and 80% of all responders ignored the strength of evidence 
of the guidelines. All the known risk factors for stress ulcer were cited, 
but the two major criteria (mechanical ventilation and coagulation 
abnormalities) were recognized in less than 30% of responders. 86% of 
responders declared that only proton pump inhibitor were appropri-
ate for SUP.
All students declared that adding this study to the global burden of 
the training period was manageable. They pointed out that building 
a study was a difficult task and declared that it was an added-value to 
the training course, and a good experience in their medical course. 
They would agree to do it again.
Discussion This study is limited by its single center design, and the 
little number of participating students and included patients.
Conclusion Helping medical students make their first steps in clinical 
research seems to be feasible in ICU. The students greatly appreciated 
this experience and judged it improved their training period. It could 
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Introduction High-fidelity simulation is a recognized tool for acquisi-
tion and performance improvement in advanced cardiac life support. 
Our study aims to assess the contribution of attending a high fidelity 
simulation session on acquisition of technical and non-technical per-
formances (crisis resource management CRM).
Materials and methods This observational prospective study 
included second-year post graduate medical residents from Lille2 
University, divided into an observational group (A) and an interven-
tion group (B). At the first session, a resident from group A observed 
a cardiac arrest scenario managed by a resident from group B (B1). A 
debriefing was performed after each session. The observers and actors 
expressed feelings, doubts and asked questions to the trainer. Three 
months later, all residents (A2 and B2) played the role of leader in 
another cardiac arrest scenario. Their technical performance was rated 
over 50 points by one trainer and CRM was retrospectively evaluated 
via a video system by three independent reviewers according to the 
Ottawa Global Rating Scale (GRS) over 35 points.
Results Thirteen residents from group A and 14 from group B were 
analyzed. The performances of the group B active residents signifi-
cantly improved from the first (B1) to the second session (B2), with 
regard to the technical score (31.6 ± 5.8 vs. 41.1 ± 4.9; p = 0.0004) as 
well as the Ottawa GRS (18.1 ± 3.2 vs. 22.7 ± 4.6; p = 0.0007). Spec-
tators (A2) had better technical performances than B1 active players 
(41 ±  3.6 vs. 31.6 ±  5.8; p  <  0.0001) and were not different from B2 
active players (41.1 ±  4.9 vs. 41 ±  3.6; p =  0.93). There was no sig-
nificant difference for the Ottawa GRS between A2 spectators and B1 
active players (20.4 ±  3.4 vs. 18.1 ±  3.2; p =  0.11), nor between A2 
spectators and B2 active players (22.7 ± 4.6 vs. 20.4 ± 3.4; p = 0.17).
Conclusion Our findings suggest that residents who observed a 
simulation session developed similar technical performances than 
residents playing for the second time an ACR scenario. This result was 
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Introduction Technical progress and development of indications 
may lead non-specialized ICU implanting ECMO, with an investment 
in equipment and appropriation of new proccess. Acquisition and 
retention of new skills to manage these specific situations isessential 
but difficult because these events are infrequent at an individual level. 
Full scale high-fidelity simulation conducted in multi professional 
team is a way to improve skills and confidence of the teams for these 
rare situations but with immediate vital risk.
Materials and methods A simulation program on emergency 
management in relation with ECMO has been jointly set up by 
members of the intensive care unit for disciplinary expertise in 
connection with the CEnSIM team for pedagogical expertise. Three 
priorities have been identified:
  • In situ high fidelity simulation
  • Multi-professional team simulation (1 intensivist physician, 2 
nurses with at least 1 ECMO referrer, 1 caregiver) by 4 h session.
 • Program proposed to the whole service to ensure support for 
uniformity in healthcare
These sessions were conducted in an intensive care room adapted 
to meet the requirements of high-fidelity simulation. Each session 
consisted of two simulations each followed by a debriefing. Two 
objectives were targeted: technical achievement and teamwork.
Beyond the reactions, the main assessment was performed by 
measuring the evolution of the participant self-efficacy defined 
by Bandura as “an individual’s belief in its ability to organize and 
execute the course of action required to produce desired results.” 
Measurements were performed before and after training using 
analogic visual scale of self-efficacy tailored specifically to each 
profession.
Results Two test sessions and ten training sessions were conducted 
over a period of 6 days, allowing the participation of all the physicians 
and ECMO referral nurses (total participants n =  44: 10 physicians, 4 
residents, 20 nurses, 10 caregivers).
This training was appreciated by all participants, both in terms of 
emotional perception (overall satisfaction: M =  4.9/5; SD =  0.3) and 
in terms of practical reinvestment (perceived usefulness: M  =  4.9/5; 
SD = 0.3).
The results show a beneficial effect of this program on self-efficacy 
for the three professional categories: Delta (pre-form–post-form) 
caregivers score = 2.63; p < 0.005; Delta (pre-form–post-form) nurses 
score =  2.6 nurses; p  <  0.001; Delta (pre-form–post-form) physicians 
score = 3.46; p < 0.001.
Conclusion Inter professional full scale simulation allows the acquisi-
tion of experiential knowledge and skills essential to the management 
of these complex situations. Beyond teamwork and technical skills, 
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significantly increased self-efficacy is an important factor in achieving 
optimal behavior in emergencies. In situ simulation performed in inter-
professional teams is probably an interesting method to optimize man-
agement of ECMO patient. Implementation and perpetuation of such 
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Introduction Mechanical ventilation is a life supporting treatment 
commonly indicated in patient’s ICU [1]. However, discrepancy in 
ventilatory settings can lead to patient–ventilator asynchrony. This 
adds a burden on the respiratory system and may increase the 
morbidity and mortality in the critically ill.
The discrepancies in ventilatory settings may be largely 
underestimated because of a frequent lack of monitoring [2].
The aim of the study was to evaluate frequency, typology and severity 
of discrepancies in ventilatory settings in a Tunisian medical ICU, and 
to identify factors associated with patient-ventilator asynchrony.
Patients and methods An audit observational study was conducted 
in a 7-beds medical ICU during 1 month period (August 2016). All con-
secutive ICU patients requiring invasive or non invasive mechanical 
ventilation were included. The data collected were: patient’s charac-
teristics, initial diagnosis, SAPSII, PaO2/FiO2 ratio, type of mechanical 
ventilation, ventilatory mode, prescribed ventilatory parameters and 
interfaces. Were analyzed, peak inspiratory pressure, plateau pressure, 
auto-PEEP, volume and inspiratory and expiratory flow waveforms. 
Patient-ventilator asynchrony was defined as: ineffective inspiratory 
efforts, auto-triggering, delayed cycling, double triggering and inspira-
tory waveform distorsion.
Results During the study period, were performed a total of 160 
ventilatory settings observations. Mean age was 59.9  ±  16.8  years, 
mean SAPSII score was 36.3  ±  11.1. 157 (98.1) patients were on 
invasive mechanical ventilation and 3(1.9) were on non-invasive 
mechanical ventilation. PaO2/FiO2, 286 ± 115; mean peak inspiratory 
pressure, auto-PEEP and plateau pressure were respectively: 
35.5 ± 11.8; 8.4 ± 4.5 and 22.0 ± 4.7 cmH2O.
Discrepancies in ventilatory settings were found in 55(34.4) patients. 
23(42) patients had frequent patient–ventilator interactions. Ineffective 
efforts and double triggering were the two most common asynchro-
nies (43.4 and 13.1% respectively). Patient–ventilator interactions were 
assessed as severe in 9(16.3). Patient-ventilator asynchronies were asso-
ciated neither to the severity (SPAS II, PaO2/FiO2) nor to the respiratory 
system mechanic (peak inspiratory pressure, autoPEEP, plateau pres-
sure and driving pressure). A simple intervention on the ventilatory set-
tings corrected the asynchronies in all the patients.
Conclusion The discrepancies in ventilatory settings reveals frequent. 
Patient-ventilator asynchronies are the most observed discrepancies. 
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Introduction First aid and cardiopulmonary resuscitation training 
have received widespread promotion throughout the world. France 
has promoted a decree establishing the mandatory teaching of basic 
life support to all French secondary pupils (Décret n° 2006-41 du 11 
janvier 2006). Large-scale feasibility of such a training, retraining and 
assessment remains a big challenge. We conducted a study to evaluate 
the training efficacy of a serious game designed for cardiopulmonary 
resuscitation and applied to secondary school students.
Materials and methods Students of 6th and 7th grades from Paris 
region were randomized (1:1) to one of the 2 groups using a com-
puterized system. Randomization was stratified by classroom. In the 
Control group, children received a 30-min teaching on nutritional 
wellbeing. In the Interventional group, children played a serious game 
reproducing real-life cardiac arrest situation (3D real-time simulation 
software, Stayingalive®, iLUMENS-Dassault Systemes) without any 
adult intervention. Two months later, each student was observed and 
evaluated by 2 assessors blinded to the study group during a cardio-
pulmonary resuscitation session using mini manikins MiniAnnePlus® 
(Laerdal Medical). The assessment scale included 15 items divided into 
4 categories (cardiac arrest recognition, call for help, chest compres-
sion and use of defibrillator). Primary endpoint was the total score 
obtained by each student. Secondary endpoints included perfor-
mance for each item.
Results A total of 97 children were included in the analysis (Inter-
ventional group n  =  50, Control group n  =  47). Median total score 
was significantly higher in the Interventional group (7 [6–9] vs 6 
[5–8], p =  0.02, Fig.  18). In this group, children performed better on 
the following items: chest compression rate [10/50 (21%) vs 2/47 
(4%), p  =  0.01], non-stop chest compression [8/50 (17%) vs 2/47 
(4%), p  =  0.04], search for a defibrillator [18/50 (38%) vs 3/47 (6%), 
p  =  0.0001], placement of electrodes [44/50 (94%) vs 36/47 (72%), 
p  =  0.005], and defibrillator activation [35/50 (74%) vs 27/47 (54%), 
p = 0.04].
Fig. 18 Mean difference between groups and according to class 
grade
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Conclusion A 30-min experience with a cardiopulmonary resusci-
tation serious game without any adult intervention improves basic 
life support performed by secondary school students. It may be fur-
ther improved by adult supervision, repeated use, and gamification 
using leaderboards. These results are promising to implement on a 
larger scale such serious games to improve knowledge and skills of 
children.
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Introduction Although the Zika virus causes predominantly mild 
symptoms, this mosquito-borne disease has become the newest 
public health challenge. Meningoencephalitis, myelitis, Guillain-Barré 
syndrome (GBS) associated with deglutition disorders, arrhythmia, 
cardiac arrest, myocardial infarction, dysautonomia and microcephaly 
in new borns are among the most serious recorded complications.
The first case of Zika in Martinique, French West Indies, was diagnosed 
in December 2015. To date, this country of 400 000 inhabitants has 
recorded over 36,260 suspected cases of Zika virus infection, including 
29 cases of GBS with Zika present in urine in 14 of them. Among 519 
pregnant women who tested positive, only two cases of microcephaly 
has been identified. One patient a 76-year- old man died. Our objective 
was to describe severe forms of Zika-associated GBS complicated by 
cardiovascular disorders in patients admitted to the Intensive Care 
Unit (ICU) during the onset of the endemic period.
Patients and methods Prospective study of all Zika-associated GBS 
in patients admitted in our ICU from 1/12/2015 to 5/25/2016 and 
presenting at least one organ failure using the SOFA score. During this 
period, all our ICU patients were systematically tested for dengue fever, 
Chickungunya and Zika viruses. Cases included in this study were 
defined by the presence of GBS clinical signs (e.g., distal paresthesias) 
with biological confirmation using RT-PCR blood and urine and also 
CSF, and/or positive serology for IgM or IgG.
Results During the study period, 22 Zika-infected patients with GBS 
were hospitalized in the ICU. The median age was 59 years [19–84] and 
male/female gender ratio 1.5. The patients presented GBS symptoms 
(N = 22), acute renal failure (N = 8), cardiac complications (including 
hemodynamic disorders and arrhythmia; N = 6), bradycardia (N = 6), 
and ARDS (N  =  7), refractory hypoxemia required ECMO VV in one 
patient. Respiratory failure mainly resulting from swallowing disorders 
required mechanical ventilation in 20 patients. Patients developed one 
organ failure (N = 4) and multiple organ failure (N = 18). Four patients 
presented cardiac arrest. Sofa score at 48  h following admission 
was 10 [2–18]. All the patients received intravenous polyvalent 
immunoglobins (0.4 g/kg/day for 5 days). The median duration of ICU 
stay was 15 days. One patient died.
Conclusion Zika infection may lead to ICU admission due to the devel-
opment of GBS. Physicans particularly cardiologists should be aware 
of additional cardiovascular complications secondary to GBS-related 
dysautonomic complications. An emergent need for collaborative and 
multidisciplinary approach is required to mitigate the imminent Zika 
outbreak in the Caribbean, by providing diagnostic laboratory facili-
ties, ICU beds availability and assistance for appropriate management 
of the environment. A prospective study is currently conducted to 
evaluate the cardiovascular complications associated with fatal cases 
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Introduction The outcome of septic shock in cancer patients has 
dramatically improved over the last two decades, but the impact 
the acute inflammatory insult on the further prognosis of cancer is 
unclear. Indeed, sepsis-induced immune dysfunctions may directly 
impact on the prognosis of the underlying malignancy in survivors. We 
are currently developing a research project in order to investigate the 
reciprocal relationships between bacterial sepsis and malignant tumor 
growth. We first reported that sepsis-induced immune suppression 
promoted malignant tumor growth when tumor cells were inoculated 
in post-septic mice. Conversely, we observed that sepsis may inhibit 
the growth of previously established local and metastatic tumors. 
The present study aimed at investigating the cellular and molecular 
mechanisms of sepsis-induced tumor inhibition.
Materials and methods We used 8–12 w.o. C57BL/6  J mice. Mice 
were first subjected to malignant tumor inoculation by subcutaneous 
injection of the MCA205 fibrosarcoma cell line. Seven days after tumor 
inoculation, mice were subjected to polymicrobial sepsis induced by 
cecal ligation and puncture (CLP), without any subsequent antibiotic 
treatment. Controls were cancer mice subjected to sham surgery. The 
features of anti-tumoral immune response were compared between 
CLP- and sham-operated cancer mice at day 1 (early assessment) and 
day 7 (late assessment) following surgery. The intra-tumoral infiltration 
of immune cells within tumor tissues and draining lymph nodes was 
assessed by flow cytometry, and the intratumoral cytokine production 
was assessed by ELISA. We also investigated the role of bacteria 
and related pathogen-associated molecular patterns on growth of 
MCA205 cells. The expression of Tlr2 and Tlr4 genes was assessed by 
southern blot after DNA amplification.
Results We first confirmed that polymicrobial was able to inhibit 
malignant tumor growth when applied in mice previously inoculated 
with fibrosarcoma MCA205 cell line. Not surprisingly, the bacterial load 
in blood, kidneys and tumors were higher at day 1 in CLP-operated 
mice than in sham-operated counterparts. Of note, the bacterial con-
tamination of tumors was not sustained at 7  days. We checked that 
MCA205 cells expressed functional Tlr2 and Tlr4 receptors. MCA205 
cells cultured in the presence of Tlr4 and Tlr2 agonists, respectively 
lipopolysaccharide (LPS) and heat-killed Staphylococcus aureus, did 
not display accelerated cell growth in vitro, suggesting that the anti-
tumoral effect of sepsis is mediated by the septic host’s response. The 
distribution of myeloid and lymphoid immune cells within tumor tis-
sue was quite similar in sham- and CLP-operated mice, with the excep-
tion of increased proportions of inflammatory monocytes and Tgd 
lymphocytes in septic mice. The intra-tumoral cytokine pattern of CLP-
operated mice was skewed towards an increased production of both 
the pro-inflammatory Tnf-a and the anti-inflammatory IL-10 cytokines 
at day 1.
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Conclusion Polymicrobial sepsis applied to cancer mice inhibits the 
local growth of a malignant fibrosarcoma tumor. This anti-tumoral 
effect is not directly driven by pathogens, but rather involves an 
enhanced intratumoral inflammatory response. In the light of mild 
quantitative cell alterations, our results suggest that sepsis induces 
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Introduction Hematological malignancies may be directly responsible 
for life-threatening organ failures through tumor lysis syndrome, 
tissue infiltration, coagulation disorders and obstruction of anatomical 
structures. Respiratory and renal dysfunctions are commonly 
encountered in this setting. In addition, some patients may develop 
a systemic inflammatory response syndrome, responsible for acute 
circulatory dysfunction, so-called sepsis-like syndrome. Besides 
advanced life support, the treatment of those cancer-related organ 
failures relies on timely administration of chemotherapy. In this study, 
we addressed the features and outcomes of patients with sepsis-like 
circulatory dysfunction related to hematological malignancies, with 
particular emphasis on the impact of chemotherapy on organ failures.
Patients and methods This was a 9-year (2007–2016) single-center 
retrospective observational study performed in a 24-bed medical ICU. 
Inclusion criteria were age ≥18 years AND presence of a hematological 
malignancy, either already known at the time of ICU admission 
or diagnosed during the ICU stay AND development of acute 
circulatory dysfunction requiring vasopressors without any evidence 
of underlying infection. Patients with hematological malignancies 
who received chemotherapy in the ICU were retrieved through the 
information systems from hospital pharmacy units involved in the 
delivery of cytostatic drugs, and all medical files were individually 
checked for inclusion criteria. Data were collected from individual 
files, and included the overall severity through the APACHE2 and SOFA 
scores computed at the time of ICU admission. The SOFA score was 
thereafter computed daily. Endpoints were the in-ICU and in-hospital 
vital status.
Results Over the study period, 24 patients (12 men, 12 females) 
fulfilled the inclusion criteria. Their mean age was 62 ± 16 years. Most 
of them were in good functional condition since 22 had a performance 
status of 0. Two patients were previously immunocompromised 
(severe combined immune deficiency and kidney transplant). The 
underlying haematological malignancies were distributed as follows: 
non-Hodgkin lymphoma (n  =  18) including 6 patients with diffuse 
large B-cell lymphoma, acute myeloid leukemia (n  =  4), Hodgkin’s 
lymphoma (n = 1) and chronic lymphocytic leukemia (n = 1). Seven 
patients had malignancies newly diagnosed in the ICU. Otherwise, the 
median time from diagnosis to ICU admission was 8 days (min 2 days; 
max 4357 days).
The primary reasons for ICU admission were respiratory (n  =  11), 
renal (n = 7), neurological (n = 6) and hemodynamic (n = 5) failures. 
The mean admission APACHE II and SOFA scores were 18.8  ±  9.0 
and 8.6  ±  3.4, respectively. The mean blood lactate level was 
4.9 ± 1.4 mmol/L. Mechanisms of organ failures were related to tumor 
lysis syndrome (n = 10), hemophagocytic lymphohistiocytosis (n = 4), 
lung (n = 4) and liver (n = 2) malignant infiltration, and disseminated 
intravascular coagulation (n  =  2). Acute circulatory failure requir-
ing vasopressors was present prior to chemotherapy in 18 patients, 
and was secondarily triggered by chemotherapy in 6 patients. In the 
first group, administration of chemotherapy was associated with 
a dramatic improvement in the circulatory conditions (Fig.  19) as 
assessed by the trend in the hemodynamic SOFA variable. The in-ICU 
and in-hospital mortality rates were 75 and 79%, respectively. The 
main cause of death was untractable multiple organ failure (n = 14).
Discussion The mechanism of organ failures in this setting is ques-
tionable, but is presumably linked to a massive release of pro-inflam-
matory cytokines and endogenous danger signals by malignant cells. 
Modulation of this overwhelming inflammatory response may repre-
sent a field of investigation as well as a potential therapeutic target in 
the future.
Conclusion Urgent administration of chemotherapy is associated with 
fast improvement in circulatory conditions in patients with sepsis-like 
shock related to hematological malignancies. However, the overall 
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Introduction Glucotoxicity is known to occur during hyperglyce-
mia and glycemic variability, situations that are associated with poor 
outcomes in sepsis patients. Although cardiovascular dysfunction is 
a major cause of mortality during sepsis, the impact of glucotoxicity 
on the cardiovascular system during sepsis remains unknown [1]. Ben-
eficial effects of protein tyrosine phosphatase 1B (PTP1B) deletion, a 
negative regulator of insulin signaling, on glucose homeostasis and 
cardiovascular dysfunction during endotoxemia have been reported. 
We hypothesized that exogenous glucose administration during 
inflammation increases cardiovascular dysfunctions by activating glu-
cotoxicity pathways and that this is prevented by endothelial PTP1B 
gene deletion.
Materials and methods For this purpose, we generated an endo-
toxinic model with glucose administration. EndoPTP1B−/− or wild 
type (WT) mice received LPS (1 mg/kg) or saline solution followed by 
five injections of glucose (2  g/kg) or saline solution each hour 12  h 
after LPS. Endothelial deletion of PTP1B was generated by crossing 
LoxP-PTP1B with Tie2-Cre mice. The exploration of the cardiac func-
tion is performed 20  h after LPS injection (H2O) by the non-invasive 
Fig. 19 Evolution of cardiovascular SOFA of patients with hemody‑
namic failure before chemotherapy, from initiation of chemotherapy 
until 7 days after
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echocardiography on anesthetized mice. The gene expression of 
PARP1(Poly (ADP-ribose) polymérase 1), iNOS, eNOS, IL1-β, TNF-
α, IL-10, IL-6, PKC δ, GRP78 (78  kDa glucose-regulated protein), 
gp91phox, CD-45, CHOP (C/EBP Homologous protein), PTP1B, ICAM-1, 
VCAM-1 and Caspase 3 is evaluated by q-RT-PCR and Western-Blot.
Results The comparison between groups WT and WT endoPTP1B−/− 
receiving glucose shows an effect of endothelial deletion of 
PTP1B−/− on the average blood glucose for the LPS-Glc groups. 
The fractional shortening tended without significance to decrease 
in mice receiving LPS with glucose compared LPS alone. Analysis of 
cardiac tissue showed a significant deleterious impact of LPS and 
glucose association on oxidative stress (gp91phox) and inflamma-
tory responses with increased cytokines production and expres-
sion of adhesion molecules (VCAM-1 and ICAM-1). The cardiac gene 
expression of CHOP and GRP78 (endoplasmic reticulum stress) in 
WT showed no change in the condition LPS with glucose. Moreover, 
expression of PARP1, sensor of DNA damages and activator of gluco-
toxicity pathways, is increased with glycemic variability. Despite an 
increased expression of PTP1B when LPS and glucose are combined 
in wild type mice, endothelial PTP1B deletion gene only reduced sig-
nificantly the cardiac expression of iNOS, PARP1 and PTP1B. Finally, 
cardiac systolic function tended without significance to be impaired 
by glucose and LPS combined.
Discussion The absence of variation in the gene and protein expres-
sion of CHOP and GRP78 shows a lack of endoplasmic reticulum stress 
in our model despite cellular stresses generated by glucose.
Conclusion In endotoxinic model, the variability of blood glucose 
aggravates the effects induced by an inflammatory trigger in the car-
diac tissue without significant impaired cardiac function in this model. 
Endothelial deletion in PTP1B, involved in the regulation of glucose 
homeostasis, provides improved glycemic control, with a reduction of 
pathological activation of iNOS, a marker of abnormal vascular func-
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Introduction Administration of a selective β1-blocker, such as 
Esmolol, in septic shock has demonstrated cardiovascular protective 
effects related to a down-regulation of inflammation. However, the 
administered dose systematically induced a reduction in heart rate 
of approximately 20%, thus limiting its prescription at bedside. The 
present study aimed to determine whether a non-chronotropic 
dose of Esmolol still maintains its protective cardiovascular and anti-
inflammatory effects in experimental septic shock.
Materials and methods Four hours after cecal ligation and punc-
ture (CLP), Wistar male rats were randomly allocated to the follow-
ing groups (n = 8): CLP, CLP + E1 (Esmolol: 1 mg kg−1 h−1), CLP + E5 
(Esmolol: 5  mg  kg−1  h−1), CLP +  E18 (Esmolol: 18  mg  kg−1  h−1). An 
additional eight rats underwent Sham operation. All rats received a 
continuous infusion of saline, analgesic and antibiotics 4  h after the 
surgery. Assessment at 18 h included in vivo cardiac function by echo-
cardiography and ex  vivo vasoreactivity by myography. Circulating 
cytokine levels (IL-6 and IL-10) were measured by ELISA. Cardiac and 
vascular protein expressions of p-NF-κB/IκBα, iNOS, p-AKT/AKT and 
p-eNOS/eNOS were assessed by Western blotting.
Results CLP induced tachycardia, hypotension, cardiac output reduc-
tion, hyperlactatemia and vascular hypo-responsiveness to vasopres-
sors. Compared to CLP animals, heart rate was unchanged in CLP + E1 
and CLP + E5 but was reduced in CLP + E18. Stroke volume, cardiac 
output, mean arterial pressure and lactatemia were improved in 
CLP  +  E1 and CLP  +  E5 while vascular responsiveness to Phenyle-
phrine was only improved in CLP  +  E5 and CLP  +  E18. Plasma IL-6 
levels were decreased in all Esmolol groups. p-NF-κB was decreased in 
both cardiac and vascular tissues in CLP + E5 and CLP + E18.
Conclusion In experimental septic shock, low doses of Esmolol, still 
improved cardiac function and vasoreactivity. These benefits appear 
to be associated with a modulation of inflammatory pathways.
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Introduction For patients treated with cisatracurium, it has been 
shown that proinflammatory cytokines (IL-1, IL-6, and IL-8) significantly 
went down during the 48 h of molecule administration as compared 
to placebo [1]. This anti-inflammatory effect is mediated in part by an 
inhibition of nicotinic acetylcholine receptor [2]. We did not find in 
the literature any study exploring the post-discontinuation phase of 
neuromuscular blocking agent apart the fact that blood oxygenation 
improved after interruption of cisatracurium infusion. The goal of 
present study was to demonstrate inflammatory rebound defined 
from the systemic inflammatory response syndrome (SIRS) criteria 
after discontinuation of cisatracurium.
Patients and methods It was a prospective, single-center, 
observational study. We included adult patients admitted to the 
medical intensive care unit of the Croix-Rousse hospital in Lyon, who 
received mechanical ventilation and cisatracurium infusion between 
February and August 2016. A rapid intravenous infusion of 15 mg of 
cisatracurium was administred followed by a continuous infusion 
of 37.5  mg per hour for at least 24  h. After inclusion in the study, 
SIRS criteria were monitored daily from cisatracurium onset until the 
72th hour after molecule interruption. The SIRS was defined by the 
presence of at least 2 of the followings: temperature >38 °C or <36 °C, 
heart rate >90/min, respiratory rate >20/min or PaCO2 <32  mmHg 
and white blood cells count >12 G/L or <4 G/L or >10% immature 
neutrophils. Inflammatory rebound was defined as the increase of SIRS 
by at least 1 criterion from the baseline defined as the cisatracurium 
discontinuation. The primary outcome was the prevalence of 
inflammatory rebound 24 h after the cisatracurium discontinuation.
Results Thirty-nine patients were enrolled. The prevalence of inflam-
matory rebound 24  h after the cisatracurium discontinuation was 
56.4%. No risk factor in the multivariate analysis was associated with 
the presence of inflammatory rebound and this rebound did not affect 
mortality. We also noticed an increased risk of inflammatory rebound 
with time after cessation of cisatracurium (Fig. 20) and this risk was not 
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depending on the length of cisatracurium administration before its 
discontinuation.
Conclusion This study demonstrated that inflammatory rebound 
occurred in more than half of patients after interruption of cisatracu-
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Introduction The Veno-Arterial ExtraCorporeal Life Support (VA-ECLS) 
is an efficient therapy in refractory cardiogenic shock. Nevertheless, 
VA-ECLS is associated with serious infectious complications. The objec-
tive of this study was to investigate the epidemiology and the risk fac-
tors of infection of femoral cannulation site in patients with VA-ECLS 
after cardiac surgery.
Materials and methods We investigated all patients underwent VA-
ECLS after cardiac surgery between January 2013 and December 2014, 
all included in the SARIC database. The infection of inguinal cannula-
tion site was defined as an inflammatory or purulent appearance of the 
cannulation site associated with a positive quantitative culture of the 
cannulation site sample. The  «infected»  and  «non-infected»  patients 
were compared by Wilcoxon or Fisher tests. A test of Log Rank and a 
Cox model was used for univariate and multivariate analysis.
Results At all, 142 patients were investigated. Diagnosis of cannula-
tion infection site was made in 38 (27%) patients. The median time 
to infection was 10  days [8; 15] (Fig.  21). Pseudomonas aeruginosa, 
Enterococcus faecalis, Escherichia coli and Enterobacter cloacae were 
identified in 16, 12, 12 and 10% respectively. The other bacteria were 
klebsiella pneumoniae in 15% and staphylococcus in 10%. In univari-
ate analysis, risk factors of cannula site infection were a multiresistant 
bacterial colonization, a bacteremia event and/or a bleeding event 
in VA-ECLS cannulation site. In multivariate analysis, only a bleeding 
event in VA-ECLS cannulation site was identified as a risk factor can-
nulation site infection.
The intrahospital mortality was similar in both groups but the hospi-
talization length stay increased in the «infected» group, 45 vs. 26 days 
(p  <  0.0001) respectively. Furthermore, reoperation increased sig-
nificantly in the  «infected»  group, 71 vs. 2% of patients (p  <  0.0001) 
respectively. After reoperation, a reconstructive surgery of the cannu-
lation site was necessary in 45% of cases.
Conclusion In patients treated with VA-ECLS after cardiac surgery, 
inguinal cannulation site infection occurs in 27% of patients. Bleeding 
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Introduction Few studies focused on patients with severe infec-
tive endocarditis (IE) in Intensive Care Unit (ICU), and despite major 
advances in both diagnosis and therapeutic procedures, it still carries 
poor prognosis. In 2009, European guidelines on antibiotic prophylaxis 
have changed and became more restrictive. The goal of this study is 
to describe changes in incidence, characteristics of patients, manage-
ment, in-hospital mortality and pathogens in an overall population of 
patients admitted to ICU for a definite IE. Through comparison of two 
Fig. 20 Cumulative risk of inflammatory rebound over time after 
cisatracurium discontinuation)
Fig. 21 Delay between the VA‑ECLS implantation and infection of 
the inguinal cannulation site (n = 38)
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periods we aim to estimate the impact of the amended recommenda-
tions issued by European society of cardiology.
Patients and methods Retrospective study based on the CUB-Rea 
register, including 31 medical and/or surgical intensive care units 
between 1997 and 2014. Statistical analysis compared the periods 
1997–2009 and 2010–2014.
Results We included 4757 definite IE over the two periods, 2848 
in 1997–2009 and 1909 in 2010–2014. We observed a significant 
increase in crude annual incidence (153.0  ±  14.9 vs 217.6  ±  46.4; 
P  =  0.018) and in incidence density relative to number of stays 
(0.79  ±  0.08 vs 1.1  ±  0.02% P  =  0.004). Despite a trend towards 
increasing number of cases over the first period (1997–2009), slopes 
of incidence density curves clearly indicate an acceleration of the 
number of cases since 2009 (P = 0.017). Patients treated during the 
second period are significantly older and more severe than those 
treated before 2009. Surprisingly, use of invasive ventilation, renal 
replacement therapy, and vasopressor were significantly lower dur-
ing second period. Contrariwise, resort to surgery has doubled 
between two periods. ICU mortality is significantly lower in the 
second period but in-hospital mortality remains unchanged. Con-
cerning pathogens, we found a significant increase in incidence of 
Streptococcus spp. and Staphylococcus spp., and no changes concern-
ing intracellular bacteria, Enterococcus spp., Candida spp. or Gram-
negative bacilli.
Conclusion Despite some limitations inherent to its retrospective 
design and to potential diagnostic coding bias, our study highlights a 
quick shifting landscape in the epidemiology of infectious endocardi-
tis in intensive care, characterized by a strong increase in the incidence 
and changes in bacterial epidemiology. Restrictive bend in antibiotic 
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Introduction Heparin is widely prescribed in patients admitted 
in surgical intensive care units (SICU) to prevent venous 
thromboembolic events. Heparin-induced thrombocytopenia (HIT) 
is a rare but potentially life-threatening complication of heparin 
therapy. HIT requires the emergent discontinuation of heparin and 
the prescription of an alternative anticoagulant therapy that could 
be difficult to manage in SICU patients and enhance the risk of 
hemorrhagic complication. The early diagnosis of HIT in SICU patients 
remains a challenge. As thrombocytopenia could reveal several 
SICU complications, the 4T score of Warkentin is a useless tool to 
efficiently discriminate patients having or not HIT and the biological 
confirmation of HIT is delayed. The HIT Expert Probability (HEP) score 
has been reported to have a higher predictive value than the 4T score 
in non-ICU patients. The purpose of the study was to compare the HEP 
score to the 4T score in the early diagnosis of HIT in SICU patients.
Materials and methods We conducted a one-center prospective 
observational cohort pilot study (www.ClinicalTrials.gov Identifier 
NCT02790567), included all consecutive patients admitted in our SICU 
between October 2013 and May 2015 and suspected to have HIT. 
Non-inclusion criteria were pregnancy, age <18  years old and treat-
ment with fondaparinux. The day the diagnosis of HIT was suspected, 
the HEP and the 4T scores were calculated and the following blood 
analyses were performed: the ID-PaGIA Heparin/PF4 test, the ELISA 
test, the heparin-induced-platelet-aggregation (HIPA), and the sero-
tonin release assay (SRA). After completion of the study, all medical 
files were reviewed by a multi-disciplinary independent committee to 
discriminate patient having (HIT group) or not (SAFE group) a HIT. The 
final diagnosis was based on the medical history of the patient, on the 
time-variation of the platelet count while heparin was discontinued or 
not, and on the results of the venous Doppler of the 4 limbs. The com-
mittee was blinded from the value of the HEP and of the 4T scores, and 
from the results of the ID-PaGIA Heparin/PF4 test. The ROC curves of 
the HEP and of the 4T score were constructed. The sensibility (Se), the 
specificity (Sp), the positive predictive value (PPV), and the negative 
predictive value (NPV) of the HEP and of the 4T scores were calculated, 
and the areas under the ROC curves (AUC) were compared by using a 
Chi2 test. Data are presented as median [interquartile range] and num-
ber of patients (percentage).
Results From the 119 patients included, 6 (5) patients had a HIT 
(age: 66 [59–74] vs 70 [54–80] year, p = 0.62; male: 80 (71) vs 6 (100), 
p = 0.18; IGSII score value: 54 [46–68] vs 46 [38–62], p = 0.25; respec-
tively in the SAFE and in the HIT groups). The global incidence of HIT 
during the study was 0.43%. The ROC curves are presented in Fig. 22. 
The Se, the Sp, the PPV and the NPV of a HEP score ≥5 and of a 4T 
score ≥6 were respectively 100 and 50%, 93 and 86%, 50 and 22%, and 
100 and 96%. All patients in the HIT group had a HEP score ≥5. The 
AUC was significantly higher for the HEP score (AUC [95% confidence 
interval] 0.967 [0.922–1.000]) than for the 4T score (AUC [95% CI] 0.707 
[0.449–0.965]) (p = 0.035).
Conclusion Based on a small prospective observational pilot study, a 
HEP score ≥5 could have a higher predictive value than a 4T score ≥6 
in the early diagnosis of HIT in SICU patients. This result needs to be 
confirmed in a larger multicenter study.
Competing interests
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Fig. 22 Receiver operating characteristic curves for the HEP and for 
the 4T scores
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Introduction Drug poisoning is a frequent cause of hospital admis-
sion especially in intensive care unit (ICU). Despite advances in treat-
ment, hospital mortality of severe acute poisoning admitted in ICU 
seems to increase. Purifying methods, continuous haemodiafiltration 
veinoveinous (CVVHDF) and molecular adsorbent recirculating system 
(MARS) were developed with promising clinical results [1]. However 
no analytical study has quantified their accurately purifying efficiency. 
It has not been assessed efficiency of the different compartments of 
MARS nor its advantages over other methods of dialysis and filtration. 
The objective of this study was to quantify the purifying efficiency of 
the different compartments of the CVVHDF and MARS and to com-
pare their respective efficiency in an ex vivo model in the most favour-
able conditions for these methods to assess their maximum capacity 
purification.
Materials and methods We performed an ex  vivo study based on 
a manipulation bench simulating intoxication pentobarbital at a 
plasma concentration of 40  mg/l injected into a central compart-
ment (5  l) devoid of transporter proteins (200 mg of pentobarbital). 
The EC extraction coefficient [EC = (in concentration − out concen-
tration)/in concentration] were calculated for each compartment of 
CVVHDF and MARS as well as the amounts withdrawn by the sum 
each compartment allows to assess the overall capacity of each 
technique.
Results At the end of 6  h simulation with CVVHDF, the remaining 
material in the central compartment was 3% of the total quantity 
injected. The cumulative amount removed in total effluent was equal 
to 95%. The non-recovered amount was equal to 2%. EC CVVHDF was 
almost constant with an average value of 14% with large variations 
however (range 2.5–27%). It was not observed to release at the end of 
manipulation.
At the end of a 6 h simulation with MARS, the remaining amount in 
the central compartment was undetectable. The cumulative amount 
removed in total effluent from the hemodiafiltration column was 
equal to 11.5% the amount removed by carbon column was 88.5%. 
The sum of the amounts removed by the effluent and the carbon 
column reflects the total amount injected. The EC hemodiafiltration 
compartments and charcoal hemoperfusion were 25 and 70% respec-
tively. Purification of pentobarbital was complete after 3 h of a MARS 
session.
Discussion MARS is the most effective purifying method in a pento-
barbital-simulated intoxication. This rapid and complete treatment 
is mainly due to purifying coal capacity. It was not observed the car-
tridge saturation for the amount of administered pentobarbital.
Conclusion Future studies should determine the parameters that may 
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Introduction Plant poisoning is generally not life-threatening. Its 
occurrence in children is commonly accidental. In adults it results from 
a suicide attempt or from its use for addictive or therapeutic purposes.
Because of their specificity in clinical presentation and outcomes, we 
have conducted this study.
The objective of this study was to report all plant poisoning cases col-
lected in Tunisian toxicological intensive care unit, with their epidemi-
ological, clinical characteristics and outcomes.
Patients and methods A retrospective study was performed between 
January 2007 and December 2015.
Epidemiological data and clinical outcomes were reviewed. Data were 
analyzed using SPSS.
Results During the study period, 38 patients were included. Sex 
ratio was 1. Mean age was 43  years (5–65). Poisoning was acci-
dental in 88% of cases. Most frequently incriminated plants were 
Datura stramonium (40%) with an anticholinergic toxidrom present 
in all cases, Ricinus communis (23%) with gastrointestinal mani-
festations (present in 88% of cases), Nerium oleander (9%) with 
digitalis toxicity–like symptom in 66% of cases, Hyoscyamus Niger 
(12%) with anticholinergic symptoms in 75% of cases and halluci-
nogenic effects in all cases, Atractylis gummifera (9%) with gastro-
intestinal and acute liver failure symptoms, and Peganum harmala 
(9%) with only gastro-intestinal effects. All patients received sup-
portive care. Mortality rate was 8, 5%, interesting children, and was 
secondary to multi-system organ failure due to ingestion of Atrac-
tylis gummifera.
Conclusion Each year 2.2% of our poison center calls report exposures 
to toxic plants. Most of these exposures are of minimal toxicity largely 
because of the fact that they involve pediatric ingestions, which are 
of low quantity. Public education is important to minimize these poi-
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Introduction Herbal remedies have been used for centuries to treat a 
variety of diseases. Mediterranean Buckthorn (Rhamnus alaternus) has 
been used for therapeutic purposes and no toxicity effects have been 
documented. Rhamnusalaternus (Rhamnaceae) is a small tree located 
mainly in the North of Tunisia, where it is known as ‘‘Oud El-khir”. It has 
traditionally been used as a diuretic, laxative, hypotensive drug and for 
the treatment of diabetes, hepatic and dermatologic complications. 
Previous phytochemical studies have shown potent antioxidant, free 
radical scavenging, antimutagenic and antigenotoxic activities of fla-
vonoids and phenol isolated from Rhamnus alaternus roots and leaves.
Patients and methods It was a retrospective study reporting a fam-
ily collective poisoning which occurred in the region of Zaghouan in 
Tunisia in July 2015. All the members of the family ingested acciden-
tally a traditional preparation of a plant “Oud El-Khir” in a juice pre-
pared for a traditional marriage.
Results On 1st July 2015, a family composed of seventeen members 
(ten men and seven women) was admitted to the teaching emergency 
and intensive care department of the regional hospital of Zaghouan 
(Tunisia). All members of the family presented dizziness, weakness, 
anorexia and dyspnea. They reported the ingestion 10 h before of a 
juice in a traditional marriage. This juice was prepared using a plant 
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called “Oud El-Khir” because of its capacity to be a lucky charm for the 
new married. The mean blood pressure was 130/60 mmHg. All mem-
bers of the family experienced nausea, vomiting, anuria and hematu-
ria. On physical examination, five members of the family had myalgia 
without other clinical signs.
For all patients: cytological reports and sputum smear were negative 
(three times) for pulmonary tuberculosis. Hepatitis B and C serology 
were also negative. Chest x-ray was normal; Blood and urine culture 
were negative. In renal ultrasonography performed in five members 
of the family, there was a significant difference in kidney sizes and 
the corticomedullary differentiation was altered. Laboratory tests 
showed hyperglycemia and renal failure with metabolic acidosis in ten 
patients. Three dialysis sessions were performed.
Samples of the herbal decoction were obtained from the juice. It was 
a dark brown suspension with fine brown deposit and a clear superna-
tant. It smelled a strong penetrating odor. Samples of both Rhamnus 
alaternus roots and its decoction were sent to be analyzed in the labo-
ratory of toxicology in the Center for Emergency Medical Assistance of 
Tunis in Tunisia.
Screening by GC–MS of both Rhamnus alaternus roots and infusion 
extracts, revealed the presence of anthraquinone glycosides such 
as 4,5-dihydroxy-9,10-dioxoanthracène-2-carboxylic acid (Rhein), 
1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione (Aloe-emo-
din) and 1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione 
(Physcion). The retention times were 8.95, 9.67 and 10.25 min respec-
tively. Anthraquinone glycosides were detected in a dichloromethane 
extract and ethyl acetate extract at pH value = 9 and only in a dichlo-
romethane extract at pH value = 7 by GC–MS analysis.
Conclusion Rhamnus alaternus can be toxic when used in an abusive 
way besides its strong antibacterial, antioxidants and antidiabetic 
activities. To our knowledge, this is the first report of cases of renal fail-
ure and rhabdomyolysis which is possibly associated with an acciden-
tal consumption of Rhamnus alaternus roots. We present these cases 
to illustrate the role of both clinical and biological investigations in 
handling cases of herbal poisonings. We aimed also to increase aware-
ness among emergency physicians about patients presenting to the 
emergency department with unexplained symptoms (renal failure, 
rhabdomyolysis…) that requires prompt diagnosis so that such life-
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Introduction Lithium overdose may result in encephalopathy and 
electroencephalographic abnormalities. Three poisoning patterns 
have been identified based on the ingested dose, previous treatment 
duration and renal function. Whether severity of lithium-induced 
encephalopathy depends on the poisoning pattern is not established.
Materials and methods We designed a rat study to investigate lith-
ium-induced encephalopathy and correlate its severity to plasma, 
erythrocyte, cerebrospinal fluid and brain lithium concentrations 
previously determined in rat models mimicking human poisoning 
patterns. Lithium-induced encephalopathy was assessed and scored 
using continuous electroencephalography.
Results We demonstrated that lithium overdose was consistently 
responsible for encephalopathy which severity depended on the 
poisoning pattern. Acutely poisoned rats developed rapid-onset 
encephalopathy which reached a maximal grade of 2/5 at 6 h and dis-
appeared at 24  h post-injection. Acute-on-chronically poisoned rats 
developed persistent and slightly fluctuating encephalopathy which 
reached a maximal grade of 3/5. Chronically poisoned rats developed 
rapid-onset but gradually increasing life-threatening encephalopathy 
which reached a maximal grade of 4/5. None of the acutely, 20% of the 
acute-on-chronically and 57% of the chronically lithium-poisoned rats 
developed seizures. The relationships between encephalopathy sever-
ity and lithium concentrations fitted a sigmoidal Emax model based 
on cerebrospinal fluid concentrations in the acute poisoning and brain 
concentrations in the acute-on-chronic poisoning. In the chronic poi-
soning, encephalopathy worsening paralleled the increase in plasma 
lithium concentrations.
Conclusion Severity of lithium-induced encephalopathy is dependent 
on the poisoning pattern, previously shown to determine the 
lithium amount accumulated in the brain. Our data supports that 
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Introduction Amitriptyline is one of the common drug poisoning that 
induces severe cardiovascular and neurological complications.
The incidence of electrocardiogram changes in Amitriptyline poison-
ing was not explored enough. Therefore, we conducted this study to 
determinate the incidence of electrocardiogram abnormalities in Ami-
triptyline poisoning.
Patients and methods It was a retrospective study conducted from 
January 2012 to July 2016 in a toxicological unit including all admitted 
patients for Amitriptyline poisoning. A 12-lead electrocardiogram was 
carried out and analyzed at admission and every 6 h.
Results One hundred and fifty patients aged 29  ±  12  years were 
included; their sex ratio was of 0.19. Among them, only 6 had a history 
of cardiovascular disease.
A loss of consciousness was noted in 58% of patients (n  =  87) and 
electrocardiogram changes in 42% of patients (n = 63). The most com-
mon electrocardiogram changes were sinus tachycardia (108  ±  13 
beats/min) (60%), widening of the QRS complex (16%) and right bun-
dle ranch block (12%). A changes in die S-T was observed in 4 patients 
and dominant secondary R wave (R’  >  3  mm) in aVR in 3. Forty-four 
percent of patients with electrocardiogram changes were comatose. 
No patient had developed hemodynamic instability especially in the 
case of widening of the QRS. These electrocardiogram abnormalities 
took 6 to 36 h to regress without specific treatment.
Conclusion Although electrocardiogram changes are common 
in Amitriptyline poisoning particularly in a patients with loss of 
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Introduction Tramadol, an opioid analgesics used to treat moderate 
to severe pain, is responsible in overdose for coma, respiratory 
depression, seizures and serotonin syndrome. The exact role of 
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naloxone to reverse tramadol-related effects is debated. We aimed at 
investigating the pathways involved in tramadol-related neurotoxicity 
and seizures in the rat, by using various antagonists of the different 
tramadol-mediated effects including naloxone, cyproheptadine, 
fexofenadine and diazepam and determining the turnover of brain 
monoamines.
Materials and methods Body temperature (using telemetry), 
respiratory effects (using plethysmography) and neurological 
effects (using clinical scales and EEG) were studied. Brain (frontal 
lobes) monoamines (serotonin, dopamine and norepinephrine) and 
their respective metabolites were measured using HPLC coupled 
to fluorimetry. For each animal and each time, we calculated the 
difference between the parameter value at that time and baseline 
and the area under the curve of its time course. Comparisons were 
performed using two-way ANOVA followed by post-tests using 
Bonferroni correction.
Results Tramadol induced sedation (p  <  0.01), seizures (early onset 
and peaking at 30 min) and increase in inspiratory time (p < 0.001) as 
well as a non-significant trend to hypothermia,. Diazepam completely 
suppressed seizures Naloxone prevented tramadol-related sedation 
and respiratory effects while did not inhibit seizures. In contrast to 
cyproheptadine which exhibited no effects, fexofenadine partially 
reduced seizures, suggesting the involvement of a histaminergic 
pathway. Monoamines turnovers were significantly reduced in 
the presence of diazepam (p  <  0.01), suggesting that diazepam-
mediated prevention of tramadol-induced seizures could be related 
to the inhibition of monoamines metabolism in addition to its usual 
GABAergic effects.
Conclusion Tramadol-induced sedation and respiratory effects 
are mediated by mu-opioid receptors. Seizures involve complex 
mechanisms including histaminergic but not serotoninergic pathways. 
Diazepam-related anticonvulsive activity to prevent tramadol-induced 
seizures may be related to the inhibition of monoamines metabolism 
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Introduction Suicide by injecting insulin is not uncommon in diabet-
ics and non-diabetics but few series were described in literature. Our 
study aimed to describe insulin intoxication in a series of cases.
Materials and methods Our study is retrospective. It included all 
patients admitted for insulin intoxication in the period between 2012 
and 2015. Insulin poising was withheld on medical history of insulin 
injection without therapeutic indication, on clinical signs of hypogly-
cemia (sweats, neurologic and digestive signs…), and on capillary glu-
cose under 0.5 g/L in non-diabetics and under 0.6 g/L in diabetics, at 
least once.
Results Forty-three patients were collected, with sex-ratio at 0.72. 
The mean age was 31 ± 13 years. Only 32% of patients were diabet-
ics. The median amount of injected dose was 120 UI [50; 302]. Rapid-
acting insulin (RI) was found in 30%, lente insulin (LI) in 58% and mixed 
intoxication in 7%. Route of administration was in all cases subcuta-
neous. Time of onset of symptoms was 1H and 45 min with extremes 
of 15 min and 2 h for RI. It was 3H with extremes of 1 and 6 h for LI. 
The most common signs were vertigo (53.5%), sweats (42%), palpita-
tions (23%), coma (21%), paresthesia (18%), nausea (14%), seizures 
(11%). The median capillary glycaemia on the first medical contact 
was 0.5 g/L [0.36; 0.71]. The median required dose of injected carbo-
hydrate was 175 g [90; 200]. Central catheter was required in only one 
case. Outcome was favorable in 93% (n = 40) with hospital discharge 
in 1.5 days ± 0.68. Outcome were fatal in two cases and one patient 
kept chronic coma because of late care.
Conclusion Insulin intoxication had good prognosis if patients 
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Introduction Tramadol poisonings are significantly increasing due 
to the increase in prescriptions since dextropropoxyphene banning 
from the European market in 2011. Tramadol-related analgesic effects 
are mediated by its antagonist activity on the norepinephrine and 
serotonin transporters in addition to the agonist activity of its major 
active metabolite M1 on the mu-opioid receptors. Thus, tramadol 
overdose may result in various toxicities including central nervous 
system depression, seizures and serotonin syndrome. The relative 
prevalence of each of these complications is debated. We aimed (1) to 
describe the clinical features in tramadol-poisoned patients and (2) to 
study the prognostic value of the plasma concentration of tramadol 
and its metabolites on ICU admission.
Patients and methods We conducted a prospective single centre 
observational study including all tramadol-poisoned patients 
admitted to the intensive care unit (ICU) from 2012 to 2016. The 
plasma concentrations of tramadol and its metabolites were 
determined using high-performance liquid chromatography coupled 
to mass spectrometry. Subgroup comparisons were performed using 
Chi-2 and Mann–Whitney tests.
Results Forty-two tramadol-poisoned patients (41  years [26; 55], 
median [25; 75 percentiles]; 30 females et 12 males; 90% with poly-
intoxications; presumed ingested dose: 2000  mg [1000; 4000]; 
plasma tramadol concentration on admission: 1.48 mg/L [1.17; 2.34]) 
were included in the study. The patients presented consciousness 
impairment (Glasgow coma score: 13 [6; 15]), opioid syndrome (48%), 
serotonin syndrome (36%) and seizures (24%). Life-threatening 
complications occurred including pre-hospital cardiac arrest 
(10%), cardiovascular failure (31%), aspiration pneumonia (34%), 
disseminated intravascular coagulation (5%) and fatality (7%). There 
was a significant relationship between plasma tramadol concentration 
measured on admission and the risk of seizure onset (p  <  0.05). 
Patients presenting opioid syndrome on admission significantly had 
lower plasma tramadol concentrations on admission than patients 
presenting serotonin syndrome (p < 0.03).
Conclusion Tramadol poisoning may result in significant morbidities 
requiring invasive ICU management. Onset of seizures is not related 
to the serotonin syndrome. Measurement of the concentrations of 
tramadol and its metabolites on ICU admission seems helpful to 
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Introduction Purpura fulminans (PF) is one of the biggest pediatrics 
emergencies. It is a septic shock associated with an extensive purpura 
complicating most often meningococcal septicemia. With a non casual 
mortality despite of advances in pediatric intensive care. Our study’s 
aim is to study purpura fulminans mortality factors in our pediatric 
intensive care unit.
Materials and methods We led a prospective study of a series of 28 
cases of purpura fulminans collected in our pediatric intensive care 
unit, Abderrahim Harouchi child hospital of Casablanca, over a period 
of 2 years from January 2014 to December 2015.
Statistical analysis used the epi-info test with significance level P ˂ 0.05.
Results Our series analysis underlined a slight male predominance 
(53.6%) and incidence peak in patients of less than 4  years (67.8%). 
Most of the patients were from a low socioeconomic level (65%). And 
earlier evolution period to hospitalization relatively long between 4 h 
and 7 days was noted in our series.
The main symptoms were fever (100%), purpura (28.6%), digestive 
disorders (42.8%) and neurological signs mainly consciousness 
disorders (28.6%). The shock, infectious syndrome, purpura, 
neurological and respiratory disorders dominated the clinical 
background at admission.
Hyperleukocytosis to polynuclear neutrophils was found in 67.9% of 
the cases, C-reactive protein was positive in 100% and the hemostatic 
assessement underlined disseminated intravascular coagulation in 
78.9% of the cases. The causative organism was isolated only in 14 
cases: meningococcus B in 11 cases (78.6%), pneumococcus in one 
case, Haemophilus in one case and Acinetobacter in one case.
Therapeutic schema used was based on fluid replacement 
and antibiotic therapy for all patients, vasoactive drugs (50%), 
corticosteroids (100%), mechanical ventilation (46.4%) and 
symptomatic treatment.
The evolution was marked by death in 42.9% of the cases, two patients 
showed out complications of skin necrosis and distal ischemia 
requiring necrosectomies. Recovery without sequelae was achieved in 
50% of the survivors.
Conclusion Mortalities factors found in our series was the time 
between the first symptoms and hospitalization exceeding 48  h, 
presence of extensive purpura of a shock on admission, presence of 
seizures, the use of mechanical ventilation and the presence of dis-
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Introduction Guillain-Barré syndrome (GBS) is an inflammatory 
disorder of the peripheral nervous system is idiopathic acute 
polyneuropathy, which has now become the most common cause of 
acute flaccid paralysis in children.
Patients and methods This is a retrospective study which runs from 
2006 to 2015 performed in the pediatric reanimation
Results Guillain-Barré syndrome was diagnosed in 50 patients aged 
9–15 years, the predominant involvement in sex with male enrollment 
ratio of 1.7 men/women
After a prodromal event, usually infectious (96%) and a free interval of 
15 days on average, start motor disorders.
These are of two types:
Consider a hypo or aref lectique flaccid paralysis of the lower limbs 
(25%) of ascending evolution in 91.4% of cases.
Let flaccid tetraplegia or hypo areflectique (75%)
The respiratory reached was observed in 64% of cases also other 
serious signs such as swallowing disorders (70%) and autonomic 
disturbances (14%) were also observed which justified a decision sup-
port in intensive care for all our patients.
The use of ventilation was required in 68% of cases and specific treat-
ments based on immunoglobulins were administered in 88% of cases
The death rate is still high (22%) and the majority of complications 
related to hospital.
The study of these patients has identified some prognostic factors 
of the intensive care unit in disease as male gender, duration of 
administration of Ig, the occurrence of autonomic disorders such 
unstable blood pressure which remains the most discriminating the 
occurrence of nosocomial infection.
Conclusion Guillain-Barré syndrome therefore a pediatric emergency 
that requires rapid diagnosis and immediate changes in severity 
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Introduction Purpura fulminans (PF) is a major cause of mortality 
and morbidity in children. Despite therapeutic advances in the 
management of PF, mortality remains high up rates that exceed 
50%. In Tunisia, the profile of such serious disease has not yet been 
described. The aim of this study was to determine the predictors of 
mortality in patients admitted in pediatric intensive care unit (PICU) 
with purpura fulminans.
Patients and methods Retrospective review of case sheets was 
done. Sixty-nine children [median age 3 years (1.6 months to 11 years 
and boy to girl ratio 1.15) admitted between January 2000 and May 
2015 with PF in PICU of the pediatric hospital Bechir Hamza in Tunis, 
were included. The diagnosis of PF was made in patients with severe 
sepsis or septic shock with an extensive purpura. The PF is considered 
secondary to meningococcal infection if Neisseria meningitidis or 
soluble antigens are found at the blood culture or cerebrospinal 
fluid. In patients whose samples are negative, the PF is considered 
secondary to meningococcal infection if no other bacterial or viral 
origin is found to explain the purpura. For each patient enrolled, 
we have clarified the demographic data, the severity of clinical 
presentation by pediatric risk score of mortality (PRISM) and Glasgow 
meningococcal septicemia prognostic score (GMSPS) and therapeutic 
data.
Results A mortality rate of 52% was observed for a predicted death 
by the PRISM score at 24.6%. Seventy-seven percent of the deaths 
occurred during the first 24 h. Twenty-five (69.4%) children died of irre-
versible septic shock and 6 (16.6%) children died of refractory hypox-
emiae. Independent predictors of mortality were the initial severity 
assessed by the GMSPS (p = 0.001) and use of high doses of vasoac-
tive drugs evaluated by the vasoactive-inotropic score (p = 0.026).
Conclusion The mortality in our PICU is high, higher than predicted by 
PRISM. It occurred mainly within 24 h of admission. Early recognition 
and prompt initial antibiotic therapy continue to be the cornerstones 
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Introduction Nosocomial infections (NI) to multi-resistant bacteria 
(BMR) is a main public health problem worldwide. They are particularly 
frequent and severe in pediatric intensive care.
Objective To evaluate the incidence, bacteriological profile, 
epidemiological characteristics and resistance associated to BMR 
antibiotics acquired in pediatric intensive care unit.
Materials and methods Retrospective study including inpatients and 
spending more than 48 h in medical-surgical pediatric intensive care 
unit, at Ibn Rochd University Hospital of Casablanca, over a period of 
12 months from 1 January 2015 to 31 December 2015. The BMR taken 
from different samples (PBDP, central catheter, hemoculture, LCR, urine 
culture and sampling devices).
Results During the study period, we collected 30 episodes of IN to 
BMR, the incidence rate was 7.1% and the incidence density was 20.6% 
per 1000 hospitalization days. Two infectious sites were preponder-
ant: pneumonia (53.3%), and central catheter infections (40%). Gram-
negative bacilli (BGN) resistant to C3G were most common (about 
120 samples: 87%). Acinetobacter baumannii was the main species 
(60 samples: 43.5%). These BGN resistant to C3G had presented resist-
ance exceeding 50% for imipenem, amikacin, gentamicin, tobramy-
cin, and cotrimoxazole. Resistance to ciprofloxacin was 16.6%. They 
had isolated 30 strains of Pseudomonas aeruginosa and 24 klebsiella 
pneumoniae strains resistant to C3G. Six strains of Staphylococcus 
coagulase negative (SCN) were isolated 2 of which resistant to vanco-
mycin. No strain was resistant to glycopeptides.
Conclusion BMR Nosocomial infections are frequent and serious in 
pediatric intensive care unit. Thus, continuous monitoring of resistance 
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Introduction S. marcescens, a gram negative bacillus, classified as an 
Enterobacteriaceae, was originally considered to be a non-pathogenic 
saprophytic water organism. Since several years, it is a well-recognised 
nosocomial pathogen involved in outbreaks in neonatal intensive care 
units [1].
Patients and methods This study describes two consecutive out-
breaks of S. marcescens clones in a mixed neonatal and paediatric 
intensive care unit and discusses its investigation and control.
Results Between October 2015 and February 2016, seven preterm 
new-borns (gestational age: 25–34  weeks) were identified with S. 
marcescens in our 15 beds unit, spread over 12 rooms. Four children 
presented severe infections (four pneumonias, one sepsis and 
one conjunctivitis). S. marcescens was isolated in the stools for 
three others. From May to June 2016, three new cases (gestational 
age: 26–34  weeks) were detected (two pneumonias and one lung 
colonisation). All infected new-borns have favourable clinical outcome.
A single S. marcescens strain was identified during each outbreak. The 
two strains were genetically unrelated and have a natural phenotype 
of resistance.
In order to contain the outbreak, active surveillance was established 
to detect infected and/or colonised patients. Strict cohort nursing 
of those patients was implemented and admissions in the unit were 
limited.
Health care workers of the unit were requested to reinforce infection 
control measures. Audit programs performed by the infection 
prevention team showed the necessity to reinforce meticulous hand 
hygiene using hydro alcoholic solution and adequate gloves wearing.
Sixty environmental samples (water, room surfaces, medical devices…) 
failed to identify S. marcescens reservoirs.
Actually, the current strategy of empiric antibiotic treatment is being 
reevaluated by a multidisciplinary group composed of a medical 
microbiologist, an infectious disease specialist and a paediatric 
intensive care clinician. Furthermore, a case–control study is being 
performed to assess the risk factors for acquiring S. marcescens in a 
mixed neonatal and paediatric intensive care unit.
The cause analysis also highlighted that:
  • due to the mixed character of our ward, patients frequently 
changed rooms during their hospitalisation in order to increase 
the admission capacity. However, this policy may increase 
infectious risks.
 • the first outbreak was detected late when three infants with S. 
marcescens were identified. During the second event, infection 
control measures were applied after detection of two cases. This 
early intervention probably limited the spread. No new case was 
detected since June 2016.
Conclusion S. marcescens can cause rapidly-spreading outbreaks 
of severe infections in neonatal units, but with appropriate control 




1. Voelz A. Outbreaks of Serratia marcescens in neonatal and pediatric inten‑
sive care units: clinical aspects, risk factors and management. Int J Hyg 
Environ Health. 2010;213:79–87.
P72 
Adjustment of antimicrobial treatment in a paediatric intensive 
care unit
Margot Diss1, Aurélie Portefaix2, Julien Berthiller3, Etienne Javouhey4, Yves 
Gillet2 
1PEDIATRIE, Hôpital Femme Mère Enfant, Bron, France; 2Réanimation 
Pédiatrique, Groupement Hospitalier Est‑Hôpital Femme Mère Enfant, 
Bron, France; 3Pôle information médicale evaluation recherche, equipe 
d’accueil 4129, hospices civils de Lyon, lyon, France; 4Réanimation pédiat‑
rique hfme, Hospices civils de Lyon, Lyon, France
Correspondence: Margot Diss ‑ margot.diss@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P72
Introduction In order to limit the emergence of antimicrobial 
resistance, it is recommended to re-evaluate every prescription 
of antimicrobial treatment within 72  h and to proceed to a 
de-escalation whenever it is possible [1]. However, evaluations of such 
recommendations are scarce, especially in paediatrics. Our goal was to 
evaluate the proportion of modification of the antimicrobial treatment 
within the first 72  h in our PICU and to determinate whether it was 
relevant or not.
Materials and methods We conducted a retrospective study during 
6  months in the paediatric intensive care unit at the Hôpital Femme 
Mere Enfant in Lyon, France. Every patient with curative antimicrobial 
treatment initiated in the unit or within 48  h before admission was 
included. Evaluation and adjustment—if any- of antimicrobial treat-
ment before 72  h, according to bacteriological results and clinical 
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evolution, were recorded. A paediatric infectious disease specialist 
reviewed the charts to determine for each patient if the modification 
or the remaining of initial treatment were relevant or not. An alterna-
tive choice was suggested in case of irrelevance.
Results We included 168 antimicrobial treatments. 87.4% were 
adjusted within 72  h after initiation. 77.3% of adjustments were 
considered as relevant. Among those that had not been adjusted, 
de-escalation would have been possible in 92.9% of cases. Among 
all those which should have needed an adjustment, 26.1% had an 
insufficient or non-realised de-escalation. Factors associated with 
absence of or irrelevant adaptation were nosocomial infection and 
absence of consultation of a paediatric infectious disease specialist 
about antibiotic modification.
Conclusion Antimicrobial treatment adjustments are globally well 
executed in our paediatric intensive care unit, but could be improved 
by obtaining expertise from an infectious diseases specialist more 
frequently. Hence antibiotic de-escalation should be improved. The 
results of this study constitute an adequate basis for a future antimicro-
bial stewardship that could be conducted in our unit while focusing on 
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Introduction Development of an infection in a critically ill patient is a 
gravity element associated with increased mortality. Elements related 
to the patient and his environment used to target the empiric antibiotic 
therapy to bacterial flora community or nosocomial kind. The choice of 
therapy is guided by direct examination of bacteriological samples.
Our objective is to identify the use of antibiotics variations in pediatric 
intensive care unit in the pediatric hospital of Canastel, in Oran, Algeria.
Patients and methods This is a retrospective study during the period 
1 January 2016 to 30 June 2016, including all patients hospitalized in 
pediatric critical care (10 beds) of Canastel, in Oran Algeria. We studied 
the age, gender, reason for hospitalization, various antibiotics used, 
length of stay and mode of discharge of patients.
Results Two hundred and sixteen patients were hospitalized during 
the first 6  months of 2016. The average age is 3  years (1  month to 
15 years), sex ration is 1.2. The most common reason for admission was 
respiratory distress 27.2%, cardiopulmonary arrest in 10.7% and status 
epilepticus in 10.1%. The most commonly used antibiotic is cefotaxime 
75% of cases, followed by Vancomycin 28.5%, Mitronidazole 
22.5%, Gentamycine 17.5%, Ceftazidime 8.8%, Imipinem 7.4%. 
About 216 patients, 27% received at least 3 antibiotics during their 
hospitalization, 29.5% received only one antibiotic and 16.5% none. 
The average hospital stay was 6 days (±12 days).
Conclusion Our study shows a heterogeneous use of antibiotics, from 
where interest of a prescription adapted to prevent the emergence 
of resistant bacteria. This problem could be better controlled by opti-
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Introduction Continuous assessment of nociception intensity dur-
ing anesthesia is crucial. Analgesia nociception index (ANI: 0–100) has 
been proposed to clinicians to objectively measure pain in both con-
scious and anesthetized patient. ANI calculation results from sophis-
ticated computing of sympathetic to parasympathetic tones balance 
using heart and respiration rate variability. Because we aimed to eval-
uate nociception during oro-tracheal intubation performed under 
apnea conditions, we conducted a study to test the reliability of ANI 
at monitoring nociception when respiratory rate was zero.
Materials and methods ASA physical status I healthy informed 
and consenting adult volunteers participated in this experimental 
prospective trial. Demographic parameters were recorded and non-
invasive hemodynamics (HD), blood pressure (BP), heart rate (HR), 
pulsed oxygen saturation (SpO2) and ANI monitoring tools were 
installed. After a 5 min resting and stabilization the volunteers lying 
on their back were asked to perform a 30  s duration apnea starting 
on command at Residual Functional Capacity (RCF). After a wash-out 
period following this first apnea period (P1) and return to baseline 
parameters, the volunteers were asked again to perform a second 
30 s duration apnea (P2) starting on command at RCF. Initiation of P2 
coincided with 30 s ulnar nerve stimulation at the wrist (single twitch, 
1  Hz, 25  mA). The different component of ANI (energy, mean, and 
instantaneous values: iANI), HR, BP and SpO2 values were recorded 
at predefined time points: T0 (baseline values, just before apnea), T1 
(end of apnea), T2 (T1 + 30 s), for P1, and the same predefined time 
points (T0′, T1′, T2′) for P2. After the experiment, volunteers were 
asked to rate the pain intensity at the wrist during P2, using a Visual 
Analogue Scale (VAS: 0–100). Evolutions of measured parameters 
were compared between P1 and P2. Values are mean ± SD.
Results 21 healthy volunteers aged 34 ± 10 were included. During 
P1 and P2, both iANI and energy were monitored. Mean VAS during 
P2 was 27/100. Figure 23 illustrates HD and iANI variations at T1/T1′ 
and T2/T2′. During P1, there is a remarkable stability of iANI at T1 
(+1%) and no significant decrease at T2 (−3%). On the opposite, a 
progressive decrease of iANI was evidenced during P2 (−5% at T1′), 
reaching a nadir 30 s after the end of nociceptive stimulation (−17% 
at T2′). HD and Sp02 remained stable and comparable in P1 and P2.
Conclusion Based upon our results, ANI seems discriminant and effi-
cient at measuring nociception in the conditions of a short apnea of 
30 s. ANI is thus probably a reliable tool to measure nociception during 
tracheal intubation. Our trial shows that HD is less sensitive than ANI 




1. Feng Y. Eur J Anaesthesiol. 2015;32(1):58–9.
P75 
Early mobilization in a medical ICU: a first Tunisian experience
Nesrine Sma1, Ahmed Khedher1, Khaoula Meddeb1, Jihene Ayachi1, Nes‑
rine Fraj1, Hend Ben Lakhal1, Messaouda Khelfa1, Hedia Hammed1, Hajer 
Hafsa1, Raja Boukadida1, Imed Chouchene1, Mohamed Boussarsar2 
1Réanimation médicale, CHU Farhat Hached, Sousse, Tunisia; 2Réanima‑
tion médicale, CHU Farhat Hached, Research Laboratory N° LR14ES05, 
Faculty of Medicine, Sousse, Tunisia
Correspondence: Mohamed Boussarsar ‑ hamadi.boussarsar@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P75
Introduction Critically ill patients are known to be complicated and 
their mobilization on the earliest days of ICU stay has shown to be 
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feasible, well tolerated and beneficial. We aimed to assess the feasibil-
ity and tolerance of early mobilization as part of routine care in a Tuni-
sian medical ICU.
Patients and methods A prospective period study conducted in a 
7-bed-medical ICU with nurse/patient ratio at 1/3 over 12  months. 
Were studied, incidence density of four predefined activity events (sit 
on bed, sit in chair, stand-up and ambulate), onset delay, limitation fac-
tors and tolerance. Six activity-related adverse events were defined as 
fall to knees, catheters or tubes removal, systolic pressure drops more 
than 30  mmHg, pulse increase by 20  beats/mn or bradycardia, SpO2 
drop <80% and extubation.
Results During the study period, we conducted a total of 1265 activ-
ity events in 127 patients. The mean length of stay was 11.8 ± 12.3 days 
and the global incidence density was 842 activities/1000 patient days. 
The mean age was 56.4 years ± 19.9. 44(34) patients had a BMI > 30 kg/
m2. Mean SAPS II score was 29.9 ± 12.9 years. At ICU admission 54(42.5) 
patients were on invasive mechanical ventilation, 38(29.9) patients 
were on NIV and 27(21.3) patients had vasopressors. Onset delay to 
the first activity was 5.8 ± 3.8 days for patients on mechanical ventila-
tion. 21(16.5) patients had vasopressors when they did their first activ-
ity and the onset delay for those patients was 5.6 ± 3.5 days. The first 
activities consisted only in “sit on bed”, 80.3% and “sit in chair”, 19.7%. 
Neither standing nor ambulation was done as a first activity. The activ-
ity events included 306(24.2) sit on bed, 629(49.8) sit in chair, 182(14.3) 
standing position and 148(11.7%) ambulation. Incidence density of 
activities was 604 activities/1000 patient days for patients with invasive 
mechanical ventilation, 1233 for those with NIV and 1004 for patients 
without mechanical ventilation. In patients on ambulation 6 had 
endotracheal tube, 19 had tracheostomy and 27 had NIV. Twenty-eight 
incidents occurred (2.1%). They consist in hypotension (32.1%), tachy-
cardia (46.4%), one fall to knees, 3 feed tube removals, one urinary tube 
removal and only one central catheter removal was registered without 
harmful consequences. No accidental extubation occurred. No barrier 
to critically ill patient was found.
Discussion Our study proves that early mobilization is feasible and 
safe for all patients including those with mechanical ventilation. Our 
results are in line with literature [1]. Sricharoenchai in an observational 
study conducted in Baltimore ICU over 30-month period including 
5267 activities showed a low incidence of early mobilization adverse 
effects (0.6%) [2].
Conclusion This study shows the feasibility and safety of an 
uncommon practice in a relatively poor resources and low patient-
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Introduction Traditionally, in French Hospitals, the team composition 
is different according of the moment: the daily team for day from 
Monday to Friday, the watch team for night, week end, and public 
holiday. It appears to be important for us to evaluate the workload in 
the different configurations. We need to know the way our ICU team 
is needed outside the ICU in order to improve the quality of the team, 
in order to anticipate the workload during different moments and in 
order to avoid reducing the team size.
Materials and methods It is a prospective monocentric study inside a 
hospital of 450 beds with an ICU of 12 beds.
The ICU team is the rescue team for every patient inside the hospital. It 
is also the referent for antibiotherapy, emergency advice, withholding 
treatment consultant.
From January 1st 2005 to December 31th 2015, every intervention of 
the ICU team outside the ICU is recorded with day, hour, time spent, 
ground of appeal, outcome of the patient.
So we define 2 situations for the ICU team:
Team configuration A: the team is composed of more than one 
senior and more than one junior (from Monday to Friday, 9.00 am to 
18.29 pm)
Team configuration B: the team is composed only of one senior and 
one junior. (From 18.30 pm to 8.59 am, all Saturdays, all Sundays and 
all public holidays)
Considering that the average time in these 11  years of each 
configuration are Team configuration A: 27%, Team configuration B: 
73%.
We compare the percentage of all interventions using the time passed 
in the interventions and the numbers of interventions.
Results The ground of appeal of interventions was a rescue request in 
8.7%. Interventions consisted of decision of withholding treatment for 
in 16.3%. These interventions ended with a transfer to ICU in 30.6% as 
direct outcome.
Inside these transfers, 64.5% were for the Hospital ICU, 35.5% for 
ICU of other hospital including for Neuro surgical center, immediate 
Interventional radiography and Neuro vascular ICU.
See Table 17.
Conclusion Clinical activity outside the ICU is not reduced when the 
ICU team is the smallest, it respects the time ratio of 27/73. More time 
is needed outside the ICU. The smallest team has to deal with a huge 
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Introduction Besides the “real” urgent medical cases, emergency 
department hire people who took by themselves the decision to 
come, as well as those addressed by other doctors. The purpose of 
this study was to determine the profile of patients who arrived at the 
emergency for a general medical consultation.
Patients and methods This study carried out in an emergency depart-
ment of a university hospital included all patients over 15  years, 
Fig. 23 iANI and HD variations (%) according to the stimulation
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having consulted with medical emergencies over a week. The data 
collected were epidemiological and socio-economic, the reason for 
the consultation and the future of consultants. The consultations were 
deemed appropriate or not by the doctor on duty depending on the 
nature of the disease, day and time of the consultation and the age of 
the symptoms.
Results We collected 469 consultants. The average age was 43.45 years 
(16–104 years) for a sex ratio of 0.87. The main reasons were an oro-
pharyngeal infection or bronchopulmonary (17.3%), asthenia (13.4%), 
chest pain (11.9%). More than 50% of the consultations were deemed 
inappropriate. These patients were younger than 35 years in 48.4% of 
cases, and jobless in 58.6% of cases. There was no significant differ-
ence in the number of inappropriate consultations between the two 
genders. The days and times of arrival did not differ between appro-
priate consultation and not appropriate. After review, 6% of patients 
were admitted to unit short hospitalization, 49.9% referred to a spe-
cialist consultation, other consultants put outgoing, equipped (39.7%) 
or not (4.5%) of a therapeutic prescription.CV
Discussion The use of emergency would be linked to the absence 
of prior appointment, and continuity of care. The consultants 
have the option of availability, some for conditions not covered by 
the emergency. The high proportion of younger people without 
profession is explained by the free care. The elderly rarely autonomous 
and complex diseases carriers, are fewer in the “inadequate 
consultation” group.
Conclusion Develop a care system and quality of care in basic 
health facilities, educate and convince patients to get there, would 
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Introduction Hospital funding for ICU stays in France is made of reim-
bursement of a fixed amount according the diagnosis-related group 
(DRG) of the patients and of extra funding for each day spent in ICU if 
the patient fulfilled criteria of severity (SAPS2 > 15) and of treatment 
intensity (use of organ support). The tariffs of reimbursement for the 
different DRGs and for the extra funding are updated every year. We 
measured the impact of these updates on the income of our ICU.
Patients and methods DRG and length of stay of all the patients 
hospitalized during 2011 in our 12-bed ICU were extracted from the 
administrative database of our institution. We computed the reim-
bursement for the care of these patients with the tariffs of 2011, 2012, 
2013, 2014, 2015 and 2016 (data from the Agence Technique pour 
l’Information Hospitalière). Inflation was taken into account according 
to the recommendations of the Institut national de la statistique et des 
études économiques.
Results 592 ICU stays (3224  days) have been analyzed. The patients 
were classified in 237 DRG. The income of the ICU decreased from 
8,416,260, 14€ in 2011 to 7,816,786, 72€ (−7%).
Income decreased every year, with the most important lessenings 
during the first years (2012: −2.37%; 2013: −2.47%; 2014: −0.81%; 
2015: −0.82%; 2016: −0.84%)
This reduction was explained by both a lowering of the tariffs of the 
different DRG (mean evolution −4.6%) and a diminution of the extra 
funding (814,32 € per day in 2011, 801,19 € in 2016, −1.6%).
Discussion These results are based on a small number of ICU stays but 
are probably representative of the global trends of ICU reimbursement 
because of the high number of DRG analyzed.
Conclusion This simulation gives an estimate of the economical 
pressure sustained by the French ICUs during the last 6 years. 
Productivity gains are necessary to cope the tariff evolution and 
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Introduction Hemorrhagic complications during placenta previa are 
unpredictable and may indicate an extremely urgent C section. Our 
study goal is to determine the risk factors and prognosis of this urgent 
situation.
Patients and methods This is a case–control study, prospective and 
analytic over the second semester of 2015. We included all patients 
who underwent emergency C section for placenta previa bleeding. 
The witness cases are represented by C section performed in 
emergency for another reason, at random.
Results We identified 42 cases for 126 witnesses. The over 30  years 
patients accounted for 45.23% in the case group against 22.2% in the 
control group (p =  0.03). The average rate for cases was 3–2 against 
the controls (p =  0.001). For instance, the admission was referred in 
76.19% in the case group against 80.95% for controls. At least an 
ultrasound was performed during pregnancy in 23.8% of case group 
against 32.5% for control. Maternal complications in the case group 
are represented by a maternal anemia in 85.71% against 15.07% for 
controls (p = 0.002), fetal complications due to hypotrophy represent 
19.04% in the case group against 11.1% for controls (p = 0.04).the per-
inatal mortality was 26.19% in the case group against 9.5% for controls 
(p = 0.03).
Conclusion The placenta previa is still a serious disease of pregnancy. 
Early ultrasound diagnosis would enable appropriate monitoring and 
prevention of all obstetric complications of this disease.
Competing interests
None.
Table 17 Time data
Time data Team Config A Team Config B
Number of interventions 2342 4287
Percentage of interventions 35.3 64.7
Total duration of all interventions (h) 1088 2575
Percentage of duration of all 
interventions
29.7 70.3
Average time of intervention (min) 28 36
Maximal duration (min) 285 390
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Introduction Unusual venous thrombosis are those whose site is 
other than the lower limbs. They are quite rare. Clinical expressions 
depend on their locations (digestive, brain or upper limbs).
Their diagnosis and treatment are much less codified than the lower 
limbs locations. Their causes should be carefully sought for better 
management.
Materials and methods Retrospective and descriptive study of 
patient records who experienced deep vein thrombosis and were 
followed in the service during the period between 1985 and 2015. 
Our work aims to classify these atypical localizations in our patients, 
and to study the epidemiology, etiology, treatment, and finally their 
evolution
Results We collected 120 cases of deep vein thrombosis, of which 
25 cases are unusual location, it is 6 inferior vena cava thrombosis, 
1 superior vena cava thrombosis, 8 thrombosis of renal vein, one 
thrombosis of hepatic vein, 4 cerebral localizations.
4 locations at the Superior Members, 1 thrombosis of the internal 
jugular vein and 2 of the subclavian vein and 2 of the axillary veins.
One thrombosis of the central vein of the retina and one of thrombosis 
renal graft vein. There were 17 women and 8 men whose average age 
was 43.4 years.
The diagnostic tool was Doppler ultrasound in 60% of cases, CT or 
magnetic resonance imaging in 40% of cases.
The etiologic survey found that 7 patients had glomerular 
nephropathy with an intense nephrotic syndrome, 1 patient had lupus, 
4 patients with Behçet’s disease, 4 patients had neoplasia, 1 patient 
had protein C and S deficiency, 1 patient had hyperhomocysteinemia 
and no etiology was found in 1 case.
All patients were put on anticoagulants associated with etiological 
treatment. The outcome was favorable in 13 patients, 2 patients 
had pulmonary embolism, 2 patients died, in 3 patients thrombosis 
recurred and 5 patients were lost to view.
Conclusion In the contrary to the literature, the neoplasti origin of 
unusual thrombosis does not prevail in our series where the causes 
are dominated vasculitis and renal disease which is explained by the 
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Introduction The management of pain is an emergency medicine’s 
priority. It is a criterion of quality care. We conducted a survey that 
assesses the degree of patient satisfaction overlooked the pain 
therapy.
Patients and methods Prospective observational study performed 
in the emergency department, which included all patients aged over 
10  years consulting for acute pain requiring the use of an analgesic 
treatment. The intensity of pain was measured by visual analogue 
scale (VAS). Patients unable to assess pain by VAS or having a vital dis-
tress are excluded from this study
Results Over a period of 3 months, we included 183 patients. The aver-
age age was 41 ± 16 years. The sex ratio was 1.7. The mechanism of 
pain was traumatic in 25 patients (13.7%). VAS means at the entry was 
5.8 ± 1.6. At the exit, it was 6.4 ± 2.3. We used the painkillers levels 1 in 
145 patients (79.2%), levels 2 in 27 patients (14.8%) and levels 3 in 11 
patients (6%). Only 6% of patients are not satisfied, 38.8% are dissatis-
fied, while 44.8% are satisfied or very satisfied (10.4%).
Conclusion This study shows that nearly 50% of patients are few or 
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Introduction Transcranial Doppler (TCD) is currently used at the 
bedside of critically ill children and can detect cerebral blood flow 
modifications. Use and impact of TCD in non-traumatic critically ill 
children is unknown. We aimed to describe and to assess the TCD and 
related impact in this population.
Patients and methods This French prospective and multicentric 
study included all children (0–18 years) who had TCD in four pediatric 
intensive care units during 1 year. A questionnaire was completed for 
each performed TCD by the intensivist. TCD interpretation and impact 
were accorded to the intensivist. Factors associated with impact, and 
especially diagnostic and therapeutic impacts were identified.
Results 152 patients were included with a median age of 7.6 months 
(0–206 months). TCD was performed in 6.7% of all admitted patients 
during the inclusion period. 61% of patients were aged between 
28 days and 2 years. 67% of patients were admitted for a neurological 
motive. Diagnosis were: neurological (70%), hemodynamic (10%) 
respiratory (10%), hepatic (7%) and renal (1%), others (2%). TCD 
was performed for monitoring of neurological disorders in 56% of 
cases. Intracranial hypertension was the most frequently suspected 
abnormality, and most often searched by young operators (p < 0.001). 
Hyperperfusion was most often suspected by experienced intensivists 
(p < 0.05). Discrepancy between the interpretation of DTC values and 
published reference values was found in 116 patients (76%). TCD had 
an impact for 116 patients (76%), with a strong impact (diagnosis’ 
confirmation or exclusion, therapeutic impact) for 98 patients (64%). 
Confirmation of diagnosis was statistically associated with patients 
severity: mortality, catecholamines, intubation, PELOD score (p < 0.05). 
Hemodynamic dysfunction (OR 6.4; p =  0.007) and less experienced 
operators (OR 3.9; p  =  0.012) were independent factors affecting 
therapeutic impact in multivariate analysis.
Discussion This original study is at our best of knowledge the first 
to describe use of TCD in heterogeneous diseases in critically ill chil-
dren without traumatic brain injury. TCD was performed not only in 
patients with neurological disorders, highlighting the wide field of 
applications of this exam. This study showed the difficulty of TCD inter-
pretation, whose reference values are not well-known by operators. 
Moreover, TCD values could be biased by several systemic parameters, 
usually not controlled in these unstable patients. TCD’s impact was 
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highly retained, and depending on severity of patients and on inten-
sivist’s experience.
Conclusion TCD is performed in heterogeneous diseases in non-
traumatic critically ill children. TCD has an important impact, 
dependent on the operator’s experience and on patient’s severity. 
Regarding the difficulty of accurate interpretation of TCD’s values, 
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Introduction The sublingual microcirculation is impaired in states of 
severe sepsis and septic shocks. The microcirculatory dysfunctions 
are prognostic markers of survival and organ failures in critically ill 
adult patients. In children, the sublingual microcirculation is also 
impaired in septic shock [1] and severe respiratory failures [2]. We 
hypothesized that the microcirculation impairments related to the 
severity of respiratory and circulatory failures could be reversible 
under extracorporeal membrane oxygenation (ECMO). The aims of the 
study are (1) assess the feasibility of the sublingual microcirculation 
monitoring in pediatric ECMO, (2) compare the microcirculation 
parameters under ECMO between J1 and J3.
Patients and methods Prospective observational study in the 
pediatric intensive care unit at Trousseau hospital, Paris. The videos 
have been acquired with Microscan® device (Microvision, Amsterdam) 
in sublingual areas. The data analyses have been performed by the 
AVA3 software. The statistical analyses have been performed by PRISM 
5 software.
Results We have included 10 children on ECMO. The age and weight 
were respectively 5 ± 14.8 months [0;47] and 4.7 ± 4 kg [2.5;16]. The 
sexe ratio (M/F) was 3/7. The ECMO indications were refractory acute 
respiratory distress syndromes (4), septic shocks (3), cardiac arrest (1), 
diaphragmatic hernias (3), refractory pulmonary hypertension (1). 
During the pre-ECMO period 9 children have been treated with Nitric 
Oxide for pulmonary arterial hypertension and 9 children needed cat-
echolamine support. During ECMO 8 children have been treated with 
noradrenaline, 3 with adrenaline, 6 with dobutamine. The mean cat-
echolamines duration was 6.5 ± 8.2 days [0; 25]. Five children received 
a arterio-venous ECMO, 2 veno-venous ECMO, and 3 multimodal 
ECMO (A-V and V-V). The mean ECMO duration was 9.4 ± 3.3 days [2; 
13] and hospitalization duration was 29.6 ±  20  days [9;64]. Concern-
ing the microcirculation parameters the microvascular flow index 
(MFI) was significantly improved in the small microvessels (2.1 ± 0.36 
[1.3; 2.5] at day 1 and 2.5 ± 0.27 [2.2; 3] at day 3; p = 0.0173) and in 
the medium microvessels (2.6 ± 0.24 [2.2; 2.9] at day 1 and 2.8 ± 0.2 
[2.5; 3] at day 3; p = 0.045). Regarding the biological markers the pH 
increased between day 1 and day 3 (7.3 ± 0.12 [7.1, 7.5] vs 7.4 ± 0.11 
[7.3, 7, 6]; p = 0.0064). See Fig. 24.
Discussion In this preliminary study the children had severe hemo-
dynamic failures or severe respiratory failures with pulmonary hyper-
tension which needed of catecholamines and ECMO support. The 
alteration of the sublingual microcirculation was confirmed at day 1 
under ECMO. The microvascular perfusion parameters were reduced 
compared to the normal value of healthy subjects (MFI = 3). The par-
tial MFI restoration confirmed the microcirculation recruitment in 
these patients. Now, further studies are needed to confirm this micro-
circulation’s recruitment in a larger pediatric ECMO cohort and to 
investigate the impact of this recruitment on the prognosis.
Conclusion The microcirculation was impaired in the initial phase of 
ECMO in children with severe respiratory or circulatory failures and it 




1. Top AP, Ince C, de Meij N, van Dijk M, Tibboel D. Persistent low 
microcirculatory vessel density in nonsurvivors of sepsis in pediatric 
intensive care. Crit Care Med. 2011;39(1):8–13.
2. Top AP, Ince C, Schouwenberg PH, Tibboel D. Inhaled nitric oxide 
improves systemic microcirculation in infants with hypoxemic respiratory 
failure. Pediatr Crit Care Med. 2011;12(6):e271–4.
P85 
Impedance cardiography by PhysioFlow® for non‑invasive 
cardiac output monitoring: a comparison with trans‑thoracic 
echocardiography in pediatric intensive care patients
Yasemin Karaca‑Altintas1, Astrid Botte1, Julien Labreuche2, Elodie 
Drumez2, David Brossier1, Patrick Devos2, Franck Bour3, Francis Leclerc1, 
Stéphane Leteurtre1 
1Pediatric intensive care unit, CHU Lille, F‑59000 Lille, France; 2Depart‑
ment of biostatistics, CHU Lille, F‑59000 Lille, France; 3Physioflow, 
Manatec Biomedical, F‑78300 Poissy, France
Correspondence: Yasemin Karaca‑Altintas ‑ millistate@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P85
Introduction Impedance cardiography (IC) is a promising non-inva-
sive, continuous cardiac output (CO) monitoring method. PhysioFlow® 
(PF®) is a new IC technique never studied in pediatric intensive care 
unit (PICU). The aim of the study was to compare CO and cardiac 
index (CI) measurements in PICU patients by IC using PF® with those 
obtained by the method of reference, trans-thoracic Doppler echocar-
diography (TTE), with regard to accuracy, precision of agreement and 
reproducibility.
Patients and methods In this single-center prospective method com-
parison study, all PICU patients aged between 28 days and 10-year-old 
and requiring TTE were included, except those with complex congeni-
tal heart disease or poor IC signal and/or TTE quality. Simultaneous 
sets of three measurements were realized by TTE and PF®. CO and CI 
measured by TTE (COTTE and CITTE) were compared with CO and CI 
obtained by PF® (COIC and CIIC). Concordance correlation coefficient 
(CCC) and Bland–Altman analysis were used to analyze the concord-
ance rate and compare accuracy and percentage error (PE) between 
the two methods. As required, data were logarithmically transformed 
prior to Bland–Altman analysis. Reproducibility was evaluated with 
intraclass correlation coefficient (ICC) and using the calculation of the 
precision of the method [1]. Post-hoc signal analysis was performed to 
evaluate the quality of IC signal.
Results A total of 43 patients (median age: 13  months, interquartile 
range (IQR) 4–34 months) were included. Median PIM2 probability of 
death was 1.04 (IQR 0.34–5.11), 9.3% of patients had inotropic sup-
port and 30.2% had a mechanic ventilation. On 129 paired measure-
ments, mean COTTE was 1.74 ±  0.93 L/min whereas mean COIC was 
2.23 ± 1.21 L/min. Concordance for CO measurements was considered 
Fig. 24 Time course of the sublingual microcirculation and pH 
during ECMO. MFI The microvascular flow index evaluates the micro 
vascular perfusion. *p < 0.05; **p < 0.005
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as good, since CCC was r =  0.54 (95% CI 0.43–0.63). However, mean 
absolute bias for CO was 0.80 L/min (40%) with an unacceptable PE of 
158%. Concerning CI measurements, mean CITTE was 3.74 ±  1.00 L/
min/m2 whereas mean CIIC was 4.93 ±  1.95 L/min/m2. Concordance 
for CI measurements was low, since CCC was r = 0.12 (95% CI −0.08 
to +0.31). Mean absolute bias for CI was 0.77 L/min/m2 (18%) with an 
unacceptable PE of 62%. Nevertheless, reproducibility of PF® for CO 
and CI measurements was very good: ICC were r = 0.94 and r = 0.90 
for CO and CI, respectively. Precision of PF® for CO measurements 
was 6.9% (IQR 4.6–11.6%) and 7.3% for CI (IQR 4.2%-12.2%). Age, sex, 
weight heart rate, and hematocrit didn’t affect differences of CO and CI 
between the two methods. Post-hoc signal analysis revealed that only 
67.4% patients had an acceptable quality for IC signal, and PF®’s algo-
rithm didn’t recognize adequately the whole IC signal in 37.2% of our 
pediatric patients.
Conclusion In this first method comparison study testing CO 
monitoring by IC with PF® in PICU, PF® can’t accurately estimate CO 
and CI in comparison with TTE, mainly because of signal analysis and 
algorithm failure. Nevertheless, PF® has a very good reproducibility 
for CO and CI measurements. Trending ability of PF® should be tested, 
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Introduction Accurate and reliable evaluation of cardiac index (CI) 
in critically ill pediatric patients can optimize their management. The 
ultrasonic cardiac output monitoring (USCOM, USCOM Pty Ltd, Coffs 
Harbour, NSW, Australia) device provides a new method of non-
invasively assessing cardiac output (CO). It has been successfully used 
in adults, but there have been few studies in children. This device is 
less expensive than the echocardiography and simpler to handle. In 
this study, we compared non-invasive cardiac index (CI) measurements 
by USCOM-1A with transthoracic echocardiography (TTE).
Patients and methods Paired measurements of CI in pediatric 
critical ill patients without congenital heart disease were performed 
simultaneously using the USCOM-1A and echocardiography (Sonosite 
Turbo-M). Correlation and agreement between aortic outflow tract 
diameter (OTD), velocity time integral (VTI) and CO were assessed by 
Pearson correlation and Bland–Altman analysis.
Results Fifty-eight pediatric intensive care patients were enrolled 
(age 92  ±  277  days). The USCOM-1A and TTE measurements of CI, 
OTD, and VTI in all subjects were 4.18  ±  1.32 versus 2.9  ±  1.06 L/
min/m2, 0.7  ±  0.16 versus 0.65  ±  0.19  cm and 17.23  ±  5.03 versus 
12.61  ±  2.63  cm, respectively. The bias and limits of agreement of 
USCOM-1A compared to TTE CI were 1.29 (−0.77 to 3.32) L/min/m2. 
The percentage error in CI measurements with USCOM-1A was 49.35% 
relative to TTE measurements.
Conclusion These results suggest that the two devices can track, indi-
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Introduction We previously showed that the selective neuronal 
NO synthase inhibitor 7-nitroindazole (7-NI) increases cerebral 
microcirculation in a juvenile ischemic rat model [1]. We address the 
roles of COX-elaborated prostaglandins (Pgs) in collateral recruitment 
and blood supply.
Materials and methods Fourteen-day-old (P14) rats were subjected 
to ischemia–reperfusion, and treated with either PBS or 7-NI (25 mg/
kg) at the reperfusion onset. Six-keto-PGF1α was measured using 
ELISA. COX-1 and COX-2, and prostaglandins terminal synthesizing 
enzymes were evaluated using reverse-transcriptase polymerase chain 
reaction and immunofluorescence. Microvascular blood flow indexes 
(artery diameter, capillaries number) were measured using sidestream 
dark-field videomicroscopy in PBS- and 7-NI-treated ischemic rats 
in the absence or presence of the COX-2 inhibitor NS-398 (5 mg/kg). 
Cell death was measured with the TUNEL assay and cleaved-caspase-3 
immunostaining.
Results Six-keto-PGF1α and COX-2, associated with a PgE synthase, 
were significantly increased in PBS- and 7-NI-treated animals 15  min 
and 1  h after ischemia–reperfusion, respectively. In contrast and as 
compared to PBS, 7-NI significantly decreased prostacyclin synthase 
(PGIS) and cytosolic PgE synthase (cPGES) mRNA. Selective COX-2 inhi-
bition significantly decreased BF indexes, and significantly reversed 
the effects of 7-NI including the number of TUNEL+- and cleaved-cas-
pase-3+-nuclei. See Fig. 25 below.
Discussion We here report a role for prostaglandins (Pgs) in CBF regu-
lation after ischemia–reperfusion in the juvenile brain. We identify 
specific up- (COX-2 and mPGES1) and down- (COX-1 and PGIS) regula-
tion enzymes in the better outcome observed after nNOS inhibition. 
The early vascular responses of the immature and juvenile brain to 
ischemia are not enough investigated and well understood, however 
are likely to play a critical role in outcome because early cerebral per-
fusion inversely correlates with the extent of the lesion [2]. These data 
indicate (1) various Pgs biosynthesis (PgI2 in adult, PgI2, PgE2, PgF2 
and/or PgD2 in neonatal-juvenile) and up- and down-regulation of 
Fig. 25 COX‑2 inhibitor NS‑398 reverse the 7‑NI‑mediated blood 
supply. a Number of capillaries measured at 5 (M5) and 15 (M15) 
min after re‑flow in PBS‑, NS‑398‑, 7‑NI‑ and [7‑NI+NS‑398]‑treated 
rats (n = 6 per group). b Digital SDF photomicrographs (0.94 × 0.75 
mm) of the ipsilateral (IL) cortical circulation at 5 min after re‑flow. 
**p < 0.01, *** p < 0.001 vs PBS. # p < 0.05; ## p < 0.01; ### p < 0.001 
[7‑NI+NS‑398] vs [7‑NI+NS‑398] vs 7‑NI. £p < 0.05 [NS‑398+7‑NI] vs 
NS‑398
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specific terminal synthesis enzymes according to the developmental 
stage, and (2) an interaction between NO and prostaglandin synthesis 
via COX-2 in the juvenile P14 ischemic rat. Increasing evidences sug-
gest a “cross talk” between NO and Pgs biosynthetic pathways but still 
remains to be better elucidated, namely during brain development.
Conclusion These results show that the juvenile rat brains mostly 
responds to ischemia by a COX-2-dependent prostaglandins pro-
duction, and suggest that the transcriptional responses observed 
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Introduction Congenital diaphragmatic hernia is a rare anomaly 
that occurs in <1–5 of every 10,000 births. Pulmonary hypoplasia and 
pulmonary hypertension are commonly associated with congenital 
diaphragmatic hernia and explain its high morbidity and mortality. 
Despite significant advances in neonatal intensive care and protective 
ventilation, mortality remains as high as 50%. The development 
of extracorporeal membrane oxygenation (ECMO) support has 
improved the outcome but its use is controversial in this pathology. 
The main objective of this study is to determine associated factors 
with extracorporeal membrane oxygenation (ECMO) in congenital 
diaphragmatic hernia and to explore ECMO’s indications, causes of 
death, and evolution after discharge for survivors.
Patients and methods We led a retrospective study in all neonates 
born with congenital diaphragmatic hernia and admitted to our 
institution between 2003 and 2015. Antenatal data, including 
observed/expected foetal pulmonary volume by magnetic resonance 
imaging, data of the first day in paediatric intensive care unit before 
ECMO initiation, complications, causes of death, characteristics of 
ECMO group, surgical parameters and evolution of survivors after 1 
month of life were recorded in the national database for congenital 
diaphragmatic hernia and patients’ charts.
Results Among the 62 cases of congenital diaphragmatic hernia, 50 
infants were included with 14 (36%) requiring ECMO. Global survival 
rate at 1 month of life was 39/50 (78%). Lowest observed/expected 
lung foetal volume (p  =  0.016), lowest Apgar at 1  min (p  =  0.041), 
highest oxygenation index (p  <  0.001), highest SNAP-PE 2 score 
(p  <  0.001), left ventricle dysfunction (p =  0.046), highest lactatemia 
(p =  0.002), highest PaCO2 (p =  0.007) were significantly associated 
with ECMO support. Among 6 (17%) deaths in the non-ECMO group, 5 
(83%) were due to absolute contraindications to ECMO. Complications 
occurred more frequently in the infants requiring extracorporeal 
membrane oxygenation support.
Conclusion Associated factors for the need for ECMO in congenital 
diaphragmatic hernia have been identified. They should be useful to 
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Introduction Administration of fluid to increase cardiac output is a 
cornerstone of the hemodynamic resuscitation. The respiratory varia-
tion in aortic blood flow peak velocity (ΔVpeak) is the only variable to 
reliably predict fluid responsiveness in children. It requires assist con-
trol ventilation with high tidal volume (>10 ml/kg) [1]. The purpose of 
this study was to evaluate the clinical usefulness of assessing variation 
of stroke volume during a calibrated abdominal compression for the 
prediction of fluid responsiveness in children during acute circulatory 
failure.
Patients and methods This study was approved by local institutional 
review boards (CPP Lyon Sud Est II). Written informed consent was 
obtained from parents. Oral consent of patients old enough to 
understand the study was also obtained. Patient, less than 8 years old 
of two paediatric intensive care unit (PICU), during a 1-year period 
inclusion, from September 2015 to September 2016 were selected. 
Stroke volume index was assessed with an echocardiography at 
baseline, after an abdominal compression (with a calibrated pressure 
of 25 mm Hg), at a return to baseline, and after a volume expansion 
(10 ml/kg of fluid challenge over 10 min). Pulse pressure (PP) Systolic 
(SAP), diastolic (DAP), and mean arterial pressure (MAP); heart rate 
(HR), respiratory aortic blood flow velocity (ΔVpeak), left ventricular 
ejection fraction (LVEF), and respiratory vena cava diameter variation 
(VCIvar) were also recorded before volume expansion. Stroke volume 
index was calculated as the left ventricular outflow tract (LVOT) 
surface multiplied by the LVOT Velocity time integer (VTI). Patients 
were classified as responders to fluid loading if their stroke volume 
index (SVI) increased by at least 15%. R software with pROC package 
was used to performed descriptive and analytic statistic. Pearson 
correlations were performed and Receiver operative characteristic 
curves were built. Bootstrap technic was used to compute confidence 
interval (CI). p < 0.05 was considered significant.
Results Thirty-one children were included, 17(±22) month old and 
weighing 8(±5) kg. Seven were not on mechanical ventilation and 
15 were in a mode allowing spontaneous breathing. 16 patients were 
fluid responders and 15 non-responders. All the echocardiography 
were performed by MJL and NT. Operators were blind from the value 
of the VTI for each condition. Coefficient of variation of the SVI was 8.4 
(CI 5.4;11.4)% and the least significant change of five averaged SVI was 
10.6 (CI 6.8–14.5)%. Changes in SVI during abdominal compression and 
after a fluid challenge were correlated (R2 = 0.796; p < 0.001). Change 
in SVI and respiratory vena cava diameter variation or delta Peak before 
abdominal compression were not significantly correlated with change 
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in SVI during volume expansion. PP variation and MAP variation dur-
ing abdominal compression were not correlated with SVI variation after 
fluid challenge. The ROC curve analysis showed that SVI change during 
abdominal compression predicts fluid responsiveness. (AUC ROC = 0.93; 
CI 0.82–0.99). The best threshold was 9.28% with a sensitivity 75% (CI: 
0.50–0.94) and a specificity of 93% (CI 79–100). AUROC of VCIvar was 
0.70 (CI 0.48–0.91). AUC ROC of ΔVpeak was 0.58 (CI 0.34–0.81).
Discussion Fluid responsiveness assessment, in children especially, is 
challenging when spontaneous breathing is authorized. It represents 
the vast majority of children hospitalized in PICU for acute circula-
tory failure. Abdominal compression is an old technic used to modify 
preload. Historically assessed with arterial pressure, it has never been 
formally evaluated so far. Our method seems quite reliable to pre-
dict fluid responsiveness, it was shown to be superior to VCIvar and 
ΔVpeak in our settings.
Conclusion SVI variation during abdominal compression was the sole 
reliable method to predict fluid responsiveness in a mixed population 
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Introduction Data on fatal anaphylaxis in France are limited. The aim 
of this study was to define the anaphylaxis mortality rate (AMR) in 
France between 1979 and 2011, in general and pediatric populations, 
and to examine the repartition by age, sex, cause and geographical 
regions.
Patients and methods All deaths in France are recorded by a 
physician and death certificates are collected and analyzed by the 
CEPIDC Unit (National Institute of Health and Medical Research, 
INSERM). Each death certificate records primary and secondary 
causes of death, demographic data including sex, age, birthday 
and geographic region of death. Anaphylaxis related deaths were 
identified by using the International Classification of Diseases (ICD) 
codes on the death certificates.
Databases of the French National Institute for Economical and Statisti-
cal Studies (INSEE) are available freely (www.insee.fr). Data regarding 
the characteristics of the French population, by region, year, sex and 
age were collected.
AMR were expressed per million persons and per year. All regression 
analyses were adjusted for age-effect and a multivariable log-linear 
Poisson regression model was further performed by including all of 
the predictors.
Results There were 1603 anaphylaxis related deaths in metropolitan 
France between 1979 and 2011, with 39 deaths in pediatric population 
(age less than 20  years). AMR was lower in pediatric population 
(0.08 per million population per annum, 95% CI 0.05–0.1) than in 
general population (0.83 per million population per annum, 95% CI 
0.79–0.88) (p < 0.01). In general population, AMR was higher in male 
sex (1.08 per million population per annum, 95% CI 1–1, 16) than in 
female sex (0.86 per million population per annum, 95% CI 0.78–0.89) 
(p  <  0.01). Annual percentage change for case fatality rate was −2% 
(95% CI −2.5 to −1.5) indicating a decrease during the study period 
(p < 10–4). Latrogenic cause was the most common (63%), followed by 
«unspecified» (23%), venom (14%) and alimentation (0.6%). AMR was 
the highest in persons aged ≥70 years (3.50 [95% CI 3.25–3.76]) and 
the lowest in children. Venom-induced mortality rate was higher in the 
South region (0.16) compared to the North (0.11) (p = 0.003). Only 8 
food-induced fatalities were recorded (age  <  32  years in 7). With the 
multivariate analysis, older age and male sex were associated with an 
increased risk for anaphylaxis death of any cause (p < 10–4).
Conclusion Fatal anaphylaxis decreased in France between 1979 
and 2011. Higher rates of fatal anaphylaxis are observed in male sex, 
group aged 70  years and older and iatrogenic cause. In pediatric 
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Introduction The burn out is an emotional state of exhaustion and 
loss of performance in response to chronic work stress. This study aims 
to assess the prevalence and determine the Burn out of risk factors in 
medical and paramedical staff in the anesthesiology department.
Patients and methods This was a multicenter, transversal analytic 
study performed within the medical and paramedical staff of the oper-
ation rooms in the central anesthesiology department in IBN ROCHD 
hospital in CASABLANCA. Caregivers were asked to freely and anony-
mously complete a questionnaire involving demographic variables, 
professional and an assessment of the causes and consequences of 
stress at work.
Results On a population composed of 60 caregivers, 41.7% had a 
score of high emotional exhaustion, 11.98% a high score of deper-
sonalization and 47.38% a low score of professional achievement. Le 
burnout was found at 62.52% of our caregivers: 39.62% of them had 
low levels of burnout; 21.34% presented a moderate level and 1.58% 
had the highest level of burn out. In multivariate analysis, Doctors and 
Nurses Residents were most at risk of burn out. Fear of malpractice 
and the unsatisfactory salary multiplied the risk of burnout, respec-
tively 2.14 and 1.83.
Conclusion Burn out is a threatning reality of the anesthesiology 
environment. The consequences could be severe on the personal and 
professional performance of the health institution, which involves 
the implementation of preventive strategies highlighting the value of 
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Introduction Evaluation of family satisfaction has become an essen-
tial part of the responsibility of intensivists and a major criterion for 
assessing the quality of care. Family satisfaction could depend on 
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organizational and architectural characteristics of ICU. Starting from 
March 2016 our ICU was transferred to new buildings. The aim of the 
present study is to compare the level of family satisfaction before and 
after the change of the ICU buildings.
Materials and methods In a cross-sectional study we measured family 
members’ satisfaction in two periods (Period I: July–September 2009, old 
buildings; period II: August–September 2016, new buildings).We used 
the Critical Care Family Needs Inventory Questionnaire (CCFNI) which 
includes demographic characteristics of family members (age, sex, rela-
tionship, education level) and that of patients (age, sex, marital status, 
SAPS II, diagnosis, outcome). The 14 items of CCFNI are scored 1 point 
if the answer was “all the time” or “most of the time” (indicating satisfac-
tion) and a rating of 0 if the response was “only sometimes” or “never”).
Results During the first and second study periods we included respec-
tively 139 and 78 relatives of 44 and 17 patients, respectively hospital-
ized in our ICU for more than 48  h. The demographic characteristics 
of patients were similar in the two study periods: age: 59  years (IQR 
19), 62% female, SAPS II = 33 (IQR 33), 78% were married, 82% of them 
were suffering from a chronic disease. Respiratory failure was the 
most frequent reason for hospitalization (73%), ICU length of stay was 
14 days (IQR 19) and ICU mortality was 27%. After the transfer to new 
ICU, family members were more often satisfied with the information 
provided by the medical team (82 vs 46%; p < 0.001); only one-third 
of them (during both 2 periods) said they recognized the function of 
each member of the team (31 vs 29.4%, p = 0.4), 24.6 and 21.8% found 
inconsistencies in the information provided respectively in 2009 and 
2016 (p = 0.38). The satisfaction of respondents on the quality of the 
waiting room was substantially higher in the second period than in 
the first period (98 vs 27.3%; p < 0.001). The average CCFNI score after 
the transfer of the ICU was significantly higher in the second period: 
11.19 ± 2.24 vs 9.41 ± 1.64, p < 0.001(Fig 26).
Conclusion The transfer to a new ICU building without implementing 
any new policy is associated with a higher a higher satisfaction of 
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Introduction The improvement of patient safety and quality of health 
care is the main goal of the Joint Commission International standards. 
One of these sections covers medication management and use. The 
standard recommends the requirement for a trained professional to 
review medication orders or prescriptions for appropriateness. In prac-
tice, this review process is usually performed by a clinical pharmacist. 
The aim of our study was to evaluate the impact of the clinical phar-
macist intervention in medication orders.
Patients and methods This prospective study was conducted 
in a 7-bed medical ICU in Sousse, between November 2014 and 
August 2015. Patients who were admitted for at least one overnight 
stay were included. This study was performed in two periods, 1/an 
audit to identify the discrepancies of the medical prescriptions, 2/a 
“before/after” intervention study to evaluate the impact on medical 
prescriptions. The French Society of Clinical Pharmacy sheet was used 
to collect data.
Results Over a 10 months’ period, 68 patients were followed and 
379 sheets were analyzed, gathering all the pharmacological 
classes. 148(39) discrepancies were identified, mainly related to drug 
interactions (69 (46.6)). 42% had no clinical impact, 42% had mild 
and none had severe impact. The most common classes involved in 
medication discrepancies were anti-infective, 53 (35.8); cardiovascular, 
43 (29); systemic hormonal preparations, 14 (9.5) and anticoagulants, 
13 (8.7). The post intervention period was addressed to the anti-
infective drugs’ prescription. The discrepancies rate was significantly 
reduced from 53 (63) to 33 (39) respectively in a total of 84 patients.
Conclusion Discrepancies seem to be common in a medical ICU, 
involving mainly drug interactions with rather a mild clinical impact. 
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Introduction Some aircraft accidents are linked to human error. 50% 
of deaths syndrome Hellp (SH) are due to late diagnosis, these acci-
dents could be avoided by the application of particular procedures 
involving the human factor (HF). Yet the management of (HS), con-
tinues not consider the complications at an angle of disease severity. 
Human behavior, strongly influenced by the lack of training, organiza-
tion, awareness is rarely implicated in the chain of events that leads 
to failure. Our goal is to improve the management of SH based on the 
(HF), largely underestimated in obstetric emergencies. While this sec-
tor requires alertness, concentration and responsiveness on the part 
of medical staff.
Patients and methods Single-center prospective study at the Uni-
versity Hospital Establishment OranFirst Observational from 1 Janu-
ary 2014 until the end of December 2014, Interventional then from 1 
January 2015 until the end of December 2015 by the introduction of 
HF which necessitated a revision of the monitoring protocols accord-
ing to the latest recommendations, with patients developing a train-
ing record of their pathology and awareness of nursing staff on shift 
work, the interest of the multidisciplinary management, good coordi-
nation and the establishment of an electronic registry Excel facilitating 
monitoring of each patient and for comparing characteristics taken 
into charge of two populations.Fig. 26 Comparison of CCFN1 scores between 2009 and 2016
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The average waiting time (AWT): Average time between the arrival of 
the patient and her admission.
The average time management (ATM): Average time between hospi-
talization and administration of the first treatment.
The mean time to blood components (MTBC): Average time between 
the application and administration of blood products.
The average hospital stay (AHS).
Results Records of these women were studied. The characteristics of 
women are the same for both populations, but there is a net reduction 
of maternal mortality 0–4 and the satisfaction rate increased from 31 
to 71%. The features of management are summarized (see Table 18).
Discussion Our institution demand for unscheduled care and fre-
quency of emergencies are increasing in the service of emergency 
obstetric gynecological similar phenomenon reported in some publi-
cations. Our study marks a reduced waiting time in half, as in a study 
published in France [2]. Despite the protocol established for the sec-
ond population, we note a major impact for the average time of care, 
and the average time to obtain blood components is as long, related 
organizational deficits at night and on weekends, but this has allowed 
us to reduce the mortality rate and duration so stay on the economic 
cost.
Conclusion The human factor has a direct impact on the length of 
hospitalization and thus the economic cost, on maternal mortality, 
an indirect impact on satisfaction patient. Il is time to realize that the 
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Introduction In the absence of specific academic training in intensive 
care for paramedical personnel and in order to improve skills, training 
is necessary especially before the opening of a new unit. The aim of 
our study was to evaluate the training of newly recruited in intensive 
care paramedical staff.
Patients and methods For initiation of a new intensive care unit, 
medical staff prepared a specific training program of resuscitation. 
The schedule of the training has been distributed to all relevant staff 
in advance.
Presentations (basics and technical data sheets) on various resuscita-
tion themes were prepared by the staff and reviewed by doctors’ lead-
ers. The evaluation form contained 16 tests (T). Each test consisted of 
five questions before the presentation and five after.
An increase in the evaluation mark obtained after the presentation is 
considered an improvement in knowledge.
Results Twenty of the staff: twelve nurses, four technicians in intensive 
care and four healthcare assistant participated in the training. Fifty-
five percent of the staff were working in the private sector before their 
recruitment. The median time between graduation and recruitment 
was 1 year and a half. Technicians group had the highest level of 
knowledge (Table 19).
The analysis of the post-formative evaluation noted an increase in 
knowledge. The healthcare assistant group had the lowest rate of 
improvement (Table 20).
Conclusion The direct involvement of paramedical staff in their own 
training increases their motivation without harming the quality and 
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Introduction Burnout is a severe form of stress that affects mostly 
health professionals, in particular intensive care staff. Our study aims 
Table 18 Features of management
AWT average waiting time, ATM average time management, MTBC mean time to 
blood components, AHS average hospital stay
Population 1  
(N = 92 patients)
Population 2  
(N = 112 patients)
AWT 30 min 15 min
ATM 49 min 24.5 min
MTBC 4 h 30 2 h 30
AHS 29 days 20 days
Table 19 Evaluation of pre‑formative knowledge: rate score above average
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 T13 T14 T15 T16 M
Nurse (%) 11 0 60 20 10 20 10 50 54 83 27 75 90 90 33 91 45
Technicien (%) 0 75 75 100 0 25 100 75 100 100 33 100 100 66 66 66 67
Healthcare assistant (%) 0 0 25 50 0 0 25 25 33 33 0 75 100 50 50 100 33
Table 20 Knowledge improvement percentage
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 T13 T14 T15 T16 M
Nurse (%) 60 55 70 80 50 60 90 75 70 36 66 63 30 77 41 58 63
Technicien (%) 100 25 75 25 25 75 50 25 66 66 66 66 100 100 33 33 58
Healthcare assistant r (%) 75 50 75 66 0 100 66 25 25 66 100 66 0 0 25 25 47
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to assess the burnout prevalence in newly recruited paramedical 
intensive care staff before and after theory and practical training.
Patients and methods Before the opening of a new intensive care 
unit, three questionnaires were filled by the paramedical staff: at the 
taking up, at the end of theory training and 3 months after practical 
training in intensive care units.
The level of burnout was assessed using the “Maslach Burn Out 
Inventory” score and the degree of depression with Major Depression 
Inventory (MDI) test.
Results Twenty of the paramedical staff: twelve nurses, four techni-
cians in intensive care and four healthcare assistants participated in 
the study. Only one questionnaire has not been analyzed, it belonged 
to a nurse presenting a serious mood disorder. Forty-five percent of 
the study population was unemployed before their recruitment. Eight 
individuals (40%) showed burnout the first day of work, 11 (55%) at 
the end of training and 12 (60%) after 3 months of training (Table 21).
Regarding the sub-dimensions of burnout there was an improvement 
of professional fulfillment (increasing from 35 to 45% after training 
and practicum). We also noticed a worsening of emotional distress 
(increasing from 0 to 25%). There was also an improvement in mood 
disorders (decreasing of 35–15%).
Conclusion Theoretical and practical courses enhanced the level of 
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Introduction Procalcitonin (PCT) is a pro-hormone mainly produced 
by the thyroid C cells and routinely used as diagnostic biomarker of 
bacterial infection. PCT synthesis has never been described in the 
liver. To our best knowledge, no study investigated the possible pre-
dictive value of PCT in acetaminophen poisoning. Our objectives were 
to report the distribution of serum PCT values in acetaminophen-
poisoned patients according to the onset and severity of their toxic 
liver injury in order to assess any possible predictive value for this 
biomarker.
Patients and methods We conducted a retrospective single centre 
observational study including all acetaminophen-poisoned patients 
(either accidentally or voluntary) admitted to the ICU from 2013 to 
2016. Patients were treated with the 3-bag N-acetylcysteine protocol 
according to the international recommendations based on the inter-
pretation (when possible) of the plasma acetaminophen concentra-
tion on the Rumack-Matthew nomogram (line to treat the patient 
starting at 150  mg/L at the 4th hour). Serum PCT was measured 
using an automated method (Elecsys® and Cobase® analyzers; range: 
0.02–100  ng/mL) and plasma acetaminophen concentrations were 
determined using spectrophotometry. Comparisons were performed 
using Chi-2 and Mann–Whitney tests.
Results Seventy patients (50F/20M; age: 34 years [21; 53] (median [25; 
75 percentiles]; poly-intoxications: 83%) were included in the study. 
The presumed ingested acetaminophen dose was 15.5  g [8.0; 29.0]. 
The delay between acetaminophen ingestion and N-acetylcysteine 
infusion was 4.5 h [2.9; 9.0]. Serum PCT was markedly increased above 
the 1 μg/L threshold in the patients who already presented or further 
developed significant liver cytolysis defined by serum alanine ami-
notransferase (ALAT) >100 UI/l (2 N) despite the treatment with N-ace-
tylcysteine and independently of the onset of any bacterial infection, 
with a specificity of 97.9% and sensitivity of 69.6%.
Conclusion Serum PCT measurement in acetaminophen-poisoned 
patients admitted to the ICU is helpful to early identify patients who 
present significant acetaminophen-related liver toxicity already estab-
lished or in progress on admission despite the administration of N-ace-
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Introduction Venlafaxine, an antidepressant drug with properties of 
serotonin and norepinephrine reuptake inhibition, may be respon-
sible in overdose for life-threatening cardiovascular complications. 
Venlafaxin-related toxicity additionally includes a possible interac-
tion at elevated concentrations with the membrane sodium chan-
nels resulting in membrane stabilizing effects. To date, vulnerability 
factors to develop such cardiovascular complications are unknown. 
Based on a limited number of reported cases, poor cytochrome P450 
(CYP) 2D6 metabolizers have been suggested to develop increased 
cardiovascular toxicity. This liver enzyme metabolizes venlafaxine to 
O-desmethyl-venlafaxine (or norvenlafaxine) and altered norvenla-
faxine-to-venlafaxine metabolic ratio was suggested to support car-
diotoxicity onset. We aimed to describe venlafaxine-related toxicity 
in patients admitted to the intensive care unit (ICU) and test the pro-
posed hypothesis of vulnerability.
Patients and methods We conducted a prospective single centre 
observational study including all venlafaxine-poisoned patients 
admitted to the ICU from 2010 to 2016. Plasma venlafaxine 
and norvenlafaxine concentrations were determined using gas 
chromatography coupled to nitrogen–phosphorus detector (GC-NPD) 
after initial detection using high-performance liquid chromatography 
coupled to diode array detector and mass spectrometer (LC-DAD/
MS). CYP2D6 genotyping was performed with the patient’s consent, 
allowing classifying the patients into poor, rapid, and ultra-rapid 
CYP2D6 metabolizers.
Results Fifty-two patients (60% F/40% M; age: 44  years [32; 52], 
median [25; 75 percentiles]) exposed to venlafaxine (presumed 
ingested dose: 1.9  g [1.0; 3.0]; plasma venlafaxine concentration 
on admission: 0.8 mg/L [0.3; 2.0] and at the peak: 0.9 mg/L [0.4; 2.7]; 
98% poly-intoxications) were included. Clinical features included 
consciousness impairment (Glasgow coma score: 8 [4; 14]) and 
seizure onset (14%), requiring mechanical ventilation (56%). Nineteen 
patients (37%) presented cardiovascular complications and three 
patients (6%) died in the ICU. Based on an univariate analysis, onset of 
cardiovascular toxicity was significantly associated with deeper coma 
(p =  0.04), reduced PaO2/FiO2 ratio (p =  0.004), onset of acute renal 
failure (p  =  0.02), requirement of mechanical ventilation (p  =  0.02) 
Table 21 Burnout level








Low 8 8 3
Moderated 0 2 6
High 0 1 3
Page 86 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
and fatality (p = 0.04). No statistical relationships were found between 
cardiovascular toxicity and plasma venlafaxine concentration and 
norvenlafaxine-to-venlafaxine ratio on admission and at their 
respective peaks. When focusing on the patients with cardiovascular 
manifestations strictly attributed to venlafaxine toxicity, no statistical 
link was found with CYP2D6 phenotype.
Conclusion Venlafaxine poisoning may result in severe complications 
including cardiovascular toxicity and even fatality. Cardiac toxicity is 
responsible for increased morbi-mortality but is not related to CYP2D6 
phenotype. However, inclusion of additional patients is still warranted 
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Introduction Suicide attempts represent a major public health 
problem in Tunisia according to recent data published in 2015 by 
the Tunisian National Social Observatory. However, data about the 
incidence of life threatening suicide attempts requiring intensive care 
unit (ICU) admission are lacking.
The aim of this study is to describe the epidemiological profile of crit-
ically-ill patients admitted for suicide attempts and to identify factors 
predicting prolonged ICU stay (>3 days).
Patients and methods We conducted a retrospective study in the 
medical ICU of Bizerte city (Tunisia). From January 2009 to December 
2015, 219 patients were consecutively admitted for suicide attempt. 
Three patients were excluded because of lacking data and 216 cases 
were included in the study.
Results The median age was 23  years [12–69]. The mean IGS2 score 
was 20.5  ±  14.5 and the mean APACHE2 was 8.1  ±  7. Psychotropic 
drugs overdose (43.1%) and pesticides ingestion (25.5%) were the 
two most common causes of suicide attempts. Eighty-one patients 
(37.5%) had a psychiatric history. Coma (32.9%) and respiratory 
distress (22.7%) were the two major reasons for ICU admission. 
Mechanical ventilation was required for 84 patients (38.9%). Median 
duration of mechanical ventilation was 2 days [1–9]. Overall mortality 
was 3.2%. The median ICU length of stay for the 209 survivors was 
2j [1–19]. Factors associated with prolonged ICU stay (>3  days) were 
coma, hemodynamic instability, hypoxia, aspiration and mechanical 
ventilation.
Conclusion The current study is the largest study in Tunisia describing 
the epidemiological features of critically-ill patients admitted for 
suicide attempts. Identifying the underlying risk factors leading 
to suicide attempts and psychiatric follow-up starting upon ICU 
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Introduction Severity of lithium poisoning depends on the ingested 
dose, previous treatment duration and renal function. No animal 
study has investigated neurobehavioral differences in relation to the 
lithium poisoning pattern observed in humans, while differences in 
lithium pharmacokinetics have been reported in lithium-pretreated 
rats mimicking chronic poisonings with enhanced brain accumulation 
in rats with renal failure. Our objectives were: (1) to investigate lithium-
related effects in overdose on locomotor activity, anxiety-like behav-
ior, spatial recognition memory and anhedonia in the rat; (2) to model 
the relationships between lithium-induced effects on locomotion and 
plasma, erythrocyte, cerebrospinal fluid and brain concentrations pre-
viously obtained according to the poisoning pattern.
Materials and methods Open-field, elevated plus-maze, Y-maze and 
sucrose consumption tests were used. We developed acute (intraperi-
toneal administration of 185  mg/kg Li2CO3 in naive rats), acute-on-
chronic (intraperitoneal administration of 185  mg/kg Li2CO3 in rats 
receiving 800 mg/l Li2CO3 in water during 28 days), and chronic poi-
soning models (intraperitoneal administration of 74 mg/kg Li2CO3 dur-
ing 5 days in rats with 15 mg/kg K2Cr2O7-induced renal failure).
Results In acutely lithium-poisoned rats, we observed horizontal 
(p  <  0.001) and vertical hypolocomotion (p  <  0.0001), increased 
anxiety-like behavior (p  <  0.05) and impaired memory (p  <  0.01) 
but no altered hedonic status. Horizontal (p  <  0.01) and vertical 
(p  <  0.001) hypolocomotion peaked more markedly 24  h after 
lithium injection and was more prolonged in acute-on-chronically 
versus acutely lithium-poisoned rats. Hypolocomotion in chronically 
lithium-poisoned rats with impaired renal function did not differ 
from acutely poisoned rats 24 h after the last injection. Interestingly, 
hypolocomotion/concentration relationships best fitted a sigmoidal 
Emax model in acute poisoning and a linear regression model linked 
to brain lithium in acute-on-chronic poisoning.
Conclusion Lithium overdose alters rat behaviour and consistently 
induces hypolocomotion which is more marked and prolonged 
in repeatedly lithium-treated rats. Our data suggest that 
differences between poisoning patterns regarding lithium-induced 
hypolocomotion are better explained by the duration of lithium 
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Introduction Cyproheptadine (Periactin®) is a histamine H1 receptor 
and serotonin antagonist, it has also anticholinergic effects. It is used 
to treat allergic type symptoms and as an appetite stimulator. Cypro-
heptadine poisoning has been rarely reported.
That’s why we conduct this study, to identify the epidemiological 
characteristics and clinical outcomes of cyproheptadine poisoning 
and to define the association between the ingested dose and clinical 
manifestations.
Patients and methods Retrospective study was performed between 
January 2011 and December 2015. Epidemiological data, clinical 
data and outcome were reviewed. Data were analyzed by statistical 
methods in SPSS.
Results A total of 36 patients were reviewed with a mean age of 21 
[14, 27]. All patients had no psychiatric background. All cases were 
self-inflicted. Mean ingested dose was 72  mg [34,143]. Mean delay 
of symptoms onset was 2  h [1, 4]. Neurological symptoms included 
delirium in 17% of cases, agitation, and hallucinations. Thirty-six per-
cent of patients had peripheral anticholinergic symptoms. Gastric lav-
age was performed in 8% of cases. Four patients were admitted to ICU 
and required mechanical ventilation (MV) for neurologic impairment. 
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Mean duration of MV was 17  h ±  4. The outcome was favourable in 
all cases. Length of hospital stay was less than 24  h with an average 
of 22  h [20, 24]. There is no correlation between coma and assumed 
ingested dose.
Conclusion Cyproheptadin overdose causes mainly neurological 
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Introduction In spite of its rarity, the acute Beta blockers (BB) intoxica-
tion represents a major cause of mortality as a result of cardiovascular 
toxicity. (CS) is the most serious complication of this intoxication.
The objectives of this study were to determine epidemiological, clini-
cal, management and prognosis of cardiogenic shock (CS) complicat-
ing acute BB intoxication.
Patients and methods This was a retrospective descriptive study 
conducted at the Medical Intensive Care Unit of CAMU over a 10 years 
period from January 2006 to December 2015. All hospitalized patients 
for cardiogenic shock complicating pure acute BB intoxication were 
included.
Results Twenty-five patients were included. The average age was 
23  ±  7  years with a female predominance (sex ratio  =  0.32). Three 
different molecules were involved: Acebutolol (n  =  22), Atenolol 
(n  =  2) and Propranolol (n  =  1). The assumed average dose of 
ingested Acebutolol was 4000 [3200; 4800] mg. All patients were 
hospitalized in the first 3 h of taking and CS occurred within 3 h post 
ingestion in all cases. Bradycardia was reported in all patients who 
have ingested Atenolol or Propranolol. For patients who ingested 
Acebutolol, bradycardia was observed in 45% of cases (n  =  10). 
Electrocardiographic signs included a ventricular atrioventricular block 
in 5 cases (as first degree in 3 cases and 3rd degree in 2 cases) and a 
membrane stabilizing effect in 10 cases. Digestive decontamination 
was performed in 14 patients (56%). All patients were treated using 
catecholamines: epinephrine in 18 patients (72%), both dobutamine 
and norepinephrine in 6 patients and only dobutamine in 3 patients. 
Glucagon was administered in 8 cases. Semi- molar bicarbonate 
intake as infusion of 500 ml into 30 min was prescribed to 10 patients 
who have membrane stabilizing effect. Eighteen patients required 
mechanical ventilation. The median duration of hospital stay was 72 
[18; 120] h. Thirteen patients (52%) died within 24 h.
Conclusion Management of Cardiogenic shock complicating acute 
BB intoxication is largely symptomatic and based on vasopressors, 
positive inotropic agents. Sodium salts could be an alternative 
measure in cases of membrane stabilizing effect, and temporary 
cardiac electrical pacing if high degrees BAV. In refractory shock 
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Introduction Drug poisoning is a frequent cause of hospital 
admission especially in intensive care unit (ICU). Despite progress, 
hospital mortality of severe acute poisoning admitted in ICU seems 
to increase. Purifying methods such as continuous haemodiafiltration 
veinoveinous (CVVHDF) and molecular adsorbent recirculating system 
(MARS), were developed with promising clinical results (1). However 
no analytical study has quantified accurately their purifying efficiency. 
It has not been assessed efficiency of the different compartments 
of the MARS nor its advantages over other methods of dialysis and 
filtration. The objective of this study was to quantify the purifying 
efficiency of the different compartments of the CVVHDF and MARS 
and to compare their respective efficiency in an ex  vivo model in 
the most favourable conditions for these methods to assess their 
capability maximum treatment.
Materials and methods We performed a ex  vivo study based on 
manipulation bench simulating intoxication verapamil with a theoreti-
cal plasma doses of 1, 2.5 and 5 mg/l injected into a central compart-
ment of 5 L. Sampling and assays were carried out at various points of 
the circuit CVVHDF and MARS. The EC extraction coefficient [EC = (in 
concentration  −  out concentration)/in concentration] was calcu-
lated for each compartment of the CVVHDF and MARS as well as the 
amounts withdrawn by the sum each compartment allows assessing 
the overall capacity of each technique. Three manipulations were per-
formed for each concentration.
Results CVVHDF EC was 22, 22 and 28% for theoretical concentrations 
of 1, 2.5 and 5  mg/l. For the 3 previous concentrations, EC was not 
constant but decreased steadily over the sessions to cancel 0 +10, +5 
and +4 h for the different concentrations with even become negative 
after up to 14 h (end handling). At the end of handling the amount 
remaining in the central compartment was 6, 3 and 4% of injected 
dose. The amounts found in the effluent corresponded to 16, 20 and 
28% of injected dose. In fact the amounts “not found” accounted for 
78, 79 and 69% of injected dose. A desorption ultrasound membranes 
revealed that verapamil was fixed by the membrane of the CVVHDF. 
During all handling (12–14  h) concentrations in the circuit output 
“patient” for the CVVHDF have never been undetectable but remained 
stable.
The different compartments of MARS led instead to an undetectable 
concentration at the exit of “patient” circuit. Similarly the concentration 
of verapamil remaining in the central compartment was undetectable 
at the end of the handling and this for all three concentrations studied. 
The quantities withdrawn by the hemodiafiltration compartment 
MARS corresponded to 8, 18 and 12% of the injected quantity, 
EC varied between 10 and 20% remaining stable. The quantities 
withdrawn by the coal compartment activated MARS was 92, 82 and 
89% of the injected amount, the EC induced by MARS cartridge was 
stable in the order of 70% throughout the manipulation.
Discussion CVVHDF and MARS are 2 effective purifying methods for 
removal of a simulated poisoning by verapamil. Their action and per-
formance modes are very different. The membrane used in CVVDHF, 
adsorption verapamil realized 80% of the elimination of the toxic but 
with a residual salting out effect. A 8 h session of MARS had the effect 
of making them undetectable concentrations in the central compart-
ment. The purifying effect is bound to 80% to the effect of carbon car-
tridge and for 10–20% to hemodiafiltration.
Conclusion Clearance is a simple parameter that two determinants 
are EC and flow in the scrubber compartment. Pharmacokinetic mod-
eling that require constant clearance. CVVHDF is characterized by a 
decrease in EC resulting in a variable clearance and preventing mod-
eling. Elimination of verapamil is mainly due to unspecific binding 
properties. MARS is particularly effective in poisoning by verapamil. 
These results must be tempered by the fact that the conditions of our 
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manipulations, without protein in the central compartment, evaluate 
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Introduction Beta-adrenergic antagonists are commonly used 
worldwide to treat hypertension, tremor, migraines, ischemic heart 
disease, heart failure, arrhythmias, portal hypertension, angina 
and panic attack. Propranolol, a beta-adrenergic antagonist with 
membrane stabilizing proprieties, is the most common toxic used in 
suicide attempts in Martinique.
Through respiratory depression, bronchopasm, bradycardia, severe 
hypotension, and seizures may result from beta blocker intoxication, 
cardiovascular depression appears to be the most common cause 
of morbidity and mortality in severe acute beta blocker poisoning. 
Massive beta-blocker ingestions may cause prolonged QRS intervals 
may also be associated with refractory cardiac failure. Our objectives 
were to determine factors that are associated with the development of 
cardiovascular mortality.
Patients and methods We conducted a retrospective study over 
10  years (January 2005 to December 2015), including all poisoned 
patients admitted and treated to the Emergency Department and 
the Intensive Care Unit. During this period, there were over 10 beta-
adrenergic antagonist exposures per year reported by the medical 
records department. These poisonings accounted for an average of 5 
deaths annually.
Results Three Hundred and eight patients (173 males/135 females) 
were admitted to the ICU for severe acute poisonings. Median age, 
46.5% years (16–79); SAPS II, 120 (49–94). Among these 308 patients, 
100 had ingested high doses of cardiotoxicants [class I ant-arrhythmic 
drugs (40%), β-blockers (15%), calcium-channel blockers (10%)]. Fifty 
patients (50%) survived, including 18 to prolonged cardiac arrest. Bad 
prognostic factors in ECLS-treated poisoned patients for beta blocker 
poisoning, were as follows: QRS enlargement on admission, SAPS II 
score on admission, Extracorporeal Life Support (ECLS) performance 
under massage, potential co-ingestants, arterial pH and lactate 
concentration (10.5 mmol/l).
Conclusion The most important factor associated with an increased 
risk of cardiovascular mortality in beta blocker poisoning is the 
exposure to a beta blocker with stabilizing activity. The identification 
of risk factors allows physicians to identify patients at greatest risk. 
ECLS appears to be an efficient salvage technique in case of refractory 
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Introduction Accidental acute intoxications are part of pediatric 
medical emergencies of our hospital experience. Children are 
most at risk of accidental poisoning due to characteristics of their 
development and their environment. Our Goal is to point to the toxic 
substances involved and to draw up the outcome profile in these 
patients.
Patients and methods Retrospective study, covering all poisoning 
cases occurred in children under 6 years old and admitted to PICU in 
the university hospital Oran.
We specified the characteristics of children, the nature of the toxic, 
symptoms on admission, the therapeutic aspect, the evolutionary 
mode and length of hospital stay. The duration of our study was to 
4 years, from 2011 to 2015.
Results In those years, the ICU admitted 365 poisonings occurring in 
children. They represent 13% of all admissions and 71% (260 children) 
under 6 years old. The average age of addicts was 5.08 ± 1.36 years old 
with a male predominance.
All product types were involved in the poisoning. According to data, 
72% caustic toxic (189 cases) followed by drug poisoning (in 28 
cases) and it is basically a case of psychotropic and narcotic (01 case), 
and then in descending order are rodenticides poison (19 cases), 
organophosphorus insecticides like (11 cases), Hydrocarbon (7 cases) 
ingestion of plants (3 cases), making cosmetics (2 cases) and poisoning 
of industrial glue (01 cases). Upon arrival at the hospital, 68% of young 
children had gastrointestinal disorders, and 2.3% had neurological 
disorders (seizures, ataxia and abnormal movements), 1.1% were in 
respiratory distress.
After observation for most children, symptomatic treatment was 
introduced, 6 patients have been put under non invasive ventilation, 
intubation and mechanical ventilation was required in 01 patient for 
16 days also put under Hemodynamic Support.
The outcome was favorable with an average hospital stay of 28  h 
in survivors, and 01 death occurred following an ingestion of 
hydrocarbons.
Discussion Children in pre-school age are often at risk of domestic 
accidents in relation to their age and environment. They ingest prod-
ucts wrongly deconditioned or transferred into current use contain-
ers. These by catch happen to be in the kitchen at a large household 
or in the bathroom. They also ingest drugs for adults and thus higher 
dosage: these drugs are too easily left to reach those children who are 
not suspected faculties to identify seize and swallow what they take 
to candy. A study in India positioned intoxication hydrocarbons 1st 
place (50.9%), followed by organophosphates (11.9%), medication and 
caustic identify (4.8%) cases each [1]. In Oran (Algeria) taking caustic 
remains at the level of poisoning in children. Overall mortality by poi-
soning is lower in children compared to adults. (The products in ques-
tion are heterogeneous drugs, household products, plants, pesticides) 
We recorded 01 death secondary to acute respiratory distress syn-
drome following ingestion by siphoning gasoline.
Conclusion At the end of our study, it appears that the acute poi-
soning in children is a very common event. However, developments 
remain favorable in most cases. This should not obscure the potential 
severity of the poisoning, nor lose sight of the necessary prophylac-
tic measures. This prophylaxis should include education of the popu-
lation, prevention of certain tragedies related to toxins or aberrant 
behavior, and triggering alerts to reduce morbidity and mortality 
related to poisoning.
Our ACCIPED laboratory medical university Oran for a future mission 
secondary and tertiary prevention through continuous training 
for general practitioners, to respond to any request for advice on 
diagnosis and treatment of these accidents, assess risk through 
telemedicine and through a website continuously 24 h/24 h.
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Introduction Noninvasive ventilation has become the preoxygena-
tion reference technique. In PreOx study [1], Hanouz et al. showed that 
the preoxygenation is faster with positive pressure ventilation with 
or without positive end expiratory pressure (PEEP) than spontaneous 
ventilation. However, during preoxygenation imperfect seal between 
the face mask and patient’s face can induce a leak decreasing its effec-
tiveness. We assume that noninvasive ventilation could cancel the 
effect of the leak in non-obese subjects.
Materials and methods Experimental prospective study, randomised 
in cross-over of healthy volunteers from March to July 2016, in Caen 
university hospital. None of them were obese, smoked or had a chronic 
lung disease. Healthy volunteers conducted a preoxygenation with 
fraction of inspired oxygen at 100%: spontaneous ventilation (SV) and 
noninvasive ventilation (NIV, pressure support +6  cmH2O and PEEP +5  cmH2O) without and with calibrated leak (SV-leak and NIV-leak). 
From the volunteer mouth at respirator, subjects breathed through a 
mouthpiece (with a nose clip), mount catheter, antibacterial filter and 
Y-piece of respirator. In modes of ventilation with calibrated leaks, the 
leak was placed on mount catheter. The leak was characterized as a 
turbulent flow with the flow/pressure curve. The fraction of expired 
oxygen (FeO2), changes in respiratory rate and end-tidal of carbon 
dioxide were measured. A PreOx was deemed effective if FeO2 > 90%. 
The primary endpoint was the time to achieve a FeO2  >  90%. The 
secondary endpoint was the proportion of subject with FeO2 > 90% at 
the third minute.
Results The study included 20 healthy volunteers. The time to achieve 
a FeO2 > 90% was 85 [68–110] s, 78 [69–84] s and 84 [72–110] s in SV 
group, NIV and NIV-leak, respectively. The SV-leak group never reached 
a FeO2 > 90% (p < 0.001). After 3 min, 19 (95%) in SV group, 20 (100%) 
in NIV group, 19 (95%) in NIV-leak group and 0 (0%) in SV-leak group 
volunteers had a FeO2  >  90%. Cox proportional-hazards regression 
showed that NIV [hazard ratio 2.13; 95% confidence interval (95% 
CI) 1.09 to 4.18); p =  0.02] was associated with a shorter time to an 
expired O2 fraction of 90% than NIV-leak or SV-leak.
Discussion In the presence of calibrated leaks, preoxygenation is 
effective with noninvasive ventilation than spontaneous ventilation. 
The breathing patterns of every subject seems to influence the 
existence of inspiratory leaks. Some volunteers had more inspiratory 
leaks than others, and experienced a longer length of preoxygenation 
than others. This is probably explained by a different instantaneous 
inspiratory flow [2]. These results hypothesize that individual 
preoxygenation is needed for each subject.
Conclusion Noninvasive ventilation allows effective preoxygenation 
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Introduction Manikin-based studies for evaluation of ventilation 
performance show high heterogeneity in the analysis and 
experimental methods used as we pointed out in previous studies. In 
this work, we aim to evaluate these potential limitations and propose a 
new analysis methodology to reliably assess ventilation performance.
Patients and methods One hundred forty healthcare providers were 
selected to ventilate a manikin with two adult self-inflating bags in 
random order. Ventilation parameters were analysed using different 
published analysis methods compared to ours.
Results Using different methods impact the evaluation of ventilation 
efficiency which ranges from 0% to 45.71%. Our new method proved 
to be relevant and showed that all professionals tend to hyperventilate 
and revealed a significant relationship between professional 
category, grip strength of the hand keeping the mask and ventilation 
performance (p = 0.0049 and p = 0.0297 respectively).
Discussion Using adequate analysis methods is crucial to avoid many 
biases. Extrapolations to humans still have to be taken with caution 
as many factors impact the evaluation of ventilation performance. 
Healthcare professionals tend to hyperventilate with current devices.
Conclusion We believe that problems related to manual ventilation 
efficiency could be prevented by implementing monitoring tools in 
order to give a direct feedback to healthcare professionals regarding 
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Introduction Basic and advanced airway management as Bag-Valve-
Mask (BVM) and Endotracheal Intubation (ETI) are procedures used in 
prehospital resuscitation. In this work, we compare manual ventilation 
performance with both techniques and analyse their variability and 
also try to assess what factors may affect their performance.
Patients and methods One hundred forty healthcare providers were 
selected to ventilate an intubated and not-intubated manikin with two 
adult bags for 5 min each in a random order. Ventilation performance 
were analysed using a new analysis method we described in a previous 
study which takes into account ventilation variability.
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Results Five hundred sixty ventilation tests (280 for ventilation using 
a facemask and 280 for ventilation with an Endotracheal Tube (ETT)) 
were performed by the 140 healthcare professionals. Results show a 
significant difference between ventilation performance with a mask 
compared to ETT (p  <  0.05) with more ventilation efficiency when 
healthcare professionals ventilate with an ETT than a mask (37 vs. 21 
ventilation tests). Furthermore, a significant relationship is observed 
between participants’ professional category, the size of the hand 
squeezing the bag and manual ventilation performance (p < 0.05).
Discussion Healthcare professionals have performed 560 ventilation 
tests on an ETT and a facemask. Among them, only 58 (10.41%) were 
efficient and 502 (89.64%) are inadequate (of which 11.4% insufficient 
and 78.2% excessive). Whatever the kind of ventilation technique 
used, they are still struggling to perform manual ventilation efficiently 
according to international guidelines.
Conclusion The high ventilation performance failure observed in this 
study shows that “to intubate or not to intubate the patient” is not the 
question, but we should focus on how to improve efficiency of manual 
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Introduction Devices’ ergonomics are major determinants of task fail-
ure, especially in stressful environments. The aim of the study was to 
provide a global evaluation of ICU ventilator ergonomics using novel 
exploration tools.
Materials and methods Devices and physicians 6 new-generation 
ventilators were evaluated (Dräger Evita V300, Covidien PB980, 
Philips V680, Hamilton S1, GE Carescape R860, Maquet Servo-U) and 
compared to an old one (Carefusion Avea). 20 senior physicians were 
included, each testing up to 4 ventilators in a randomized order.
Objective task completion 11 specific tasks were to be completed. The 
test was a failure if the correct response was given ≥120 s, or in case of 
incorrect response or abandoned task
User-friendliness evaluation System Usability Scale (SUS) was devel-
oped to measure device’s usability. It has a range of 0–100, the highest 
score being the best value. Mental Workload evaluation (MWL) is an 
indicator for human–machine interface (HMI) comparison. 3 dimen-
sions depending to user and 3 dimensions depending to HMI are sub-
sequently weighed to obtain TLX result. The higher the TLX, the higher 
the MWL.
Physiological measurement Pupil diameter modifications were assessed 
by eye-tracking (SMI ETG 1); heart, respiratory rate and thoracic vol-
ume variations were measured with a dedicated device (Hexoskin).
Results No users could set inspiratory flow on Servo U, and only 
18% succeeded with S1. Servo U had the worst global results (failure 
rate = 42%) and Avea the best (failure rate = 13%) (p = 0.12). Among 
all ventilators, Avea had the best SUS and TLX values, and Philips V680 
the worst (p  <  0.05). Eye tracking, respiratory rate and tidal volume 
activation differed between ventilators (p  <  0.05). V300 caused the 
higher eye-tracking activation rate when compared to Avea (p = 0.03) 
and R860 (p = 0.019) (Fig. 27).
Conclusion Ergonomics evaluation is mandatory when evaluating 
new devices in the ICU. Most ICU ventilators presented poor HMI capa-
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Introduction Hypotension and oxygen desaturation are the most 
common critical events occurring in 17% of emergency transports. 
They are mainly related to ventilator issues and the type of ventilator 
might mitigate the rate of adverse events. We decided to compare the 
most suitable ventilators for out-of hospital transport.
Materials and methods This experimental bench test was designed 
to evaluate the technical characteristics, ergonomics, accuracy of vol-
ume and pressure delivery, triggering performance, pressurization and 
depressurization capacity, patient asynchrony and leak compensation 
of transport ventilators. We simulated many patient profiles and condi-
tions by adjusting lung compliances (30, 100 ml cmH2O
−1) and resist-
ances (5, 20, 50 cmH2O L
−1 s), inspiratory efforts (2.5, 5, 10 cmH2O), and 
leakage levels (<1, 3, 6, 12 L min−1). The ventilators were used in pres-
sure control, volume control, and pressure support ventilatory modes 
in non-invasive and invasive settings.
Results Even if the technical characteristics of portable ventilators are 
quite similar, their ergonomics and performance are unequal. Major 
differences were found on tidal volume delivery, with mean relative 
errors ranging from +1.7 to −14.9%. Triggering delays and pressuri-
zation capacity also showed significant heterogeneity with a mean 
pressure time product (PTP) varying from 883 to 3018 cmH2O ms. The 
resistance of the expiratory circuit also differed across ventilators (from 
0.96 to 1.82  cmH2O  L
−1  s), impacting the mean exhalation time and 
inducing air trapping and dynamic hyperinflation. Finally, while all 
ventilators were able to synchronize with patient’s demand at baseline 
(leakage <1 L min−1), only one showed adequate patient synchrony at 
high leakage level.
Discussion The main characteristics of last-generation ventilators are 
comparable, but major differences remain, especially in the concep-
tion of their basic ventilation modes. For instance, Hamilton T1 VC 
mode is actually a hidden pressure control mode that does not ensure 
Fig. 27 See text for description
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tidal volume accuracy under changing lung conditions, unlike speci-
fied by international guidelines.
Conclusion While it is still difficult to determine which ventilator best 
meets clinician expectations, this study will help to select the most 
appropriate device in regard to his own needs and make a clear com-
parison between ventilator performances.
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Introduction Even though limitingtidal volume (TV) in ARDS patients 
is recommended, this goal may not be achieved once spontaneous 
breathing comes up and assisted modes are used. Furthermore ICU 
ventilators offer numerous assisted ventilation modes that work dif-
ferently across the brands. We underwent present bench study to sys-
tematically investigate the effect of assisted mechanical modes on a 
single ICU ventilator on size and variability of TV at different breathing 
frequencies (f ), patient effort and ARDS severity.
Materials and methods We performed a bench study in our univer-
sity laboratory on an ICU ventilator (V500 Infinity, Dräger, Germany) 
using ASL 5000 lung model. Compliance was set at value mimick-
ing mild, moderate and severe ARDS as recently reported. Thirteen 
assisted ventilation modes were tested falling into three categories, 
namely volume controlled ventilation with mandatory minute ventila-
tion (VCV-MMV), pressure-controlled ventilation (PCV) including air-
way pressure release ventilation (APRV) and biphasic positive airway 
pressure (BPAP), and pressure support ventilation (PSV). fand effort 
were tested each at two levels for each ARDS severity in each mode. TV 
was expressed as median (first-third quartiles) and compared across 
modes using non parametric tests. The probability for TV  >  6  ml/kg 
ideal body weight (IBW) was assessed by binomial regression and 
expressed as odds ratio (OR) with 95% confidence intervals (CI). The 
variability of TV was measured from the coefficient of variation.
Results The distribution of TV over all f, effort and ARDS categories 
significantly differed across modes (P < 0.001, Kruskal–Wallis test). TV 
was significantly greater with PSV (420  mL (332- 527) than with any 
other mode except for the three modes accommodating a variable PS 
level. The risk for TV to be greater than 6 ml/kg IBW was significantly 
increased with spontaneous breaths assisted by PSV modes (for PSV 
OR 19.36; [12.37–30.65]) and significantly reduced in APRV (OR 0.44; 
[0.26–0.72]) and PSV with guaranteed volume mode. The risk increased 
with increasing effort and decreasing f. Coefficients of variation of TV 
were greater for low f and for VCV-MMV and PCV modes. APRV had the 
greatest within-mode variability.
Conclusion The ventilation mode had an important impact on TV in 
this study. The risk of TV  >  6  ml/kg IBW was significantly reduced in 
APRV and PSV with guaranteed volume mode. APRV had the high-
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Introduction Single-Use Fiberscopes (SUF) have recently become 
available for ICU clinical practice to overcome 3 main problems 
associated with Re-Usable Fiberscopes (RUF) resulting in systematic: 
immediate availability of a sterile device, short lag time to endoscopic 
treatment and removal of the cross contamination risk. However 
endoscopy of the upper airway and lung (EAWL) is a medical act that 
generates significant costs. We thus conducted a medico-economical 
evaluation of RUF versus SUF.
Patients and methods The study was conducted over 1 year (2015) in 
3 French university hospitals. The medical evaluation was conducted 
in one of them while the cost analysis included the 3 hospitals. 
Medical evaluation was based upon a qualitative questionary filed by 
the clinician after each EAWL. Calculating the cost of RUF included the 
amount of money paid for the device acquisition and its equipment, 
and the cost related to both sanitary (systematic and post gesture) and 
technical maintenances. The cost of SUF was calculated based upon 
acquisition and the cost of disposable medical waste.
Results Medical evaluation performed upon 368 EAWL (60% SUF and 
40 RUF) showed quality parameters either similar or better for SUF 
as compared to RUF except for one paramater: suction performance. 
Cost details of 922 EAWL were analyzed. Depending upon center 
organisations, cost per EAWL ranged between € 203 to € 240 for SUF, as 
compared to € 189 and € 269 for RUF. Saving related to SUF exclusive 
use would have ranged between € 2097 and € 7636 depending upon 
center’s settings.
Discussion SUF is efficient and performant for EAWL. Although costs 
associated with the use of SUF and RUF for ICU EAWL are close, select-
ing SUF induces substantial savings. The permanent and immediate 
availability of sterile equipment allowing to significantly shorten the 
lag time to treatment may have important clinical outcome for the 
patients.
Conclusion At a time when health authorities are focusing their 
efforts on the prevention of nosocomial infections, elimination of 
endoscopes-related cross-contamination risk by using SUF, especially 
in ICU is a major issue. Improvement of Suction capability will promote 
clininal superiority of SUF over RUF.
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Introduction Oro-tracheal Intubation (OTI) is thought to be one of 
the highest nociceptive stimulation for the patient but this dogma has 
never been clearly proved. We tightly monitored hemodynamics (HD), 
nociception, and consciousness during OTI with the aim of pragmati-
cally revisiting this dogma.
Patients and methods After ethic comity approval, consenting 
informed patients scheduled for elective cardiac or vascular surgery 
were included in this observational prospective study. Patients were 
orally premedicated (hydroxyzine) 1  h before admission into the 
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operating room, where invasive blood pressure (BP), Bis-spectral (BIS) 
and Analgesia Nociception Index (ANI) monitoring were installed. The 
induction procedure of anesthesia with target-controlled infusion was 
standardized using sufentanil and propofol. Timed OTI maneuver was 
performed after monitored (corrugator supercillii muscle) deep neu-
romuscular blockade (atracurium) was installed. OTI maneuver which 
duration could not exceed 30 s was truncated in 3 periods (P) of pre-
defined duration. P1 lasted 10 to 15  s and corresponded with direct 
laryngoscopy. P2 lasted 5 to 10 s and corresponded with tracheal tube 
(TT) manipulation. Finally, P3 coincided with TT cuff inflation to con-
trolled 35 cm H2O lasted less than 5 s. Recorded HD, BIS and ANI data 
were analyzed at 6 predefined time points. T0: stable baseline values 
after monitors installation, T1: post induction of anesthesia and just 
before OTI, T2: end of P1, T3: end of P2, T4: end of P3, T5 and T6, respec-
tively 1 and 5 min after the end of OTI. Recorded parameters evolution 
was compared using standard statistics.
Results Thirty-nine patients were included in this trial, but 4 were 
secondarily excluded because of OTI lasting more than 30 s. Figure 28 
shows mean (SD) variations of monitored parameters: mean arterial 
pressure (MAP), heart rate (HR), BIS, and ANI, from T0 to T6. P1 is char-
acterized by a remarkable stability of all measured parameters. P2 and 
even more P3, are associated with intense and significant HD and ANI 
variations. ANI variations are completely superimposed, but opposite, 
to those of MAP and HR. BIS variations during TI were negligible.
Conclusion Our data does not support the dogma but rather suggests 
that laryngoscopy may not be the most intense nociceptive stimulus 
applied to patients during OTI. Both laryngeal and/or tracheal stimu-
lation resulting from tracheal tube passage and cuff inflation seem to 
promote very intense nociception. Interestingly, such phenomenon 





1. Boselli E. Minerva Anestesiol Mars 2015;81(3):288–97.
P117 
Comparisons and time course of mixed venous and central venous 
saturation are independent of severe sepsis and septic shock 
origin
Yoann Marechal1, Patrick Biston1, Michael Piagnerelli1 
1Reanimation polyvalente, Hôpital Civil Marie Curie, Charleroi, Belgium
Correspondence: Yoann Marechal ‑ yoann.marechal@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P117
Introduction Low (<70%) mixed venous saturation (SvO2) was one of 
the independent variable related to mortality in septic shock patients 
[1]. Nevertheless, values of central venous saturation (ScVO2) may be 
considered as a surrogate to SvO2 for early goal directed therapy in 
severe sepsis and septic shock. In sepsis, difference between ScVO2 and 
SVO2 (ΔSVO2) was approximately of 5% [2]. This delta SVO2 ignores the 
origin of sepsis: supra or infra-diaphragmatic where this gradient could 
be higher due to increased oxygen extraction by organs under dia-
phragm (gut, liver and kidney). We compared the correlation between 
ScVO2 and SVO2, the time course of delta SVO2 and effects of therapeu-
tic challenge on delta SVO2 between patients in severe sepsis or septic 
shock due to supra or infra diaphragmatic infection. Enter the text.
Patients and methods We included patients in severe sepsis or septic 
shock monitored by Swan Ganz catheter and continuous ScVO2, hos-
pitalized in a 24 bed medico-surgical ICU of CHU-Charleroi. Hemody-
namic data and delta SVO2 were recorded from catheter insertion to 
withdrawal and before and after each therapeutic intervention (fluid 
challenge, dobutamine initiation or dosage modifications). Demo-
graphic data and mortality were also collected.
Graphpad prism was used for statistical analysis and graph, Bland–Alt-
mann analysis was used and results were compared by Mann–Whitney 
U test when not specified. Data were expressed in median values (IQR 
25–75 percentiles).
Results 34 patients were included which 26 presented a septic shock 
of upper diaphragmatic origin.
Median Apache II score was 24 (16–30). Eighteen patients (53%) out 
of 34 died before hospital discharge. At inclusion, mean arterial 
pressure, SvO2, cardiac index and norepinephrine infusion rate were 
respectively 71 (67–82) mmHg, 66 (59–72)%, 2.7 (2.2–3.4) L/min/m2, 
and 0.09 (0.00–0.50) (mcg/kg/min).
For all patients included, a total of 442 paired blood samples were 
obtained (321 for upper diaphragmatic group). ScvO2 overestimate 
SvO2 by an average of 4.96% (−6.4 to 16.3) for all paired data. No 
difference between upper (bias 5.24, limits −6.1 to 16.56) and under 
diaphragmatic (bias 4.21, limits −7.1 to 15.53) paired (ΔSvO2) was 
observed (p = 0.1).
Time course of SCVO2 and SVO2 were similar during the study period 
and independent of the sepsis origin.
No difference in ΔSvO2 was observed in relation the baseline SvO2 
values (<50% and higher values (p = 0.11)).
Median SvO2 and ScVO2 were not statistically different before (64 
[55–72] and 70 [63–78]% respectively) and after intervention (67 [56–
75] and 72 [65–78]% respectively (p = 0.27 for SvO2 and p = 0.40 for 
ScvO2)). Therefore, ΔSvO2 was the same before and after interventions 
in the 2 groups of patients (p = 0.99) (Fig. 29).
Conclusion As in other studies, ScvO2 overestimate SvO2 by nearly 
5.0% in patients with septic shock independently of the sepsis origin. 





1. Varpula M, Karlsson S, Ruokonen E, Pettilä V. Intensive Care Med. 2006 
Sep; 32(9):1336–43.
2. Bloos F, Reinhart K. Intens Care Med. 2005; 31: 911–13.
P118 
Diagnostic accuracy of the inferior vena cava collapsibility 
to predict fluid responsiveness in spontaneously breathing 
patients with cardiac arrhythmia
Perrine Bortolotti1, Delphine Colling1, Vincent Colas2, Benoit Voisin1, 
Florent Dewavrin2, Thierry Onimus1, Patrick Girardie1, Fabienne Saulnier1, 
Sebastien Preau1 
Réanimation médicale, Centre Hospitalier Régional Universitaire de Lille, 
Lille, France; 2Réanimation Polyvalente, Centre Hospitalier De Valenci‑
ennes, Valenciennes, France
Correspondence: Perrine Bortolotti ‑ perrine.bortolotti@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P118
Fig. 28 See text for description
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Introduction To investigate whether respiratory variations of the infe-
rior vena cava diameter (cIVC) assessed during a simple standardized 
breathing maneuver predict fluid responsiveness in spontaneously 
breathing patients with septic acute circulatory failure and irregular 
heartbeats.
Patients and methods This prospective, bicentric study, was per-
formed in the intensive care units of a general and a teaching hos-
pital. Spontaneously breathing patients with cardiac arrhythmia 
considered for volume expansion for clinical signs of acute circulatory 
failure related to sepsis were included. Echocardiography and Dop-
pler ultrasound were used to record the stroke volume (SV) and IVC 
collapsibility index (cIVC) defined as [maximum expiratory diameter 
(edIVC) − minimum inspiratory diameter (idIVC)]/edIVC × 100 at base-
line and after a 500 ml colloid infusion. Vena cava pertinent diameters 
were measured 15–20  mm caudal to the hepatic vein junction and 
recorded by bi-dimensional imaging on a subcostal long axis view. We 
measured the edIVC and idIVC during standardized (st) and unstand-
ardized (ns) breathing, and calculated cIVCst and cIVCns before fluid 
loading. Standardized respiratory cycles consisted of a deep standard-
ized inspiration followed by passive exhalation. A positive response to 
fluid loading was defined as an increase of the SV > 10%.
Results Fifty-five patients were included, 29 (53%) with atrial fibrilla-
tion and 25 with atrial extrasystols >6/min. Twenty-nine (53%) patients 
were responders to fluid loading. A cIVCns  >  19% predicts fluid 
responsiveness with a sensibility of 83%, a specificity of 68%, and an 
area under the ROC curve of 0.83 (95% CI 0.72–0.94). A cIVCst > 39% 
predicts fluid responsiveness with a sensibility of 93%, a specificity of 
88%, and an area under the ROC curve of 0.93 [IC95: 0.86–1]. The area 
of uncertainty was restricted between 41 and 46%. Interestingly, idI-
VCst < 12 mm predicts fluid responsiveness with a sensibility of 83%, 
a specificity of 88%, and an area under the ROC curve of 0.93 (95% CI 
0.86–1). The area of uncertainty ranged between 10 and 13 mm.
Discussion A simple standardized inspiratory maneuver improves the 
accuracy of cVCI to predict fluid responsiveness with high specificity 
and sensibility and a limited grey area in patients with cardiac arrhyth-
mia. Moreover, idIVCst demonstrates very good performance to pre-
dict fluid responsiveness. This easy to acquire parameter may be more 
suitable for bedside patient’s management.
Conclusion cIVCst is a powerful index to predict fluid responsiveness 
in spontaneously breathing patients with sepsis and irregular heart-
beats. Interestingly, idIVCst shows similar performance to predict fluid 
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Introduction Acute pulmonary embolism (PE) is a common condi-
tion responsible for morbidities such as chronic pulmonary hyper-
tension and deaths. The evaluation of PE severity is mainly based on 
arterial blood pressure and right ventricular abnormalities. According 
to recent ESC guidelines, patients with high risk of death had systolic 
hypotension and intermediate-high risk patients had right ventricular 
injury (defined by biological and echocardiographic alterations). How-
ever, the predictive value of tissue perfusion remains unknown. We 
aimed to investigate the relationship between 28-day mortality and 
tissue hypoperfusion parameters on patients admitted to intensive 
care units (ICU) for symptomatic acute PE.
Patients and methods We conducted a retrospective observational 
study in a 18-bed ICU in a tertiary teaching hospital. From January 
1993 to December 2015, all consecutive patients older than 18 years 
admitted for acute EP were included. Patients were identified by que-
rying the electronic health records with the following keywords (in 
French): “pulmonary embolism”, “anticoagulant”, “deep venous throm-
bosis”, “cardiac arrest”, “heparin”, “vitamin K antagonists” and “cava 
filter”.
General characteristics of the patients were recorded: demographics, 
biological data, diagnoses, severity of illness evaluated by the SOFA 
score and SAPS II. Global hemodynamic and tissue perfusion (arterial 
lactate level, skin mottling and urinary output) parameters were col-
lected. We investigate the relationship between these parameters and 
28-day mortality.
Results Over a 22-year period, we identified 317 patients admitted 
to our ICU with a diagnosis of acute PE. Of these 120 patients were 
excluded because PE was not the main diagnosis of ICU admission 
and 85 patients because of missing data, leaving 112 patients for 
study. At admission, the SOFA score was 2 [1–6] and the SAPS II was 
31 [17–43]. 31 patients (27%) were infused by vasopressors and 32 
received mechanical ventilation support (28%). According to interna-
tional guidelines, 49 patients (35%) were classified as high risk and 73 
patients (65%) were classified as intermediate-high risk [1]. Thirty-nine 
patients (35%) received thrombolytic therapy. Day-28 mortality rate 
was 26%.
At admission, when compared to 28-day survivors, non-survivor 
patients had higher lactate level (4.2  ±  5.9 vs. 1.5  ±  2.9  mmol/L, 
Mann–Whitney test P  <  0.001), more frequent mottling around the 
knee area (50 vs. 24%, Chi squared test P = 0.02) and a lower urinary 
output (during the first 24 h) (0.5 ± 0.6 vs. 0.9 ± 0.8 mL/kg/h, Mann–
Whitney test P = 0.02). Interestingly, 28-day mortality increased with 
the number of tissue perfusion alterations defined as hyperlactatemia 
(>2 mmol/L), oliguria (<0.5 mL/kg/h) and mottling presence. The mor-
tality at day 28 increased from 10% for no failure to 22% for 1 altera-
tion, 32% for 2 alterations and finally to 58% for 3 tissue perfusion 
alterations (P = 0.02, Chi squared for a trend test).
Discussion Several studies in emergency and pneumology depart-
ments have investigated global hemodynamic parameters to predict 
outcome of PE patients. Low systolic blood pressure called “shock” 
and right ventricular dysfunction were identified as predictors of 
bad outcome. We were interested in the exploration of tissue perfu-
sion because in septic shock several studies highlighted the discord-
ance between global hemodynamic parameters and tissue perfusion. 
Moreover, during severe infections, hypoperfusion markers such as 
lactatemia, mottling or oliguria have been identified as predictive of 
ICU mortality. Recently, Vanni et al. [2] suggested lactate could be use-
ful to identify normotensive PE patients at high risk of early death.
Fig. 29 Response to therapeutic intervention Bland and Altman plot 
showing the agreement between ΔSvO2 after and before interven‑
tion (Bias −0.62%, limits of agreement from −17.83 to 16.58 (dotted 
lines on graph)
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Here, we found that, at admission, non-survivors patients at day-28 
had more severe tissue hypoperfusion than non-survivors. In addition, 
mortality increased with the number of tissue hypoperfusion parame-
ters. These results have to be confirmed prospectively in a large cohort 
of PE patients but suggest that tissue hypoperfusion could be helpful 
for triage and potentially for guiding treatment.
Conclusion In a retrospective study, we observed an association 
between tissue hypoperfusion parameters and 28-day outcome in ICU 
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Introduction The administration of intravenous fluids is a key concern 
in the ICU. Fluids are used in many cases for renal protection, dilution 
of medications and as “maintenance” fluids. Moreover, they are consid-
ered as the cornerstone in resuscitation of patients with shock states 
[1]. Accordingly, large amounts of fluids are often administered with a 
resulting positive fluid balance and fluid overload.
Currently, several studies have identified a relationship between fluid 
overload and mortality [2]. Most of them have estimated fluid over-
load by calculating the cumulated fluid balance. This calculation is 
subject to numerous inaccuracies. Another method is daily measure-
ment of body weight. Few studies demonstrated the link between ICU 
mortality and early weight gain [2].
The aim of this study was to evaluate the association between early 
weight gain and ICU outcome.
Patients and methods All patients admitted from the 1st January 
2012 to 31th December 2013 in a medical ICU of a University Hospi-
tal for which a weight was recorded on admission (Day 0) and at Day 
3 were included. Demographic data, comorbidities, SOFA score, cause 
of ICU admission, length of stay and mortality were recorded. Weight 
changes were calculated by subtracting body weight as measured on 
third day from one as measured on admission.
Values are expressed as mean or median [min–max]. Univariate and 
multivariate linear or logistic regression analyses were performed to 
evaluate factors associated with clinical outcomes.
Results Two hundred and thirty-eight patients (mean age 64  years; 
61% male) were included. Median length of stay was 8  days [3–44]. 
ICU mortality rate was 12.6%. Significant differences were found 
between survivors and non survivors with regard to Day 0 SOFA score 
on admission (p < 0.005), need for mechanical ventilation (p = 0.012 
and hemodialysis (p = 0.048). Median body weight gain between Day 
0 and Day 3 was 1.3 kg [−5 to 10] in non-survivors and 0.8 kg [−13 to 
14] in survivors (p = 0.069). Admission SOFA score (OR 1.288; 95% CI 
1.103–1.503; p = 0.001), PaO2/FiO2 ratio on admission (OR 1.006; 95% 
CI 1.002–1.011; p = 0.002) and weight gain between Day 0 and Day 3 
(OR 1.123; 95% CI 1.001–1.261; p = 0.047) were independent mortal-
ity factors in multivariate analysis. Body weight gain (>1  kg  day 0 to 
3) was also correlated with a longer stay in the ICU (OR 1.39; 95% CI 
1.15–1.68; p = 0.0008).
Conclusion This study is one of the few to establish that early weight 
gain is an independent risk factor for mortality in ICU patients. The 
body weight, though subject to difficulties and possible errors in 
measurement is an indirect marker of fluid overload. It remains to 
establish if the control of fluid overload based on an early weight-gain 
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Introduction The PROSEVA study was the first randomized controlled 
study having shown a positive effect of prone position (PP) on ARDS 
mortality [1]. Unlike previous randomized controlled trial, PEEP was 
adjusted with a PEEP-FIO2 table, whose consequence was a small but 
significant decrease in the PEEP level. The aim of this study was to 
investigate the effect of PEEP variation during prone position on car-
diac index in ARDS patients.
Patients and methods Single center retrospective observational 
study performed on ARDS patients hospitalized in a medical ICU 
between July 2012 and March 2016. Patients included were adults 
fulfilling the Berlin definition for ARDS, undergoing at least one prone 
position session, under hemodynamic monitoring by the Picco ® 
device, with availability of hemodynamic measurements performed 
before (T1), at the end (T2), and after the prone position session (T3). 
Prone position sessions were excluded if they were performed >7 days 
after ARDS onset. The following variables were recorded: demo-
graphic, SAPSII, ARDS severity and risk factor, SOFA score and cumu-
lative fluid balance at PP onset, delay between ARDS session and PP 
session, hemodynamic, arterial blood gas, ventilatory settings, plateau 
pressure, catecholamine dose and additional treatments. Statistical 
analyses were performed using prone position session as statistical 
unit and mixed models taking into account both multiple prone posi-
tion sessions by patient and multiple measurements during a prone 
position session. Variables associated with cardiac index with a p value 
below 0.1 in univariate analysis were selected for inclusion in a mul-
tivariable mixed logistic regression model, using backward stepwise 
descending selection. p < 0.05 was chosen for statistical significance. 
Data are expressed as mean ± standard deviation.
Results 85 patients fulfilled the inclusion criteria over the study 
period, totalizing 149 prone position sessions (2  ±  1 sessions per 
patient). PEEP level decreased significantly from 9 ± 3 to 8 ± 2 cm H2O 
between T1 and T2. PEEP decreased by at least 5 cm of H2O in 18 (12%) 
of the PP sessions. Multivariate analysis identified 7 variables indepen-
dently associated with cardiac index (model 1, cf. Table 22). Multivari-
ate analysis also identified measurement time, age, sex, PEEP and pH 
as being independently related to global end-diastolic volume. After 
removing the effect of global end-diastolic volume by forcing it out of 
the model, PEEP became significantly related to cardiac index (model 
2, cf. Table 22), with a coefficient β suggesting a marginal effect on car-
diac index (−0.03 l min−1 m−2 per 1 cm H2O increase of PEEP).
Conclusion PEEP decrease during prone position as a consequence of 
improvement of oxygenation has a marginal but significant positive 
effect on cardiac index, related to an increase in global end-diastolic 
volume and probably venous return.
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Introduction Hyperammonaemia is defined as ammonaemia above 
80 µmol/L when child is under 1 month old and 55 µmol/L when over 
1 month old. Hyperammonaemia over 200 µmol/L was proved to be 
an independent factor of mortality. The recommended treatment for 
hyperammonaemia due to inherited error of metabolism is based on 
the association of sodium phenyl-acetate and sodium benzoate called 
Ammonul®. In order to improve management of hyperammonaemia 
in pediatric intensive care unit (PICU), an Ammonul® delivery proto-
col was implemented since the 30th August 2008. The purpose of our 
study was to evaluate the impact of this delivery protocol on morbid-
ity and mortality for patient admitted in PICU for hyperammonaemia.
Patients and methods A retrospective study was conducted from 
January 1st 2000 to May 31st 2016 in the PICU of the CHU Sainte Jus-
tine. Every patient with hyperammonaemia receiving Ammonul® and 
admitted in the PICU was included. Patients under 18 years old or for 
whom decision to withhold or withdraw treatment was taken, or brain 
dead at admission, or if treatment was started in another hospital 
were excluded. Patients were allocated in two groups, without or with, 
depending on if they were treated after or before the implementation 
of the protocol.
Results Ammonul® was prescribed for 32 patients during the study 
period, 4 of them weren’t admitted in PICU. Among the remaining 
28, 6 were excluded, especially for treatment timing reasons. Finally, 
22 patients were studied, 8 in the without protocol group and 14 in 
the with protocol group. Patients were aged 9  month [0–452] in the 
without group and 238 [0–512] in the with group (p  =  0.09). There 
was no difference between groups in term of weight (6 [3–43] vs 24 
[3–67]), ammonaemia level (328 [75–2022] vs 239 [150–830]) and 
severity score (PIMII 18 [5–54] vs 19 [2–100]). The principal cause 
of hyperammonaemia was inherited error of metabolism in both 
groups (6 (75%) vs 9 (64%)). The median delay between diagnosis and 
Ammonul prescription was 100 min [75–209] in the without group and 
47 min [0–81] in the with group (p < 0.001), the median delay between 
diagnosis and Ammonul administration was 173 min [95–339] in the 
without group and 173  min [73–276] in the with group (p  =  0.63). 
The mortality during hospitalisation was 50% (4) in the without group 
and 35% (5) in the with group (p = 0.34). The median PICU stay was 
104 [26–469] in the without group and 75.5  h [12–1305] in the with 
group (p = 0.73). There was no difference concerning liver transplant, 
ventilation and renal replacement therapy between groups.
Discussion This study is one the most important series of paediat-
ric patients treated with Ammonul®. Our study succeeded to show 
improvement in delay between diagnosis and prescription, but failed 
to show any improvement in morbi-mortality. Further analysis must be 
perform. One of the explanation of this lack of improvement would be 
the absence of difference between groups concerning delay between 
diagnosis and treatment administration.
Conclusion Our study showed that the implementation of a sodium 
phenyl-acetate and sodium benzoate delivery protocol shorten the 
delay between diagnosis of hyperammonaemia and treatment pre-
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Introduction In France, since 2006, legislation for pediatric critical 
care organization approved the establishment of pediatric intermedi-
ate care units, between pediatric wards and pediatric intensive care 
units. In pediatric intermediate units, children require close monitor-
ing and/or continuous monitoring due to potential organ failure, with-
out requiring resuscitation. The aim of this study is to describe patients 
characteristics of French pediatric intermediate care units.
Patients and methods We performed a prospective observational 
cohort study in pediatric intermediate care units of seven regional 
hospitals in northern of France. All consecutive patients under 
18  years, admitted in these seven pediatric intermediate care units 
were included (September 2012–January 2014).
Results Among 2909 consecutive screened patients, 2868 patients 
were included. Sex ratio was 1.26. Median of age was 29[5–103] 
months. Median of length of stay was 1 [1–3] day. Thirty-three per-
cent had comorbidities. Seventy per cent were transferred from emer-
gency unit. The type of stay was medical for 95%. The primary reason 
for admission was essentially respiratory (44%) and neurologic (22%). 
Infection was the main cause of respiratory failure (79%). The destina-
tion was pediatric ward in 53% and home in 36%. Three per cent were 
transferred in pediatric intensive care unit and one patient deceased.
Conclusion The patients hospitalized in pediatric intermediate care 
unit were young. The length of stay in these units was short and the 
respiratory failure was more frequent.
Competing interests
None.
Table 22 Multivariate analyses of  variables associated 
with cardiac index
Model 1 Model 1 Model 2 Model 2
β p β p
Age −0.043 <0.001 −0.021 <0.05
SOFA score 0.071 <0.001 0.103 <0.001
Neuromuscular blocking 
agents (ref = no)
0.450 <0.001 0.336 <0.05
Global end‑diastolic volume 
(mL m−2)
0.003 <0.001 – –
Dobutamine dose 
(µg kg min−1)
−0.021 <0.01 −0.023 <0.01
PaCO2 (mmHg) 0.014 <0.01 0.013 <0.05
PaO2/FiO2 (mmHg) −0.002 <0.001 −0.001 <0.05
PEEP (cm H2O) NS NS −0.030 <0.05
Time between ARDS onset 
and PP session
NS NS −0.044 <0.05
Renal replacement therapy 
(ref = no)
NS NS −0.355 <0.05
Measurement time 
[ref = before PP (T1)]
NS NS <0.001
 End of PP (T2) 0
 After PP (T3) −0.204
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Introduction Pediatric Early warning systems were created to quantify 
severity of illness across in hospitalized children in pediatric ward or 
emergency unit. Pediatric intermediate care units are alternative struc-
tures for moderate ill children. The aim of this study was to assess the 
validity of three pediatric early warning scores in pediatric intermedi-
ate care units.
Patients and methods We did a prospective, observational, mul-
ticenter cohort study in seven French regional hospitals (09/2012–
01/2014). All consecutive children <18  years were included. Three 
scores (PAWS, PEWS, and BedPEWS) were calculated each 8  h and 
more if deterioration. Binary outcome criteria were “medical call”, and 
“admission to Pediatric intensive care Unit (PICU)”. When one or two 
monitoring parameters necessary to calculate the score were missing, 
the score was still calculated and the missing value was considered 
normal and these scores were called “imputed scores”. We used areas 
under the ROC curve (AUC) to estimate discrimination.
Results 2868 children were included for a total of 19,071 observa-
tions for calculating the three scores. Median scores for the three 
scores were respectively 2, 2 and 1. Medical call was observed in 11% 
(n = 2056), and admission to PICU in 0.45% (n = 85). AUCs calculated 
for the three scores for predicting medical call were ranged from 0.92 
to 0.93. AUCs for predicting PICU admission were ranged from 0.89 to 
0.92 (Table 23).
Conclusion The three Pediatric Early warning scores, developed from 
pediatric ward and emergency department, can be used to detect 
deterioration requiring a medical intervention or PICU admission in 
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Introduction No study have been published to specifically evaluate or 
measure breastfeeding disruption during hospitalisation for bronchi-
olitis although the high number of hospitalisation for bronchiolitis in 
children potentially breastfed makes it an important health issue. We 
conducted a pilot study to try to measure that risk.
Patients and methods This is a single center prospective observa-
tional study conducted between the 1st of October 2015 and the 15th 
of February 2016 in a tertiary care teaching hospital. All patients under 
6  month hospitalized with acute bronchiolitis and receiving at least 
partial breastfeeding were considered for study. Patients discharged at 
home whose parents accepted to be contacted by phone were pro-
spectively included. The primary outcome was unwanted weaning 
from breastfeeding. The secondary outcome was trying to identify risk 
factors for weaning. Data are expressed as median values (with mini-
mum and maximum value) for continuous variables, and number and/
or frequency (%) for binary or categorical data.
Results During the study period 144 breastfed patients under 6 month 
were hospitalised at our hospital for bronchiolitis, 84 patients (58%) 
could be included in the study. Length of hospital stay was 3  days 
[1; 34] and 27 patients (32%) patients spent some time in PICU. One 
patient (1.2%) only needed invasive ventilation for 10 days, 18 (21%) 
received either NIV or high flow oxygen for 3  days [1;9], 34 patients 
(40%) received standard oxygen for 3  days [1; 7] and 34 patients 
(40%) received no respiratory support. Forty-five (53%) patients 
received nutritional support, either enteraly (N =  38, 45%) or paren-
teraly (N = 5, 6%) or both (N = 2, 2.4%). Most breastfeeding mothers 
(96%) did not smoke and lived as a couple (98%), 2% of mothers were 
working at the time of hospitalisation. Sixty-five patients (77%) were 
exclusively breastfed before hospitalisation. The median delay for 
phone contact was 3 month [0.5; 6]. Forty-three mothers (51%) stated 
that their breastfeeding had been modified by the hospitalisation 
of their child: 17 stopped breastfeeding (Group 1), 12 switched from 
total to partial breastfeeding (Group 2) and 14 reduced breasfeeding 
without stopping (Group 3). Remaining mothers (Group 4) (41, 49%) 
stated to have kept breastfeeding as before or that their breastfeed-
ing modification was personal choice. Patients whose breastfeeding 
was more impacted had a tendency to being younger with a median 
age of 34  days [3;166] vs 50  days [16;159] on admission, p 0.06) and 
to be exclusively breastfed before (81 vs 73%, NS). No difference was 
observed for birth weight, gestational age, daily growth before stay, 
length of stay, need for respiratory support, need for nutritional sup-
port, need for PICU admission between groups 1 + 2 + 3 and group 4. 
Mothers stated first cause of breastfeeding disturbance had been lack 
of support and advices (32.5%) followed with some logistics problem 
(difficulties to draw breast milk, room accommodation, introduction of 
formula milk) in 15.7% cases and severity of child’s respiratory disease 
in 16.8% cases.
Discussion This is the first study to highlight the effect of hospitali-
zation for bronchiolitis on breastfeeding, and to question the various 
factors involved. Our study is subject to possible bias (single cen-
tered, long delay between hospitalisation and questionnaire) but we 
Table 23 Discrimination of  three pediatric early warning 
systems for predicting medical call or admission to PICU
AUC area under the curve, OR odds ratio to increase score one point, CI 
confidence intervals
Scores Medical call Admission to PICU
AUC OR [95% CI] AUC OR [95% CI]
Complete PAWS 0.93 1.44 [1.38–1.51] 0.90 2.37 [1.97–2.85]
Imputed PAWS 0.93 1.34 [1.28–1.39] 0.91 2.44 [2.08–2.87]
Complete PEWS 0.92 1.67 [1.57–1.78] 0.91 2.82 [2.27–3.49]
Imputed PEWS 0.93 1.55 [1.47–1.63] 0.89 2.73 [2.25–3.30]
Complete BedPEWS 0.92 1.29 [1.25–1.33] 0.92 1.84 [1.60–2.11]
Imputed BedPEWS 0.93 1.29 [1.25–1.33] 0.92 1.85 [1.66–2.06]
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still achieved to reach a big number of patients (84 patients in one 
epidemic season). We observed a very high rate of breastfeeding dis-
turbance during hospitalisation for bronchiolitis in our hospital (over 
50%). We expected to find severity of respiratory disease as the first 
risk factor but only 16.8% of mothers pointed out severity of disease 
as a reason for unwanted weaning and respiratory distress on medi-
cal charts was also not significantly different. Lack of support from 
caregivers was the first factor pointed out. It is a modifiable factor for 
further practice, especially in younger infants for witch breastfeeding 
has just begun and is still precarious.
Conclusion Bronchiolitis is a high risk event for breastfeeding with 
about half of mothers in our hospital either stopping or diminishing 
their breastfeeding during hospitalisation. Correct advice and support 
could be a determining factor of breastfeeding’s continuation and 
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Introduction The explosion of non invasive ventilation (NIV) and high 
frequency canula therapy (HFNCT) in bronchiolitis for the last 10 years 
led to a decreased rate of intubation [1]. There are lacking data con-
cerning the clinical and biological factors associated with severe bron-
chiolitis defined by the need for an intensive level of NIV or for invasive 
ventilation (IV).
Patients and methods Two hundred and fifty-two patients aged of 
less than 6 months were included in a retrospective study conducted 
over a three winter period from 2013 to 2016 in a 16 bed French PICU. 
We aimed to compare patients hospitalized for severe bronchiolitis, 
defined by the need for an intensive level of NIV or for invasive 
ventilation (IV) to non severe patients that were treated with nasal 
continuous positive airway pressure (nCPAP) or HFNCT. We secondly 
analyzed the evolution of patients characteristics over a three 
winter period and factors associated with HFNCT failure. Clinical and 
biological factors were recorded at the admission of the patients and 
4 h after (H4).
Results One hundred patients were included in the non severe 
bronchiolitis group and 152 in the severe group. Factors significantly 
associated with severe bronchiolitis were a young age, a small weight 
and the presence of apneas at the admission. The Wang severity score, 
the heart rate, the apH and the PaCO2 were significantly different 
between the two groups at the admission and at H4. The level of 
oxygenation at H4 were also higher in the non severe group. The rate 
of bacterial coinfection, the length of stay in PICU and of ventilation 
were higher in the severe group. Over the 3 years period, the rate of 
IV and NIV bilevel positive airway pressure significantly decreased 
in parallel with the increased utilization of HFNCT. Comparing 
patients responders or not to HFNCT, the weight, the Wang score, 
the respiratory rate, the apH and the PaCO2 at H4 were significantly 
different.
Discussion First, we found that clinical and biological factors asso-
ciated with the need for a NIV bi level positive airway pressure were 
similar of those associated with the need for IV previously described 
[2]. We can hypothesize that patients at risk of severe bronchiolitis and 
NIV failure are actually better identified with prompt modification of 
ventilation parameters and a greater tolerance for permissive hyper-
capnia under NIV support. All of these factors lead to a reduction of 
the rate of intubation [1]. Secondly, patients hospitalized seemed to 
be less severe according to biological parameters (apH and PaCO2) 
and the decreased need for IV all along the three seasons studied. 
This could be in relation with an earlier recognition of critically illness 
patients and no delayed respiratory support treatment. This could 
also be related to an increased administration of HFNCT to patients 
usually treated with standard oxygen treatment. Finally, we reported 
factors associated with HFNCT failure. Even if HFNCT is not actually 
recommended in the first line treatment of bronchiolitis, some authors 
described its efficiency in this pathology, with similar results as nCPAP 
and superiority to standard nasal oxygen with reduced respiratory 
rate, respiratory work, length of stay and level of oxygenation.
Conclusion NIV is a useful respiratory support technique in paediat-
ric patients with bronchiolitis. Younger and heavier patients, clinical 
severity score, respiratory and heart rate or biological parameters like 




1. Mayordomo‑Colunga J, Medina A, Rey C, Díaz JJ, Concha A, Los Arcos 
M, Menéndez S. Predictive factors of non invasive ventilation failure in 
critically ill children: a prospective epidemiological study. Intensive Care 
Med. 2009;35(3):527–36.
2. Ganu SS, Gautam A, Wilkins B, Egan J. Increase in use of non‑invasive 
ventilation for infants with severe bronchiolitis is associated with 
decline in intubation rates over a decade. Intensive Care Med. 
2012;38(7):1177–83.
P128 
Practice survey on prone positioning in French‑speaking pediatric 
intensive care units (nursing part)
Julien Denot1, Véronique Berthelot1, Emilie Thueux1, Marie Reymond1, 
Alexandra De Larrard1, Alain Amblard1, Jérôme Rambaud1, Pierre‑Louis 
Leger1 
1Réanimation néonatale et pédiatrique, Hopital pour enfants Trousseau, 
Paris, France
Correspondence: Pierre‑Louis Leger ‑ leger.pierrelouis@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P128
Introduction The prone positioning (PP) is a strategy widely used in 
the treatment of severe forms of acute respiratory distress syndrome 
(ARDS) in adults. Its early use significantly reduces mortality [1]. 
However, the studies do not strongly demonstrate its prognostic 
impact in pediatric ARDS. The aim of this study was to describe the 
prone positioning practices in the French-speaking pediatric intensive 
care units (PICU).
Patients and methods This survey was conducted by email ques-
tionnaire to pediatric intensivists belonging to the French Society of 
Intensive Care Medicine and the French-speaking Group of Pediat-
ric Intensive Care and Emergency Medicine. It was conducted From 
February to May 2016. The survey was addressed to doctors, nurses, 
physiotherapists practicing in PICU. It included 29 questions about 
indications, contraindications, techniques and medical devices used, 
and complications.
Results One hundred and three persons answered (69 doctors and 33 
nurses) which work in 28 French hospitals and 1 Canadian hospital. The 
thoraco-abdominal support is use whatever the age (neonates, infants, 
children) and frequently made with non-specific material: sheets and 
undersheets (64%), cocoons with balls (44%), pillows and bolsters 
(38%). The members are placed in flexion or half-flexion (71% of inter-
viewed persons) without systematic changes of the positions. The PP is 
frequently stopped during the dressings (72% of interviewed persons), 
less frequently to achieve a toilet (44%), radiography (43%) or physi-
otherapy session (29%). Seventy-six percent of interviewed persons 
say that the kind and location of prostheses (catheter, drains, stomy) 
are not contraindications to the PP. Concerning respiratory care 74% of 
interviewed persons frequently use a closed system for tracheal aspira-
tions. Moreover, 45% of interviewed persons say that respiratory physi-
otherapy sessions are not classically realized in PP periods. Concerning 
the enteral nutrition 59% of persons do not change their practices 
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during PP and only 10% reduce or stop it. Finally the mucocutaneous 
complications are the most frequent (54% of interviewed persons) just 
before the displacement of protheses (37%). The prevention of cutane-
ous pressure ulcers by the use of specific mattress is widespread (61% 
of interviewed persons) but no supplemental care in prone compared 
to supine positioning.
Discussion The survey aimed to describe the techniques and modali-
ties of PP in children, as well as several aspects of care associated with 
PP. The results show that the quality of care seems unaffected by the 
PP. The interviewed persons do not reported technical contraindica-
tion of PP. However, a special attention should be put on hemody-
namic instability, tracheostomy or umbilical venous catheter. The 
survey reported the same complications in children and adult [2]. 
Finally, we also report the absence of paramedical care protocol for the 
PP. Future clinical studies will assess the impact of nursing protocols 
to limit complications, improve quality and comfort of care in children 
during PP periods.
Conclusion The prone positioning in French-speaking pediatric 
intensive care units is not very well protocolized. Nevertheless, the 
care not seems to be significantly impacted by the prone positioning. 
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Introduction The Mechanical ventilation (MV) is the main technical 
motivating ICU admission and involves on average 30% of children 
(range 20–60%), half is extubated within 48 h. Weaning from mechani-
cal ventilation, should be as early as possible in order to reduce the risk 
of iatrogenic complications, hospital stay in intensive care and costs.
Our purpose is the implementation of a written protocol of weaning 
from mechanical ventilation in a pediatric intensive care unit.
Patients and methods This is a prospective study including all 
children aged between 1 month and 15  years, admitted to the 
pediatric intensive care unit at Canastel Hospital in Oran Algeria 
during the period from 1 March 2015 to 31 August 2016.
The weaning protocol involves the systematic and daily search for 7 
criteria for sevrabilité allowing extubation:
  • Resolution of the case
  • FiO2 < 50% or SaO2 > 90% and ≤5 cm H2O PEEP
  • Dobutamine or noradrenaline ≤ 5 ≤ 0.2/kg/min
  • Conscious or slightly sedated or Glasgow >12
  • Cough, effective deglutition
  • No surgery <12 h
 • T < 38.5°C
Results We included 43 children. The average age is 6 years (1 month–
14  years), sex ratio is 1.2. The most common reason for admission in 
ICU was the severe brain injury in 21.4% and the status epilepticus 
19%. The patients were intubated in 70.7% of cases for an alteration of 
the state of consciousness. Ten patients (25.6%) had a post extubation 
dyspnea, 3 required reintubation within 24 h. A corticosteroids admin-
istered in 67.4% of patients in the 12 h before extubation. No deaths 
during the study.
Conclusion Weaning from mechanical ventilation is a key direction for 
the prognosis of ICU patients where the value of a weaning protocol 
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Introduction Chlamydia pneumoniae (CP) and Mycoplasma pneu-
moniae (MP) are intracellular pathogens that account up to 20% of 
community acquired. These patients with “atypical pneumonia” may 
require ICU admission for acute respiratory failure.
Patients and methods Medical charts of adult patients hospitalized 
between 2000 and 2015 in the ICU of 20 French hospitals with proven 
atypical pneumonia (positive serology or PCR) were retrospectively 
reviewed. Patients with Mycoplasma pneumoniae infections were 
compared to microbiologically documented Streptococcus pneumonia 
patients (SP).
Results 104 patients were included (71 men, 33 women) with a 
median age of 56 [44–67] years, mainly admitted to the ICU for acute 
respiratory failure (n  =  96, 92%). Mycoplasma pneumoniae was the 
causative agent in 76 patients (73%) and Chlamydia pneumoniae in 
28 (27%). Atypical pneumonia was more frequent during autumn and 
winter. Superinfection was reported in 19 cases (viruses in 47%). Clini-
cally, 33 patients (32%) had at least one extra pulmonary symptom. 
Chest-X-ray disclosed an involvement of 2 [1–4] quadrants, alveolar 
opacities (n  =  61, 75%), interstitial opacities (n  =  32, 40%) or pleu-
ral effusion (n =  6, 7%). During ICU stay, 75 patients (72%) required 
mechanical ventilation. Among them, 34 had ARDS. More than one-
third of the patients (n  =  41) received vasopressors. ICU length of 
stay was 14 days [6–21] in patients that were discharged alive and 23 
[18–41] in patients who died in the ICU-days; 11 (11%) patients died in 
the ICU. Factors associated with mortality, in univariate analysis, were 
age ≥65 years (p = 0.033), signs of respiratory distress (p = 0.017) and 
interstitial opacities on chest X-ray (p = 0.017).
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Characteristics at admission for SP and MP patients were compared 
(Table 24). HIV infection was more frequently associated with SP pneu-
monia (16 vs. 3%, p = 0.009). SP patients presented more frequently 
with shock in (32 vs. 8%, p = 0.0004) and acute renal failure (13 vs. 9%, 
p =  0.008). SP pneumonia was associated with higher ICU mortality 
(20 vs. 5% at 28 days, p = 0.005).
Conclusion Critically ill patients with severe atypical bacterial pneu-
monia have a 11% case fatality. This study maintains a high level of 
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Introduction Legionnaire’s disease (LD) is a severe pneumonia com-
monly caused by Legionella pneumophila serogroup 1. Despite 
advances in critical care management and antimicrobial thearapy its 
morbimortality remains still high. No epidemiologic studies had been 
reported in Tunisia.
Objectives: To study characteristics and outcomes of patients admit-
ted in ICU with severe community acquired pneumonia due to LD over 
17 years.
Patients and methods It was a retrospective cohort study from the 
1st of January 2000 to the 15th of September 2016. We described 
epidemiology, clinical features, treatment and outcomes of patients 
admitted to ICU.
Results 19 patients were enrolled, the overall cumulative inci-
dence was 0.2 episodes/1000 admissions and 0.17% of all commu-
nity acquired pneumonia hospitalized during this period. Eighteen 
patients were males. Median age was 51 years [25–81 years]. A sum-
mer and autumnal peaks was observed. Comorbidities were observed 
in 9 patients. Mean IGSII score was 42 [23–79] and major criteria of ATS 
were present in 5 cases. At admission in ICU, all patients had acute 
respiratory failure; 3 gastrointestinal symptoms; 9 hyponatremia, 8 
rhabdomyolysis and 12 had elevated liver enzymes. Acute respiratory 
distress syndrome (ARDS) was present in 16 cases (severe n = 5, mild 
n = 6, light n = 5). Septic shock and acute renal failure were observed 
respectively in 5 and 8 cases. Diagnosis was made in all cases by uri-
nary antigen test. Legionella pneumophila was present also in sputum 
in 5 cases. Mechanical ventilation was needed in 13 cases; it was ini-
tially NIV in 46%. Fifteen patients were treated by a combination anti-
biotherapy: It was macrolide and quinolone in 52% (n = 10), quinolone 
and rifampicine in 31% (n  =  5), the others were treated with mac-
rolide or quinolones in monotheray. Median duration of ventilation 
was 7 days [2–29 days]. Median length of ICU stay was 13 days. Seven 
patients were died. Univariate analysis showed that presence of major 
criteria of ATS score at admission (p = 0.001), severe ARDS (p = 0.004), 
elevated liver enzymes (p =  0.047), needs of mechanical ventilation 
(p = 0.024) or intubation (p = 0.00), septic shock (p = 0.001); dialysis 
(p = 0.020) were associated with a higher mortality. Multivariate analy-
sis showed that independent predictive factors of mortality were ATS 
major criteria OR 3.5 [95% CI (1.08–11.92)]; mechanical ventilation OR 
0.5 [95% CI (0.28–0.88)]; severe ARDS OR 0.117 [95% CI (0.017–0.80)]; 
septic shock OR 0.09 [95% CI (0.015–0.65)] and need of dialysis OR 0.14 
[95% CI (0.02–1.06)].
Conclusion Our study confirms that LD requiring hospitalization in 
ICU is associated with high morbimortality. Presence of ATS major cri-
teria, severe ARDS, mechanical ventilation, septic shock and dialysis 
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Introduction Patients on chronic hemodialysis are prone to develop 
overload pulmonary edema (OPE) but also infections, and have been 
reported to be regularly admitted to the intensive care unit (ICU) [1, 
2]. Acute respiratory failure (ARF) in this specific population can be 
challenging for the intensivist, as OPE requires ultrafiltration which 
could be deleterious in other causes. The objectives of this study were 
(1) to describe the spectrum of ARF causes in patients on chronic 
hemodialysis and (2) to identify predictors of pulmonary edema 
diagnosis.
Patients and methods We performed a monocentric retrospective 
study in the 18-bed ICU of a non-teaching hospital with a nephrology 
unit. All patients on chronic hemodialysis admitted to the ICU for ARF 
Table 24 Characteristics at  admission for  SP patients 
and MP patients











 Respiratory rate 33 [27–38] 30 [26–36] 0.43
 Signs of respira‑
tory distress
33 (49%) 34 (45%) 0.74
 Ronchi 9 (15%) 12 (16%) 1
 Crackles 36 (61%) 44 (59%) 1
 Signs of consolida‑
tion
5 (9%) 22 (30%) 0.008
 Decreased vesicu‑
lar breath sound
10 (17%) 28 (38%) 0.007
Clinical presentation
 Time since 
symptom onset 
(days)
6 [4–9] 3 [2–7] 0.0008
 Fever 58 (83%) 54 (71%) 0.12
 Shock 6 (8%) 24 (32%) 0.0004
 Neurological 
disorders
1 (1%) 20 (26%) <0.0001
 Gastro intestinal 
symptoms
1 (1%) 15 (20%) 0.0003
Radiological features
 Number of quad‑
rants
  <2 37 (49%) 66 (87%)
  >2 16 (21%) 9 (12%)
 Alveolar opacities 42 (75%) 69 (92%)
 Interstitial opaci‑
ties
20 (36%) 6 (8%)
 Pleural effusion 3 (5%) 17 (23%)
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in the period 2011–2015 were included. Patients with unknown diag-
nosis on ICU discharge were excluded.
We defined ARF as either use of oxygen at ≥6  l/min dioxygen to 
achieve a pulse oximetry measurement of ≥90% (88% in COPD 
patients) or partial pressure of arterial oxygen (PaO2) <60  mmHg on 
room air or need for mechanical ventilation plus of one of the follow-
ing signs: a respiratory rate of >25 breaths/min, use of accessory res-
piratory muscles, or cyanosis associated to worsening dyspnea. The 
following data were collected: previous dry weight, time from last 
dialysis session, clinical, biological and imaging data on admission, 
number of dialysis sessions performed in ICU and total ultrafiltration 
volume required to withdraw oxygen therapy, weight on discharge, 
treatment and outcome, Patients were classified as having OPE (OPE 
group) or not (non-OPE group) based on the final diagnosis on ICU dis-
charge. The two groups were compared with univariate analysis using 
non parametric tests.
Results 44 patients with 59 episodes of ARF were included in the final 
analysis.
46 (78%) episodes were due to OPE and 13 (22%) to other causes, 
including: 8 (61.5%) lower respiratory tract infections, 4 (30.8%) COPD 
exacerbation and one pulmonary embolism (7.7%). Patients admit-
ted for OPE had higher systolic blood pressure at first medical contact 
(median [25–75 IQR]: 194  mmHg [176–215] vs 105  mmHg [91–119]; 
p < 0.0000001), lower CRP on arrival (10 mg/l [6–17] vs 53.5 mg/l [9.8–
133.8]; p = 0.006), higher weight gain related to dry weight (2.1 [1–3] 
vs 0.5 [−0.25 to 2]; p = 0.01) and longer time since last dialysis (2 days 
[2–3] vs 1 [0–2.5]; p = 0.02). We did not find significant differences in 
temperature on arrival, white blood cells count nor NT-proBNP. Chest 
X-Ray interpretation was correct in 82% of cases of OPE patients but 
could not conclude in 46% of non-OPE episodes. Non-OPE patients 
had a more severe prognosis 38.5% of death (n  =  5) versus 2.2% 
(n = 1).
Conclusion In this small retrospective monocentric study, ARF in 
patients on chronic hemodialysis is due to non-OPE cause in 22% of 
cases. A lower blood pressure, a higher CRP, and a shorter time from 
last dialysis session could prompt physician to search for a non-OPE 
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Introduction Both haematological and solid malignancies may be 
directly responsible for life-threatening organ failures including 
obstruction of anatomical structures, tissue infiltration, tumor lysis 
syndrome, or coagulation disorders. Besides advanced life support and 
eventual instrumental interventions, the treatment of cancer-related 
organ failures relies on timely administration of chemotherapy. Pub-
lished data about requirements of chemotherapy in the ICU are mostly 
related to patients with haematological malignancies, while reports of 
patients with solid tumors are scarce. In this study, we addressed the 
features and outcomes of patients with organ failures directly related 
to solid neoplasms.
Patients and methods We performed a retrospective multicenter 
study within the GrrrOH research network. All adult patients who were 
admitted to the ICU with organ failures related to solid malignan-
cies and treated with chemotherapy between 2000 and 2015 were 
enrolled into the study. Data were collected from individual files, and 
included the overall severity through the SOFA score computed at the 
time of ICU admission, the type and mechanism of organ failures, and 
the modalities of chemotherapy administration. Endpoints were the 
in-ICU and in-hospital vital status.
Results 136 patients were included. The most common underlying 
malignancy was lung cancer (n = 90), distributed between small cell 
lung cancer (SCLC) (n =  57) and non-small cell lung cancer (NSCLC) 
(n = 33). Most malignancies were newly diagnosed (n = 122, 89.7%), 
the diagnosis being made in the ICU for 80 patients (58.9%). The 
majority of patients (n = 82, 60.3%) had metastasis. The main reason 
for ICU admission was acute respiratory failure in 111 (81.6%) patients. 
Compression and tissue infiltration by tumor cells were the lead-
ing mechanisms resulting in organ involvement in 78 (57.4%) and 47 
(34.6%) patients. Other indications for ICU admission relied on para-
neoplastic manifestations in 11 cases. The treatment was based on 
combined and single chemotherapy in 120 (88.2%) and 16 (11.8%) 
patients, respectively. The dosing was reduced in 20 patients (20%) 
mostly linked to renal failure, and the sequence of drug administration 
was modified in 18 patients (18%). Thirty-four patients (25%) required 
either instrumental or surgical adjuvant procedures. Eighty-nine 
patients received invasive mechanical ventilation with duration of 13 
(5–25) days, 39 patients required vasopressors (28.7%) and 11 required 
renal replacement therapy (8.1%).
The overall in-ICU, in-hospital, 6-month and 1-year mortality rates 
were 37, 58, 74 and 88%, respectively. In a multivariate logistic regres-
sion analysis, SCLC was identified as an independent predictor of hos-
pital survival. However this gain in survival was not sustained since the 
1-year survival rates of SCLC, NSCLC and non-lung cancer patients all 
dropped below 20%.
Discussion The prognosis of solid neoplasm-related organ failures 
relies on multidisciplinary management involving both intensivists 
and oncologists. Appropriate management of cytostatic drugs is 
paramount to improve their efficacy on tumor cells while minimizing 
their toxicity. Dosing of chemotherapy in critically ill patients 
represents a still unexplored area of research owing to a number of 
factors that may result in drug underdosing or overdosing.
Conclusion Acute respiratory failure related to lung cancer repre-
sents the main indication for urgent administration of chemotherapy 
in the ICU. Urgent chemotherapy along with aggressive management 
of organ failures in the ICU can be life-saving in a number of cancer 
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Introduction Pneumonia is a frequent and severe complication 
of major cardiac surgery, contributing to postoperative morbidity 
and death [1]. Diagnosis of pneumonia remains a challenge in 
ventilated patients, notably after cardiac surgery, and the diagnostic 
performance of Clinical Pulmonary Infection Score (CPIS) remains 
controversial. Lung ultrasound (LUS) has been successfully used 
for the diagnosis and the management of community acquired 
pneumonia and ventilator-associated pneumonia (VAP) [2], but LUS 
usefulness and reliability was never investigated in the specific ICU 
patients after cardiac surgery with cardiopulmonary bypass (CPB). 
This pilot observational study investigated the clinical relevance of 
lung ultrasonography (LUS) for diagnosis of pneumonia in cardiac 
postoperative patients with acute respiratory failure (ARF).
Patients and methods Adult patients were prospectively enrolled 
from January through May 2015 in presence of acute respiratory 
failure (ARF) less than 3  days after a cardiac surgery with CPB. Lung 
ultrasound examination was performed as follows: subpleural consoli-
dation, lobar consolidation, dynamic and static air bronchogram, and 
intrapulmonary shunt. We compared this ultrasound approach to the 
post hoc diagnosis of pneumonia established from clinical, radiologic, 
and biologic data by three blinded experts. Then, we compared the 
diagnostic performances of CPIS, ultrasound criteria and a lung ultra-
sound based CPIS, LUS-CPIS, with or without radiology criteria. The 
study was approved by the Comité de Protection des Personnes Ile de 
France III; IRB 2015-A00127-42 Réf. S.C. 3275.
Results Fifty-one patients (age 65 ±  12  years, male sex 72.6%) with 
ARF were included in the study, and pneumonia was diagnosed in 
26 of them. No difference was observed between patients with or 
without pneumonia among demographic data, type of surgery, CPB 
length. In case of pneumonia, the most frequently identified patho-
gens were Enterobacteriaceae (37%), Pseudomonas aeruginosa (15%) 
and Haemophilus influenza (8%). Multivaried analysis showed that 
intrapulmonary shunt was the best predictive criteria of pneumonia 
(odds-ratio 1.92; 95% CI [1.00; 5.43]). The ultrasound diagnosis was 
more accurate than the simplified CPIS for the diagnosis of pneumo-
nia, area under the curve (AUC) respectively 0.75 (95% CI [0.62; 0.87] 
vs 0.59 (95% CI [0.47; 0.71]). Receiver operating characteristic curves 
analysis showed that the most accurate score for diagnosis of pneu-
monia was LUS-CPIS without radiology (AUC, 0.80 [0.69; 0.91]), with a 
sensitivity of 92% (95% CI [0.85; 0.99]) and a specificity of 68% (95% CI 
[0.55; 0.81]), a positive predictive value of 75% (95% CI [0.64; 0.88]) and 
a negative predictive value of (95% CI [0.63; 0.87]) (Fig.  30). Further-
more, our results suggest the use of ultrasound data may consistently 
reduce misuse of antibiotics of 70%.
Discussion A new score, combination of simplified CPIS and a sim-
ple ultrasound parameter, intra-pulmonary shunt, predicts efficiently 
the presence of pneumonia after cardiac surgery with CPB. Two LUS 
parameters, presence of a shunt and a bronchogram aeric within a 
consolidation, are crucial for discerning pneumonia from another eti-
ology. This approach has the advantage to make an early diagnosis 
of pneumonia in ARF patients with an inexpensive, non-invasive and 
convenient at bedside technology.
Conclusion This prospective observational study is the first one show-
ing that LUS combined with a clinical score can be a reliable tool for 
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Introduction Acute respiratory infection (ARI) is the most common 
infectious cause for admission to Intensive Care Unit (ICU) and the 
prevalence of infection increases with age. Changes in population 
demographics and comorbid illness may drive important changes in 
the composition of patients admitted to the ICU. Notably, how the 
population aging impacts on the incidence of hospitalized patients 
for ARI and how it increases the demand for critical care services is 
unknown. To address this knowledge gap, we sought to describe 
trends in demographics changes among elderly patients admitted to 
ICU for ARI on a 9-year period.
Materials and methods We conducted a retrospective cross-sectional 
study based on hospital discharge databases (HDDs) from January 1, 
2006 to December 31, 2014. We selected patients over 18  years old 
(y-o) who were hospitalized for ARI in a French region (Centre Val de 
Loire region, 2.5 million inhabitants, served by one university hospital, 
one regional hospital and 37 general and private hospitals). Cases of 
ARI were extracted from the HDD with an algorithm based on ICD-10 
specific diagnosis codes, taking into account the type, number and 
position of these codes in the hospital discharge report. We previously 
validated the ICD-10 case definition reviewing a sample of medical 
charts as the gold standard. Giving the acceptable accuracy and pre-
cision of our algorithm, the following data were extracted from the 
Fig. 30 See text for description
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HDD: patient characteristics and comorbidities, ICU hospitalization, 
use of mechanical ventilation, length of stay, occurrence of death.
Results On the study period, the number of hospitalization for ARI has 
almost doubled: from 6751 cases in 2006 to 11,744 cases in 2012, and 
10,167 cases in 2014. The incidence of ARI increased in all age class but 
was more important for patient over 85 y-o. Among these hospitalized 
patients, 740 were hospitalized in ICU in 2006 and nearly 2000 in 2014. 
Importantly, the rate of ICU-hospitalization among hospitalized patients 
for ARI increased on the study period: 11% in 2006 whereas it was supe-
rior to 17% since 2010. This trend for increase ICU admission was propor-
tional with aging: 2-fold increase at 75–79 y-o, 2.5-fold increase at 80–84 
y-o, threefold increase at 85–90 y-o, and 4.5-fold increase for patient 
over 90 y-o. The overall hospital-mortality was relatively stable and var-
ied between 6.7 and 9% for non-ICU patients and 14.4–17.2% in ICU-
patients. Regarding patients over 90 y-o hospitalized in ICU, the mortality 
has been drastically reduced: from 40.9 to 22.2% on the study period.
Discussion This large prospective study provides a contemporary 
view of elderly with severe ARI admitted to ICUs. We found significant 
increase in elderly patient with a primary diagnosis of ARI hospital-
ized in ICU. We highlighted that ARI is an increasing reason for death 
among ICU-hospitalized patient and still a major public health prob-
lem. Interestingly, our results are consistent with longitudinal changes 
in ICU admission also observed in this study period in the United 
States.
Conclusion We found substantial increase of ARI diagnoses leading 
to hospitalization between 2006 and 2014 with a growing demand for 
critical care service. Further studies are needed to evaluate the ben-
efits of intensive care hospitalization for the very elderly patients. We 
cannot arbitrary reject the very elderly from the doors of the ICU—it 
is ageism—but we need information to select more accurately the 
patients with the highest probability of survival, and to avoid useless 
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Introduction Pulmonary embolism is a major complication observed 
in critical ill patients. ICU environment patients are at high risk of deep 
vein thrombosis and pulmonary embolism. The objective of our study 
is to determine the incidence of this pathology and to analyze the 
prognosis of patients having a pulmonary embolism in ICU.
Patients and methods Prospective study included all patients with 
confirmed pulmonary embolism by a spiral computed tomography 
scan showing one or more filling defects in the pulmonary artery or in 
its branches, over a period of 1 year from 1 July 2014 to 30 June 2015. 
We studied the epidemiological, clinical, biological and radiological 
these patients. We compare two groups in univariate analysis: survi-
vors and deaths.
Results During the study period, 705 patients were admitted in our 
ICU. The diagnosis of PE was confirmed in 75 patients (10.6%). The 
mean age was 53.2. The sex ratio (M/W) was 5.25. SAPSII was 37, SAPSIII 
was 43 and SOFA was 5. At admission in ICU, 90% of patients were ven-
tilated. The mean delay of development of PE was 7.15. On the day of 
PE diagnosis, shock index was 0.94, clinical examination showed that 
22 patients (29.3%) were hypotensive, 33 (44.4%) have SIRS, 9 (12%) 
have clinical manifestations of DVT and 69 (92%) have respiratory dis-
tress requiring mechanical ventilation. All patients underwent spiral 
computed tomography scan. PE was proximal in 58 patients (77%) 
and bilateral in 7 patients (9.3%). In our study, intravenous unfrac-
tionated heparin was used in 70 cases (93.3%) and low molecular 
weight heparins were used in 5 cases (6.66%). The mean ICU stay was 
20.2 ± 25.3 days and the mean hospital stay was 26.3 ± 26 days. The 
mortality rate in ICU was 38.7%.
Moreover, comparison between survivors and deceased showed 
that factors associated with deaths were: high SAPS II score on ICU 
admission, high SAPS III score on ICU admission, high SOFA score, 
low shock index on the day of pulmonary embolism, hypoxemia with 
PaO2/FiO2 < 200 mmHg and the presence of shock.
Conclusion Pulmonary embolism (PE) is a frequent, in ICU. It is associ-
ated with a high ICU and in-hospital mortality rate. high SAPS II score 
on ICU admission, high SAPS III score on ICU admission, high SOFA 
score, low shock index on the day of pulmonary embolism, hypoxemia 
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Introduction Intracranial hypertension is suspected on clinical, radio-
logical and ophthalmological criteria. The measurement of intracranial 
pressure is the reference method. Due to infectious and hemorrhagic 
risks, other non-invasive techniques have been developed such as the 
transcranial color-coded duplex sonography (TCCDS) and the optic 
nerve sheath diameter (ONSD). The aim of our study was to compare 
TCCDS data to the ONSD measurements and to CT scanning data in 
predicting intracranial hypertension.
Patients and methods Prospective study enrolling all patients 
admitted to our ICU for severe traumatic brain injury between 
February and August 2016. The intracranial hypertension was studied 
by CT scanning, TCCDS and ocular ultrasonography. CT defines 
intracranial hypertension by a midline shift >5  mm, collapsed third 
ventricle, presence of hydrocephalus and erased basal cisterns 
with significant edema. TTCDS identifies a significant intracranial 
hypertension by a pulsatile index (PI) >1.2 and a diastolic velocity 
<20  cm/s. An ONSD  >  5  mm is considered abnormal. The study of 
associations was done using non-parametric tests (Wilcoxon and 
Fisher) and data analysis was performed by epi-info software.
Results Sixty patients with severe traumatic brain injury were 
included in the study. The average age was 42 ± 17 years. The sex-ratio 
was 1.4. The intracranial hypertension was diagnosed by pupillary 
abnormalities in 36% of cases, CT scanning in 84% of cases, TTCDS 
in 68% of cases and ONSD in 69% of cases. There was no significant 
correlation between an ONSD  >  5  mm and CT scanning findings 
(p  =  0.58) nor with TCCDS (p  =  0.08) in predicting intracranial 
hypertension.
Conclusion ONSD is a quick and simple method that has been widely 
proven to predict intracranial hypertension. A larger sample is needed 
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Introduction Head injuries are a public health problem. Studies on 
the epidemiology and especially the prognosis of head trauma are rare 
in developing countries. The objective of our study is to determine the 
epidemiological aspects and to identify factors correlated with short- 
and long-term prognosis.
Patients and methods It was a retrospective study during 4  years 
(January 2009–December 2012) included 694 patients with traumatic 
brain injury due to traffic accidents. We studied the factors correlated 
with poor prognosis in terms of death or Glasgow Outcome Scale 
(GOS) in univariate and multivariate analysis.
For study according to GOS, patients (n =  694) were divided in two 
groups: favorable GOS for patients having a good recovery or recovery 
with a minor handicap [GOS class 4 or5] and unfavorable GOS for 
patients having a severe handicap or vegetative state [GOS class 1or 
2] or died [GOS1].
Results During the study period, 694 patients (18.7% of all patients) 
were admitted to our ICU with traumatic brain injury due to traffic 
accidents. The mean of age was 31.9. The sex ratio was 5.8. In 
admission, 20% of patients had hypotension, 17.4% of patients had 
respiratory distress and the mean GSC was 8.8. The mortality rate was 
28.5%. 496 patients were survivor: 13 patients with vegetative state, 
133 with severe handicap (19.3%), 185 patients with minor handicap 
(26.7%), and 163 patients with good recovery (23.6%). The predictive 
independent factors correlated to mortality in multivariate analysis 
were: age ≥38, hypotension, hypoxemia, SGS ≤ 8, unilateral or bilateral 
mydriasis, cerebral edema, Marshall Class VI, initial hemoglobin ≤11.3, 
Blood sugar ≥8.3  mmol/l. The predictive factors correlated with 
poor prognosis according GOS were: age ≥38, initial shock, SGC ≤ 8, 
unilateral or bilateral mydriasis, post traumatic coma duration more 
than 5  days, cerebral edema, initial hemoglobin ≤11.7  g/dl, blood 
sugar ≥8.4 mmol/l and catecholamine using.
Conclusion The short-term prognosis of head trauma seems recently 
stabilized even for the most serious patients, but the distant conse-
quences of head trauma are fairly frequent, heavy and often underval-
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Introduction Fifteen percent of the trauma has a chest trauma. 
Depending on the type of injury, mortality raises from 4 to 60%. There 
are no surgical guidelines concerning rib fracture except for flail chest 
needing mechanical ventilation. No trial has yet assessed the global 
benefit of both surgical and medical treatment.
The primary endpoint was to determine wether rib fixation on the one 
hand and epidural analgesia on the other hand reduces pneumonia. 
The secondary endpoints were to show a decrease of mechanical ven-
tilation duration and lengths of stay in intensive care and hospital.
Materials and methods We performed a pre/post osteosynthe-
sis study. We determined two groups. From 01/2011 to 08/2014, all 
patients admitted for chest trauma were screened by a thoracic sur-
geon in order to select those with a rib fixation indication. They formed 
the historical cohort: «not fixed». From 08/2014 to 08/2016, all patients 
with chest trauma and rib fixation were included. They formed the 
group «fixed». Were excluded patients who died within the first 48 h. 
The surgical treatment is defined by a rib fixation. The medical treat-
ment is defined by epidural analgesia and noninvasive ventilation.
Results One hundred and twelve patients with equivalent surgical 
indication of rib fixation were enrolled from January 2011 to August 
2016. Fifty-seven patients were not fixed and 55 patients were fixed. 
Eighty-two (73%) were men of 57 (20–86) years old. The mean ISS was 
22 (4–66). The mean SAPS II was 25 (6–86). Eighty-five patients (80%) 
were hospitalized in Intensive care. 72 patients (64%) had an epidural 
analgesia. Fifty percent of the patients were operated on within the 
first 24 h. Thirty-three patients suffered from pneumonia that occurred 
on average on the fifth (2–10) day. Epidural analgesia significantly 
decreased the incidence of pneumonia (p  <  0.001). Rib fixation had 
no impact on the incidence of pneumonia (p =  0.1). Both length of 
stay in hospital and in intensive care were neither reduced by epidural 
analgesia nor by rib fixation. Epidural analgesia reduced mechanical 
ventilation duration. Rib fixation didn’t reduce mechanical ventilation 
duration.
Conclusion It is the first study to assess the importance of both medi-
cal and surgical care of chest trauma. Epidural analgesia is effective in 
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Introduction Serious liver injuries classified have very high mortality 
figures despite improved care systems and means of paraclinical 
investigations.
Stud Objective: The purpose of this study was to determine the prog-
nostic factors of severe liver injury by evaluating epidemiological, 
diagnostic, therapeutic and evolutionary data and this to promote 
conservative therapeutic management.
Patients and methods In this retrospective clinical study over a 
period of 3  years (May 2013–May 2016), patients admitted to the 
intensive care surgical emergencies Ibn Rochd CHU Casablanca for 
serious liver injury were evaluated on specific criteria for inclusion 
and exclusion in using a pre-established operating profile including 
epidemiological, clinical, biological, radiological and therapeutic 
findings with a significance level set at 5%.
Results After this study, 23 patients were compiled. 19 patients were 
male and 4 female, mean ages was 34 ± 11.7 years with a range from 
17 to 58, the etiologies were dominated by accidents of the high way 
followed by assaults and finally fall from heights.
An unstable hemodynamic status was initially found in 6 cases (26%) 
and the use of vasoconstrictor was necessary in 18 patients (78.2%).
Ultra sonography was performed in 16 patients (69.5%) and objectified 
isolated hem peritoneum or associated with visceral lesions in all 
patients.
Abdominal CT scan was performed to 20 patients (87%) objectifying in 
10 cases (50%) different findings with those of ultrasound.
An emergency surgery was raised in 15 cases and delayed surgery was 
indicated in 3 patients.
Mortality in our study was 39.13% where hemorrhagic shock presents 
the leading cause. The prognosis was closely linked to the value of sys-
tolic blood pressure at admission, the SPO2, the Glasgow coma scale, 
haemoglobin value, the presence of hem peritoneum of great abun-
dance and whether or not a use of vasoconstrictors.
Conclusion The development of imaging techniques in emergency, 
especially FAST ultrasound and computerized tomography scan, 
have modified diagnostic and therapeutic attitude in severe liver I 
jury over the last years. The yellow a conservative approach based 
on the stability of the hemodynamic status and the response to new 
resuscitation techniques, this approach requires strict supervision and 
Page 104 of 104  Ann. Intensive Care 2017, 7(Suppl 1):8
involves a multidisciplinary team (intensivist, surgeon and radiologist) 
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Introduction Early burn resuscitation of major burn-injured patients 
is the cornerstones of burn care and aims to improve outcome and 
decreases morbidity and mortality rates of these patients. So, initial 
care of severely burned patients requires participation of all physians 
in every discipline and in every hospital. The goal of this study was 
to examine characteristics of burn patients acutely transferred to our 
intensive burn care unit and to assess their prognosis.
Patients and methods A prospective study was conducted in inten-
sive burn care center in Tunis. All consecutive adult burned patients 
acutely transferred to our burn center, from January 1st to September 
23st, 2016 were included in the study. Demograhic, clinical and bio-
logical data of patients were recorded.
Results During the 9  month study period, 190 patients were admitted 
among which 101 patients were acutely transferred from other hospitals 
(53%). The mean age was 37 ± 15 years. The mean surface burned area 
announced was 44  ±  22 versus 36  ±  22% reevaluated at admission. 
Patients were transferred with a delay of 40 H after burns [H1–H264]. Burn 
injuries were caused by domestic accidents in 42%, self immolation in 
26% and work related burns in 14%. Transfer with medical agreement was 
noted in 57% of cases. At admission, 12% of patients had burn shock and 
43% had endotracheal intubation. A central venous cathter was placed 
in 51% of cases, nasogastric tubes in 11% and urinary devices in 55% of 
cases. Dressing were performed in 66% of cases. Fluid resuscitation was 
initiated in 74% of cases with crystalloid: Ringer lactate (42%) and/or nor-
mal saline (19%). Initial lactate of patients was 3.36 ±  1.7  mmol [1–8.8] 
with pH at 7.33 [6.6–7.51] and bicarbonates at 20 ± 5 [9–34]. We noted 
that patients transferred without medical agreement had more burn 
shock (16.2 vs 8.6%) and a higher mortality (25.5 vs 17.2%).
Conclusion Early critical care of severely burned patients, especially, 
fluid resuscitation and monitoring, coupled with appropriate early 
referral to a specialist, greatly help in minimizing complications and 
optimizing prognosis.
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